0000310764-20-000069.txt : 20200501 0000310764-20-000069.hdr.sgml : 20200501 20200501164910 ACCESSION NUMBER: 0000310764-20-000069 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 64 CONFORMED PERIOD OF REPORT: 20200331 FILED AS OF DATE: 20200501 DATE AS OF CHANGE: 20200501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: STRYKER CORP CENTRAL INDEX KEY: 0000310764 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 381239739 STATE OF INCORPORATION: MI FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-13149 FILM NUMBER: 20841521 BUSINESS ADDRESS: STREET 1: 2825 AIRVIEW BLVD CITY: KALAMAZOO STATE: MI ZIP: 49002 BUSINESS PHONE: 2693892600 MAIL ADDRESS: STREET 1: 2825 AIRVIEW BLVD CITY: KALAMAZOO STATE: MI ZIP: 49002 10-Q 1 syk10q3312020.htm 10-Q Document
false--12-31Q120200000310764880000001000000000.10.1 0000310764 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.125Due2027Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes1.125Due2021Member 2020-01-01 2020-03-31 0000310764 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.625Due2030Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotesVariableInterestRateDueNovember2020Member 2020-01-01 2020-03-31 0000310764 2020-03-31 0000310764 2019-01-01 2019-03-31 0000310764 2019-12-31 0000310764 us-gaap:NoncontrollingInterestMember 2020-03-31 0000310764 us-gaap:RetainedEarningsMember 2019-03-31 0000310764 us-gaap:CommonStockMember 2018-12-31 0000310764 us-gaap:RetainedEarningsMember 2018-12-31 0000310764 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000310764 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000310764 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000310764 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000310764 us-gaap:CommonStockMember 2019-03-31 0000310764 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0000310764 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000310764 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000310764 us-gaap:CommonStockMember 2020-03-31 0000310764 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000310764 us-gaap:CommonStockMember 2019-12-31 0000310764 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000310764 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000310764 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000310764 us-gaap:NoncontrollingInterestMember 2019-03-31 0000310764 2019-03-31 0000310764 us-gaap:RetainedEarningsMember 2020-03-31 0000310764 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000310764 us-gaap:RetainedEarningsMember 2019-12-31 0000310764 us-gaap:ParentMember 2020-03-31 0000310764 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000310764 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000310764 us-gaap:ParentMember 2019-03-31 0000310764 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000310764 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000310764 2018-12-31 0000310764 syk:NeurotechnologyMember us-gaap:NonUsMember syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 syk:NeurotechnologyMember country:US syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 syk:SustainabilityMember us-gaap:NonUsMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 us-gaap:NonUsMember syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 us-gaap:NonUsMember syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 country:US syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:InstrumentsMember us-gaap:NonUsMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:SpineMember country:US syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 country:US syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:OtherOrthopaedicsDomain country:US syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:InstrumentsMember country:US syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:MedicalMember us-gaap:NonUsMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:KneesMember us-gaap:NonUsMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:TraumaandExtremitiesMember country:US syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:HipsMember us-gaap:NonUsMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:KneesMember country:US syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:SpineMember us-gaap:NonUsMember syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 syk:OtherOrthopaedicsDomain country:US syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:InstrumentsMember us-gaap:NonUsMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:EndoscopyMember country:US syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 country:US syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 syk:EndoscopyMember us-gaap:NonUsMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:EndoscopyMember us-gaap:NonUsMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 country:US syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:SustainabilityMember us-gaap:NonUsMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:KneesMember us-gaap:NonUsMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 us-gaap:NonUsMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:TraumaandExtremitiesMember country:US syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:SpineMember country:US syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 syk:SpineMember us-gaap:NonUsMember syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 syk:InstrumentsMember country:US syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 country:US syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:MedicalMember country:US syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 us-gaap:NonUsMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 us-gaap:NonUsMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 country:US 2019-01-01 2019-03-31 0000310764 country:US 2020-01-01 2020-03-31 0000310764 us-gaap:NonUsMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:OtherOrthopaedicsDomain us-gaap:NonUsMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:EndoscopyMember country:US syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:HipsMember country:US syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 country:US syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 syk:NeurotechnologyMember country:US syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 syk:NeurotechnologyMember us-gaap:NonUsMember syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 syk:HipsMember us-gaap:NonUsMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 us-gaap:NonUsMember 2020-01-01 2020-03-31 0000310764 syk:MedicalMember us-gaap:NonUsMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 us-gaap:NonUsMember 2019-01-01 2019-03-31 0000310764 syk:OtherOrthopaedicsDomain us-gaap:NonUsMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:SustainabilityMember country:US syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:MedicalMember country:US syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:HipsMember country:US syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:TraumaandExtremitiesMember us-gaap:NonUsMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:KneesMember country:US syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:TraumaandExtremitiesMember us-gaap:NonUsMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:SustainabilityMember country:US syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:HipsMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:HipsMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:EndoscopyMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:OtherOrthopaedicsDomain syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:TraumaandExtremitiesMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:SpineMember syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 syk:SustainabilityMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 syk:EndoscopyMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:InstrumentsMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:NeurotechnologyMember syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 syk:MedicalMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:MedicalMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:KneesMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 syk:InstrumentsMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:TraumaandExtremitiesMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:SustainabilityMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:KneesMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:SpineMember syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 syk:OtherOrthopaedicsDomain syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:NeurotechnologyMember syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-03-31 0000310764 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-03-31 0000310764 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000310764 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-03-31 0000310764 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000310764 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000310764 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0000310764 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000310764 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000310764 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000310764 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-03-31 0000310764 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0000310764 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0000310764 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000310764 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-03-31 0000310764 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0000310764 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-31 0000310764 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-03-31 0000310764 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-03-31 0000310764 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0000310764 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-31 0000310764 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0000310764 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-03-31 0000310764 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0000310764 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember 2019-01-01 2019-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-03-31 0000310764 us-gaap:NetInvestmentHedgingMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember 2020-01-01 2020-03-31 0000310764 us-gaap:NetInvestmentHedgingMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000310764 us-gaap:ForeignExchangeContractMember 2019-01-01 2019-12-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:ForeignExchangeContractMember 2019-12-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000310764 us-gaap:AccruedLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000310764 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-11-30 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-07-31 0000310764 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-11-30 0000310764 us-gaap:FairValueInputsLevel2Member 2019-12-31 0000310764 us-gaap:FairValueInputsLevel3Member 2020-03-31 0000310764 us-gaap:FairValueInputsLevel3Member 2019-12-31 0000310764 us-gaap:FairValueInputsLevel3Member 2020-01-01 2020-03-31 0000310764 us-gaap:FairValueInputsLevel2Member 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member 2020-03-31 0000310764 us-gaap:FairValueInputsLevel1Member 2019-12-31 0000310764 us-gaap:FairValueInputsLevel1Member 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000310764 us-gaap:FairValueInputsLevel3Member 2018-12-31 0000310764 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000310764 us-gaap:FairValueInputsLevel3Member 2019-01-01 2019-12-31 0000310764 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2020-03-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:CertificatesOfDepositMember 2020-03-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:USTreasurySecuritiesMember 2020-03-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:CertificatesOfDepositMember 2019-12-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:USTreasurySecuritiesMember 2019-12-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember 2020-03-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2020-03-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember 2019-12-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:AssetBackedSecuritiesMember 2020-03-31 0000310764 srt:MinimumMember 2020-03-31 0000310764 srt:MaximumMember 2020-03-31 0000310764 2019-01-01 2019-12-31 0000310764 syk:WrightMember 2019-12-13 2019-12-13 0000310764 syk:WrightMember 2019-11-01 2019-11-30 0000310764 syk:MobiusMember 2019-10-01 2019-10-31 0000310764 syk:OrthoSpaceLtd.Member 2019-03-01 2019-03-31 0000310764 syk:OrthoSpaceLtd.Member 2019-12-31 0000310764 syk:OrthoSpaceLtd.Member us-gaap:DevelopedTechnologyRightsMember 2019-12-31 0000310764 syk:MobiusMember 2019-12-31 0000310764 syk:MobiusMember 2019-01-01 2019-12-31 0000310764 syk:MobiusMember us-gaap:DevelopedTechnologyRightsMember 2019-12-31 0000310764 syk:OrthoSpaceLtd.Member us-gaap:CustomerRelationshipsMember 2019-12-31 0000310764 syk:MobiusMember us-gaap:NoncompeteAgreementsMember 2019-12-31 0000310764 syk:OrthoSpaceLtd.Member 2019-01-01 2019-12-31 0000310764 syk:MobiusMember syk:InternallyDevelopedSoftwareMember 2019-12-31 0000310764 syk:OrthoSpaceLtd.Member us-gaap:NoncompeteAgreementsMember 2019-12-31 0000310764 syk:MobiusMember us-gaap:CustomerRelationshipsMember 2019-12-31 0000310764 syk:OrthoSpaceLtd.Member syk:InternallyDevelopedSoftwareMember 2019-12-31 0000310764 us-gaap:RevolvingCreditFacilityMember 2020-03-31 0000310764 us-gaap:RevolvingCreditFacilityMember syk:CreditAgreementMember us-gaap:SubsequentEventMember 2020-04-30 0000310764 us-gaap:CommercialPaperMember 2020-01-01 2020-03-31 0000310764 us-gaap:RevolvingCreditFacilityMember syk:CreditAgreementMember us-gaap:SubsequentEventMember 2020-04-30 2020-04-30 0000310764 syk:SeniorUnsecuredNotes4375Due2020Member 2020-01-31 0000310764 us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember 2020-04-30 0000310764 srt:MaximumMember us-gaap:CommercialPaperMember 2020-03-31 0000310764 syk:SeniorUnsecuredNotes1.125Due2021Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.375due2025MemberMember 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.375due2024Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes0.750due2029Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotesVariableInterestRateDueNovember2020Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.625due2021MemberDomain 2019-12-31 0000310764 syk:SeniorUnsecuredNotes4.625due2046MemberDomainDomain 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.125Due2027Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes2.625Due2030Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes410Due2043Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes1.125Due2021Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes1.000due2031Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.50due2026MemberDomain 2020-03-31 0000310764 syk:SeniorUnsecuredNotes4375Due2020Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes4.375due2044Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.625due2021MemberDomain 2020-03-31 0000310764 syk:SeniorUnsecuredNotes0.250due2024Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes3.650due2028Domain 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes1.125Due2021Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotesVariableInterestRateDueNovember2020Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes4.625due2046MemberDomainDomain 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes410Due2043Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.650due2028Domain 2019-12-31 0000310764 syk:SeniorUnsecuredNotes410Due2043Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes2.125Due2027Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.625Due2030Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes4.625due2046MemberDomainDomain 2019-12-31 0000310764 syk:SeniorUnsecuredNotes3.375due2025MemberMember 2019-12-31 0000310764 syk:SeniorUnsecuredNotes0.250due2024Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes4375Due2020Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes3.375due2024Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes0.750due2029Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotesVariableInterestRateDueNovember2020Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes0.250due2024Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes4.375due2044Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes1.000due2031Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes3.375due2025MemberMember 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.125Due2027Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes1.000due2031Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.625Due2030Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes0.750due2029Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.650due2028Domain 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.50due2026MemberDomain 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.375due2024Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.625due2021MemberDomain 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.50due2026MemberDomain 2019-12-31 0000310764 syk:SeniorUnsecuredNotes4375Due2020Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes4.375due2044Member 2020-01-01 2020-03-31 0000310764 us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-03-31 0000310764 us-gaap:MaterialReconcilingItemsMember 2020-01-01 2020-03-31 0000310764 us-gaap:OperatingSegmentsMember syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-03-31 0000310764 us-gaap:OperatingSegmentsMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 us-gaap:OperatingSegmentsMember syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-03-31 0000310764 us-gaap:OperatingSegmentsMember 2019-01-01 2019-03-31 0000310764 us-gaap:OperatingSegmentsMember 2020-01-01 2020-03-31 0000310764 us-gaap:OperatingSegmentsMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 us-gaap:OperatingSegmentsMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 us-gaap:OperatingSegmentsMember syk:MedsurgMember 2019-01-01 2019-03-31 xbrli:pure iso4217:EUR utreg:Rate iso4217:EUR xbrli:shares xbrli:shares iso4217:USD iso4217:USD xbrli:shares


 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 

FORM 10-Q
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2020
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission file number: 001-13149
strykerlogoa74.jpg
STRYKER CORPORATION
(Exact name of registrant as specified in its charter)
Michigan
 
 
 
 
 
38-1239739
(State of incorporation)
 
 
 
 
 
(I.R.S. Employer Identification No.)
 
 
 
 
 
 
 
 
2825 Airview Boulevard
 Kalamazoo,
Michigan
 
49002
(Address of principal executive offices)
 
(Zip Code)
 
 
 
 
 
 
 
 
 
 
(269)
385-2600
 
 
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $.10 Par Value
SYK
New York Stock Exchange
1.125% Notes due 2023
SYK23
New York Stock Exchange
0.250% Notes due 2024
SYK24A
New York Stock Exchange
2.125% Notes due 2027
SYK27
New York Stock Exchange
0.750% Notes due 2029
SYK29
New York Stock Exchange
2.625% Notes due 2030
SYK30
New York Stock Exchange
1.000% Notes due 2031
SYK31
New York Stock Exchange
Floating Rate Notes due 2020
SYK20A
New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒    No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes ☒    No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer
☒
 
Accelerated filer
☐
 
Emerging growth company
☐
Non-accelerated filer
☐
 
Small reporting company
☐
 
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes ☐    No ☒
There were 375,378,477 shares of Common Stock, $0.10 par value, on March 31, 2020.
 

STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

PART I – FINANCIAL INFORMATION
ITEM 1.
FINANCIAL STATEMENTS
Stryker Corporation and Subsidiaries
CONSOLIDATED STATEMENTS OF EARNINGS (Unaudited)
 
Three Months

2020
 
2019
Net sales
$
3,588

 
$
3,516

Cost of sales
1,257

 
1,233

Gross profit
$
2,331

 
$
2,283

Research, development and engineering expenses
254

 
225

Selling, general and administrative expenses
1,330

 
1,403

Recall charges
(6
)
 
13

Amortization of intangible assets
118

 
114

Total operating expenses
$
1,696

 
$
1,755

Operating income
$
635

 
$
528

Other income (expense), net
(45
)
 
(48
)
Earnings before income taxes
$
590

 
$
480

Income taxes
97

 
68

Net earnings
$
493

 
$
412

 
 
 
 
Net earnings per share of common stock:
 
 
 
Basic
$
1.32

 
$
1.10

Diluted
$
1.30

 
$
1.09

 
 
 
 
Weighted-average shares outstanding (in millions):
 
 
 
Basic
374.8

 
373.3

Effect of dilutive employee stock compensation
4.9

 
6.0

Diluted
379.7

 
379.3

 
 
 
 
Cash dividends declared per share of common stock
$
0.575

 
$
0.52

Anti-dilutive shares excluded from the calculation of dilutive employee stock options were de minimis in all periods.


CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
 
Three Months
 
2020
 
2019
Net earnings
$
493

 
$
412

Other comprehensive income (loss), net of tax:
 
 
 
Marketable securities
—

 
1

Pension plans
(4
)
 
(4
)
Unrealized gains (losses) on designated hedges
(26
)
 
(16
)
Financial statement translation
13

 
85

Total other comprehensive income (loss), net of tax
$
(17
)
 
$
66

Comprehensive income
$
476

 
$
478


See accompanying notes to Consolidated Financial Statements.

Dollar amounts are in millions except per share amounts or as otherwise specified.
1
STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

CONSOLIDATED BALANCE SHEETS
 
March 31
 
December 31
 
2020
 
2019
 
(Unaudited)
 
 
Assets
 
 
 
Current assets
 
 
 
Cash and cash equivalents
$
3,964

 
$
4,337

Marketable securities
84

 
88

Accounts receivable, less allowance of $100 ($88 in 2019)
2,646

 
2,893

Inventories:
 
 
 
Materials and supplies
738

 
677

Work in process
187

 
178

Finished goods
2,434

 
2,427

Total inventories
$
3,359

 
$
3,282

Prepaid expenses and other current assets
683

 
760

Total current assets
$
10,736

 
$
11,360

Property, plant and equipment:
 
 
 
Land, buildings and improvements
1,419

 
1,263

Machinery and equipment
3,357

 
3,451

Total property, plant and equipment
$
4,776

 
$
4,714

Less accumulated depreciation
2,169

 
2,147

Property, plant and equipment, net
$
2,607

 
$
2,567

Goodwill
9,025

 
9,069

Other intangibles, net
4,107

 
4,227

Noncurrent deferred income tax assets
1,537

 
1,575

Other noncurrent assets
1,428

 
1,369

Total assets
$
29,440

 
$
30,167

 
 
 
 
Liabilities and shareholders' equity

 
 
Current liabilities
 
 
 
Accounts payable
$
736

 
$
675

Accrued compensation
430

 
955

Income taxes
227

 
171

Dividends payable
216

 
213

Accrued expenses and other liabilities
1,450

 
1,527

Current maturities of debt
1,103

 
859

Total current liabilities
$
4,162

 
$
4,400

Long-term debt, excluding current maturities
9,404

 
10,231

Income taxes
1,026

 
1,068

Other noncurrent liabilities
1,733

 
1,661

Total liabilities
$
16,325

 
$
17,360

Shareholders' equity
 
 
 
Common stock, $0.10 par value
38

 
37

Additional paid-in capital
1,676

 
1,628

Retained earnings
12,024

 
11,748

Accumulated other comprehensive loss
(623
)
 
(606
)
Total shareholders' equity
$
13,115

 
$
12,807

Total liabilities and shareholders' equity
$
29,440

 
$
30,167


See accompanying notes to Consolidated Financial Statements.

Dollar amounts are in millions except per share amounts or as otherwise specified.
2
STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited)
 
Three Months
 
2020
 
2019
Common stock shares outstanding (in millions)
 
 
 
Beginning
374.5

 
374.4

Issuance of common stock under stock compensation and benefit plans
0.9

 
1.3

Repurchase of common stock
—

 
(1.9
)
Ending
375.4

 
373.8

 
 
 
 
Common stock
 
 
 
Beginning
$
37

 
$
37

Issuance of common stock under stock compensation and benefit plans
1

 
—

Ending
$
38

 
$
37

Additional paid-in capital
 
 
 
Beginning
$
1,628

 
$
1,559

Issuance of common stock under stock compensation and benefit plans
(8
)
 
(48
)
Repurchase of common stock
—

 
(8
)
Share-based compensation
56

 
35

Ending
$
1,676

 
$
1,538

Retained earnings
 
 
 
Beginning
$
11,748

 
$
10,765

Net earnings
493

 
412

Repurchase of common stock
—

 
(299
)
Cash dividends declared
(217
)
 
(195
)
Ending
$
12,024

 
$
10,683

Accumulated other comprehensive (loss) income
 
 
 
Beginning
$
(606
)
 
$
(631
)
Other comprehensive income (loss)
(17
)
 
66

Ending
$
(623
)
 
$
(565
)
Total Stryker shareholders' equity
$
13,115

 
$
11,693

Non-controlling interest
—

 
—

Total shareholders' equity
$
13,115

 
$
11,693


See accompanying notes to Consolidated Financial Statements.

Dollar amounts are in millions except per share amounts or as otherwise specified.
3
STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
 
Three Months
 
2020
 
2019
Operating activities
 
 
 
Net earnings
$
493

 
$
412

Adjustments to reconcile net earnings to net cash provided by operating activities:
 
 
 
Depreciation
80

 
76

Amortization of intangible assets
118

 
114

Share-based compensation
56

 
35

Recall charges
(6
)
 
13

Sale of inventory stepped-up to fair value at acquisition
6

 
24

Changes in operating assets and liabilities:
 
 
 
Accounts receivable
204

 
50

Inventories
(122
)
 
(139
)
Accounts payable
63

 
(12
)
Accrued expenses and other liabilities
(550
)
 
(166
)
Recall-related payments
(4
)
 
(20
)
Income taxes
84

 
9

Other, net
169

 
(83
)
Net cash provided by operating activities
$
591

 
$
313

Investing activities
 
 
 
Acquisitions, net of cash acquired
(23
)
 
(180
)
Purchases of marketable securities
(8
)
 
(20
)
Proceeds from sales of marketable securities
12

 
19

Purchases of property, plant and equipment
(144
)
 
(122
)
Net cash used in investing activities
$
(163
)
 
$
(303
)
Financing activities
 
 
 
Proceeds (payments) on short-term borrowings, net
4

 
(12
)
Payments on long-term debt
(500
)
 
(1,341
)
Dividends paid
(215
)
 
(195
)
Repurchases of common stock
—

 
(307
)
Cash paid for taxes from withheld shares
(56
)
 
(97
)
Other financing, net
(1
)
 
5

Net cash provided by (used in) financing activities
$
(768
)
 
$
(1,947
)
Effect of exchange rate changes on cash and cash equivalents
(33
)
 
(5
)
Change in cash and cash equivalents
$
(373
)
 
$
(1,942
)
Cash and cash equivalents at beginning of period
4,337

 
3,616

Cash and cash equivalents at end of period
$
3,964

 
$
1,674


See accompanying notes to Consolidated Financial Statements.

Dollar amounts are in millions except per share amounts or as otherwise specified.
4
STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)
NOTE 1 - BASIS OF PRESENTATION
General Information
Management believes the accompanying unaudited Consolidated Financial Statements contain all adjustments, including normal recurring items, considered necessary to fairly present the financial position of Stryker Corporation and its consolidated subsidiaries (the "Company," "we," us" or "our") on March 31, 2020 and the results of operations for the three months 2020. The results of operations included in these Consolidated Financial Statements may not necessarily be indicative of our annual results. These statements should be read in conjunction with our Annual Report on Form 10-K for 2019.
Certain prior year amounts have been reclassified to conform with current year presentation of segment results.
New Accounting Pronouncements Not Yet Adopted
We evaluate all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB) for consideration of their applicability. ASUs not included in our disclosures were assessed and determined to be either not applicable or are not expected to have a material impact on our Consolidated Financial Statements.
Accounting Pronouncements Recently Adopted
On January 1, 2020 we adopted ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard replaces the incurred loss impairment methodology with a methodology that reflects expected credit losses for accounts receivables, loans and other financial instruments. The adoption of this update did not have a material impact on our Consolidated Financial Statements.
NOTE 2 - REVENUE RECOGNITION
Our policies for recognizing sales have not changed from those described in our Annual Report on Form 10-K for 2019.
We disaggregate our net sales by product line and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.
Net Sales by Product Line
 
 
 
Three Months
 
2020
2019
Orthopaedics:
 
 
Knees
$
432

$
439

Hips
316

336

Trauma and Extremities
392

396

Other
82

79

 
$
1,222

$
1,250

MedSurg:
 
 
Instruments
$
513

$
461

Endoscopy
455

470

Medical
587

531

Sustainability
67

65

 
$
1,622

$
1,527

Neurotechnology and Spine:
 
 
Neurotechnology
$
483

$
469

Spine
261

270

 
$
744

$
739

Total
$
3,588

$
3,516

 
Net Sales by Geography
 
 
 
 
 
 
Three Months 2020
 
Three Months 2019
 
United States
International
 
United States
International
Orthopaedics:
 
 
 
 
 
Knees
$
322

$
110

 
$
320

$
119

Hips
201

115

 
213

123

Trauma and Extremities
260

132

 
254

142

Other
69

13

 
63

16

 
$
852

$
370

 
$
850

$
400

MedSurg:
 
 
 
 
 
Instruments
$
410

$
103

 
$
365

$
96

Endoscopy
364

91

 
376

94

Medical
454

133

 
416

115

Sustainability
66

1

 
64

1

 
$
1,294

$
328

 
$
1,221

$
306

Neurotechnology and Spine:
 
 
 
 
 
Neurotechnology
$
301

$
182

 
$
300

$
169

Spine
196

65

 
208

62

 
$
497

$
247

 
$
508

$
231

Total
$
2,643

$
945

 
$
2,579

$
937

Contract Assets and Liabilities
On March 31, 2020 there were no contract assets recorded on our Consolidated Balance Sheets.
Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. We generally satisfy performance obligations within one year from the contract inception date. Our contract liabilities were $361 and $313 on March 31, 2020 and December 31, 2019.
NOTE 3 - ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME (AOCI)
Three Months 2020
Marketable Securities
Pension Plans
Hedges
Financial Statement Translation
Total
Beginning
$
(3
)
$
(179
)
$
47

$
(471
)
$
(606
)
OCI
1

(6
)
(39
)
55

11

Income taxes
—

—

11

(37
)
(26
)
Reclassifications to:
 
 
 
 
 
Cost of sales
—

—

3

—

3

Other (income) expense
(1
)
3

(1
)
(7
)
(6
)
Income taxes
—

(1
)
—

2

1

Net OCI
$
—

$
(4
)
$
(26
)
$
13

$
(17
)
Ending
$
(3
)
$
(183
)
$
21

$
(458
)
$
(623
)

Three Months 2019
Marketable Securities
Pension Plans
Hedges
Financial Statement Translation
Total
Beginning
$
(4
)
$
(137
)
$
50

$
(540
)
$
(631
)
OCI
1

(6
)
(19
)
94

70

Income taxes
—

1

6

(9
)
(2
)
Reclassifications to:
 
 
 
 
 
Cost of sales
—

—

(2
)
—

(2
)
Other (income) expense
—

1

—

—

1

Income taxes
—

—

(1
)
—

(1
)
Net OCI
$
1

$
(4
)
$
(16
)
$
85

$
66

Ending
$
(3
)
$
(141
)
$
34

$
(455
)
$
(565
)


Dollar amounts are in millions except per share amounts or as otherwise specified.
5
STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

NOTE 4 - DERIVATIVE INSTRUMENTS
We use operational and economic hedges, foreign currency exchange forward contracts, net investment hedges (both derivative and non-derivative financial instruments) and interest rate derivative instruments to manage the impact of currency exchange and interest rate fluctuations on earnings, cash flow and equity. We do not enter into derivative instruments for speculative purposes. We are exposed to potential credit loss in the event of nonperformance by our counterparties on our outstanding derivative instruments but do not anticipate nonperformance by any of our counterparties. Should a counterparty default, our maximum loss exposure is the asset balance of the instrument. We have not changed our hedging strategies, accounting practices or objectives from those disclosed in our Annual Report on Form 10-K for 2019.
Foreign Currency Hedges
March 2020
Cash Flow
Net Investment
Non-Designated
Total
Gross notional amount
$
837

$
1,094

$
5,275

$
7,206

Maximum term in days
 
 
 
1555

Fair value:
 
 
 
 
Other current assets
$
30

$
—

$
100

$
130

Other noncurrent assets
5

105

—

110

Other current liabilities
(2
)
—

(27
)
(29
)
Other noncurrent liabilities
—

—

—

—

Total fair value
$
33

$
105

$
73

$
211


December 2019
Cash Flow
Net Investment
Non-Designated
Total
Gross notional amount
$
801

$
1,113

$
6,174

$
8,088

Maximum term in days
 
 
 
1646

Fair value:
 
 
 
 
Other current assets
$
5

$
—

$
180

$
185

Other noncurrent assets
1

40

—

41

Other current liabilities
(10
)
—

(11
)
(21
)
Other noncurrent liabilities
(2
)
—

—

(2
)
Total fair value
$
(6
)
$
40

$
169

$
203


In December 2019 and November 2018 we designated the issuance of €2,400 and €2,250 of senior unsecured notes as net investment hedges to selectively hedge portions of our investment in certain international subsidiaries. The currency effects of our euro-denominated senior unsecured notes are reflected in AOCI within shareholders' equity where they offset gains and losses recorded on our net investment in international subsidiaries. On March 31, 2020 the total after tax gain amount in AOCI related to these designated net investment hedges was $83.
In July 2019 we entered into €1.0 billion in certain forward currency contracts and designated these as net investment hedges to hedge a portion of our investments in certain of our entities with functional currencies denominated in Euros.
Net Currency Exchange Rate Gains (Losses)
 
 
Three Months
Derivative instrument
Recorded in:
2020
2019
Cash Flow
Cost of sales
$
(3
)
$
2

Net Investment
Other income (expense), net
7

—

Non-Designated
Other income (expense), net
(7
)
(2
)
 
Total
$
(3
)
$
—


 
Pretax gains (losses) on derivatives designated as cash flow of $26 and net investment hedges of $27 recorded in AOCI are expected to be reclassified to cost of sales and other income (expense) in earnings within 12 months as of March 31, 2020. This cash flow hedge reclassification is primarily due to the sale of inventory that includes previously hedged purchases. A component of the AOCI amounts related to net investment hedges is reclassified over the life of the hedge instruments as we elected to exclude the initial value of the component related to the spot-forward difference from the effectiveness assessment.
Interest Rate Hedges
In conjunction with our offering of senior unsecured notes in November 2019 we terminated cash flow hedges with gross notional amounts of €600 designated as forward starting interest rate swaps of our interest rates, the impact of which will be recognized over time as a benefit within interest expense. Pretax gains recorded in AOCI related to closed interest rate hedges of $6 are expected to be reclassified to other income (expense) in earnings within 12 months of March 31, 2020.
On March 31, 2020 we had interest rate swap agreements with notional amounts of $750 designated as forward starting interest rate swaps in anticipation of future debt issuances. Pretax losses of $62 were recorded in AOCI as of March 31, 2020. Upon the probable issuance of the debt, these amounts will be released to interest expense over the term of the debt. The cash flow effect of these hedges is recorded in cash flow from operations.
NOTE 5 - FAIR VALUE MEASUREMENTS
Our policies for managing risk related to foreign currency, interest rates, credit and markets and our process for determining fair value have not changed from those described in our Annual Report on Form 10-K for 2019.
There were no significant transfers into or out of any level in 2020.
Assets Measured at Fair Value
March
December
2020
2019
Cash and cash equivalents
$
3,964

$
4,337

Trading marketable securities
127

149

Level 1 - Assets
$
4,091

$
4,486

Available-for-sale marketable securities:
 
 
Corporate and asset-backed debt securities
$
32

$
32

United States agency debt securities
3

2

United States Treasury debt securities
45

49

Certificates of deposit
4

5

Total available-for-sale marketable securities
$
84

$
88

Foreign currency exchange forward contracts
240

226

Interest rate swap asset
—

17

Level 2 - Assets
$
324

$
331

Total assets measured at fair value
$
4,415

$
4,817


Liabilities Measured at Fair Value
March
December
2020
2019
Deferred compensation arrangements
$
127

$
149

Level 1 - Liabilities
$
127

$
149

Foreign currency exchange forward contracts
$
29

$
23

Interest rate swap liability
62

—

Level 2 - Liabilities
$
91

$
23

Contingent consideration:
 
 
Beginning
$
306

$
117

Additions
—

298

Change in estimate
—

(10
)
Settlements
—

(99
)
Ending
$
306

$
306

Level 3 - Liabilities
$
306

$
306

Total liabilities measured at fair value
$
524

$
478



Dollar amounts are in millions except per share amounts or as otherwise specified.
6
STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

Fair Value of Available for Sale Securities by Maturity
 
March 2020
December 2019
Due in one year or less
$
46

$
50

Due after one year through three years
$
38

$
38


On March 31, 2020 and December 31, 2019 the aggregate difference between the cost and fair value of available-for-sale marketable securities was nominal. Interest and marketable securities income recorded in other income (expense), net, was $40 and $39 in the three months 2020 and 2019.
Our investments in available-for-sale marketable securities had a minimum credit quality rating of A2 (Moody's), A (Standard & Poor's) and A (Fitch). We do not plan to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis, which may be maturity.
NOTE 6 - CONTINGENCIES AND COMMITMENTS
We are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor, intellectual property and other matters that are more fully described below. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings, the claimants seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect future operating results. We are self-insured for product liability claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.
Recall Matters
In June 2012 we voluntarily recalled our Rejuvenate and ABG II Modular-Neck hip stems and terminated global distribution of these hip products. Product liability lawsuits relating to this voluntary recall have been filed against us. In November 2014 we entered into a settlement agreement to compensate eligible United States patients who had revision surgery prior to November 3, 2014 and in December 2016 the settlement program was extended to patients who had revision surgery prior to December 19, 2016. We continue to offer support for recall-related care and reimburse patients who are not eligible to enroll in the settlement program for testing and treatment services, including any necessary revision surgeries. In addition, there are remaining lawsuits that we will continue to defend against.
In August 2016 and May 2018 we voluntarily recalled certain lot-specific sizes and offsets of LFIT Anatomic CoCr V40 Femoral Heads. Product liability lawsuits and claims relating to this voluntary recall have been filed against us. In November 2018 we entered into a settlement agreement to resolve a significant number of claims and lawsuits related to the recalls. The specific terms of the settlement agreement, including the financial terms, are confidential.
We have incurred, and expect to incur in the future, costs associated with the defense and settlement of these matters. Based on the
 
information that has been received, we have estimated the remaining range of probable loss related to these matters globally to be approximately $290 to $535. We have recorded charges to earnings representing the minimum of the range of probable loss. The final outcomes of these matters are dependent on many factors that are difficult to predict. Accordingly, the ultimate cost related to these matters globally may be materially different than the amount of our current estimate and accruals and could have a material adverse effect on our results of operations and cash flows.
Leases
March
 
December
2020
 
2019
Right-of-use assets
$
393

 
$
384

Lease liabilities, current
$
89

 
$
86

Lease liabilities, non-current
$
306

 
$
301

 
 
 
 
Other information
 
 
 
Weighted-average remaining lease term
5.9 years

 
6.2 years

Weighted-average discount rate
3.09
%
 
3.34
%
 
Three Months
 
2020
 
2019
Operating lease cost
$
36

 
34


NOTE 7 - ACQUISITIONS
We acquire stock in companies and various assets that continue to support our capital deployment and product development strategies. The aggregate purchase price of our acquisitions, net of cash acquired was $23 and $308 in the three months 2020 and 2019.
In October 2019 we completed the acquisition of Mobius Imaging and Cardan Robotics for net cash consideration of $360 and future regulatory and commercial milestone payments of up to $130. Mobius Imaging is a leader in point-of-care imaging technology focused on integrating advanced imaging technologies into medical workflow. Cardan Robotics is working to develop innovative robotics and navigation technology systems for surgical and interventional radiology procedures. Mobius Imaging and Cardan Robotics (Mobius) are part of our Spine business within Neurotechnology and Spine. For income tax purposes the acquisition was treated as an asset purchase. Goodwill attributable to the acquisition is deductible for tax purposes.
In March 2019 we completed the acquisition of OrthoSpace, Ltd. (OrthoSpace) for net cash consideration of $110 and future regulatory milestone payments of up to $110. OrthoSpace is a medical device company specializing in orthopaedic biodegradable technology for the treatment of irreparable rotator cuff tears. OrthoSpace is part of our Endoscopy business within MedSurg. Goodwill attributable to the acquisition is not deductible for tax purposes.
In November 2019 we announced a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. (Wright) for $30.75 per share, or an aggregate purchase price of approximately $5.4 billion (including convertible notes). Pursuant to the agreement, on December 13, 2019 our wholly owned subsidiary, Stryker B.V., commenced a tender offer to purchase all of the outstanding ordinary shares, par value €0.03 per share, of Wright at a price of $30.75 per share, without interest, but subject to any applicable withholding of taxes. We expect the acquisition to close in the second half of 2020, subject to the expiration of the waiting period (and any extension thereof) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the receipt of other required approvals and clearances under applicable antitrust laws and other customary conditions. Wright is a global medical device company focused on extremities and biologics. Following closing, we plan to integrate

Dollar amounts are in millions except per share amounts or as otherwise specified.
7
STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

Wright into our Trauma and Extremities business within Orthopaedics.
Purchase price allocations for our significant acquisitions are presented below:
Purchase Price Allocation of Acquired Net Assets
 
2019
 
Mobius
 
OrthoSpace
Tangible assets:
 
 
 
Accounts receivable
$
3

 
$
1

Inventory
6

 
1

Other assets
2

 
1

Contingent consideration
(4
)
 
—

Other liabilities
(10
)
 
(29
)
Intangible assets:
 
 
 
Customer relationship
7

 
—

Developed technology and patents
59

 
120

In-process research and development
98

 
—

Non-compete agreements
9

 
—

Goodwill
303

 
114

Purchase price, net of cash acquired
$
473

 
$
208

Weighted-average life of intangible assets
12

 
18


The purchase price allocation for Mobius is based on preliminary valuations, primarily related to intangible assets that are subject to change within the measurement period. The purchase price allocation for OrthoSpace was finalized in 2020.
Estimated Amortization Expense
Remainder of 2020
2021
2022
2023
2024
$
341

$
440

$
438

$
417

$
386


NOTE 8 - DEBT AND CREDIT FACILITIES
We have lines of credit issued by various financial institutions that are available to fund our day-to-day operating needs. Certain of our credit facilities require us to comply with financial and other covenants. We were in compliance with all covenants on March 31, 2020.
Our commercial paper program allows us to have a maximum of $1,500 in commercial paper outstanding with maturities up to 397 days from the date of issuance. On March 31, 2020 there were no amounts outstanding under our commercial paper program.
Summary of Total Debt
March 2020
 
December 2019
Senior unsecured notes:
 
 
 
 
Rate
 
Due
 
 
 
 
4.375%
 
January 15, 2020
$
—

 
$
500

 
Variable
 
November 30, 2020
328

 
333

 
2.625%
 
March 15, 2021
749

 
749

 
1.125%
 
November 30, 2023
599

 
609

 
3.375%
 
May 15, 2024
588

 
587

 
0.250%
 
December 3, 2024
923

 
938

 
3.375%
 
November 1, 2025
746

 
746

 
3.500%
 
March 15, 2026
991

 
991

 
2.125%
 
November 30, 2027
815

 
829

 
3.650%
 
March 7, 2028
596

 
596

 
0.750%
 
March 1, 2029
869

 
884

 
2.625%
 
November 30, 2030
700

 
712

 
1.000%
 
December 3, 2031
809

 
823

 
4.100%
 
April 1, 2043
392

 
391

 
4.375%
 
May 15, 2044
395

 
395

 
4.625%
 
March 15, 2046
981

 
981

Other
26

 
26

Total debt
$
10,507

 
$
11,090

Less current maturities of debt
1,103

 
859

Total long-term debt
$
9,404

 
$
10,231

 
 
 
 

 
 
March 2020
 
December 2019
Unamortized debt issuance costs
$
56

 
$
58

Available secured borrowing capacity
$
1,403

 
$
1,403

Fair value of senior unsecured notes
$
10,904

 
$
11,910


The fair value of the senior unsecured notes was estimated using quoted interest rates, maturities and amounts of borrowings based on quoted active market prices and yields that took into account the underlying terms of the debt instruments. Substantially all of our debt is classified within Level 2 of the fair value hierarchy.
In January 2020 we repaid $500 of senior unsecured notes with a coupon of 4.375% that were due on January 15, 2020.
On April 30, 2020 we amended our primary credit facility. The principal change was to increase the leverage ratio financial covenant from 3.5:1 to 4.5:1 at the end of each fiscal quarter ending on or prior to June 30, 2021.
On April 30, 2020 we entered into a credit agreement that provides for up to $1,500 of borrowings in U.S. Dollars pursuant to a 364-day revolving credit facility, which matures on April 29, 2021 and is available for working capital and general corporate purposes.
NOTE 9 - INCOME TAXES
Our effective tax rates were 16.4% and 14.2% in the three months 2020 and 2019. The increase in the effective tax rate for the three months was primarily due to a lower tax benefit related to share-based compensation.
In March 2020 the Coronavirus Aid, Relief and Economic Security Act (the "CARES Act") was signed into law in the United States. We do not expect the provisions of the CARES Act to have a material impact on our annual effective tax rate or Consolidated Financial Statements in 2020.
NOTE 10 - SEGMENT INFORMATION
 
Three Months
 
2020
2019
Orthopaedics
$
1,222

$
1,250

MedSurg
1,622

1,527

Neurotechnology and Spine
744

739

Net sales
$
3,588

$
3,516

Orthopaedics
$
392

$
437

MedSurg
401

377

Neurotechnology and Spine
206

199

Segment operating income
$
999

$
1,013

Items not allocated to segments:
 
 
Corporate and other
(137
)
(132
)
Acquisition and integration-related charges
(37
)
(138
)
Amortization of intangible assets
(118
)
(114
)
Restructuring-related charges
(54
)
(56
)
Medical device regulations
(24
)
(7
)
Recall-related matters
6

(13
)
Regulatory and legal matters
—

(25
)
Consolidated operating income
$
635

$
528


There were no significant changes to total assets by segment from information provided in our Annual Report on Form 10-K for 2019.

Dollar amounts are in millions except per share amounts or as otherwise specified.
8
STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

ITEM 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
ABOUT STRYKER
Stryker Corporation ("we" or "our") is one of the world's leading medical technology companies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
We segregate our operations into three reportable business segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. Orthopaedics products consist primarily of implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg products include surgical equipment and surgical navigation systems (Instruments), endoscopic and communications systems (Endoscopy), patient handling, emergency medical equipment and intensive care disposable products (Medical), reprocessed and remanufactured medical devices (Sustainability) and other medical device products used in a variety of medical specialties. Neurotechnology and Spine products include neurosurgical, neurovascular and spinal implant devices.
COVID-19 Pandemic
The COVID-19 outbreak, which has been declared a global pandemic, has led to severe disruptions in the market and the global and United States economies that may continue for a prolonged duration and trigger a recession or a period of economic slowdown. In response, various governmental authorities and private enterprises have implemented numerous measures to contain the pandemic, such as travel bans and restrictions, quarantines, shelter-in-place orders and shutdowns. A significant number of our global suppliers, vendors, distributors and manufacturing facilities are located in regions that have been affected by the pandemic, such as, among others, the United States, China, France, Germany, Switzerland and the United Kingdom. Those operations have been, and will continue to be, materially adversely affected by restrictive government and private enterprise measures implemented in response to the pandemic.
Some of our products are particularly sensitive to reductions in elective medical procedures. Elective medical procedures were suspended in the first quarter of 2020 in many of the markets where our products are marketed and sold, which negatively affected our business, cash flows, financial condition and results of operations. To the extent individuals are required to continue to de-prioritize or delay elective procedures as a result of the COVID-19 pandemic or otherwise, our business, cash flows, financial condition and results of operations could be negatively affected.
In addition, certain of our MedSurg products, such as emergency relief beds and personal protective equipment, have experienced, and could continue to experience, higher demand as our customers focus on treating COVID-19 patients. Unpredictable increases in demand for certain of our products could exceed our capacity to meet such demand timely, which could adversely affect our customer relationships and result in negative publicity. In this regard, the accelerated development and production of products and services in an effort to address medical and other requirements as a result of the pandemic could increase the risk of regulatory enforcement actions, product defects or related claims.
Further, in an effort to increase the wider availability of needed medical and other supplies and products in response to the
 
pandemic, governments may require us (such as under the United States Defense Production Act) to allocate manufacturing capacity in a way that adversely affects our regular operations, results in differential treatment of customers and/or adversely affects our reputation and customer relationships. It is also possible that certain of our operations are deemed non-essential and thus subject to suspension or other restrictions by government orders. We cannot predict how these changes in operations, if implemented, would affect our future operations and commercial activities as the impact of the pandemic begins to subside.
In addition, in March 2020 the Coronavirus Aid, Relief and Economic Security Act (the "CARES Act") was signed into law in the United States. We do not expect the provisions of the CARES Act to have a material impact on our annual effective tax rate or Consolidated Financial Statements in 2020.
Finally, the COVID-19 pandemic’s significant disruption on global financial markets may limit our ability to access capital, and the terms on which we are able to access capital may be substantially less favorable than those existing prior to the pandemic.
Overview of the Three Months
The response to the COVID-19 pandemic has included unprecedented measures to slow the spread of the virus taken by local governments and health care authorities globally, including the deferral of elective medical procedures and social contact restrictions, which have had, and we expect will continue to have, a significant negative impact on Stryker’s operations and financial results. While we reported an overall increase in unit volumes in the quarter, most of our businesses saw significant declines in the month of March 2020.
In the three months 2020 we achieved sales growth of 2.0%. Excluding the impact of acquisitions sales grew 2.4% in constant currency. We reported operating income margin of 17.7%, net earnings of $493 and net earnings per diluted share of $1.30. Excluding the impact of certain items, adjusted operating income margin contracted by 110 basis points to 24.0%, with adjusted net earnings(1) of $699 and a reduction of 2.1% in adjusted net earnings per diluted share(1).
Recent Developments
In January 2020 we repaid $500 of our senior unsecured notes with a coupon of 4.375% that were due on January 15, 2020.
In the three months 2020 we did not repurchase any shares of our common stock under our authorized repurchase program. The total dollar value of shares of our common stock that could be acquired under our authorized repurchase program was $1,033 as of March 31, 2020. As previously announced we intend to suspend our share repurchase program for 2020 and 2021.
On April 30, 2020 we amended our primary credit facility. The principal change was to increase the leverage ratio financial covenant from 3.5:1 to 4.5:1 at the end of each fiscal quarter ending on or prior to June 30, 2021.
On April 30, 2020 we entered into a credit agreement that provides for up to $1,500 of borrowings in U.S. Dollars pursuant to a 364-day revolving credit facility, which matures on April 29, 2021 and is available for working capital and general corporate purposes.
(1) Refer to "Non-GAAP Financial Measures" for a discussion of non-GAAP financial measures used in this report and a reconciliation to the most directly comparable GAAP financial measure.

Dollar amounts are in millions except per share amounts or as otherwise specified.
9
STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

 
CONSOLIDATED RESULTS OF OPERATIONS
 
Three Months
 
 
 
Percent Net Sales
Percentage
 
2020
2019
2020
2019
Change
Net sales
$
3,588

$
3,516

100.0
 %
100.0
 %
2.0
 %
Gross profit
2,331

2,283

65.0

64.9

2.1

Research, development and engineering expenses
254

225

7.1

6.4

12.9

Selling, general and administrative expenses
1,330

1,403

37.1

39.9

(5.2
)
Recall charges
(6
)
13

(0.2
)
0.4

nm

Amortization of intangible assets
118

114

3.3

3.2

3.5

Other income (expense), net
(45
)
(48
)
(1.3
)
(1.4
)
(6.3
)
Income taxes
97

68

 
 
42.6

Net earnings
$
493

$
412

13.7
 %
11.7
 %
19.7
 %
 
 
 
 
 
 
Net earnings per diluted share
$
1.30

$
1.09

 
 
19.3
 %
Adjusted net earnings per diluted share(1)
$
1.84

$
1.88

 
 
(2.1
)%

nm - not meaningful
Geographic and Segment Net Sales
Three Months
 
 
 
Percentage Change
 
2020
2019
As Reported
Constant
Currency
Geographic:
 
 
 
 
United States
$
2,643

$
2,579

2.5
 %
2.5
 %
International
945

937

0.8

4.2

Total
$
3,588

$
3,516

2.0
 %
2.9
 %
Segment:
 
 
 
 
Orthopaedics
$
1,222

$
1,250

(2.1
)%
(1.2
)%
MedSurg
1,622

1,527

6.2

7.0

Neurotechnology and Spine
744

739

0.7

1.5

Total
$
3,588

$
3,516

2.0
 %
2.9
 %
Supplemental Net Sales Growth Information
 
Three Months
 
 
Percentage Change
 
 
 
 
United States
International
 
2020
2019
As Reported
Constant Currency
As Reported
As Reported
Constant Currency
Orthopaedics:
 
 
 
 
 
 
 
Knees
$
432

$
439

(1.7
)%
(0.8
)%
0.6
 %
(7.8
)%
(4.5
)%
Hips
316

336

(5.9
)
(4.8
)
(5.7
)
(6.4
)
(3.2
)
Trauma and Extremities
392

396

(0.8
)
0.2

2.7

(6.9
)
(4.3
)
Other
82

79

4.7

5.3

9.4

(14.3
)
(11.5
)

$
1,222

$
1,250

(2.1
)%
(1.2
)%
0.3
 %
(7.3
)%
(4.3
)%
MedSurg:
 
 
 
 
 
 
 
Instruments
$
513

$
461

11.1
 %
11.9
 %
12.0
 %
7.8
 %
11.4
 %
Endoscopy
455

470

(3.2
)
(2.4
)
(2.9
)
(4.1
)
(0.4
)
Medical
587

531

10.5

11.5

9.1

15.5

20.3

Sustainability
67

65

2.8

2.8

3.1

nm

nm


$
1,622

$
1,527

6.2
 %
7.0
 %
6.0
 %
6.9
 %
11.1
 %
Neurotechnology and Spine:
 
 
 
 
 
 
Neurotechnology
$
483

$
469

3.1
 %
4.0
 %
0.2
 %
8.1
 %
10.8
 %
Spine
261

270

(3.5
)
(2.8
)
(5.6
)
3.3

6.4


$
744

$
739

0.7
 %
1.5
 %
(2.1
)%
6.8
 %
9.6
 %
Total
$
3,588

$
3,516

2.0
 %
2.9
 %
2.5
 %
0.8
 %
4.2
 %

 
Consolidated Net Sales
Consolidated net sales were significantly negatively impacted by the global response to the COVID-19 pandemic, resulting in lower than previously expected unit volume growth rates across all segments. Consolidated net sales increased 2.0% in the three months 2020 as reported and 2.9% in constant currency, as foreign currency exchange rates negatively impacted net sales by 0.9%. Excluding the 0.5% impact of acquisitions, net sales in constant
 
currency increased by 2.8% from increased unit volume partially offset by 0.4% due to lower prices. The unit volume increase was primarily due to higher shipments of neurotechnology, medical, instruments and trauma and extremities products. In addition, preliminary estimates indicate consolidated net sales in April 2020 decreased 35% to 40% from 2019 due to the global response to the COVID-19 pandemic.

Dollar amounts are in millions except per share amounts or as otherwise specified.
10
STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

Orthopaedics Net Sales
Orthopaedics net sales decreased 2.1% in the three months 2020 as reported and 1.2% in constant currency, as foreign currency exchange rates negatively impacted net sales by 0.9%. Net sales in constant currency decreased by 1.5% due to the deferral of elective medical procedures as part of the global response to the COVID-19 pandemic and lower prices partially offset by 0.3% from higher unit volume. The unit volume increase was primarily due to higher shipments of trauma and extremities products.
MedSurg Net Sales
MedSurg net sales increased 6.2% in the three months 2020 as reported and 7.0% in constant currency, as foreign currency exchange rates negatively impacted net sales by 0.8%. Excluding the 0.7% impact of acquisitions, net sales in constant currency increased by 6.0% from increased unit volume and 0.3% due to higher prices. The unit volume increase was primarily due to higher shipments of medical, instruments and sustainability solutions products.
Neurotechnology and Spine Net Sales
Neurotechnology and Spine net sales increased 0.7% in the three months 2020 as reported and 1.5% in constant currency, as foreign currency exchange rates negatively impacted net sales by 0.8%. Excluding the 1.2% impact of acquisitions, net sales in constant currency increased by 0.3% from increased unit volume. The unit volume increase was primarily due to higher shipments of neurotechnology products.
Gross Profit
Gross profit was significantly negatively impacted by the global response to the COVID-19 pandemic. Gross profit as a percentage of sales in the three months 2020 increased to 65.0% from 64.9% in 2019. Excluding the impact of the items noted below, gross profit decreased to 65.3% of sales in the three months 2020 from 65.8% in 2019 primarily due to unfavorable product mix due to the deferral of elective medical procedures as part of the global response to the COVID-19 pandemic and lower selling prices, partially offset by increases due to leverage from higher sales volumes.
 
 
Percent Net Sales
Three Months
2020
2019
2020
2019
Reported
$
2,331

$
2,283

65.0
%
64.9
%
Inventory stepped-up to fair value
6

24

0.2

0.7

Restructuring-related and other charges
4

5

0.1

0.2

Medical device regulations
1

—

—

—

Adjusted
$
2,342

$
2,312

65.3
%
65.8
%
Research, Development and Engineering Expenses
Research, development and engineering expenses increased $29 or 12.9% to 7.1% of sales in the three months 2020 from 6.4% in 2019. Excluding the impact of the items noted below, expenses increased to 6.4% of sales in 2020 from 6.2% in 2019. Projects to develop new products, investments in new technologies and integration of recent acquisitions contributed to the increased spending levels partially offset by operating expense savings actions taken during March 2020 in response to the COVID-19 pandemic that will drive lower spending in the remainder of the year.
 
 
Percent Net Sales
Three Months
2020
2019
2020
2019
Reported
$
254

$
225

7.1
 %
6.4
 %
Medical device regulations
(23
)
(7
)
(0.7
)
(0.2
)
Adjusted
$
231

$
218

6.4
 %
6.2
 %
 
Selling, General and Administrative Expenses
Selling, general and administrative expenses decreased $73 or 5.2% in the three months 2020 and decreased as a percentage of sales to 37.1% from 39.9% in 2019. Excluding the impact of the items noted below, expenses increased to 34.8% of sales in 2020 from 34.4% in 2019, primarily due to unfavorable business mix and foreign exchange partially offset by operating expense savings actions taken during March 2020 in response to the COVID-19 pandemic that will drive lower spending in the remainder of the year.
 
 
Percent Net Sales
Three Months
2020
2019
2020
2019
Reported
$
1,330

$
1,403

37.1
 %
39.9
 %
Other acquisition and integration-related
(31
)
(114
)
(0.9
)
(3.3
)
Restructuring-related and other charges
(49
)
(52
)
(1.4
)
(1.5
)
Regulatory and legal matters
—

(25
)
—

(0.7
)
Adjusted
$
1,250

$
1,212

34.8
 %
34.4
 %
Recall Charges
Recall charges were minimal in the three months 2020 and 2019. Charges were primarily due to the previously disclosed Rejuvenate and ABGII Modular-Neck hip stems and LFIT V40 femoral head voluntary recalls. Refer to Note 6 to our Consolidated Financial Statements for further information.
Amortization of Intangible Assets
Amortization of intangible assets was $118 and $114 in the three months 2020 and 2019. The increase in 2020 was primarily due to our recent acquisitions. Refer to Note 7 to our Consolidated Financial Statements for further information.
Operating Income
Operating income was significantly negatively impacted by the global response to the COVID-19 pandemic. Operating income increased $107 or 20.3% to 17.7% of net sales in the three months 2020 from 15.0% in 2019. Excluding the impact of the items noted below, operating income decreased to 24.0% of sales in 2020 from 25.1% in 2019 primarily due to unfavorable business mix from the deferral of elective medical procedures as part of the global response to the COVID-19 pandemic, partially offset by leverage from higher sales volumes and continued focus on our operating expense savings actions that will drive lower spending in the remainder of the year.
 
 
Percent Net Sales
Three Months
2020
2019
2020
2019
Reported
$
635

$
528

17.7
 %
15.0
%
Inventory stepped-up to fair value
6

24

0.2

0.7

Other acquisition and integration-related
31

114

0.9

3.2

Amortization of purchased intangible assets
118

114

3.2

3.2

Restructuring-related and other charges
54

56

1.5

1.6

Medical device regulations
24

7

0.7

0.2

Recall-related matters
(6
)
13

(0.2
)
0.4

Regulatory and legal matters
—

25

—

0.8

Adjusted
$
862

$
881

24.0
 %
25.1
%
Other Income (Expense), Net
Other income (expense), net was ($45) and ($48) in the three months 2020 and 2019. The improvement in 2020 was primarily due to benefits in investment income partially offset by increased interest expense driven by the additional debt from the Euro bond offering completed in December 2019.

Dollar amounts are in millions except per share amounts or as otherwise specified.
11
STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

Income Taxes
The effective tax rates were 16.4% and 14.2% in the three months 2020 and 2019. The increase in the effective tax rate for the three months was primarily due to a lower tax benefit related to share-based compensation.
In March 2020 the Coronavirus Aid, Relief and Economic Security Act (the "CARES Act") was signed into law in the United States. We do not expect the provisions of the CARES Act to have a material impact on our annual effective tax rate or Consolidated Financial Statements in 2020.
Net Earnings
Earnings were significantly negatively impacted by the global response to the COVID-19 pandemic. Net earnings increased to $493 or $1.30 per diluted share in the three months 2020 from $412 or $1.09 per diluted share in 2019. Adjusted net earnings per diluted share(1) decreased 2.1% to $1.84 in 2020 from $1.88 in 2019. The impact of foreign currency exchange rates reduced net earnings per diluted share by approximately $0.02 in 2020 and $0.06 in 2019.
 
 
Percent Net Sales
Three Months
2020
2019
2020
2019
Reported
$
493

$
412

13.7
 %
11.7
%
Inventory stepped-up to fair value
5

19

0.1

0.5

Other acquisition and integration-related
24

88

0.7

2.5

Amortization of purchased intangible assets
96

91

2.7

2.6

Restructuring-related and other charges
42

50

1.2

1.5

Medical device regulations
18

6

0.5

0.2

Recall-related matters
(4
)
10

(0.1
)
0.3

Regulatory and legal matters
—

19

—

0.5

Tax matters
25

19

0.7

0.5

Adjusted
$
699

$
714

19.5
 %
20.3
%

Non-GAAP Financial Measures
We supplement the reporting of our financial information determined under accounting principles generally accepted in the United States (GAAP) with certain non-GAAP financial measures, including percentage sales growth in constant currency; percentage organic sales growth; adjusted gross profit; adjusted selling, general and administrative expenses; adjusted research, development and engineering expenses; adjusted operating income; adjusted other income (expense), net; adjusted effective income tax rate; adjusted net earnings; and adjusted net earnings per diluted share (Diluted EPS). We believe these non-GAAP financial measures provide meaningful information to assist investors and shareholders in understanding our financial results and assessing our prospects for future performance. Management believes percentage sales growth in constant currency and the other adjusted measures described above are important indicators of our operations because they exclude items that may not be indicative of or are unrelated to our core operating results and provide a baseline for analyzing trends in our underlying businesses. Management uses these non-GAAP financial measures for reviewing the operating results of reportable business segments and analyzing potential future business trends in connection with our budget process and bases certain management incentive compensation on these non-GAAP financial measures. To measure percentage sales growth in constant currency, we remove the impact of changes in foreign currency exchange rates that affect the comparability and trend of sales. Percentage sales growth in constant currency is calculated by translating current and prior year results at the same foreign currency exchange rate. To measure percentage organic sales growth, we remove the impact of changes in foreign currency exchange rates and acquisitions, which affect the comparability and trend of sales. Percentage organic sales growth is calculated by translating current year results at prior year average foreign currency exchange rates excluding the impact of acquisitions. To
 
measure earnings performance on a consistent and comparable basis, we exclude certain items that affect the comparability of operating results and the trend of earnings. These adjustments are irregular in timing and may not be indicative of our past and future performance. The following are examples of the types of adjustments that may be included in a period:
1.
Acquisition and integration-related costs. Costs related to integrating recently acquired businesses and specific costs (e.g., inventory step-up and deal costs) related to the consummation of the acquisition process.
2.
Amortization of purchased intangible assets. Periodic amortization expense related to purchased intangible assets.
3.
Restructuring-related and other charges. Costs associated with the termination of sales relationships in certain countries, workforce reductions, elimination of product lines, weather-related asset impairments and associated costs and other restructuring-related activities.
4.
Medical Device Regulations. Costs specific to updating our quality system, product labeling, asset write-offs and product remanufacturing to comply with the medical device reporting regulations and other requirements of the European Union and China regulations for medical devices.
5.
Recall-related matters. Our best estimate of the minimum of the range of probable loss to resolve the Rejuvenate, LFIT V40 and other product recalls.
6.
Regulatory and legal matters. Our best estimate of the minimum of the range of probable loss to resolve certain regulatory matters and other legal settlements.
7.
Tax matters. Charges represent the impact of accounting for certain significant and discrete tax items.
Because non-GAAP financial measures are not standardized, it may not be possible to compare these financial measures with other companies' non-GAAP financial measures having the same or similar names. These adjusted financial measures should not be considered in isolation or as a substitute for reported sales growth, gross profit, selling, general and administrative expenses, research, development and engineering expenses, operating income, other income (expense), net, effective income tax rate, net earnings and net earnings per diluted share, the most directly comparable GAAP financial measures. These non-GAAP financial measures are an additional way of viewing aspects of our operations when viewed with our GAAP results and the reconciliations to corresponding GAAP financial measures at the end of the discussion of Consolidated Results of Operations below. We strongly encourage investors and shareholders to review our financial statements and publicly-filed reports in their entirety and not to rely on any single financial measure.
The weighted-average diluted shares outstanding used in the calculation of non-GAAP net earnings per diluted share are the same as those used in the calculation of reported net earnings per diluted share for the respective period.


Reconciliation of Non-GAAP Financial Measures to the Most Directly Comparable GAAP Financial Measures
Three Months 2020
Gross Profit
Selling, General & Administrative Expenses
Research, Development & Engineering Expenses
Operating Income
Other income (expense), net
Net Earnings
Effective
Tax Rate
Diluted EPS
Reported
$
2,331

$
1,330

$
254

$
635

$
(45
)
$
493

16.4
 %
$
1.30

Reported percent net sales
65.0
%
37.1
%
7.1
%
17.7
%
(1.3
)%
13.7
%
 
 
Acquisition and integration-related charges:
 
 
 
 
 
 
 
 
Inventory stepped-up to fair value
6

—

—

6

—

5

0.1

0.01

Other acquisition and integration-related
—

(31
)
—

31

—

24

0.3

0.06

Amortization of purchased intangible assets
—

—

—

118

—

96

0.9

0.25

Restructuring-related and other charges
4

(49
)
—

54

—

42

0.6

0.11

Medical device regulations
1

—

(23
)
24

—

18

0.3

0.05

Recall-related matters
—

—

—

(6
)
—

(4
)
(0.1
)
(0.01
)
Regulatory and legal matters
—

—

—

—

—

—

—

—

Tax matters
—

—

—

—

—

25

(4.2
)
0.07

Adjusted
$
2,342

$
1,250

$
231

$
862

$
(45
)
$
699

14.3
 %
$
1.84

Adjusted percent net sales
65.3
%
34.8
%
6.4
%
24.0
%
(1.3
)%
19.5
%
 
 

Dollar amounts are in millions except per share amounts or as otherwise specified.
12
STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

Three Months 2019
Gross Profit
Selling, General & Administrative Expenses
Research, Development & Engineering Expenses
Operating Income
Other income (expense), net
Net Earnings
Effective
Tax Rate
Diluted EPS
Reported
$
2,283

$
1,403

$
225

$
528

$
(48
)
$
412

14.2
 %
$
1.09

Reported percent net sales
64.9
%
39.9
%
6.4
%
15.0
%
(1.4
)%
11.7
%
 
 
Acquisition and integration-related charges:
 
 
 
 
 
 
 
 
Inventory stepped-up to fair value
24

—

—

24

—

19

0.3

0.05

Other acquisition and integration-related
—

(114
)
—

114

—

88

2.0

0.23

Amortization of purchased intangible assets
—

—

—

114

—

91

1.3

0.24

Restructuring-related and other charges
5

(52
)
—

56

—

50

(0.3
)
0.13

Medical device regulations
—

—

(7
)
7

—

6

0.1

0.01

Recall-related matters
—

—

—

13

—

10

0.3

0.03

Regulatory and legal matters
—

(25
)
—

25

—

19

0.4

0.05

Tax matters
—

—

—

—

—

19

(3.9
)
0.05

Adjusted
$
2,312

$
1,212

$
218

$
881

$
(48
)
$
714

14.4
 %
$
1.88

Adjusted percent net sales
65.8
%
34.4
%
6.2
%
25.1
%
(1.4
)%
20.3
%
 
 

FINANCIAL CONDITION AND LIQUIDITY
Three Months
2020
2019
Net cash provided by operating activities
$
591

$
313

Net cash used in investing activities
(163
)
(303
)
Net cash provided by (used in) financing activities
(768
)
(1,947
)
Effect of exchange rate changes on cash and cash equivalents
(33
)
(5
)
Change in cash and cash equivalents
$
(373
)
$
(1,942
)
Operating Activities
Cash provided by operating activities was $591 and $313 in the three months 2020 and 2019. The increase was primarily due to increases in cash provided by working capital, primarily accounts receivable collections, accounts payable due to timing of payments and higher net earnings.
Investing Activities    
Cash used in investing activities was $163 and $303 in the three months 2020 and 2019. The decrease in cash used was primarily due to decreased payments for acquisitions in 2020.
Financing Activities
Cash used in financing activities was $768 and $1,947 in the three months 2020 and 2019. The decrease in cash used was primarily driven by the repayment of $500 of debt upon maturity in January 2020 compared to repayments of $1,341 of debt in the first quarter of 2019, along with the suspension of share repurchases.
Three Months
2020
2019
Total dividends paid to common shareholders
$
215

$
195

Total amount paid to repurchase common stock
$
—

$
307

Shares of repurchased common stock (in millions)
—

1.9

Liquidity
Cash, cash equivalents and marketable securities were $4,048 and $4,425 on March 31, 2020 and December 31, 2019. Current assets exceeded current liabilities by $6,574 and $6,960 on March 31, 2020 and December 31, 2019. Despite the impact from the COVID-19 pandemic, we anticipate being able to support our short-term liquidity and operating needs from a variety of sources including cash from operations, commercial paper, existing credit lines and capital expenditure and operating expense reductions. We maintain a revolving credit facility with $1.5 billion of committed capital which expires in August 2023 and a $1.5 billion unsecured revolving credit facility that matures on April 29, 2021.
We have a well-positioned balance sheet and liquidity profile to manage these disruptions for the foreseeable future. We raised funds in the capital markets in 2019 and 2018 and may continue to do so from time to time. We continue to have strong investment-
 
grade short-term and long-term debt ratings that we believe should enable us to refinance our debt as needed.
Our cash, cash equivalents and marketable securities held in locations outside the United States was approximately 23% on March 31, 2020 compared to 25% on December 31, 2019. We intend to use this cash to sustain operations during our response to the COVID-19 pandemic.
Critical Accounting Policies
There were no changes to our critical accounting policies from those disclosed in our Annual Report on Form 10-K for 2019.
New Accounting Pronouncements Not Yet Adopted
Refer to Note 1 to our Consolidated Financial Statements for information.
Guarantees and Other Off-Balance Sheet Arrangements
We do not have guarantees or other off-balance sheet financing arrangements, including variable interest entities, of a magnitude that we believe could have a material impact on our financial condition or liquidity.
OTHER MATTERS
Legal and Regulatory Matters
We are involved in various ongoing proceedings, legal actions and claims arising in the normal course of our business, including proceedings related to product, labor, intellectual property and other matters. Refer to Note 6 to our Consolidated Financial Statements for further information.
FORWARD-LOOKING STATEMENTS
This report contains statements referring to us that are not historical facts and are considered "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements, which are intended to take advantage of the "safe harbor" provisions of the Reform Act, are based on current projections about operations, industry conditions, financial condition and liquidity. Words that identify forward-looking statements include words such as "may," "could," "will," "should," "possible," "plan," "predict," "forecast," "potential," "anticipate," "estimate," "expect," "project," "intend," "believe," "may impact," "on track," "goal," "strategy" and words and terms of similar substance used in connection with any discussion of future operating or financial performance, an acquisition or our businesses. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. Those statements are not guarantees and are subject to risks, uncertainties and assumptions that are difficult to predict, including uncertainties related to the impact of the COVID-19 pandemic on our operations and financial results. Therefore, actual results could differ materially and adversely from these forward-looking

Dollar amounts are in millions except per share amounts or as otherwise specified.
13
STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

statements. Some important factors that could cause our actual results to differ from our expectations in any forward-looking statements include those risks discussed in Item 1A. "Risk Factors" of our Annual Report on Form 10-K for 2019 and in Part II, Item 1. "Risk Factors" on this Form 10-Q. This Form 10-Q should be read in conjunction with our Consolidated Financial Statements and accompanying notes to our Consolidated Financial Statements in our Annual Report on Form 10-K for 2019. We disclaim any intention or obligation to publicly update or revise any forward-looking statement to reflect any change in our expectations or in events, conditions or circumstances on which those expectations may be based, or that affect the likelihood that actual results will differ from those contained in the forward-looking statements.
ITEM 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We consider our greatest potential areas of market risk exposure to be exchange rate risk and the impacts of the COVID-19 pandemic on our operations and financial results. Quantitative and qualitative disclosures about exchange rate risk are included in Item 7A "Quantitative and Qualitative Disclosures About Market Risk" of our Annual Report on Form 10-K for 2019. There were no material changes from the information provided therein. We are not able to quantify the impacts of the COVID-19 pandemic on our financial results. Qualitative disclosures about the COVID-19 pandemic are included in Part I, Item 2 "Management's Discussion and Analysis of Financial Condition and Results of Operations" and Part II, Item 1A "Risk Factors" of this Form 10-Q.
ITEM 4.
CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of the Chief Executive Officer and Chief Financial Officer (the Certifying Officers), evaluated the effectiveness of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended) on March 31, 2020. Based on that evaluation, the Certifying Officers concluded the Company's disclosure controls and procedures were effective as of March 31, 2020.
Changes in Internal Control Over Financial Reporting
There was no change to our internal control over financial reporting during the three months 2020 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION
ITEM 1A.
RISK FACTORS
Except with respect to the new and/or updated risk factors set forth below, we are not aware of any material changes to the risk factors included in Item 1A "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2019.
New Risk Factors
The COVID-19 pandemic has materially adversely affected, and is expected to continue to materially adversely affect, our operations, supply chain, manufacturing, product distribution and other business activities: The COVID-19 outbreak, which has been declared a global pandemic, has led to severe disruptions in the market and the global and United States economies that may continue for a prolonged duration and trigger a recession or a period of economic slowdown. In response, various governmental authorities and private enterprises have implemented numerous
 
measures to contain the pandemic, such as travel bans and restrictions, quarantines, shelter-in-place orders and shutdowns. A significant number of our global suppliers, vendors, distributors and manufacturing facilities are located in regions that have been affected by the pandemic, such as, among others, the United States, China, France, Germany, Switzerland and the United Kingdom. Those operations have been, and will continue to be, materially affected by restrictive government measures implemented in response to the pandemic. For example, some of our distributors and indirect channels in Asia are currently unable to distribute our products or provide required services due to direct governmental action or indirect consequences of the pandemic. Any delay or shortage in the supply of components or materials or delay in delivering our products may result in our inability to satisfy consumer demand for our products in a timely manner or at all, which could harm our reputation, future sales and profitability.
In addition, the pandemic could adversely impact our ability to retain key employees and the continued service and availability of skilled personnel necessary to run our complex productions, as well as our executive officers and other members of our management team, third-party suppliers, manufacturers, distributors and vendors. To the extent our management or other personnel are impacted in significant numbers by the pandemic and are not available to perform their job duties, we could experience delays in, or the suspension of, our manufacturing operations, research and product development activities, regulatory work streams, clinical development programs and other important commercial functions. Moreover, the actions we take to mitigate the effect of the pandemic on our workforce could reduce the efficiency of our operations or prove insufficient. The extent of the pandemic’s effect on our business will depend on future developments, including the duration, spread and intensity of the pandemic, all of which are uncertain and difficult to predict. We are not able at this time to estimate with certainty the effect of these and other unforeseen factors on our business, but the adverse impact on our business, cash flows, financial condition and results of operations could be material. A prolonged impact of COVID-19 also could heighten many of the other risks described in this report and in our Annual Report on Form 10-K for the year ended December 31, 2019.
The COVID-19 pandemic has resulted in, and may continue to result in, significant disruption of global financial markets, reducing our ability to access capital, which could negatively affect our liquidity: The COVID-19 pandemic’s significant disruption on global financial markets may limit our ability to access capital, and the terms on which we are able to access capital may be substantially less favorable than those existing prior to the pandemic. In 2020 we will require additional debt financing to finance our pending acquisition of Wright Medical, fund our operations and refinance existing debt. If we are not able to access capital at a time and on terms acceptable to us, we may encounter difficulty funding our business requirements including debt repayments when they become due. Changes in our credit ratings issued by nationally recognized credit rating agencies could also adversely affect our access to and cost of financing. In addition, we could experience loss of sales and profits due to delayed payments or insolvency of healthcare professionals, hospitals and other customers and suppliers facing liquidity issues. As a result, we may be compelled to take additional measures to preserve our cash flow, including through the reduction of operating expenses or suspension of dividend payments, at least until the consequences of the pandemic subside.
We have experienced, and may continue to experience, a significant and unpredictable need to adjust our operations as market demand for certain of our products has shifted and

Dollar amounts are in millions except per share amounts or as otherwise specified.
14


continues to shift or as may be mandated by governmental authorities in response to the COVID-19 pandemic: Some of our products are particularly sensitive to reductions in elective medical procedures. Elective medical procedures were suspended in the first quarter of 2020 in many of the markets where our products are marketed and sold, which negatively affected our business, cash flows, financial condition and results of operations. It is not possible to predict the exact timing of a broad resumption of elective medical procedures and, to the extent individuals are required to continue to de-prioritize, delay or cancel elective procedures as a result of the COVID-19 pandemic or otherwise, our business, cash flows, financial condition and results of operations could be negatively affected.
In addition, our products in certain divisions, such as Medical, have experienced, and could continue to experience, higher demand as our customers focus on treating COVID-19 patients. Unpredictable increases in demand for certain of our products could exceed our capacity to meet such demand timely, which could adversely affect our customer relationships and result in negative publicity. In this regard, the accelerated development and production of products and services in an effort to address medical and other requirements as a result of the pandemic could increase the risk of regulatory enforcement actions, product defects or related claims.
Further, in an effort to increase the wider availability of needed medical and other supplies and products in response to the pandemic, governments may require us (such as under the United States Defense Production Act) to allocate manufacturing capacity in a way that adversely affects our regular operations, results in differential treatment of customers and/or adversely affects our reputation and customer relationships. It is also possible that certain of our operations are deemed non-essential and thus subject to suspension or other restrictions by government orders. We cannot predict how these changes in operations, if implemented, would affect our future operations and commercial activities as the impact of the pandemic begins to subside.
Updated Risk Factors
We may be adversely affected by product liability claims, unfavorable court decisions or legal settlements: We are exposed to potential product liability risks inherent in the design, manufacture and marketing of medical devices, many of which are implanted in the human body for long periods of time or indefinitely. We may be exposed to additional potential product liability risks related to products designed, manufactured and marketed in response to the COVID-19 pandemic, including discretionary products and products permitted under the Emergency Use Authorization granted by the FDA. We are currently defendants in a number of product liability matters, including those relating to our Rejuvenate and ABGII Modular-Neck hip stems and LFIT Anatomic CoCr V40 Femoral Heads discussed in Note 7 to our Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2019. These matters are subject to many uncertainties and outcomes are not predictable. In addition, we may incur significant legal expenses regardless of whether we are found to be liable. We are self-insured for product liability-related claims and expenses.
We may be unable to maintain adequate working relationships with healthcare professionals: We seek to maintain close working relationships with respected physicians and medical personnel in healthcare organizations such as hospitals and universities who assist in product research and development. We rely on these professionals to assist us in the development and improvement of proprietary products. As a result of the COVID-19 pandemic, our access to these professionals has been limited as hospitals have
 
restricted access for non-patients, including our research and development specialists and other employees, and governmental authorities have imposed travel restrictions, shutdowns or similar measures, which has adversely affected our ability to develop, market and sell products. If we are unable to maintain these relationships, our ability to develop, market and sell new and improved products could be further adversely affected.
We rely on indirect distribution channels and major distributors that are independent of Stryker: In many markets, we rely on indirect distribution channels to market, distribute, and sell our products. These indirect channels often are the main point of contact for the healthcare professional and healthcare organization customers who buy and use our products. Our ability to market, distribute, and sell our products through indirect channels has been adversely affected as a result of precautionary responses to the COVID-19 pandemic, including travel restrictions, suspension and shutdown orders and other measures intended to limit person-to-person contact. Our ability to continue to market, distribute, and sell our products may be at risk if the indirect channels become insolvent, choose to sell competitive products, choose to stop selling medical technology, or are subject to new or additional government regulation, whether related to the COVID-19 pandemic or for unrelated reasons.
We are subject to additional risks associated with our extensive global operations: We develop, manufacture and distribute our products globally. Our global operations are subject to risks and potential costs, including changes in reimbursement, changes in regulatory requirements, differing local product preferences and product requirements, diminished protection of intellectual property in some countries, tariffs and other trade protection measures, international trade disputes and import or export requirements, difficulty in staffing and managing foreign operations, introduction of new internal business structures and programs, political and economic instability (such as the United Kingdom's exit from the European Union, commonly referred to as "Brexit"), and disruptions of transportation due to a global pandemic of contagious diseases like COVID-19 or otherwise, such as reduced availability of air transport, port closures, increased border controls or closures, increased transportation costs and increased security threats to our supply chain. Our business could be adversely impacted if we are unable to successfully manage these and other risks of global operations in an increasingly volatile environment.
We may incur goodwill impairment charges related to one or more of our business units: We perform our annual impairment test for goodwill in the fourth quarter of each year, or more frequently if indicators are present or changes in circumstances suggest that impairment may exist. In evaluating the potential for impairment we make assumptions regarding revenue projections, growth rates, cash flows, tax rates and discount rates. These assumptions are uncertain and by nature may vary from actual results. A significant reduction in the estimated fair values could result in impairment charges. We believe that the impact of the COVID-19 pandemic will negatively affect certain key assumptions used in our analysis; however, we will need to assess the extent and nature of the long-term impacts to determine if we may be required to record charges for impairments in the future. At this time, it remains uncertain whether and to what extent we will need to record charges for impairments as a result of the ongoing pandemic.
We could experience a failure of a key information technology system, process or site or a breach of information security, including a cybersecurity breach or failure of one or more key information technology systems, networks, processes, associated sites or service providers: We rely extensively on

Dollar amounts are in millions except per share amounts or as otherwise specified.
15


information technology (IT) systems to conduct business. In addition, we rely on networks and services, including internet sites, cloud and SaaS solutions, data hosting and processing facilities and tools and other hardware, software and technical applications and platforms, some of which are managed, hosted, provided and/or used by third-parties or their vendors, to assist in conducting our business. Numerous and evolving cybersecurity threats pose potential risks to the security of our IT systems, networks and product offerings, as well as the confidentiality, availability and integrity of our data. A security breach, whether of our products, of our customers’ network security and systems or of third-party hosting services, could impact the use of such products and the security of information stored therein. While we have made investments seeking to address these threats, including monitoring of networks and systems, hiring of experts, employee training and security policies for employees and third-party providers, the techniques used in these attacks change frequently and may be difficult to detect for periods of time and we may face difficulties in anticipating and implementing adequate preventative measures. In addition, a greater number of our employees working remotely during the COVID-19 pandemic may expose us to greater risks related to cybersecurity and cyber-liability. If our IT systems are damaged or cease to function properly, the networks or service providers we rely upon fail to function properly, or we or one of our third-party providers suffer a loss or disclosure of our business or stakeholder information due to any number of causes ranging from catastrophic events or power outages to improper data handling or security breaches and our business continuity plans do not effectively address these failures on a timely basis, we may be exposed to reputational, competitive and business harm as well as litigation and regulatory action.
ITEM 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
We issued 7,578 shares of our common stock in the three months 2020 as performance incentive awards to employees. These shares are not registered under the Securities Act of 1933 based on the conclusion that the awards would not be events of sale within the meaning of Section 2(a)(3) of the Act.
In March 2015 we announced that our Board of Directors had authorized us to purchase up to $2,000 of our common stock. The manner, timing and amount of repurchases are determined by management based on an evaluation of market conditions, stock price, and other factors and are subject to regulatory considerations. Purchases are made from time to time in the open market, in privately negotiated transactions or otherwise.
In the three months 2020 we did not repurchase any shares of our common stock under our authorized repurchase program. The total dollar value of shares of our common stock that could be acquired under our authorized repurchase program was $1,033 as of March 31, 2020.
ITEM 5.
OTHER INFORMATION
Amendment to 2016 Credit Agreement
On April 30, 2020 Stryker Corporation, and certain of its subsidiaries as designated borrowers, amended its Credit Agreement, dated as of August 19, 2016, with various lenders and Bank of America, N.A., as administrative agent (the "2016 Credit Agreement"). The principal changes were to (1) increase the maximum permitted leverage ratio under the leverage ratio financial covenant from 3.5:1 to 4.5:1 at the end of any fiscal quarter of the Company ending after March 31, 2020 but on or prior to June 30, 2021, (2) allow the Company to increase the maximum permitted leverage ratio by 0.5 to 1.0 during an acquisition holiday, which the Company is permitted to elect under the 2016 Credit Agreement no more than twice during
 
the term of the 2016 Credit Agreement for a period of four consecutive fiscal quarters in connection with the consummation of certain material acquisitions and (3) make certain amendments to the 2016 Credit Agreement to address recent developments in applicable law and regulations governing financial institutions. The foregoing summary is qualified in its entirety by the terms of Amendment No. 1, dated as of April 30, 2020, to the 2016 Credit Agreement, a copy of which is filed as Exhibit 10(i) hereto and is incorporated herein by reference.
364-Day Credit Agreement
On April 30, 2020 Stryker Corporation entered into a Credit Agreement with various lenders and Bank of America, N.A., as administrative agent (the "364-Day Credit Agreement"). The principal terms of the 364-Day Credit Agreement are: (1) an aggregate principal amount of commitments of $1.5 billion, (2) a maturity date of April 29, 2021 and (3) a leverage ratio financial covenant that provides for a maximum permitted leverage ratio of 4.5:1 at the end of any fiscal quarter, with an acquisition holiday no more than twice during the term of the 364-Day Credit Agreement that permits the Company to elect to increase the maximum permitted leverage ratio by 0.5 to 1.0 for a period of four consecutive fiscal quarters in connection with the consummation of certain material acquisitions. The representations and warranties, covenants and events of default contained in the 364-Day Credit Agreement are substantially the same as those contained in the 2016 Credit Agreement, as amended. The 364‑Day Credit Agreement has an annual facility fee ranging from 20 to 40 basis points and bears interest at the LIBOR Rate, as defined in the 364-Day Credit Agreement, plus an applicable margin ranging from 105 to 135 basis points, with a 0.75% LIBOR floor. Both the facility fee and the applicable margin are dependent on the Company’s credit ratings. The foregoing summary is qualified in its entirety by the terms of the 364-Day Credit Agreement, a copy of which is filed as Exhibit 10(ii) hereto and is incorporated herein by reference.
ITEM 6.
EXHIBITS
10(i) †
10(ii) †
31(i)*
31(ii)*
32(i)*
32(ii)*
101.INS
iXBRL Instance Document
101.SCH
iXBRL Schema Document
101.CAL
iXBRL Calculation Linkbase Document
101.DEF
iXBRL Definition Linkbase Document
101.LAB
iXBRL Label Linkbase Document
101.PRE
iXBRL Presentation Linkbase Document
104
Cover Page Interactive Data File (the cover page XBRL tags are embedded within the Inline XBRL document)
 
† Filed with this Form 10-Q
 
* Furnished with this Form 10-Q

Dollar amounts are in millions except per share amounts or as otherwise specified.
16
STRYKER CORPORATION
 
2020 First Quarter Form 10-Q

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
STRYKER CORPORATION
 
 
 
(Registrant)
 
 
 
 
 
 
 
 
Date:
May 1, 2020
 
/s/ KEVIN A. LOBO
 
 
 
Kevin A. Lobo
 
 
 
Chairman and Chief Executive Officer
 
 
 
 
 
 
 
 
Date:
May 1, 2020
 
/s/ GLENN S. BOEHNLEIN
 
 
 
Glenn S. Boehnlein
 
 
 
Vice President, Chief Financial Officer

 
 
17
 EX-10.1 2 ex10iamendcreditagreement.htm EXHIBIT 10.1 Exhibit
Exhibit 10(i)

AMENDMENT NO. 1

AMENDMENT NO. 1, dated as of April 30, 2020 (this “Amendment Agreement”), to the Credit Agreement, dated as of August 19, 2016 (as in effect on the date hereof, the “Existing Credit Agreement” and, as amended by this Amendment Agreement, the “Amended Credit Agreement”), among STRYKER CORPORATION, a Michigan corporation (the “Company”), certain Subsidiaries of the Company party thereto (each a “Designated Borrower” and, together with the Company, the “Borrowers” and, each a “Borrower”), the lenders party thereto and BANK OF AMERICA, N.A. (the “Administrative Agent”), as Administrative Agent, Swing Line Lender and a L/C Issuer (capitalized terms used but not defined herein having the meaning provided in the Amended Credit Agreement).
W I T N E S S E T H
WHEREAS, the Borrowers have requested that the Administrative Agent and the Required Lenders agree to amend the Existing Credit Agreement as provided for herein; and
WHEREAS, the Borrowers, the Administrative Agent and the Required Lenders have agreed to amend the Existing Credit Agreement as provided for herein.
NOW, THEREFORE, the parties hereto agree as follows:
SECTION 1.Amendments of the Existing Credit Agreement. On the terms and subject to the conditions set forth herein, effective as of the Amendment Effective Date (as defined below), the Existing Credit Agreement is hereby amended as follows:
(a)    Section 1.01 of the Existing Credit Agreement is hereby amended by adding the following new defined terms in the appropriate alphabetical order:
“Affected Financial Institution” means (a) any EEA Financial Institution or (b) any UK Financial Institution.
“Beneficial Ownership Certification” means a certification regarding beneficial ownership required by the Beneficial Ownership Regulation.
“Beneficial Ownership Regulation” means 31 C.F.R. § 1010.230.
“BHC Act Affiliate” of a party means an “affiliate” (as such term is defined under, and interpreted in accordance with, 12 U.S.C. 1841(k)) of such party.
“BofA Securities” means BofA Securities, Inc. (or any other registered broker-dealer wholly-owned by Bank of America Corporation to which all or substantially all of Bank of America Corporation’s or any of its subsidiaries’ investment banking, commercial lending services or related businesses may be transferred following the date of this Agreement) and its successors. BofA Securities is not a party hereto, but shall be entitled to the benefits provided by this Agreement to the Indemnitees.

1
Exhibit 10(i)

“Covered Entity” means any of the following:
(i)    a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b);
(ii)    a “covered bank” that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or
(iii)    a “covered FST” that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).
“Covered Party” has the meaning assigned to in in Section 10.24.
“Default Right” has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable.
“QFC” has the meaning assigned to the term “qualified financial contract” in, and shall be interpreted in accordance with, 12 U.S.C. 5390(c)(8)(D).
“QFC Credit Support” has the meaning assigned to it in Section 10.24.
“Resolution Authority” means an EEA Resolution Authority or, with respect to any UK Financial Institution, a UK Resolution Authority.
“Supported QFC” has the meaning assigned to it in Section 10.24.
“UK Financial Institution” means any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended form time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person falling within IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.
“UK Resolution Authority” means the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.
“U.S. Special Resolution Regime” has the meaning assigned to it in Section 10.24.
(b)    Section 1.01 of the Existing Credit Agreement is hereby amended by deleting each of the defined terms “Arrangers”, “Bail-In Action”, “Bail-In Legislation”, “Relevant Resolution Authority” and “Write-Down and Conversion Powers” in their entirety and replacing them as follows:
“Arrangers” means BofA Securities and WFS, in their capacity as joint lead arrangers and joint bookrunners. The Arrangers, in such capacity, are not party hereto but shall be entitled to the benefits provided by this Agreement to the Indemnitees.

2
Exhibit 10(i)

“Bail-In Action” means the exercise of any Write-Down and Conversion Powers by the Relevant Resolution Authority in respect of any liability of an Affected Financial Institution.
“Bail-In Legislation” means, (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the European Union, the implementing law, regulation, rule or requirement for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule and (b) with respect to the United Kingdom, Part I of the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings).
“Relevant Resolution Authority” means, with respect to any Affected Financial Institution, the Resolution Authority with the ability to exercise any Write-Down and Conversion Powers in relation to such Affected Financial Institution.
“Write-Down and Conversion Powers” means, (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule. and (b) with respect to the United Kingdom, any powers of the Relevant Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change the form of a liability of any UK Financial Institution or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers.
(c)    Article I of the Existing Credit Agreement is hereby amended by adding a new Section 1.11 as follows:
1.11    Divisions. For all purposes under the Loan Documents, in connection with any division or plan of division under Delaware law (or any comparable event under a different jurisdiction’s laws): (a) if any asset, right, obligation or liability of any Person becomes the asset, right, obligation or liability of a different Person, then it shall be deemed to have been transferred from the original Person to the subsequent Person, and (b) if any new Person comes into existence, such new Person shall be deemed to have been organized and acquired on the first date of its existence by the holders of its Equity Interests at such time.
(d)    Section 5.13 of the Existing Credit Agreement is hereby amended and restated in its entirety as follows:

3
Exhibit 10(i)

5.13    Affected Financial Institutions. No Borrower is or such Designated Borrower is not, as the case may be, an Affected Financial Institution.
(e)    Section 6.02 of the Existing Credit Agreement is hereby amended by (i) deleting the word “and” appearing at the conclusion of clause (b) thereof, (ii) replacing the period at the end of clause (c) thereof with “; and”, and (iii) inserting a new clause (d) thereof as follows:
(d)    promptly following any request therefor, provide information and documentation reasonably requested by the Administrative Agent or any Lender for purposes of compliance with applicable “know your customer” and anti-money-laundering rules and regulations, including, without limitation, the Patriot Act and the Beneficial Ownership Regulation.
(f)    Section 7.05 of the Existing Credit Agreement is hereby amended and restated in its entirety as follows:
7.05    Leverage Ratio. Permit the Leverage Ratio to be greater than (i) 3.5 to 1.0 at the end of any fiscal quarter of the Company ending on or prior to March 31, 2020, (ii) 4.5 to 1.0 at the end of any fiscal quarter of the Company ending after March 31, 2020 but on or prior to June 30, 2021, and (iii) 3.5 to 1.0 at the end of any fiscal quarter of the Company ending after June 30, 2021; provided that the Company may, only twice during the term of this Agreement, in connection with an Acquisition for which the aggregate consideration paid or to be paid in respect thereof exceeds $500,000,000, elect to increase the maximum Leverage Ratio permitted hereunder by 0.5 to 1.0 for a period of four consecutive fiscal quarters commencing with the fiscal quarter in which such Acquisition occurs (any such election in respect of the maximum Leverage Ratio pursuant to this Section 7.05 being referred to as an “Acquisition Holiday”); provided, further that at least one (1) complete fiscal quarter must have elapsed between the end of the first Acquisition Holiday and the beginning of the second Acquisition Holiday.
(g)    Section 10.22 of the Existing Credit Agreement is hereby amended and restated in its entirety as follows:

4
Exhibit 10(i)

10.22    Acknowledgement and Consent to Bail-In of Affected Financial Institutions. Solely to the extent any Lender or L/C Issuer that is an Affected Financial Institution is a party to this Agreement and notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any Lender or L/C Issuer that is an Affected Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of the Relevant Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by:
(a)    the application of any Write-Down and Conversion Powers by the Relevant Resolution Authority to any such liabilities arising hereunder which may be payable to it by any Lender or L/C Issuer that is an Affected Financial Institution; and
(b)    the effects of any Bail-In Action on any such liability, including, if applicable:
(i)    a reduction in full or in part or cancellation of any such liability;
(ii)    a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such Affected Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document; or
(iii)    the variation of the terms of such liability, as deemed necessary by the Relevant Resolution Authority, to give effect to the exercise of the Write-Down and Conversion Powers of the Relevant Resolution Authority.
(h)    Article X of the Existing Credit Agreement is hereby amended by adding a new Section 10.24 as follows:
10.24    Acknowledgement Regarding Any Supported QFCs. To the extent that the Loan Documents provide support, through a guarantee or otherwise, for any Swap Contract or any other agreement or instrument that is a QFC (such support, “QFC Credit Support”, and each such QFC, a “Supported QFC”), the parties acknowledge and agree as follows with respect to the resolution power of the Federal Deposit Insurance Corporation under the Federal Deposit Insurance Act and Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act (together with the regulations promulgated thereunder, the “U.S. Special Resolution Regimes”) in respect of such Supported QFC and QFC Credit Support (with the provisions below applicable notwithstanding that the Loan Documents and any Supported QFC may in fact be stated to be governed by the laws of the State of New York and/or of the United States or any other state of the United States):
(a)    In the event a Covered Entity that is party to a Supported QFC (each, a “Covered Party”) becomes subject to a proceeding under a U.S. Special Resolution

5
Exhibit 10(i)

Regime, the transfer of such Supported QFC and the benefit of such QFC Credit Support (and any interest and obligation in or under such Supported QFC and such QFC Credit Support, and any rights in property securing such Supported QFC or such QFC Credit Support) from such Covered Party will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if the Supported QFC and such QFC Credit Support (and any such interest, obligation and rights in property) were governed by the laws of the United States or a state of the United States. In the event a Covered Party or a BHC Act Affiliate of a Covered Party becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under the Loan Documents that might otherwise apply to such Supported QFC or any QFC Credit Support that may be exercised against such Covered Party are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if the Supported QFC and the Loan Documents were governed by the laws of the United States or a state of the United States. Without limitation of the foregoing, it is understood and agreed that rights and remedies of the parties with respect to a Defaulting Lender shall in no event affect the rights of any Covered Party with respect to a Supported QFC or any QFC Credit Support.
(b)    As used in this Section 10.24, the following terms have the following meanings:
“BHC Act Affiliate” of a party means an “affiliate” (as such term is defined under, and interpreted in accordance with, 12 U.S.C. 1841(k)) of such party.
“Covered Entity” means any of the following: (i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b); (ii) a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or (iii) a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).
“Default Right” has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable.
“QFC” has the meaning assigned to the term “qualified financial contract” in, and shall be interpreted in accordance with, 12 U.S.C. 5390(c)(8)(D).
SECTION 2.    Conditions to Effectiveness of Amendment. The amendment of the Existing Credit Agreement set forth herein shall become effective as of the first date on which each of the following conditions to effectiveness have been satisfied or have been waived in accordance with Section 10.01 of the Existing Credit Agreement (the “Amendment Effective Date”):
(a)    The Administrative Agent shall have received a counterpart of this Amendment Agreement, executed and delivered by a duly authorized officer of each of the Borrowers and by the Required Lenders.

6
Exhibit 10(i)

(b)    The Administrative Agent shall have received (i) for the account of each Lender that provides to the Administrative Agent its executed signature page to this Amendment by 5:00 p.m. (Eastern time) on April 29, 2020, a consent fee in an amount equal to $10,000 for each such consenting Lender, and (ii) payment of all expenses required to be reimbursed by the Borrowers under or in connection with this Amendment Agreement, including those expenses set forth in Section 5 hereof.
(c)    The representations and warranties made or deemed to be made in Section 3 hereof shall be true and correct.
(d)    (i) Upon the reasonable request of any Lender made at least five days prior to the Amendment Effective Date, the Borrower shall have provided to such Lender, and such Lender shall be reasonably satisfied with, the documentation and other information so requested in connection with applicable “know your customer” and anti-money-laundering rules and regulations, including, without limitation, the Patriot Act, in each case at least three days prior to the Amendment Effective Date and (ii) at least three days prior to the Amendment Effective Date, any Borrower that qualifies as a “legal entity customer” under the Beneficial Ownership Regulation shall have delivered, to each Lender that so requests at least five days prior to the Amendment Effective Date, a Beneficial Ownership Certification in relation to such Borrower (it being understood that, upon the execution and delivery by any Lender of its signature page to this Amendment, the condition set forth in this clause (d) shall be deemed to be satisfied as to such Lender).
The Administrative Agent shall notify the Borrowers and the Lenders of the Amendment Effective Date and such notice shall be conclusive and binding.
SECTION 3.    Representations and Warranties. Each of the Borrowers hereby represents and warrants to the Administrative Agent and each Lender on the Amendment Effective Date that:
(a)    The execution, delivery and performance by each Borrower of this Amendment Agreement and the performance by each Borrower of the Amended Credit Agreement has been duly authorized by all necessary corporate or other organizational action.
(b)    This Amendment Agreement has been duly executed and delivered by each Borrower.
(c)    This Amendment Agreement and the Amended Credit Agreement constitute legal, valid and binding obligations of such Borrower, enforceable against such Borrower in accordance with its terms, except as may be limited by bankruptcy, solvency, reorganization, moratorium or similar law relating to or limiting creditor’s rights generally or by equitable principles relating to enforceability.
(d)    After giving effect to this Amendment Agreement, the representations and warranties of the Borrowers contained in Article V of the Amended Credit Agreement or in any other Loan Documents (other than those representations and warranties in Sections 5.01(b)(i), 5.01(c), 5.01(d), all of Sections 5.06 and 5.08, the last sentence of Section 5.09 and all of Section 5.10

7
Exhibit 10(i)

of the Amended Credit Agreement) shall be true and correct in all material respects (or in all respects in the case of any representation and warranty qualified by materiality or “Material Adverse Effect”) on and as of the Amendment Effective Date, except that to the extent that such representations and warranties specifically refer to an earlier date, in which case they shall be true and correct in all material respects (or in all respects in the case of any representation and warranty qualified by materiality or “Material Adverse Effect”) as of such earlier date.
(e)    After giving effect to this Amendment Agreement, no Default or Event of Default has occurred and is continuing or would result from this Amendment Agreement.
(f)    As of the Amendment Effective Date, the information included in any Beneficial Ownership Certification delivered as of the date hereof, if applicable, is true and correct in all respects.
SECTION 4.    Effects on Loan Documents; No Novation. o Except as expressly set forth herein, this Amendment Agreement shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Existing Credit Agreement, the Amended Credit Agreement or any other Loan Document, all of which shall continue to be in full force and effect and are hereby in all respects ratified and confirmed.
(b)    The execution, delivery and effectiveness of this Amendment Agreement shall not operate as a waiver of any right, power or remedy of any Lender or the Administrative Agent under any of the Loan Documents, nor constitute a waiver of any provision of the Loan Documents or in any way limit, impair or otherwise affect the rights and remedies of the Administrative Agent or the Lenders under the Loan Documents. Nothing herein shall be deemed to entitle any Borrower to a consent to, or a waiver, amendment, modification or other change of, any of the terms, conditions, obligations, covenants or agreements contained in the Amended Credit Agreement or any other Loan Document in similar or different circumstances.
(c)    On and after the Amendment Effective Date, each reference in the Amended Credit Agreement to “this Agreement”, “hereunder”, “hereof”, “herein” or words of like import, and each reference to the “Credit Agreement”, “thereunder”, “thereof”, “therein” or words of like import in any other Loan Document, shall be deemed a reference to the Amended Credit Agreement. The Borrowers and the other parties hereto acknowledge and agree that this Amendment Agreement shall constitute a Loan Document for all purposes of the Existing Credit Agreement, the Amended Credit Agreement and the other Loan Documents.
(d)    Neither this Amendment Agreement nor the effectiveness of the Amended Credit Agreement shall extinguish the obligations for the payment of money outstanding under the Existing Credit Agreement. Nothing herein contained shall be construed as a substitution or novation of the Obligations outstanding under the Existing Credit Agreement, which shall remain in full force and effect, except as modified hereby or by instruments executed concurrently herewith. Nothing expressed or implied in this Amendment Agreement, the Amended Credit Agreement or any other document contemplated hereby or thereby shall be construed as a release or other discharge of any Borrower under any Loan Document from any of its obligations and liabilities thereunder.

8
Exhibit 10(i)

SECTION 5.    Expenses. The Borrowers agree to reimburse the Administrative Agent for its reasonable and documented out of pocket expenses in connection with this Amendment Agreement to the extent required under Section 10.04(a) of the Existing Credit Agreement.
SECTION 6.    GOVERNING LAW, JURISDICTION, WAIVER OF JURY TRIAL. THE PROVISIONS OF SECTIONS 10.18 AND 10.19 OF THE EXISTING CREDIT AGREEMENT ARE HEREBY INCORPORATED BY REFERENCE HEREIN, MUTATIS MUTANDIS.
SECTION 7.    Counterparts; Electronic Signatures. This Amendment Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. Delivery of an executed counterpart of a signature page of this Amendment Agreement by facsimile or in electronic format (i.e., “pdf” or “tif”) shall be effective as delivery of a manually executed counterpart of this Amendment Agreement. The words “execution,” “signed,” “signature,” and words of like import in this Amendment Agreement shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, or any other state laws based on the Uniform Electronic Transactions Act.
SECTION 8.    Notices. All notices, requests and demands to or upon the respective parties hereto shall be given in the manner, and become effective, as set forth in Section 10.02 of the Existing Credit Agreement.
SECTION 9.    Headings. Section headings in this Amendment are included herein for convenience of reference only and shall not constitute a part of this Amendment for any other purpose.
[Remainder of page intentionally left blank.]



9
Exhibit 10(i)

IN WITNESS WHEREOF, the parties hereto have caused this Amendment Agreement to be duly executed and delivered by their respective proper and duly authorized officers as of the day and year first above written.
STRYKER CORPORATION
By:
/s/ JEANNE M. BLONDIA
 
Name: Jeanne M. Blondia
 
Title: Vice President, Finance and Treasurer
STRYKER HOLDINGS B.V.
By:
/s/ Stuart Silk
 
Name: Stuart Silk
 
Title: Director
STRYKER INTERNATIONAL HOLDINGS B.V.
By:
/s/ Stuart Silk
 
Name: Stuart Silk
 
Title: Director
STRYKER CAPITAL B.V.
By:
/s/ Stuart Silk
 
Name: Stuart Silk
 
Title: Director
STRYKER IFSC DESIGNATED ACTIVITY COMPANY
By:
/s/ HUGH COURTNEY
 
Name: Hugh Courtney
 
Title: Director
STRYKER EUROPEAN OPERATIONS LIMITED
By:
/s/ HUGH COURTNEY
 
Name: Hugh Courtney
 
Title: Director





Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)


BANK OF AMERICA, N.A., as the Administrative Agent
By:
/s/ MOLLIE S. CANUP
 
Name: Mollie S. Canup
 
Title: Vice President


Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)


Bank of America, N.A.                           , as a Lender
By:
/s/ YINGHUA ZHANG
 
Name: Yinghua Zhang
 
Title: Director

Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)


IN WITNESS WHEREOF, the undersigned has caused this Amendment to be executed as of the date first written above.

WELLS FARGO BANK, NATIONAL ASSOCIATION
By:
/s/ ANDREA S. CHEN
 
Name: Andrea S. Chen
 
Title: Managing Director

Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)

JPMorgan Chase Bank, N.A., as a Lender
By:
/s/ HELEN D. DAVIS
 
Name: Helen D. Davis
 
Title: Authorized Officer

Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)

BARCLAYS BANK PLC, as a Lender
By:
/s/ EVAN MORIARTY
 
Name: Evan Moriarty
 
Title: Vice President


Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)


BNP Paribas, as a Lender
By:
/s/ BRENDAN HENEGHAN
 
Name: Brendan Heneghan
 
Title: Director

By:
/s/ CHRISTOPHER SKED
 
Name: Christopher Sked
 
Title: Managing Director


Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)

IN WITNESS WHEREOF, the undersigned has caused this Amendment to be executed as of the date first written above.

Citibank, N.A.
By:
/s/ PANJAL GAMBHIR
 
Name: Panjal Gambhir
 
Title: Vice President


Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)


MIZUHO BANK, LTD., as a Lender
By:
/s/ TRACY RAHN
 
Name: Tracy Rahn
 
Title: Executive Director

Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)


Goldman Sachs Bank USA, as a Lender
By:
/s/ JAMIE MINIERI
 
Name: Jamie Minieri
 
Title: Authorized Signatory

Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)


MUFG BANK, LTD., as a Lender
By:
/s/ DAVID MEISNER
 
Name: David Meisner
 
Title: Vice President

Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)


HSBC Bank USA, N.A., as a Lender
By:
/s/ IAIN STEWART
 
Name: Iain Stewart
 
Title: Managing Director


Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)

IN WITNESS WHEREOF, the undersigned has caused this Amendment to be executed as of the date first written above.

Morgan Stanley Bank, N.A.
By:
/s/ GILROY D'SOUZA
 
Name: Gilroy D'Souza
 
Title: Authorized Signatory


Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)

IN WITNESS WHEREOF, the undersigned has caused this Amendment to be executed as of the date first written above.

The Northern Trust Company
By:
/s/ WILL HICKS
 
Name: Will Hicks
 
Title: Vice President

Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)

IN WITNESS WHEREOF, the undersigned has caused this Amendment to be executed as of the date first written above.

PNC BANK, NATIONAL ASSOCIATION, as a Lender
By:
/s/ BROCK DANA
 
Name: Brock Dana
 
Title: Senior Vice President


Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)

IN WITNESS WHEREOF, the undersigned has caused this Amendment to be executed as of the date first written above.

Citizens Bank, N.A.
By:
/s/ MARK GUYESKI
 
Name: Mark Guyeski
 
Title: Vice President

Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

Exhibit 10(i)

IN WITNESS WHEREOF, the undersigned has caused this Amendment to be executed as of the date first written above.

US Bank, National Association
By:
/s/ MICHAEL WEST
 
Name: Michael West
 
Title: Senior Vice President






Signature Page to Amendment No. 1 to Credit Agreement
Stryker Corporation, et al.

 EX-10.2 3 ex10ii364creditagreement.htm EXHIBIT 10.2 Exhibit
Exhibit 10(ii)

EXECUTION COPY

CREDIT AGREEMENT
Dated as of April 30, 2020
among
STRYKER CORPORATION

as Borrower,

BANK OF AMERICA, N.A.,
as Administrative Agent,
WELLS FARGO BANK, NATIONAL ASSOCIATION,
JPMORGAN CHASE BANK, N.A.
and BNP PARIBAS,
as Co-Documentation Agents,
and
the Other Lenders Party Hereto


BOFA SECURITIES, INC.,
WELLS FARGO SECURITIES, LLC, JPMORGAN CHASE BANK, N.A.
and BNP PARIBAS SECURITIES CORP.
as
Joint Lead Arrangers and Joint Bookrunners




TABLE OF CONTENTS
exhibit10ii.jpg




 
 
Page
ARTICLE I
DEFINITIONS AND ACCOUNTING TERMS
1
 
 
 
1.01
Defined Terms
1
1.02
Other Interpretive Provisions
18
1.03
Accounting Terms
19
1.04
Rounding
20
1.05
References to Agreements and Laws
20
1.06
Times of Day
20
1.07
Divisions
20
 
 
 
ARTICLE II
THE COMMITMENTS AND BORROWINGS
20
 
 
 
2.01
Loans
20
2.02
Borrowings, Conversions and Continuations of Loans
20
2.03
Prepayments
22
2.04
Reduction or Termination of Commitments
22
2.05
Repayment of Loans
23
2.06
Interest
23
2.07
Fees
23
2.08
Computation of Interest and Fees
24
2.09
Evidence of Debt
24
2.10
Payments Generally; Administrative Agent’s Clawback
24
2.11
Sharing of Payments
26
2.12
Defaulting Lenders
26
 
 
 
ARTICLE III
TAXES, YIELD PROTECTION AND ILLEGALITY
27
 
 
 
3.01
Taxes
27
3.02
Illegality
29
3.03
Inability to Determine Rates; LIBOR Successor Rate
30
3.04
Increased Cost and Reduced Return; Capital Adequacy; Reserves on LIBOR Rate Loans
32
3.05
Funding Losses
34
3.06
Survival
34
 
 
 
ARTICLE IV
CONDITIONS PRECEDENT TO BORROWINGS
35
 
 
 
4.01
Conditions of Effectiveness of this Agreement
35
4.02
Conditions to all Borrowings
36
 
 
 
ARTICLE V
REPRESENTATIONS AND WARRANTIES
37
 
 
 
5.01
Existence, Qualification and Power; Compliance with Laws
37
5.02
Authorization; No Contravention
37
5.03
Governmental and Third-Party Authorization
37

 
i
 

TABLE OF CONTENTS
(continued)

 
 
Page
5.04
Binding Effect
37
5.05
Financial Statements
37
5.06
Litigation
37
5.07
No Default
38
5.08
Environmental Compliance
38
5.09
Taxes
38
5.10
ERISA Compliance
38
5.11
Margin Regulations; Investment Company Act; Anti-Corruption Laws and Sanctions
39
5.12
Disclosure
39
5.13
Affected Financial Institutions
40
 
 
 
ARTICLE VI
AFFIRMATIVE COVENANTS
40
 
 
 
6.01
Financial Statements
40
6.02
Certificates; Other Information
40
6.03
Notices
41
6.04
Payment of Taxes
42
6.05
Preservation of Existence, Etc.
42
6.06
Maintenance of Properties
42
6.07
Maintenance of Insurance
42
6.08
Compliance with Laws
42
6.09
Books and Records
42
6.10
Inspection Rights
42
6.11
Use of Proceeds
42
 
 
 
ARTICLE VII
NEGATIVE COVENANTS
43
 
 
 
7.01
Liens
43
7.02
Subsidiary Indebtedness
45
7.03
Fundamental Changes
46
7.04
Dispositions
46
7.05
Leverage Ratio
46
 
 
 
ARTICLE VIII
EVENTS OF DEFAULT AND REMEDIES
47
 
 
 
8.01
Events of Default
47
8.02
Remedies Upon Event of Default
48
8.03
Application of Funds
48
 
 
 
ARTICLE IX
ADMINISTRATIVE AGENT
49
 
 
 
9.01
Appointment and Authorization of Administrative Agent
49
9.02
Rights as a Lender
49
9.03
Exculpatory Provisions
49
9.04
Reliance by Administrative Agent
50

 
ii
 

TABLE OF CONTENTS
(continued)

 
 
Page
9.05
Delegation of Duties
51
9.06
Resignation of Administrative Agent
51
9.07
Non-Reliance on Administrative Agent and Other Lenders
52
9.08
No Other Duties, Etc.
52
9.09
Administrative Agent May File Proofs of Claim
52
 
 
 
ARTICLE X
MISCELLANEOUS
52
 
 
 
10.01
Amendments, Etc.
53
10.02
Notices; Effectiveness; Electronic Communication
54
10.03
No Waiver; Cumulative Remedies; Enforcement
56
10.04
Expenses; Indemnity; Damage Waiver
56
10.05
Payments Set Aside
58
10.06
Successors and Assigns
58
10.07
Treatment of Certain Information; Confidentiality
62
10.08
Set-off
63
10.09
Interest Rate Limitation
63
10.10
Counterparts; Integration; Effectiveness
64
10.11
Survival of Representations and Warranties
64
10.12
Severability
64
10.13
No advisory or Fiduciary Responsibility
64
10.14
Electronic Execution of Assignments and Certain Other Documents
65
10.15
Tax Forms
65
10.16
Replacement of Lenders
66
10.17
Governing Law; Jurisdiction; Etc.
67
10.18
Waiver of Jury Trial
68
10.19
USA PATRIOT Act Notice
68
10.20
Acknowledgement and Consent to Bail-In of Affected Financial Institutions
68
10.21
ENTIRE AGREEMENT
69
10.22
Acknowledgement Regarding Any Supported QFCs
69


 
iii
 

TABLE OF CONTENTS
(continued)

SCHEDULES
2.01    Commitments and Applicable Percentages
5.10(d)    Pension Plans
7.01    Existing Liens
7.02    Existing Indebtedness
10.02    Addresses for Notices

EXHIBITS
Form of
A    Loan Notice
B    Note
C    Compliance Certificate
D-1    Assignment and Assumption
D-2    Administrative Questionnaire


 
iv
 

Exhibit 10(ii)

CREDIT AGREEMENT
This CREDIT AGREEMENT (“Agreement”) is entered into as of April 30, 2020, among STRYKER CORPORATION, a Michigan corporation (the “Borrower”), each lender from time to time party hereto (collectively, the “Lenders” and individually, a “Lender”), and BANK OF AMERICA, N.A., as Administrative Agent.
In consideration of the mutual covenants and agreements herein contained, the parties hereto covenant and agree as follows:
Article I
DEFINITIONS AND ACCOUNTING TERMS
1.01    Defined Terms. As used in this Agreement, the following terms shall have the meanings set forth below:
“Acquired Indebtedness” means Indebtedness of any Person (a) that is existing at the time such Person is acquired by, or merged or consolidated with or into, the Borrower or a Subsidiary of the Borrower or that is secured by an asset (and only such asset) when such asset is acquired by the Borrower or a Subsidiary, and (b) that is not created in contemplation of such Person becoming a Subsidiary or such acquisition.
“Acquisition” means the acquisition of (i) a controlling equity or other ownership interest in another Person, or (ii) assets of another Person which constitute all or substantially all of the assets of such Person or of a line or lines of business conducted by such Person.
“Acquisition Adjustments” means the adjustments to certain financial terms and computations more particularly described in Section 1.03(c).
“Acquisition Holiday” has the meaning assigned to such term in Section 7.05.
“Administrative Agent” means Bank of America (including its branches and affiliates) in its capacity as administrative agent under any of the Loan Documents, or any successor administrative agent.
“Administrative Agent’s Office” means the Administrative Agent’s address as the Administrative Agent may from time to time notify to the Borrower and the Lenders.
“Administrative Questionnaire” means an Administrative Questionnaire in substantially the form of Exhibit D-2 or any other form approved by the Administrative Agent.
“Affected Financial Institution” means (a) any EEA Financial Institution or (b) any UK Financial Institution.
“Affiliate” means, with respect to any Person, another Person that directly, or indirectly through one or more intermediaries, Controls or is Controlled by or is under common Control with the Person specified.
“Aggregate Commitments” means the Commitments of all the Lenders.
“Agreement” means this Credit Agreement.

1    
Exhibit 10(ii)

“Anti-Corruption Laws” means all laws, rules, and regulations of any jurisdiction applicable to the Borrower or its Subsidiaries from time to time concerning or relating to bribery or corruption, including, without limitation, the United States Foreign Corrupt Practices Act of 1977 and the UK Bribery Act 2010.
“Applicable Margin” means, from time to time, for the purpose indicated, the respective percentages per annum, based upon the Issuer Rating, as set forth below:
Pricing Level
Issuer Rating 
S&P/Moody’s
Facility Fee
LIBOR Rate Loans

Base Rate Loans
1
> A+ / A1
0.20%
1.050%
0.050%
2
A / A2
0.25%
1.125%
0.125%
3
A- / A3
0.30%
1.200%
0.200%
4
BBB+ / Baa1
0.35%
1.275%
0.275%
5
< BBB / Baa2
0.40%
1.350%
0.350%

“Issuer Rating” means, as of any date of determination, the long-term issuer credit rating as determined by either S&P or Moody’s (collectively, the “Issuer Ratings”) of the Borrower. In the case of a split rating, the higher rating will apply (with Pricing Level 1 above being the highest and Pricing Level 5 above being the lowest), in the case of a multiple split rating, the rating that is one level lower than the higher rating will apply, and in the case of only one rating, such rating will apply.
Effective as of the Closing Date, the Applicable Margin shall be based on Pricing Level 3. Thereafter, each change in the Applicable Margin resulting from a publicly announced change in the Issuer Rating shall be effective during the period commencing on the date of the public announcement thereof and ending on the date immediately preceding the effective date of the next such change. Notwithstanding the foregoing, at any time no Issuer Rating exists, the Applicable Margin shall be based on Pricing Level 5.
“Applicable Percentage” means with respect to any Lender at any time, the percentage (carried out to the ninth decimal place) of the Aggregate Commitments represented by such Lender’s Commitment at such time; provided that, in the case of Section 2.12 when a Defaulting Lender shall exist, “Applicable Percentage” shall mean the percentage of the Aggregate Commitments (disregarding any Defaulting Lender’s Commitment) represented by such Lender’s Commitment. If the commitment of each Lender to make Loans has been terminated pursuant to Section 8.02 or if the Aggregate Commitments have expired, then the Applicable Percentage of each Lender shall be determined based on the Applicable Percentage of such Lender most recently in effect, giving effect to any subsequent assignments and to any Lender’s status as a Defaulting Lender at the time of determination. The initial Applicable Percentage of each Lender is set forth opposite the name of such Lender on Schedule 2.01 or in the Assignment and Assumption pursuant to which such Lender becomes a party hereto, as applicable.
“Approved Fund” means any Fund that is administered or managed by (a) a Lender, (b) an Affiliate of a Lender or (c) an entity or an Affiliate of an entity that administers or manages a Lender.
“Arranger” means BofA Securities, in its capacity as joint lead arranger and joint bookrunner. The Arranger, in such capacity, is not party hereto but shall be entitled to the benefits provided by this Agreement to the Indemnitees.

2    
Exhibit 10(ii)

“Assignee Group” means two or more Eligible Assignees that are Affiliates of one another or two or more Approved Funds managed by the same investment advisor.
“Assignment and Assumption” means an assignment and assumption entered into by a Lender and an Eligible Assignee (with the consent of any party whose consent is required by Section 10.06(b)), and accepted by the Administrative Agent, in substantially the form of Exhibit D-1 or any other form (including electronic documentation generated by use of an electronic platform) approved by the Administrative Agent.
“Attributable Indebtedness” means, on any date, in respect of any Permitted Securitization Transaction, the net outstanding amount theretofore paid, directly or indirectly, by a funding source to a Securitization Entity in respect of the assets sold, conveyed, contributed or transferred or pledged in connection with such Permitted Securitization Transaction (it being the intent of the parties that the amount of Attributable Indebtedness at any time outstanding approximate as closely as possible the principal amount of Indebtedness which would be outstanding at such time under the Permitted Securitization Transaction, if the same were structured as a secured lending agreement rather than an agreement providing for the sale, conveyance, contribution to capital, transfer or pledge of such assets or interests therein).
“Audited Financial Statements” means the audited consolidated balance sheet of the Borrower and its Subsidiaries for the fiscal year ended December 31, 2019, and the related consolidated statements of earnings, stockholders’ equity and cash flows for such fiscal year of the Borrower and its Subsidiaries, including the notes thereto.
“Availability Period” means the period from and including the Closing Date to the earliest of (a) the Maturity Date, (b) the date of termination of the Aggregate Commitments pursuant to Section 2.04, and (c) the date of termination of the commitment of each Lender to make Loans pursuant to Section 8.02.
“Bail-In Action” means the exercise of any Write-Down and Conversion Powers by the Relevant Resolution Authority in respect of any liability of an Affected Financial Institution.
“Bail-In Legislation” means, (a) with respect to any EEA Member Country implementing Article 55 of Directive 2014/59/EU of the European Parliament and of the Council of the European Union, the implementing law, regulation, rule or requirement for such EEA Member Country from time to time which is described in the EU Bail-In Legislation Schedule and (b) with respect to the United Kingdom, Part I of the United Kingdom Banking Act 2009 (as amended from time to time) and any other law, regulation or rule applicable in the United Kingdom relating to the resolution of unsound or failing banks, investment firms or other financial institutions or their affiliates (other than through liquidation, administration or other insolvency proceedings).
“Bank of America” means Bank of America, N.A. and its successors.
“Base Rate” means, for any day, a rate per annum equal to the greatest of (a) the Prime Rate in effect on such day, (b) the Federal Funds Rate in effect on such day plus ½ of 1% and (c) the LIBOR Rate for a one month Interest Period on such day (or if such day is not a Business Day, the immediately preceding Business Day) plus 1%, provided that, for the avoidance of doubt, the LIBOR Rate for any day shall be based on the rate appearing on the applicable Bloomberg screen page (or, to the extent not available on such page, on any successor or substitute page of such page as shall be selected by the Administrative Agent from time to time in its reasonable discretion) at approximately 11:00 a.m. London time on such day. Any change in the Base Rate due to a change in the Prime Rate, the Federal Funds Rate or the LIBOR Rate shall be effective from and including the effective date of such change in the Prime Rate, the Federal Funds Rate or

3    
Exhibit 10(ii)

the LIBOR Rate, respectively. For the avoidance of doubt, if the Base Rate shall be less than 1.75%, such rate shall be deemed to be 1.75% for purposes of this Agreement.
“Base Rate Loan” means a Loan that bears interest based on the Base Rate.
“Beneficial Ownership Certification” means a certification regarding beneficial ownership required by the Beneficial Ownership Regulation.
“Beneficial Ownership Regulation” means 31 C.F.R. § 1010.230.
“BHC Act Affiliate” has the meaning assigned to it in Section 10.22.
“BofA Securities” means BofA Securities, Inc. (or any other registered broker-dealer wholly-owned by Bank of America Corporation to which all or substantially all of Bank of America Corporation’s or any of its subsidiaries’ investment banking, commercial lending services or related businesses may be transferred following the date of this Agreement) and its successors. BofA Securities is not a party hereto, but shall be entitled to the benefits provided by this Agreement to the Indemnitees.
“Borrower” has the meaning set forth in the introductory paragraph hereto.
“Borrowing” means a borrowing consisting of simultaneous Loans of the same Type and, as to LIBOR Rate Loans, having the same Interest Period made by each of the Lenders pursuant to Section 2.01.
“Business Day” means any day other than a Saturday, Sunday or other day on which commercial banks are authorized to close under the Laws of, or are in fact closed in, New York City and, if such day relates to any interest rate settings as to a LIBOR Rate Loan, any fundings, disbursements, settlements and payments in respect of any such LIBOR Rate Loan, or any other dealings to be carried out pursuant to this Agreement in respect of any such LIBOR Rate Loan, means any such day that is also a London Banking Day.
“Change in Law” means the occurrence, after the date of this Agreement (or with respect to any Lender, if later, the date on which such Lender becomes a Lender), of any of the following: (a) the adoption or taking effect of any law, rule, regulation or treaty, (b) any change in any law, rule, regulation or treaty or in the administration, interpretation, implementation or application thereof by any Governmental Authority, or (c) the making or issuance of any request, rules, guideline, requirement or directive (whether or not having the force of law) by any Governmental Authority; provided however, that notwithstanding anything herein to the contrary, (i) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines, requirements and directives thereunder, issued in connection therewith or in implementation thereof, and (ii) all requests, rules, guidelines, requirements and directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities, in each case pursuant to Basel III, shall in each case be deemed to be a “Change in Law” regardless of the date enacted, adopted, issued or implemented.
“Change of Control” means, with respect to any Person, an event or series of events by which:
(a)    any “person” or “group” (as such terms are used in Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, but excluding any employee benefit plan of such Person or its Subsidiaries, and any person or entity acting in its capacity as trustee, agent or other fiduciary or administrator of any such plan) other than any member or members of the Stryker Family Group becomes the “beneficial owner” (as defined in Rules 13d-3 and 13d-5 under the Securities Exchange

4    
Exhibit 10(ii)

Act of 1934, except that a person or group shall be deemed to have “beneficial ownership” of all securities that such person or group has the right to acquire (such right, an “option right”), whether such right is exercisable immediately or only after the passage of time), directly or indirectly, of 35% or more of the equity securities of such Person entitled to vote for members of the board of directors or equivalent governing body of such Person on a fully diluted basis (i.e., taking into account all such securities that such person or group has the right to acquire pursuant to any option right); or
(b)    during any period of 12 consecutive months, a majority of the members of the board of directors or other equivalent governing body of such Person cease to be composed of individuals (i) who were members of that board or equivalent governing body on the first day of such period, (ii) whose election or nomination to that board or equivalent governing body was approved by individuals referred to in clause (i) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body or (iii) whose election or nomination to that board or other equivalent governing body was approved by individuals referred to in clauses (i) and (ii) above constituting at the time of such election or nomination at least a majority of that board or equivalent governing body.
“Closing Date” means the first date all the conditions precedent in Section 4.01 are satisfied or waived in accordance with Section 4.01 (or, in the case of Section 4.01(b), waived by the Person entitled to receive the applicable payment).
“Code” means the United States Internal Revenue Code of 1986, as amended, and all regulations issued pursuant thereto.
“Commitment” means, as to each Lender, its obligation to make Loans to the Borrower pursuant to Section 2.01 in an aggregate principal amount at any one time outstanding not to exceed the amount set forth opposite such Lender’s name on Schedule 2.01 or in the Assignment and Assumption or other documentation contemplated hereby pursuant to which such Lender becomes a party hereto, as applicable, as such amount may be adjusted from time to time in accordance with this Agreement.
“Compliance Certificate” means a certificate substantially in the form of Exhibit C.
“Consolidated EBITDA” means, for any period, for the Borrower and its Subsidiaries on a consolidated basis, an amount equal to Consolidated Net Income plus, without duplication and to the extent deducted in determining such Consolidated Net Income, (a) the sum of (i) Consolidated Interest Charges, (ii) the amount of taxes, based on or measured by income, used or included in determining such Consolidated Net Income, (iii) the amount of depreciation and amortization expense, (iv) all other non-cash charges (which are not reasonably likely to be convertible into cash within twelve (12) months of the incurrence of the charge) and (v) fees, cash charges and other cash expenses paid by the Borrower or any Subsidiary in connection with any acquisition, disposition, recapitalization, investment, issuance or repayment of Indebtedness, issuance of equity interests, refinancing transaction or modification or amendment of any debt instrument (including any transaction undertaken but not completed), and minus the following to the extent included in calculating such Consolidated Net Income, (b) the sum of (i) non-cash gains on sales of assets for such period and (ii) all other non-cash items increasing Consolidated Net Income (excluding any such non-cash items to the extent they represent the reversal of an accrual) for such period, subject to any applicable Acquisition Adjustments.


5    
Exhibit 10(ii)

“Consolidated Funded Indebtedness” means, as of any date of determination, for the Borrower and its Subsidiaries, (a) Indebtedness to the extent reflected on the Borrower’s consolidated balance sheet determined in accordance with GAAP plus (b) without duplication, all Attributable Indebtedness.
“Consolidated Interest Charges” means, for any period, for the Borrower and its Subsidiaries on a consolidated basis and without duplication, the sum of (a) all interest, debt discount, premium payments, commissions, fees, charges and related expenses of the Borrower and its Subsidiaries in connection with Indebtedness (including capitalized interest) or in connection with the deferred purchase price of assets and all discount and/or interest components, fees, charges and related expenses of the Borrower and its Subsidiaries incurred with respect to any Permitted Securitization Transaction, in each case to the extent treated as interest in accordance with GAAP and (b) the portion of rent expense of the Borrower and its Subsidiaries with respect to such period under capital leases that is treated as interest in accordance with GAAP, subject to Acquisition Adjustments.
“Consolidated Net Income” means, for any period, for the Borrower and its Subsidiaries on a consolidated basis, the net income of the Borrower and its Subsidiaries without giving effect to extraordinary or nonrecurring gains or losses (excluding from the determination of such income gains or losses from Dispositions of assets other than those in the ordinary course of business) for that period, subject to Acquisition Adjustments.
“Consolidated Net Worth” means, as of any date of determination, consolidated shareholders’ equity of the Borrower and its Subsidiaries plus non-cash charges associated with the impairment of goodwill of the Borrower and its Subsidiaries as of that date determined in accordance with GAAP.
“Consolidated Tangible Assets” means, as of any date on which the amount thereof is to be determined, the total amount of all assets of the Borrower and its Subsidiaries on a consolidated basis (less depreciation, depletion and other properly deductible valuation reserves) after deducting, without duplication, the sum of goodwill, patents, trade names, trademarks, copyrights, franchises, experimental expense, organization expense, the excess of cost of shares acquired over book value of related assets and such other assets as are properly classified as “intangible assets” in accordance with GAAP.
“Consolidated Total Assets” means, as of any date on which the amount thereof is to be determined, the total amount of all assets of the Borrower and its Subsidiaries on a consolidated basis (less depreciation, depletion and other properly deductible valuation reserves).
“Contingent Obligation” means, as to any Person, any obligation, contingent or otherwise, of such Person guarantying or having the economic effect of guarantying any Indebtedness or other obligation payable or performable by another Person (the “primary obligor”) in any manner, whether directly or indirectly, and including any obligation of such Person, direct or indirect, (i) to purchase or pay (or advance or supply funds for the purchase or payment of) such Indebtedness or other obligation, (ii) to purchase or lease property, securities or services for the purpose of assuring the obligee in respect of such Indebtedness or other obligation of the payment or performance of such Indebtedness or other obligation, (iii) to maintain working capital, equity capital or any other financial statement condition or liquidity or level of income or cash flow of the primary obligor so as to enable the primary obligor to pay such Indebtedness or other obligation, or (iv) entered into for the purpose of assuring or holding harmless in any other manner the obligee in respect of such Indebtedness or other obligation of the payment or performance thereof or to protect such obligee against loss in respect thereof (in whole or in part). The amount of any Contingent Obligation shall be deemed to be an amount equal to the stated or determinable amount of the related primary obligation, or portion thereof, in respect of which such Contingent Obligation is made or, if not stated or determinable, the

6    
Exhibit 10(ii)

maximum reasonably anticipated liability in respect thereof as determined by the guarantying Person in good faith.
“Contractual Obligation” means, as to any Person, any provision of any security issued by such Person or of any agreement, instrument or other undertaking to which such Person is a party or by which it or any of its property is bound.
“Control” means the possession, directly or indirectly, of the power to direct or cause the direction of the management or policies of a Person, whether through the ability to exercise voting power, by contract or otherwise. “Controlling” and “Controlled” have meanings correlative thereto.
“Covered Entity” has the meaning assigned to it in Section 10.22.
“Covered Party” has the meaning assigned to in in Section 10.22.

“Credit Party” means the Administrative Agent or any Lender.
“CRR” means the Regulation (EU) No 575/2013 of the European Parliament and of the Council of 26 June 2013 on prudential requirements for credit institutions and investment firms and amending Regulation (EU) No 648/2012.
“Debtor Relief Laws” means the Bankruptcy Code of the United States of America, and all other liquidation, conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, examinership, reorganization, or similar debtor relief Laws of the United States of America or other applicable jurisdictions from time to time in effect and affecting the rights of creditors generally.
“Default” means any event or circumstance that constitutes an Event of Default or that, with the giving of any notice, the passage of time, or both, would be an Event of Default.
“Default Rate” means (a) an interest rate equal to (i) the Base Rate plus (ii) the Applicable Margin, if any, applicable to Base Rate Loans plus (iii) 2% per annum; provided, however, that with respect to a LIBOR Rate Loan, the Default Rate shall be an interest rate equal to the interest rate (including any Applicable Margin) otherwise applicable to such Loan plus 2% per annum.
“Default Right” has the meaning assigned to it in Section 10.22.
“Defaulting Lender” means any Lender that (a) has failed, within two (2) Business Days of the date required to be funded or paid, to (i) fund any portion of its Loans or (ii) pay over to any Credit Party any other amount required to be paid by it hereunder, unless, in the case of clause (i) above, such Lender notifies the Administrative Agent in writing that such failure is the result of such Lender’s good faith determination that a condition precedent to funding (specifically identified and including the particular default, if any) has not been satisfied, (b) has notified the Borrower or any Credit Party in writing, or has made a public statement to the effect, that it does not intend or expect to comply with any of its funding obligations under this Agreement (unless such writing or public statement indicates that such position is based on such Lender’s good faith determination that a condition precedent (specifically identified and including the particular default, if any) to funding a loan under this Agreement cannot be satisfied) or generally under other agreements in which it commits to extend credit, (c) has failed, within three (3) Business Days after request by the Administrative Agent, acting in good faith, to provide a certification in writing from an authorized officer of such Lender that it will comply with its obligations to fund prospective Loans under this Agreement,

7    
Exhibit 10(ii)

provided that such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon the Administrative Agent’s receipt of such certification in form and substance reasonably satisfactory to the Administrative Agent, or (d) has (i) become or is insolvent or has a parent company that has become or is insolvent, (ii) become the subject of a bankruptcy or insolvency proceeding, or has had a receiver, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business or custodian, appointed for it, or has taken any action in furtherance of, or indicating its consent to, approval of or acquiescence in any such proceeding or appointment or has a parent company that has become the subject of a bankruptcy or insolvency proceeding, or has had a receiver, conservator, trustee, administrator, assignee for the benefit of creditors or similar Person charged with reorganization or liquidation of its business or custodian appointed for it, or has taken any action in furtherance of, or indicating its consent to, approval of or acquiescence in any such proceeding or appointment or (iii) has, or has a parent company that has, become the subject of a Bail-In Action; provided that a Lender shall not be a Defaulting Lender solely by virtue of any ownership interest, or the acquisition of any ownership interest, in such Person by a Governmental Authority or instrumentality thereof; provided, further, that such ownership interest does not result in or provide such Person with immunity from the jurisdiction of courts within the United States or from the enforcement of judgments or writs of attachment on its assets or permit such Person (or such Governmental Authority or instrumentality) to reject, repudiate, disavow or disaffirm any contracts or agreements made by such Person. Any determination by the Administrative Agent that a Lender is a Defaulting Lender under any one or more of clauses (a) through (d) above, and of the effective date of such status, shall be conclusive and binding absent manifest error, and such Lender shall be deemed to be a Defaulting Lender (subject to Section 2.12) as of the date established therefor by the Administrative Agent in a written notice of such determination, which shall be delivered by the Administrative Agent to the Borrower and each other Lender promptly following such determination.
“Disposition” or “Dispose” means the sale, transfer, license, lease or other disposition (including any sale and leaseback transaction) of any property by any Person, including any sale, assignment, transfer or other disposal, with or without recourse, of any notes or accounts receivable or any rights and claims associated therewith.
“Dollar” and “$” means lawful money of the United States of America.
“EEA Financial Institution” means (a) any credit institution or investment firm established in any EEA Member Country which is subject to the supervision of an EEA Resolution Authority, (b) any entity established in an EEA Member Country which is a parent of an institution described in clause (a) of this definition, or (c) any financial institution established in an EEA Member Country which is a Subsidiary of an institution described in clauses (a) or (b) of this definition and is subject to consolidated supervision with its parent.
“EEA Member Country” means any of the member states of the European Union, Iceland, Liechtenstein, and Norway.
“EEA Resolution Authority” means any public administrative authority or any Person entrusted with public administrative authority of any EEA Member Country (including any delegee) having responsibility for the resolution of any EEA Financial Institution.
“Eligible Assignee” means any Person that meets the requirements to be an assignee under Section 10.06(b)(iii) and (v) (subject to such consents, if any, as may be required under Section 10.06(b)(iii))

8    
Exhibit 10(ii)

“EMU Legislation” means legislative measures of the European Council (including without limitation European Council regulations) for the introduction of, changeover to or operation of a single or unified European currency (whether known as the euro or otherwise), in each case as amended or supplemented from time to time.
“Environmental Laws” means all Laws relating to environmental matters applicable to any property.
“Environmental Liability” means any liability, contingent or otherwise (including any liability for damages, costs of environmental remediation, fines, penalties or indemnities), of the Borrower directly or indirectly resulting from or based upon (a) violation of any Environmental Law, (b) the generation, use, handling, transportation, storage, treatment or disposal of any Hazardous Materials, (c) exposure to any Hazardous Materials, (d) the release or threatened release of any Hazardous Materials into the environment or (e) any contract, agreement or other consensual arrangement pursuant to which liability is assumed or imposed with respect to any of the foregoing.
“ERISA” means the Employee Retirement Income Security Act of 1974 and all regulations issued pursuant thereto.
“ERISA Affiliate” means any trade or business (whether or not incorporated) under common control with the Borrower within the meaning of Section 414(b) or (c) of the Code (and Sections 414(m) and (o) of the Code for purposes of provisions relating to Section 412 of the Code).
“ERISA Event” means (a) a Reportable Event with respect to a Pension Plan; (b) a withdrawal by the Borrower or any ERISA Affiliate from a Pension Plan subject to Section 4063 of ERISA during a plan year in which it was a substantial employer (as defined in Section 4001(a)(2) of ERISA) or a cessation of operations that is treated as such a withdrawal under Section 4062(e) of ERISA; (c) a complete or partial withdrawal by the Borrower or any ERISA Affiliate from a Multiemployer Plan or notification that a Multiemployer Plan is in reorganization; (d) the filing of a notice of intent to terminate, the treatment of a Plan amendment as a termination under Sections 4041 or 4041A of ERISA, or the commencement of proceedings by the PBGC to terminate a Pension Plan or Multiemployer Plan; (e) an event or condition which constitutes grounds under Section 4042 of ERISA for the termination of, or the appointment of a trustee to administer, any Pension Plan or Multiemployer Plan; or (f) the imposition of any liability under Title IV of ERISA, other than PBGC premiums due but not delinquent under Section 4007 of ERISA, upon the Borrower or any ERISA Affiliate.
“EU Bail-In Legislation Schedule” means the EU Bail-In Legislation Schedule published by the Loan Market Association (or any successor person), as in effect from time to time.
“Event of Default” means any of the events or circumstances specified in Article VIII.
“Existing Credit Agreement” means that certain Credit Agreement, dated as of August 19, 2016, by and among the Borrower, certain of its Subsidiaries, the lenders party thereto and Bank of America, N.A., as administrative agent thereunder, as amended, supplemented or otherwise modified prior to the date hereof.
“Facility Office” means the office(s) notified by a Lender to the Administrative Agent in writing on or before the date it becomes a Lender (or, following that date, by not less than five Business Days’ written notice) as the office or offices of a Lender through which it will perform its obligations under this Agreement.
“FASB ASC” means the Accounting Standards Codification of the Financial Accounting Standards Board.

9    
Exhibit 10(ii)

“FATCA” means Sections 1471 through 1474 of the Code, as of the date of this Agreement (or any amended or successor version that is substantively comparable and not materially more onerous to comply with), any current or future regulations or official interpretations thereof, any agreement entered into pursuant to Section 1471(b)(1) of the Code and any intergovernmental agreement entered into pursuant to the foregoing.
“Federal Funds Rate” means, for any day, the weighted average (rounded upwards, if necessary, to the next 1/100 of 1%) of the rates on overnight Federal funds transactions with members of the Federal Reserve System arranged by Federal funds brokers, as published on the next succeeding Business Day by the Federal Reserve Bank of New York, or, if such rate is not so published for any day that is a Business Day, the average (rounded upwards, if necessary, to the next 1/100 of 1%) charged to Bank of America on such day for such transactions as determined by the Administrative Agent in its reasonable discretion.
“Fee Letter” has the meaning specified in Section 2.07(b).
“Foreign Lender” means any Lender that is organized under the laws of a jurisdiction other than the United States, any State thereof or the District of Columbia.
“FRB” means the Board of Governors of the Federal Reserve System of the United States of America.
“Fund” means any Person (other than a natural person) that is (or will be) engaged in making, purchasing, holding or otherwise investing in commercial loans and similar extensions of credit in the ordinary course of its business.
“GAAP” means generally accepted accounting principles set forth in the opinions and pronouncements of the Accounting Principles Board and the American Institute of Certified Public Accountants and statements and pronouncements of the Financial Accounting Standards Board or such other principles as may be approved by a significant segment of the accounting profession, that are applicable to the circumstances as of the date of determination.
“Governmental Authority” means any nation or government, any state or other political subdivision thereof, any agency, authority, instrumentality, regulatory body, court, administrative tribunal, central bank or other entity exercising executive, legislative, judicial, taxing, regulatory or administrative powers or functions of or pertaining to government (including any supra-national bodies such as the European Union or the European Central Bank), and any corporation or other entity owned or controlled, through stock or capital ownership or otherwise, by any of the foregoing, and any group or body charged with setting financial accounting or regulatory capital rules or standards (including, without limitation, the Financial Accounting Standards Board, the Bank for International Settlements or the Basel Committee on Banking Supervision or any successor or similar authority to any of the foregoing).
“Hazardous Materials” means all explosive or radioactive substances or wastes and all hazardous or toxic substances, wastes or other pollutants, including petroleum or petroleum distillates, asbestos or asbestos-containing materials, polychlorinated biphenyls, radon gas, infectious or medical wastes and all other substances or wastes of any nature, the generation, handling, storage, transportation, disposal, treatment, release, discharge or emission of which is subject to any Environmental Law.
“Impacted Loans” has the meaning assigned to such term in Section 3.03.
“Indebtedness”, as applied to any Person, means, without duplication, (i) all indebtedness for borrowed money; (ii) that portion of obligations with respect to capital leases that is properly classified as

10    
Exhibit 10(ii)

a liability on a balance sheet in conformity with GAAP; (iii) notes payable and drafts accepted representing extensions of credit whether or not representing obligations for borrowed money; (iv) any obligation owed for all or any part of the deferred purchase price of property or services (excluding any such obligations incurred under ERISA and excluding trade accounts payable accrued in the ordinary course of business); (v) all indebtedness secured by any Lien on any property or asset owned or held by that Person regardless of whether the indebtedness secured thereby shall have been assumed by that Person or is nonrecourse to the credit of that Person (provided that with respect to indebtedness that is nonrecourse to the credit of that Person, such indebtedness shall be taken into account only to the extent of the lesser of the fair market value of the asset(s) subject to such Lien and the amount of indebtedness secured); (vi) the face amount of any letter of credit available to be drawn issued for the account of that Person or as to which that Person is otherwise liable for reimbursement of drawings; (vii) net obligations under Swap Contracts; provided, in no event shall obligations under Swap Contracts be deemed “Indebtedness” for any purpose of the definitions of the Leverage Ratio; (viii) all Attributable Indebtedness of any Securitization Entity; and (ix) Contingent Obligations in respect of any of the foregoing.
“Indemnitees” has the meaning set forth in Section 10.04(b).
“Interest Payment Date” means, (a) as to any LIBOR Rate Loan, the last day of the relevant Interest Period, any date that such Loan is prepaid or converted, in whole or in part, and the Maturity Date; provided, however, that if any Interest Period for a LIBOR Rate Loan exceeds three months, interest shall also be paid on the Business Day which falls every three months after the beginning of such Interest Period; and (b) as to any Base Rate Loan, the first Business Day following the last Business Day of each March, June, September and December and the Maturity Date; provided, further, that interest accruing at the Default Rate shall be payable from time to time upon demand of Administrative Agent.
“Interest Period” means as to each LIBOR Rate Loan, initially, the period commencing on the date such LIBOR Rate Loan is disbursed or on the date any Loan is continued as or converted into a LIBOR Rate Loan, and ending, in each case, on the date which is one, two, three or six months thereafter, as selected by the Borrower in its Loan Notice or such other period that is twelve months or less requested by the Borrower and available to all Lenders; provided that:
(i)    any Interest Period that would otherwise end on a day that is not a Business Day shall be extended to the next succeeding Business Day unless, in the case of a LIBOR Rate Loan, such Business Day falls in another calendar month, in which case such Interest Period shall end on the next preceding Business Day;
(ii)    any Interest Period pertaining to a LIBOR Rate Loan that begins on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Interest Period) shall end on the last Business Day of the calendar month at the end of such Interest Period; and
(iii)    no Interest Period shall extend beyond the scheduled Maturity Date.
“IRS” means the United States Internal Revenue Service and any successor governmental agency performing a similar function.
“Laws” means, collectively, all international, foreign, Federal, state and local statutes, treaties, rules, guidelines, regulations, ordinances, codes and administrative or judicial precedents or authorities, including the interpretation or administration thereof by any Governmental Authority charged with the enforcement, interpretation or administration thereof, and all applicable administrative or executive orders, directed duties,

11    
Exhibit 10(ii)

requests, licenses, authorizations and permits of, and agreements with, any Governmental Authority, in each case whether or not having the force of law.
“Lender” has the meaning specified in the introductory paragraph hereto.
“Lending Office” means, as to any Lender, the office or offices of such Lender, together with, in each case, any Affiliate or any domestic or foreign branch of such Lender described as such in such Lender’s Administrative Questionnaire or such other office or offices as a Lender may elect, by notice from time to time to the Borrower and the Administrative Agent, to make any Borrowing available to the Borrower.
“Leverage Ratio” means, as of any date of determination, for the Borrower and its Subsidiaries on a consolidated basis, the ratio of (a) Consolidated Funded Indebtedness as of such date to (b) Consolidated EBITDA for the period of the four fiscal quarters ending on such date.
“LIBOR Loan” means a Loan bearing interest or to bear interest at a rate based on the “LIBOR Rate”.
“LIBOR Rate” means, for any Interest Period, the rate per annum (rounded upwards, if necessary, to the next 1/16 of 1%) equal to the London interbank offered rate administered by ICE Benchmark Administration (or any other Person that takes over the administration of such rate) for Dollars for a period equal in length to such Interest Period as displayed on the applicable the Bloomberg screen page or, in the event such rate does not appear on either of such Bloomberg pages, on any successor or substitute page on such screen that displays such rate, or on the appropriate page of such other information service that publishes such rate as shall be selected by the Administrative Agent from time to time in its reasonable discretion (in each case the “LIBOR Screen Rate”) at approximately 11:00 a.m., London time, on the day that is two (2) Business Days prior to the commencement of such Interest Period for such Interest Period; provided that, if the LIBOR Screen Rate shall be less than 0.75% per annum, such rate shall be deemed to be 0.75% per annum for purposes of this Agreement. It is understood and agreed that all of the terms and conditions of this definition of “LIBOR Rate” shall be subject to Section 3.03.
“LIBOR Screen Rate” has the meaning assigned to such term in the definition of “LIBOR Rate”.
“Lien” means any lien, mortgage, pledge, assignment, security interest, charge or encumbrance of any kind (including any conditional sale or other title retention agreement or any financing lease having substantially the same economic effect as any of the foregoing) and any other preferential arrangement in the nature of a security interest.
“Loan” and “Loans” means extensions of credit by a Lender to the Borrower under Article II.
“Loan Documents” means this Agreement and each Note.
“Loan Notice” means a notice of (a) a Borrowing, (b) a conversion of Loans from one Type to the other or (c) a continuation of Loans as the same Type, pursuant to Section 2.02(a), which shall be in writing and substantially in the form of Exhibit A or such other form as may be approved by the Administrative Agent and the Borrower (including any form on an electronic platform or electronic transmission system as shall be approved by the Administrative Agent and the Borrower), appropriately completed and signed by a Responsible Officer of the Borrower.
“London Banking Day” means any day on which dealings in Dollar deposits are conducted by and between banks in the London interbank eurodollar market.

12    
Exhibit 10(ii)

“Material Adverse Effect” means (a) a material adverse change in, or a material adverse effect upon, the business, assets or financial condition of the Borrower and its Subsidiaries taken as a whole, other than any material adverse change that has been publicly disclosed in the Borrower’s filings with the SEC prior to April 30, 2020; (b) a material impairment of the ability of the Borrower to pay or perform its obligations under any Loan Document to which it is a party; or (c) a material adverse effect upon the legality, validity, binding effect or enforceability against the Borrower of any Loan Document.
“Material Disposition” means any Disposition, or series of related Dispositions, by the Borrower and its Subsidiaries of real or personal property that has a book value, as determined in accordance with GAAP, equal to or greater than 10% of Consolidated Tangible Assets determined as of the last day of the immediately preceding fiscal quarter of the Borrower.
“Material Indebtedness” means any Indebtedness of the Borrower and its Subsidiaries (other than Indebtedness hereunder and Indebtedness under Swap Contracts) having an aggregate principal amount outstanding of more than $100,000,000.
“Material Subsidiary” means (a) any direct or indirect Subsidiary of the Borrower which (i) has total assets equal to or greater than 10% of Consolidated Total Assets (calculated as of the most recent fiscal period with respect to which the Administrative Agent shall have received financial statements required to be delivered pursuant to Section 6.01(a) (or if prior to delivery of any financial statements pursuant to such Section, then calculated with respect to the Audited Financial Statements) (the “Required Financial Information”)) or (ii) has income equal to or greater than 10% of Consolidated Net Income (calculated for the most recent period for which the Administrative Agent has received the Required Financial Information) and (b) any Subsidiary that is a “Designated Borrower” under and as defined in the Existing Credit Agreement (or otherwise a borrower pursuant to any documentation evidencing any refinancing thereof).
“Maturity Date” means April 29, 2021.
“Moody’s” means Moody’s Investors Service, Inc. and any successor thereto.
“Multiemployer Plan” means any employee benefit plan of the type described in Section 4001(a)(3) of ERISA, to which the Borrower or any ERISA Affiliate makes or is obligated to make contributions, or during the preceding five plan years, has made or been obligated to make contributions.
“Multiple Employer Plan” means a Plan which has two or more contributing sponsors (including the Borrower or any ERISA Affiliate) at least two of whom are not under common control, as such a plan is described in Section 4064 of ERISA.
“Note” means a promissory note made by the Borrower in favor of a Lender evidencing Loans made by such Lender to the Borrower, substantially in the form of Exhibit B.
“Obligations” means all advances to, and debts, liabilities, obligations, covenants and duties of the Borrower arising under any Loan Document, whether direct or indirect (including those acquired by assumption), absolute or contingent, due or to become due, now existing or hereafter arising and including interest and fees that accrue after the commencement by or against the Borrower of any proceeding under any Debtor Relief Laws naming the Borrower as the debtor in such proceeding, regardless of whether such interest and fees are allowed claims in such proceeding.
“OFAC” means the Office of Foreign Assets Control of the U.S. Department of Treasury.

13    
Exhibit 10(ii)

“Organization Documents” means, the certificate or articles of incorporation and the bylaws, in each case as amended from time to time.
“Other Taxes” has the meaning therefor set forth in Section 3.01(b).
“Outstanding Amount” means, with respect to Loans on any date, the aggregate outstanding principal amount thereof after giving effect to any Borrowings and prepayments or repayments of Loans occurring on such date.
“Overnight Rate” means, for any day, the greater of (i) the Federal Funds Rate and (ii) an overnight rate determined by the Administrative Agent in accordance with banking industry rules on interbank compensation.
“Participant” has the meaning specified in Section 10.06(d).
“Participant Register” has the meaning specified in Section 10.06(d).
“Patriot Act” means the USA PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001)).
“PBGC” means the Pension Benefit Guaranty Corporation.
“Pension Act” means the Pension Protection Act of 2006.
 
“Pension Funding Rules” means the rules of the Code and ERISA regarding the minimum required contributions (including any installment payment thereof) to Pension Plans and set forth in, with respect to plan years ending prior to the effective date of the Pension Act, Section 412 of the Code and Section 302 of ERISA, each as in effect prior to the Pension Act and, thereafter, Section 412, 430, 431, 432 and 436 of the Code and Sections 302, 303, 304 and 305 of ERISA.

“Pension Plan” means any “employee pension benefit plan” (as such term is defined in Section 3(2) of ERISA), including where applicable a Multiemployer Plan or a Multiple Employer Plan, that is subject to Title IV of ERISA and is sponsored or maintained by the Borrower or any ERISA Affiliate or to which the Borrower or any ERISA Affiliate contributes or has an obligation to contribute, or in the case of a multiple employer plan (as described in Section 4064(a) of ERISA) has made contributions at any time during the immediately preceding five plan years.
“Permitted Securitization Transaction” means the transaction contemplated by any transaction or series of transactions pursuant to which the Borrower or any of its Subsidiaries may sell, convey or otherwise transfer to a Securitization Entity (in the case of a transfer by the Borrower or any of its Subsidiaries) or any other Person (in case of a transfer by a Securitization Entity), or may grant a security interest in, any accounts receivable (whether now existing or arising or acquired in the future) of the Borrower or any of its Subsidiaries, and any assets related thereto including, without limitation, all collateral securing such accounts receivable, all contracts and contract rights and all guarantees or other obligations in respect of such accounts receivable, proceeds of such accounts receivable and other assets (including contract rights) which are customarily transferred or in respect of which security interests are customarily granted in connection with asset securitization transactions involving accounts receivable.
“Person” means any natural person, corporation, limited liability company, trust, joint venture, association, company, partnership, Governmental Authority or other entity.

14    
Exhibit 10(ii)

“Plan” means any “employee benefit plan” (as such term is defined in Section 3(3) of ERISA) established by the Borrower or any ERISA Affiliate or any such Plan to which the Borrower or any ERISA Affiliate is required to contribute on behalf of any of its employees.
“Prime Rate” means the rate of interest per annum publicly announced from time to time by Bank of America as its “prime rate”; each change in the Prime Rate shall be effective from and including the date such change is publicly announced as being effective. The Prime Rate is a rate set by Bank of America based upon various factors including Bank of America’s costs and desired return, general economic conditions and other factors, and is used as a reference point for pricing some loans, which may be priced at, above, or below such announced rate.
“QFC” has the meaning assigned to it in Section 10.22.
“QFC Credit Support” has the meaning assigned to it in Section 10.22.
“Register” has the meaning set forth in Section 10.06(c).
“Related Parties” means, with respect to any Person, such Person’s Affiliates and the directors, officers, employees, agents and advisors of such Person and of such Person’s Affiliates.
“Relevant Resolution Authority” means, with respect to any Affected Financial Institution, the Resolution Authority with the ability to exercise any Write-Down and Conversion Powers in relation to such Affected Financial Institution.
“Reportable Event” means any of the events set forth in Section 4043(c) of ERISA, other than events for which the 30 day notice period has been waived.
“Required Lenders” means, as of any date of determination, Lenders having more than 50% of the Aggregate Commitments or, if the commitment of each Lender to make Loans has been terminated pursuant to Section 8.02, Lenders holding in the aggregate more than 50% of the Total Outstandings; provided that the Commitment of, and the portion of the Total Outstandings held or deemed held by, any Defaulting Lender shall be excluded for purposes of making a determination of Required Lenders.
“Resolution Authority” means an EEA Resolution Authority or, with respect to any UK Financial Institution, a UK Resolution Authority.
“Responsible Officer” means the president, chief financial officer, vice president of finance, treasurer or assistant treasurer or any other authorized signatory of the Borrower and, solely for purposes of notices given pursuant to Article II, any other officer of the Borrower so designated by any of the foregoing officers in a notice to the Administrative Agent or any other officer or employee of the Borrower designated in or pursuant to an agreement between the Borrower and the Administrative Agent. Any document delivered hereunder that is signed by a Responsible Officer of the Borrower, shall be conclusively presumed to have been authorized by all necessary corporate and/or other action on the part of the Borrower, and such Responsible Officer shall be conclusively presumed to have acted on behalf of the Borrower.
“Restricted Lender” has the meaning set forth in Section 10.16.
“S&P” means Standard & Poor’s Ratings Services, a Standard & Poor’s Financial Services LLC business, or any successor thereto.

15    
Exhibit 10(ii)

“Sanctioned Country” means, at any time, a country, region or territory which is itself the subject or target of any Sanctions (including, at the time of this Agreement, Crimea, Cuba, Iran, North Korea and Syria).
“Sanctioned Person” means, at any time, (a) any Person listed in any Sanctions-related list of designated Persons maintained by OFAC, the U.S. Department of State, the United Nations Security Council, the European Union or any EU member state (including, without limitation, OFAC’s List of Specially Designated Nationals, HMT’s Consolidated List of Financial Sanctions Targets and HMT’s Investment Ban List), (b) any Person operating, organized or resident in a Sanctioned Country or (c) any Person owned or controlled by any such Person or Persons.
“Sanctions” means economic or financial sanctions or trade embargoes imposed, administered or enforced from time to time by (a) the U.S. government, including those administered by OFAC or the U.S. Department of State or (b) the United Nations Security Council, the European Union or Her Majesty’s Treasury of the United Kingdom.
“SEC” means the Securities and Exchange Commission, or any Governmental Authority succeeding to any of its principal functions.
“Securitization Entity” means Stryker Funding Corporation, a Michigan corporation, and any other wholly-owned Subsidiary (or another Person in which the Borrower or any Subsidiary of the Borrower makes an investment and to which the Borrower or any Subsidiary of the Borrower transfers accounts receivable and related assets) that engages in no activities other than in connection with the financing of accounts receivable and that is designated by the Board of Directors of the Borrower (as provided below) as a Securitization Entity, (i) no portion of the Indebtedness (contingent or otherwise) of which (a) is guaranteed by the Borrower or any Subsidiary of the Borrower other than pursuant to Standard Securitization Undertakings, (b) is recourse to or obligates the Borrower or any Subsidiary of the Borrower in any way other than pursuant to Standard Securitization Undertakings or (c) subjects any property or asset of the Borrower or any Subsidiary of the Borrower, directly or indirectly, contingently or otherwise, to the satisfaction thereof, other than pursuant to Standard Securitization Undertakings, (ii) with which neither the Borrower nor any Subsidiary of the Borrower has any material contract, agreement, arrangement or understanding other than on terms no less favorable to the Borrower or such Subsidiary than those that might be obtained at the time from Persons that are not Affiliates of the Borrower, other than fees payable in the ordinary course of business in connection with servicing receivables of such entity, and (iii) to which neither the Borrower nor any Subsidiary of the Borrower has any obligation to maintain or preserve such entity’s financial condition or cause such entity to achieve certain levels of operating results. Any such designation by the Board of Directors of the Borrower shall be evidenced to the Administrative Agent by filing with the Administrative Agent a certified copy of the resolution of the Board of Directors of the Borrower giving effect to such designation and a certificate of a Responsible Officer certifying that such designation complied with the foregoing conditions.
“Senior Officer” means the chief executive officer, the chief financial officer or the treasurer of the Borrower.
“Standard Securitization Undertakings” means representations, warranties, covenants and indemnities entered into by the Borrower or any Subsidiary of the Borrower that are reasonably customary in accounts receivable securitization transactions.
“Stryker Family Group” means the descendants of L. Lee Stryker and members of such descendants’ families and trusts for the benefit of such Persons.

16    
Exhibit 10(ii)

“Subsidiary” of a Person means a corporation, partnership, joint venture, limited liability company or other business entity of which a majority of the shares of securities or other interests having ordinary voting power for the election of directors or other governing body (other than securities or interests having such power only by reason of the happening of a contingency) are at the time beneficially owned, or the management of which is otherwise controlled, directly, or indirectly through one or more intermediaries, or both, by such Person. Unless otherwise specified, all references herein to a “Subsidiary” or to “Subsidiaries” shall refer to a Subsidiary or Subsidiaries of the Borrower.
“Supported QFC” has the meaning assigned to it in Section 10.22.
“Swap Contract” means (a) any and all rate swap transactions, basis swaps, credit derivative transactions, forward rate transactions, commodity swaps, commodity options, forward commodity contracts, equity or equity index swaps or options, bond or bond price or bond index swaps or options or forward bond or forward bond price or forward bond index transactions, interest rate options, forward foreign exchange transactions, cap transactions, floor transactions, collar transactions, currency swap transactions, cross-currency rate swap transactions, currency options, spot contracts, or any other similar transactions or any combination of any of the foregoing (including any options to enter into any of the foregoing), whether or not any such transaction is governed by or subject to any master agreement, and (b) any and all transactions of any kind, and the related confirmations, which are subject to the terms and conditions of, or governed by, any form of master agreement published by the International Swaps and Derivatives Association, Inc., any International Foreign Exchange Master Agreement, or any other master agreement (any such master agreement, together with any related schedules, a “Master Agreement”), including any such obligations or liabilities under any Master Agreement.
“Swap Termination Value” means, in respect of any one or more Swap Contracts, after taking into account the effect of any legally enforceable netting agreement relating to such Swap Contracts, (a) for any date on or after the date such Swap Contracts have been closed out and termination value(s) determined in accordance therewith, such termination value(s), and (b) for any date prior to the date referenced in clause (a), the amount(s) determined as the mark-to-market value(s) for such Swap Contracts, as determined based upon one or more mid-market or other readily available quotations provided by any recognized dealer in such Swap Contracts (which may include a Lender or any Affiliate of a Lender).
“Taxes” has the meaning therefor set forth in Section 3.01(a).
“Threshold Amount” means 10% of Consolidated Net Worth as of the end of the most recently completed fiscal quarter of the Borrower for which financial statements have been furnished pursuant to the terms hereof.
“Total Outstandings” means the aggregate Outstanding Amount of all Loans.
“Type” means with respect to a Loan, its character as (a) a Base Rate Loan or (b) a LIBOR Rate Loan.
“UK Financial Institution” means any BRRD Undertaking (as such term is defined under the PRA Rulebook (as amended form time to time) promulgated by the United Kingdom Prudential Regulation Authority) or any person falling within IFPRU 11.6 of the FCA Handbook (as amended from time to time) promulgated by the United Kingdom Financial Conduct Authority, which includes certain credit institutions and investment firms, and certain affiliates of such credit institutions or investment firms.

17    
Exhibit 10(ii)

“UK Resolution Authority” means the Bank of England or any other public administrative authority having responsibility for the resolution of any UK Financial Institution.
“Unfunded Pension Liability” means the excess of a Pension Plan’s benefit liabilities under Section 4001(a)(16) of ERISA, over the current value of that Pension Plan’s assets, determined in accordance with the assumptions used for funding the Pension Plan pursuant to Section 412 of the Code for the applicable plan year.
“United States” or “U.S.” means the United States of America.
“U.S. Special Resolution Regime” has the meaning assigned to it in Section 10.22.
“Write-Down and Conversion Powers” means, (a) with respect to any EEA Resolution Authority, the write-down and conversion powers of such EEA Resolution Authority from time to time under the Bail-In Legislation for the applicable EEA Member Country, which write-down and conversion powers are described in the EU Bail-In Legislation Schedule. and (b) with respect to the United Kingdom, any powers of the Relevant Resolution Authority under the Bail-In Legislation to cancel, reduce, modify or change the form of a liability of any UK Financial Institution or any contract or instrument under which that liability arises, to convert all or part of that liability into shares, securities or obligations of that person or any other person, to provide that any such contract or instrument is to have effect as if a right had been exercised under it or to suspend any obligation in respect of that liability or any of the powers under that Bail-In Legislation that are related to or ancillary to any of those powers.
1.02    Other Interpretive Provisions. With reference to this Agreement and each other Loan Document, unless otherwise specified herein or in such other Loan Document:
(a)    The meanings of defined terms are equally applicable to the singular and plural forms of the defined terms.
(b)    (i)    The words “herein” and “hereunder” and words of similar import when used in any Loan Document shall refer to such Loan Document as a whole and not to any particular provision thereof.
(ii)    Article, Section, Exhibit and Schedule references are to the Loan Document in which such reference appears.
(iii)    The term “including” is by way of example and not limitation.
(iv)    The term “documents” includes any and all instruments, documents, agreements, certificates, notices, reports, financial statements and other writings, however evidenced, whether in physical or electronic form.
(v)    Whenever the context may require, any pronoun shall include the corresponding masculine, feminine and neuter forms.
(vi)    The word “will” shall be construed to have the same meaning and effect as the word “shall.”
(vii)    Unless the context requires otherwise, (A) any reference herein to any Person shall be construed to include such Person’s successors and permitted assigns, and (B) the words “asset”

18    
Exhibit 10(ii)

and “property” shall be construed to have the same meaning and effect and to refer to any and all tangible and intangible assets and properties, including cash, securities, accounts and contract rights.
(c)    In the computation of periods of time from a specified date to a later specified date, the word “from” means “from and including;” the words “to” and “until” each mean “to but excluding;” and the word “through” means “to and including.”
(d)    Each reference to “basis points” or “bps” shall be interpreted in accordance with the convention that 100 bps = 1.0%.
(e)    Section headings herein and in the other Loan Documents are included for convenience of reference only and shall not affect the interpretation of this Agreement or any other Loan Document.
1.03    Accounting Terms. (a) All accounting terms not specifically or completely defined herein shall be construed in conformity with, and all financial data (including financial ratios and other financial calculations) required to be submitted pursuant to this Agreement shall be prepared in conformity with GAAP (except as otherwise expressly noted therein), as in effect from time to time (subject to Section 1.03(b) below), applied in a manner consistent with that used in preparing the Audited Financial Statements and without giving effect to any changes in GAAP occurring after the Closing Date, the effect of which would be to cause leases which would be treated as operating leases under GAAP as of the Closing Date to be treated as capital leases under GAAP. Notwithstanding the foregoing, for purposes of determining compliance with any covenant (including the computation of any financial covenant) contained herein, Indebtedness of the Borrower and its Subsidiaries shall be deemed to be carried at 100% of the outstanding principal amount thereof, and the effects of FASB ASC 825 and FASB ASC 470-20 on financial liabilities shall be disregarded.
(b)    If at any time any change in GAAP would affect the computation of any financial ratio or requirement set forth in any Loan Document, and either the Borrower or the Required Lenders shall so request, the Administrative Agent, the Lenders and the Borrower shall negotiate in good faith to amend such ratio or requirement to preserve the original intent thereof in light of such change in GAAP; provided that, until so amended, (i) such ratio or requirement shall continue to be computed in accordance with GAAP prior to such change therein and (ii) the Borrower shall provide to the Administrative Agent and the Lenders financial statements and other documents required under this Agreement or as reasonably requested hereunder setting forth a reconciliation between calculations of such ratio or requirement made before and after giving effect to such change in GAAP.
(c)    With respect to any Acquisition consummated on or after the Closing Date, at the Borrower’s discretion, the following shall apply:
(i)    For each period of four fiscal quarters of the Borrower ending next following the date of any Acquisition, Consolidated EBITDA shall include the results of operations of the Person or assets so acquired on a historical pro forma basis to the extent information in sufficient detail concerning such historical results of such Person is reasonably available, and which amounts may include such adjustments as are permitted under Regulation S‑X of the Securities and Exchange Commission or reasonably satisfactory to the Administrative Agent;
(ii)    For each period of four fiscal quarters of the Borrower ending next following the date of each Acquisition, Consolidated Interest Charges shall include the results of operations of the Person or assets so acquired, which amounts shall be determined on a historical pro forma basis to

19    
Exhibit 10(ii)

the extent information in sufficient detail concerning such historical results of such Person is reasonably available; provided, however, Consolidated Interest Charges shall be adjusted on a historical pro forma basis to (i) eliminate interest expense accrued during such period on any Indebtedness repaid in connection with such Acquisition and (ii) include interest expense on any Indebtedness (including Indebtedness hereunder) incurred, acquired or assumed in connection with such Acquisition (“Incremental Debt”) calculated (A) as if all such Incremental Debt had been incurred as of the first day of such period of four fiscal quarters and (B) at the following interest rates: (I) for all periods subsequent to the date of the Acquisition and for Incremental Debt assumed or acquired in the Acquisition and in effect prior to the date of Acquisition, at the actual rates of interest applicable thereto, and (II) for all periods prior to the actual incurrence of such Incremental Debt, equal to the rate of interest actually applicable to such Incremental Debt hereunder or under other financing documents applicable thereto as at the end of each affected period of such four fiscal quarters, as the case may be.
(d)    With respect to any Material Disposition consummated on or after the Closing Date, for each period of four fiscal quarters of the Borrower ending next following the date of such Material Disposition, Consolidated EBITDA for such period shall be either (i) reduced by an amount equal to the Consolidated EBITDA (if positive) attributable to the property that is the subject of such Material Disposition for such period or (ii) increased by an amount equal to the Consolidated EBITDA (if negative) attributable to such property for such period and Consolidated Funded Indebtedness shall exclude any debt repaid with the proceeds of such Material Disposition.
1.04    Rounding. Any financial ratios required to be maintained by the Borrower pursuant to this Agreement shall be calculated by dividing the appropriate component by the other component, carrying the result to one place more than the number of places by which such ratio is expressed herein and rounding the result up or down to the nearest number (with a rounding-up if there is no nearest number).
1.05    References to Agreements and Laws. Unless otherwise expressly provided herein, (a) references to agreements (including the Loan Documents) and other contractual instruments shall be deemed to include all subsequent amendments, restatements, extensions, supplements and other modifications thereto, but only to the extent that such amendments, restatements, extensions, supplements and other modifications are not prohibited by any Loan Document; and (b) references to any Law shall include all statutory and regulatory provisions consolidating, amending, replacing, supplementing or interpreting such Law and, unless otherwise specified, shall refer to such Law as amended, modified or supplemented from time to time.
1.06    Times of Day. Unless otherwise specified, all references herein to times of day shall be references to Eastern time (daylight or standard, as applicable).
1.07    Divisions. For all purposes under the Loan Documents, in connection with any division or plan of division under Delaware law (or any comparable event under a different jurisdiction’s laws): (a) if any asset, right, obligation or liability of any Person becomes the asset, right, obligation or liability of a different Person, then it shall be deemed to have been transferred from the original Person to the subsequent Person, and (b) if any new Person comes into existence, such new Person shall be deemed to have been organized and acquired on the first date of its existence by the holders of its Equity Interests at such time.


20    
Exhibit 10(ii)

ARTICLE II    
THE COMMITMENTS AND BORROWINGS
2.01    Loans. Subject to the terms and conditions set forth herein, each Lender severally agrees to make loans (each such loan, a “Loan”) to the Borrower in Dollars from time to time, on any Business Day during the Availability Period, in an aggregate amount not to exceed at any time outstanding the amount of such Lender’s Commitment; provided, however, that after giving effect to any Borrowing, (i) the Total Outstandings shall not exceed the Aggregate Commitments, and (ii) the aggregate Outstanding Amount of the Loans of any Lender shall not exceed such Lender’s Commitment. Within the limits of each Lender’s Commitment, and subject to the other terms and conditions hereof, the Borrower may borrow under this Section 2.01, prepay under Section 2.03, and reborrow under this Section 2.01. Loans may be Base Rate Loans or LIBOR Rate Loans as further provided herein.
2.02    Borrowings, Conversions and Continuations of Loans.
(a)    Borrowings, Conversions and Continuations of Loans. Each Borrowing, each conversion of Loans from one Type to the other, and each continuation of Loans shall be made upon the Borrower’s irrevocable notice to the Administrative Agent, which may be given by (A) telephone or (B) a Loan Notice; provided that any telephonic notice must be confirmed immediately by delivery to the Administrative Agent of a Loan Notice (provided that the lack of such prompt confirmation shall not affect the conclusiveness or binding effect of such telephonic notice). Each such Loan Notice must be received by the Administrative Agent not later than 12:00 noon (i) three Business Days prior to the requested date of any Borrowing of, conversion to or continuation of LIBOR Rate Loans and (ii) on the requested date of any Borrowing of Base Rate Loans or of any conversion of LIBOR Rate Loans to Base Rate Loans; provided, however, that if the Borrower wishes to request LIBOR Rate Loans having an Interest Period other than one, two, three or six months in duration as provided in the definition of “Interest Period”, the applicable notice must be received by the Administrative Agent not later than 12:00 noon three Business Days prior to the requested date of such Borrowing, conversion or continuation of LIBOR Rate Loans, whereupon the Administrative Agent shall give prompt notice to the Lenders of such request and determine whether the requested Interest Period is acceptable to all of them. Not later than 1:00 p.m. three Business Days before the requested date of such Borrowing, conversion or continuation of LIBOR Rate Loans, the Administrative Agent shall notify the Borrower (which notice may be by telephone) whether or not the requested Interest Period has been consented to by all the Lenders. Each Borrowing of, conversion to or continuation of LIBOR Rate Loans shall be in a principal amount of $5,000,000 or a whole multiple of $1,000,000 in excess thereof. Each Borrowing of or conversion to Base Rate Loans shall be in a principal amount of $500,000 or a whole multiple of $100,000 in excess thereof. Each Loan Notice shall specify (i) whether the Borrower is requesting a Borrowing, a conversion of Loans from one Type to the other, or a continuation of LIBOR Rate Loans, (ii) the requested date of the Borrowing, conversion or continuation, as the case may be (which shall be a Business Day), (iii) the principal amount of Loans to be borrowed, converted or continued, (iv) the Type of Loans to be borrowed or to which existing Loans are to be converted, and (v) if applicable, the duration of the Interest Period with respect thereto. If the Borrower fails to specify a Type of Loan in a Loan Notice or if the Borrower fails to give a timely notice requesting a conversion or continuation of a LIBOR Rate Loan, then the applicable Loans shall be made as or converted to a Base Rate Loan and the Administrative Agent shall notify each Lender of the details thereof. If the Borrower requests a Borrowing of, conversion to, or continuation of LIBOR Rate Loans in any such Loan Notice, but fails to specify an Interest Period, it will be deemed to have specified an Interest Period of one month.

21    
Exhibit 10(ii)

(b)    Following receipt of a Loan Notice, the Administrative Agent shall promptly notify each Lender of the amount of its Applicable Percentage of the applicable Loans. In the case of a Borrowing, each Lender shall make the amount of its Loan available to the Administrative Agent in Dollars in immediately available funds at the Administrative Agent’s Office not later than 1:00 p.m. on the Business Day specified in the applicable Loan Notice; provided that, each Lender may, at its option, make any Borrowing available to the Borrower by causing any Lending Office of such Lender to make such Loan; provided further that any exercise of such option shall not affect the obligation of the Borrower to repay such Borrowing. Upon satisfaction of the applicable conditions set forth in Section 4.02 (and, if such Borrowing is the initial Borrowing, Section 4.01), the Administrative Agent shall make all funds so received available to the Borrower in like funds as received by the Administrative Agent either by (i) crediting the account of the Borrower on the books of Bank of America with the amount of such funds or (ii) wire transfer of such funds, in each case in accordance with instructions provided to (and reasonably acceptable to) the Administrative Agent by the Borrower.
(c)    Except as otherwise provided herein, a LIBOR Rate Loan may be continued or converted only on the last day of the Interest Period for such LIBOR Rate Loan. During the existence of an Event of Default, no Loans may be requested as, converted into or continued as LIBOR Rate Loans without the consent of the Required Lenders, and the Required Lenders may demand that any or all of the then outstanding LIBOR Rate Loans be converted immediately to Base Rate Loans.
(d)    The Administrative Agent shall promptly notify the Borrower and the Lenders of the LIBOR Rate applicable to any Interest Period for any LIBOR Rate Loan upon determination of such LIBOR Rate in accordance with the definition thereof.
(e)    After giving effect to all Borrowings, all conversions of Loans from one Type to the other, and all continuations of Loans as the same Type, there shall not be more than ten Interest Periods in effect with respect to Loans.
(f)    Notwithstanding anything to the contrary in this Agreement, any Lender may exchange, continue or rollover all of the portion of its Loans in connection with any refinancing, extension, loan modification or similar transaction permitted by the terms of this Agreement, pursuant to a cashless settlement mechanism approved by the Borrower, the Administrative Agent, and such Lender.
2.03    Prepayments.
(a)    The Borrower may, upon notice to the Administrative Agent, at any time or from time to time voluntarily prepay Loans in whole or in part without premium or penalty; provided that (i) such notice must be received by the Administrative Agent not later than 12:00 noon (A) two Business Days prior to any date of prepayment of LIBOR Rate Loans and (B) on the date of prepayment of Base Rate Loans; (ii) any prepayment of LIBOR Rate Loans shall be in a principal amount of $5,000,000 or a whole multiple of $1,000,000 in excess thereof; and (iii) any prepayment of Base Rate Loans shall be in a principal amount of $5,000,000 or a whole multiple of $1,000,000 in excess thereof, or, in each case, if less, the entire principal amount thereof then outstanding. Each such notice shall specify the date and amount of such prepayment and the Type(s) of Loans to be prepaid and, if LIBOR Rate Loans are to be prepaid, the Interest Period(s) of such Loans. The Administrative Agent will promptly notify each Lender of its receipt of each such notice, and of such Lender’s Applicable Percentage of such prepayment. If such notice is given by the Borrower, the Borrower shall make such prepayment and the payment amount specified in such notice shall be due and payable on the date specified therein. Any prepayment of a LIBOR Rate Loan shall be accompanied by all accrued interest thereon, together with any additional

22    
Exhibit 10(ii)

amounts required pursuant to Section 3.05. Subject to Section 2.12, each such prepayment shall be applied to the Loans of the Lenders in accordance with their respective Applicable Percentages.
(b)    If the Administrative Agent notifies the Borrower at any time that the Total Outstandings at such time exceed the Aggregate Commitments then in effect, then, within two Business Days after receipt of such notice, the Borrower shall prepay Loans in an aggregate amount sufficient to reduce such Outstanding Amount as of such date of payment to an amount not to exceed 100% of the Aggregate Commitments then in effect.
2.04    Reduction or Termination of Commitments. The Borrower may, upon notice to the Administrative Agent, terminate the Aggregate Commitments, or permanently reduce the Aggregate Commitments to an amount not less than the Total Outstandings; provided that (i) any such notice shall be received by the Administrative Agent not later than 12:00 noon one Business Day prior to the date of termination or reduction, and (ii) any such partial reduction shall be in an aggregate amount of $10,000,000 or any whole multiple of $1,000,000 in excess thereof. The Administrative Agent shall promptly notify the Lenders of any such notice of reduction or termination of the Aggregate Commitments. Once reduced in accordance with this Section, the Aggregate Commitments may not be increased. Any reduction of the Aggregate Commitments shall be applied to the Commitment of each Lender according to its Applicable Percentage. All facility fees accrued until the effective date of any termination of the Aggregate Commitments shall be paid on the effective date of such termination.
2.05    Repayment of Loans. The Borrower shall repay to the Lenders on the Maturity Date the aggregate principal amount of Loans made to the Borrower outstanding on such date.
2.06    Interest.
(a)    Subject to the provisions of subsection (b) below, (i) each LIBOR Rate Loan shall bear interest on the outstanding principal amount thereof for each Interest Period at a rate per annum equal to the LIBOR Rate for such Interest Period plus the Applicable Margin; and (ii) each Base Rate Loan shall bear interest on the outstanding principal amount thereof from the applicable Borrowing date at a rate per annum equal to the Base Rate plus the Applicable Margin.
(b)    If any amount of principal on any Loan is not paid when due (after giving effect to all applicable grace periods) or if any interest, fee or other amount payable by the Borrower under any Loan Document is not paid when due (after giving effect to all applicable grace periods), in each case, whether at stated maturity, by acceleration or otherwise, then such amount shall thereafter bear interest at a fluctuating interest rate per annum at all times equal to the Default Rate to the fullest extent permitted by applicable Laws. Accrued and unpaid interest on past due amounts (including interest on past due interest) shall be due and payable upon demand.
(c)    Except as provided in clause (b) above, interest on each Loan shall be due and payable in arrears on each Interest Payment Date applicable thereto and at such other times as may be specified herein. Interest hereunder shall be due and payable in accordance with the terms hereof before and after judgment, and before and after the commencement of any proceeding under any Debtor Relief Law.
2.07    Fees.
(a)    Facility Fee. The Borrower shall pay to the Administrative Agent for the account of each Lender in accordance with its Applicable Percentage, a facility fee equal to the Applicable Margin

23    
Exhibit 10(ii)

applicable to the facility fee times the actual daily amount of the Aggregate Commitments (or, if the Aggregate Commitments have terminated, on the Outstanding Amount of all Loans), regardless of usage, subject to adjustment as provided in Section 2.12. The facility fee shall accrue at all times during the Availability Period (and thereafter so long as any Loans remain outstanding) and shall be due and payable quarterly in arrears on the last Business Day of each March, June, September and December, commencing with the first such date to occur after the Closing Date, and on the last day of the Availability Period (and, if applicable, thereafter on demand). The facility fee shall be calculated quarterly in arrears, and if there is any change in the Applicable Margin during any quarter, the actual daily amount shall be computed and multiplied by the Applicable Margin separately for each period during such quarter that such Applicable Margin was in effect. The facility fee shall accrue at all times, including at any time during which one or more of the conditions in Article IV is not met.
(b)    Agency Fees. The Borrower shall pay an agency fee to the Administrative Agent for the Administrative Agent’s own account, in the amount and at the time specified in the letter agreement, dated April 30, 2020 (the “Fee Letter”), among the Borrower, Bank of America and Bank of America Securities, Inc. Such fees shall be fully earned when paid and shall be nonrefundable for any reason whatsoever.
(c)    Lenders’ Upfront Fee. On the Closing Date, the Borrower shall pay to the Administrative Agent, for the account of the Lenders in accordance with their respective pro rata share of the Aggregate Commitments, an upfront fee in the amount and at the time specified in the Fee Letter. Such upfront fees are for the credit facility committed by the Lenders under this Agreement and are fully earned on the date paid. The upfront fee paid to each Lender is solely for its own account and is nonrefundable for any reason whatsoever.
2.08    Computation of Interest and Fees. Interest on Base Rate Loans shall be calculated on the basis of a year of 365 or 366 days, as the case may be, and the actual number of days elapsed. Computation of all other types of interest and all fees shall be calculated on the basis of a year of 360 days and the actual number of days elapsed, which results in a higher yield to the payee thereof than a method based on a year of 365 or 366 days. Interest shall accrue on each Loan for the day on which the Loan is made, and, subject to Section 2.10(a), shall not accrue on a Loan, or any portion thereof, for the day on which the Loan or such portion is paid; provided that any Loan that is repaid on the same day on which it is made shall bear interest for one day. Each determination by the Administrative Agent of an interest rate or fee hereunder shall be presumptively correct, absent manifest error.
2.09    Evidence of Debt. The Borrowings made by each Lender shall be evidenced by one or more accounts or records maintained by such Lender and by the Administrative Agent in the ordinary course of business. The accounts or records maintained by the Administrative Agent and each Lender shall be presumptively correct absent manifest error of the amount of the Borrowings made by the Lenders to the Borrower and the interest and payments thereon. Any failure to so record or any error in doing so shall not, however, limit or otherwise affect the obligation of the Borrower hereunder to pay any amount owing with respect to the Obligations. In the event of any conflict between the accounts and records maintained by any Lender and the accounts and records of the Administrative Agent in respect of such matters, the accounts and records of the Administrative Agent shall be presumptively correct in the absence of manifest error. Upon the request of any Lender to the Borrower made through the Administrative Agent, the Borrower shall execute and deliver to such Lender (through the Administrative Agent) a Note, which shall evidence such Lender’s Loans to the Borrower in addition to such accounts or records. Each Lender may attach schedules to its Note and endorse thereon the date, Type (if applicable), amount and maturity of the applicable Loans and payments with respect thereto.

24    
Exhibit 10(ii)

2.10    Payments Generally; Administrative Agent’s Clawback.
(a)    General. All payments to be made by the Borrower of principal, interest, fees and other amounts required to be made hereunder or under any other Loan Document shall be made by wire transfer of immediately available funds in Dollars and shall be made without condition or deduction for any counterclaim, defense, recoupment or set-off. Except as otherwise expressly provided herein, all payments by the Borrower hereunder shall be made to the Administrative Agent, for the account of the respective Lenders to which such payment is owed, at the Administrative Agent’s Office not later than 12:00 noon on the date specified herein. The Administrative Agent will promptly distribute to each Lender its Applicable Percentage (or other applicable share as provided herein) of such payment in like funds as received by wire transfer to such Lender’s Lending Office. All payments received by the Administrative Agent after 12:00 noon shall be deemed received on the next succeeding Business Day and any applicable interest or fee shall in each case continue to accrue. If any payment to be made by the Borrower shall come due on a day other than a Business Day, payment shall be made on the next following Business Day, and such extension of time shall be reflected in computing interest or fees, as the case may be.
(b)    (i)     Funding by Lenders; Presumption by Administrative Agent. Unless the Administrative Agent shall have received notice from a Lender prior to the proposed date of any Borrowing of LIBOR Rate Loans (or, in the case of any Borrowing of Base Rate Loans, prior to 12:00 noon on the date of such Borrowing) that such Lender will not make available to the Administrative Agent such Lender’s share of such Borrowing, the Administrative Agent may assume that such Lender has made such share available on such date in accordance with Section 2.02 (or, in the case of a Borrowing of Base Rate Loans, that such Lender has made such share available in accordance with and at the time required by Section 2.02) and may, in reliance upon such assumption, make available to the Borrower a corresponding amount. In such event, if a Lender has not in fact made its share of the applicable Borrowing available to the Administrative Agent, then the applicable Lender and the Borrower severally agree to pay to the Administrative Agent forthwith on demand (or, in the case of the Borrower only, one Business Day following demand) such corresponding amount in Dollars in immediately available funds with interest thereon, for each day from and including the date such amount is made available to the Borrower to but excluding the date of payment to the Administrative Agent, at (A) in the case of a payment to be made by such Lender, the Overnight Rate, plus any administrative, processing or similar fees customarily charged by the Administrative Agent in connection with the foregoing, and (B) in the case of a payment to be made by the Borrower, the interest rate applicable to Base Rate Loans. If the Borrower and such Lender shall pay such interest to the Administrative Agent for the same or an overlapping period, the Administrative Agent shall promptly remit to the Borrower the amount of such interest paid by the Borrower for such period. If such Lender pays its share of the applicable Borrowing to the Administrative Agent, then the amount so paid shall constitute such Lender’s Loan included in such Borrowing. Any payment by the Borrower shall be without prejudice to any claim the Borrower may have against a Lender that shall have failed to make such payment to the Administrative Agent.
(ii)    Payments by Borrower; Presumptions by Administrative Agent. Unless the Administrative Agent shall have received notice from the Borrower prior to the date on which any payment is due to the Administrative Agent for the account of the Lenders hereunder that the Borrower will not make such payment, the Administrative Agent may assume that the Borrower has made such payment on such date in accordance herewith and may, in reliance upon such assumption, distribute to the Lenders the amount due. In such event, if the Borrower has not in fact made such payment, then each of the Lenders severally agrees to repay to the Administrative Agent forthwith on demand the amount so distributed to such Lender in Dollars in immediately available funds with

25    
Exhibit 10(ii)

interest thereon, for each day from and including the date such amount is distributed to it to but excluding the date of payment to the Administrative Agent, at the Overnight Rate.
A notice of the Administrative Agent to any Lender or the Borrower with respect to any amount owing under this subsection (b) shall be presumptively correct, absent manifest error.
(c)    Failure to Satisfy Conditions Precedent. If any Lender makes available to the Administrative Agent funds for any Loan to be made by such Lender to the Borrower as provided in the foregoing provisions of this Article II, and such funds are not made available to the Borrower by the Administrative Agent because the conditions to the applicable Borrowing set forth in Article IV are not satisfied or waived in accordance with the terms hereof, the Administrative Agent shall return such funds (in like funds as received from such Lender) to such Lender, without interest.
(d)    Obligations of Lenders Several. The obligations of the Lenders hereunder to make Loans and to make payments pursuant to Section 10.04(c) are several and not joint. The failure of any Lender to make any Loan or to make any payment under Section 10.04(c) on any date required hereunder shall not relieve any other Lender of its corresponding obligation to do so on such date, and no Lender shall be responsible for the failure of any other Lender to so make its Loan or to make its payment under Section 10.04(c).
(e)    Funding Source. Nothing herein shall be deemed to obligate any Lender to obtain the funds for any Loan in any particular place or manner or to constitute a representation by any Lender that it has obtained or will obtain the funds for any Loan in any particular place or manner.
2.11    Sharing of Payments. If any Lender shall, by exercising any right of set-off or counterclaim or otherwise, obtain payment in respect of any principal of or interest on any of the Loans made by it resulting in such Lender’s receiving payment of a proportion of the aggregate amount of such Loans or participations and accrued interest thereon greater than its pro rata share thereof as provided herein, then the Lender receiving such greater proportion shall (a) notify the Administrative Agent of such fact, and (b) purchase (for cash at face value) participations in the Loans of the other Lenders, or make such other adjustments as shall be equitable, so that the benefit of all such payments shall be shared by the Lenders ratably in accordance with the aggregate amount of principal of and accrued interest on their respective Loans and other amounts owing them; provided that:
(a)    if any such participations or subparticipations are purchased and all or any portion of the payment giving rise thereto is recovered, such participations or subparticipations shall be rescinded and the purchase price restored to the extent of such recovery, without interest; and
(b)    the provisions of this Section shall not be construed to apply to (y) any payment made by the Borrower pursuant to and in accordance with the express terms of this Agreement (including the application of funds arising from the existence of a Defaulting Lender) or (z) any payment obtained by a Lender as consideration for the assignment of or sale of a participation in any of its Loans to any assignee or participant, other than to the Borrower or any Subsidiary thereof (as to which the provisions of this Section shall apply).
The Borrower consents to the foregoing and agrees, to the extent it may effectively do so under applicable law, that any Lender acquiring a participation pursuant to the foregoing arrangements may exercise against the Borrower, subject to Section 10.08, rights of set-off and counterclaim with respect to such participation as fully as if such Lender were a direct creditor of the Borrower in the amount of such participation.

26    
Exhibit 10(ii)

2.12    Defaulting Lenders. Notwithstanding any provision of this Agreement to the contrary, if any Lender becomes a Defaulting Lender, then the following provisions shall apply for so long as such Lender is a Defaulting Lender to the extent permitted by applicable Law:
(a)    each Defaulting Lender shall be entitled to receive a facility fee for any period during which that Lender is a Defaulting Lender only to extent allocable to the outstanding principal amount of the Loans funded by it;
(b)    the Commitment of such Defaulting Lender and such Defaulting Lender’s Applicable Percentage of the Total Outstandings shall not be included in determining whether the Required Lenders have taken or may take any action hereunder (including any consent to any amendment, waiver or other modification pursuant to, but subject to, Section 10.01); and
(c)    any payment of principal, interest, fees or other amounts received by the Administrative Agent for the account of such Defaulting Lender (whether voluntary or mandatory, at maturity or otherwise) or received by the Administrative Agent from a Defaulting Lender pursuant to Section 10.08 shall be applied at such time or times as may be determined by the Administrative Agent as follows: first, to the payment of any amounts owing by such Defaulting Lender to the Administrative Agent hereunder; second, as the Borrower may request (so long as no Default or Event of Default exists), to the funding of any Loan in respect of which such Defaulting Lender has failed to fund its portion thereof as required by this Agreement, as determined by the Administrative Agent; third, if so determined by the Administrative Agent and the Borrower, to be held in a deposit account and released pro rata in order to satisfy such Defaulting Lender’s potential future funding obligations with respect to Loans under this Agreement; fourth, to the payment of any amounts owing to the Lenders as a result of any judgment of a court of competent jurisdiction obtained by any Lender against such Defaulting Lender as a result of such Defaulting Lender’s breach of its obligations under this Agreement; fifth, so long as no Default or Event of Default exists, to the payment of any amounts owing to the Borrower as a result of any judgment of a court of competent jurisdiction obtained by the Borrower against such Defaulting Lender as a result of such Defaulting Lender's breach of its obligations under this Agreement; and sixth, to such Defaulting Lender or as otherwise directed by a court of competent jurisdiction; provided that if (x) such payment is a payment of the principal amount of any Loans in respect of which such Defaulting Lender has not fully funded its appropriate share, and (y) such Loans were made at a time when the conditions set forth in Section 4.02 were satisfied or waived, such payment shall be applied solely to pay the Loans of all non-Defaulting Lenders on a pro rata basis prior to being applied to the payment of any Loans of such Defaulting Lender until such time as all Loans are held by the Lenders pro rata in accordance with the Commitments hereunder.
In the event that each of the Administrative Agent and the Borrower agrees in writing that a Defaulting Lender has adequately remedied all matters that caused such Lender to be a Defaulting Lender, then such Lender shall cease to be a Defaulting Lender for all purposes hereof and on such date such Lender shall purchase at par such of the Loans of the other Lenders as the Administrative Agent shall determine may be necessary in order for such Lender to hold such Loans in accordance with its Applicable Percentage; provided that no adjustments will be made retroactively for fees accrued or payments made by or on behalf of the Borrower while such Lender was a Defaulting Lender; provided, further, that, except to the extent otherwise expressly agreed by the affected parties, no change hereunder from Defaulting Lender to non-Defaulting Lender will constitute any waiver or release of any claim hereunder resulting from such Lender having been a Defaulting Lender.

27    
Exhibit 10(ii)

ARTICLE III    
TAXES, YIELD PROTECTION AND ILLEGALITY
3.01    Taxes.
(a)    Any and all payments by the Borrower to or for the account of the Administrative Agent or any Lender under any Loan Document shall be made free and clear of and without deduction for any and all present or future taxes, duties, levies, imposts, deductions, assessments, fees, withholdings or similar charges, and all liabilities with respect thereto, excluding, in the case of the Administrative Agent and each Lender, (i) taxes imposed on or measured by its net income (however denominated), franchise taxes imposed on it (in lieu of net income taxes) and branch profits taxes imposed by the United States and any similar taxes imposed on it, by the jurisdiction (or any political subdivision thereof) under the Laws of which the Administrative Agent or such Lender, as the case may be, is organized or the principal office or applicable Lending Office is maintained or is otherwise treated as doing business in such jurisdiction, (ii) taxes as a result of a failure of the Lender or the Administrative Agent to provide any required forms or exemption certificate or other documentation it was legally entitled to provide or a failure to comply with any of its covenants and agreements herein, including, without limitation, Section 10.15, (iii) in the case of a Lender, any withholding tax that is imposed on amounts payable to or for the account of such Lender with respect to an applicable interest in a Loan pursuant to a law in effect on the date on which such Lender becomes a party hereto or designates a new lending office, except in each case to the extent that amounts with respect to such Taxes were payable either to such Lender’s assignor immediately before such Lender acquired the applicable interest in a Loan or to such Lender immediately before it changed its lending office, (iv) any U.S. backup withholding taxes, (v) any U.S. Federal withholding taxes imposed by FATCA (including taxes on passthru payments made by the Borrower, the Administrative Agent, any Lender, any Participant or any of their respective successors or assigns), (vi) any other taxes imposed as a result of the Administrative Agent’s or any Lender’s gross negligence or willful misconduct and (vii) taxes and special assessments of any kind imposed solely as a result of a present or former connection between such recipient and the jurisdiction of the Governmental Authority imposing such tax or special assessment (other than any such connection arising solely from such recipient having executed, delivered or performed its obligations or received a payment under, or enforced, any of the Loan Documents) (all such non-excluded taxes, duties, levies, imposts, deductions, assessments, fees, withholdings or similar charges, and liabilities being hereinafter referred to as “Taxes”). If the Borrower shall be required by any Laws to deduct any Taxes from or in respect of any sum payable under any Loan Document to the Administrative Agent or any Lender, (i) the sum payable shall be increased as necessary so that after making all required deductions (including deductions applicable to additional sums payable under this Section), the Administrative Agent and such Lender receives an amount equal to the sum it would have received had no such deductions been made, (ii) the Borrower shall make such deductions, (iii) the Borrower shall pay the full amount deducted to the relevant Governmental Authority in accordance with applicable Laws, and (iv) within 30 days after the date of such payment, the Borrower shall furnish to the Administrative Agent (which shall forward the same to such Lender) the original or a certified copy of a receipt evidencing payment thereof.
(b)    In addition, the Borrower agrees to pay any and all present or future stamp, court or documentary taxes and any other similar excise or property taxes or charges or levies which arise from any payment made under any Loan Document or from the execution, delivery, performance, enforcement or registration of, or otherwise with respect to, any Loan Document, excluding, however, such amounts imposed as a result of an assignment or a grant of a participation (hereinafter referred to as “Other Taxes”).

28    
Exhibit 10(ii)

(c)    The Borrower agrees to indemnify and hold harmless each Lender and the Administrative Agent for the full amount of Taxes and Other Taxes payable or paid by such Lender and the Administrative Agent in the full amount (including any Taxes or Other Taxes imposed or asserted by any jurisdiction on amounts payable under this Section 3.01, but in all cases, without duplication) that are necessary to preserve the after-tax yield (taking into account and giving effect to any tax benefits afforded such Lender or the Administrative Agent in connection with or directly as a result of the imposition of such Taxes or Other Taxes) such Lender would have received if such Taxes or Other Taxes, as the case may be, had not been imposed, and any liability (including penalties, interest, additions to tax and expenses) arising therefrom or with respect thereto, except with respect to any Lender or the Administrative Agent, as the case may be, for such Taxes, Other Taxes or a liability arising from such Lender’s or the Administrative Agent’s, as the case may be, willful misconduct or gross negligence. Payment under this indemnification shall be made within 30 days after the date the applicable Lender or Agent makes written demand therefor specifying in reasonable detail the basis therefor. Failure or delay on the part of any Lender to demand compensation pursuant to this Section 3.01 shall not constitute a waiver of such Lender’s right to demand such compensation; provided that the Borrower shall not be required to compensate a Lender pursuant to this Section 3.01 for any Taxes or Other Taxes imposed on such Lender more than 60 days prior to the date that such Lender notifies the Borrower of such Taxes or Other Taxes and of such Lender’s intention to claim compensation therefor; provided further that, if the imposition of such Taxes or Other Taxes is retroactive, then the 60-day period referred to above shall be extended to include the period of retroactive effect thereof.
(d)    Unless required by applicable Laws, at no time shall the Administrative Agent have any obligation to file for or otherwise pursue on behalf of a Lender, or have any obligation to pay to any Lender, any refund of Taxes withheld or deducted from the funds paid for the account of such Lender, as the case may be. If the Administrative Agent or any Lender in good faith determines that it has received a refund of any Taxes or Other Taxes as to which it has been indemnified by the Borrower or with respect to which the Borrower has paid additional amounts pursuant to this Section, it shall pay to the Borrower an amount equal to such refund (but only to the extent of indemnity payments made, or additional amounts paid, by the Borrower under this Section with respect to the Taxes or Other Taxes giving rise to such refund), net of all reasonable out-of-pocket expenses incurred by the Administrative Agent or such Lender, as the case may be, and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund), provided that the Borrower, upon the request of the Administrative Agent or such Lender, agrees to repay the amount paid over to the Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent or such Lender in the event the Administrative Agent or such Lender is required to repay such refund to such Governmental Authority. This subsection shall not be construed to require the Administrative Agent or any Lender to make available its tax returns (or any other information relating to its taxes that it deems confidential) to the Borrower or any other Person.
(e)    If the Borrower is required to pay any amount to any Lender or the Administrative Agent pursuant to this Section 3.01, then such Lender or the Administrative Agent, as the case may be, shall use reasonable efforts (consistent with legal and regulatory restrictions) to change the jurisdiction of its applicable Lending Office so as to eliminate, or reduce the amount of, any such additional payment by the Borrower which may thereafter accrue, if such change in the reasonable judgment of such Lender or the Administrative Agent, as the case may be, is not otherwise materially disadvantageous to such Person.
(f)    Each Lender shall severally indemnify the Administrative Agent, within 30 days after demand therefor, for (i) any Taxes or Other Taxes attributable to such Lender (but only to the extent that the Borrower has not already indemnified the Administrative Agent for such Taxes or Other Taxes and

29    
Exhibit 10(ii)

without limiting the obligation of the Borrower, if any, to do so), (ii) any Taxes attributable to such Lender’s failure to comply with the provisions of Section 10.06(d) relating to the maintenance of a Participant Register and (iii) any excluded taxes, duties, levies, imposts, deductions, assessments, fees, withholdings or similar charges and liabilities attributable to such Lender, in each case, that are payable or paid by the Administrative Agent in connection with any Loan Document, and any reasonable expenses arising therefrom or with respect thereto, whether or not such taxes, duties, levies, imposts, deductions, assessments, fees, withholdings or similar charges and liabilities were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to any Lender by the Administrative Agent shall be conclusive absent manifest error. Each Lender hereby authorizes the Administrative Agent to set off and apply any and all amounts at any time owing to such Lender under any Loan Document or otherwise payable by the Administrative Agent to the Lender from any other source against any amount due to the Administrative Agent under this Section 3.01(f).
3.02    Illegality. If any Lender determines that any Law has made it unlawful, or that any Governmental Authority has asserted that it is unlawful, for any Lender or its applicable Lending Office to make, maintain or fund LIBOR Rate Loans, as it would otherwise be obligated hereunder to make, maintain or fund, or materially restricts the authority of such Lender to purchase or sell, or to take deposits of, Dollars in the London interbank market, or to determine or charge interest rates based upon the LIBOR Rate, then, on notice thereof by such Lender to the Borrower through the Administrative Agent, (i) any obligation existing hereunder of such Lender to make or continue LIBOR Rate Loans or to convert Base Rate Loans to LIBOR Rate Loans shall be suspended and (ii) if such notice asserts the illegality of such Lender making or maintaining Base Rate Loans the interest rate on which is determined by reference to the LIBOR Rate component of the Base Rate, the interest rate on which Base Rate Loans of such Lender shall, if necessary to avoid such illegality, be reasonably determined by the Administrative Agent without reference to the LIBOR Rate component of the Base Rate, in each case until such Lender notifies the Administrative Agent and the Borrower that the circumstances giving rise to such determination no longer exist. Upon receipt of such notice, (x) the Borrower shall, upon demand from such Lender (with a copy to the Administrative Agent), prepay or, if applicable, convert all LIBOR Rate Loans of such Lender to Base Rate Loans (the interest rate on which Base Rate Loans of such Lender shall, if necessary to avoid such illegality, be reasonably determined by the Administrative Agent without reference to the LIBOR Rate component of the Base Rate), either on the last day of the Interest Period thereof, if such Lender may lawfully continue to maintain such LIBOR Rate Loans to such day, or immediately, if such Lender may not lawfully continue to maintain such LIBOR Rate Loans, and (y) if such notice asserts the illegality of such Lender determining or charging interest rates based upon the LIBOR Rate, the Administrative Agent shall during the period of such suspension compute the Base Rate applicable to such Lender without reference to the LIBOR Rate component thereof until the Administrative Agent is advised in writing by such Lender that it is no longer illegal for such Lender to determine or charge interest rates based upon the LIBOR Rate. Upon any such prepayment or conversion, the Borrower shall also pay accrued and unpaid interest on the amount so prepaid or converted. Each Lender agrees to designate a different Lending Office if such designation will avoid the need for such notice and will not, in the good faith judgment of such Lender, otherwise be materially disadvantageous to such Lender or make it impracticable for such Lender to fund Loans within the time periods required under this Agreement.
3.03    Inability to Determine Rates; LIBOR Successor Rate.
(a)    If in connection with any request for a LIBOR Rate Loan or a conversion to or continuation thereof, (i) the Administrative Agent determines that (A) Dollar deposits are not being offered to banks in the London interbank market for the applicable amount and Interest Period of such LIBOR Rate Loan,

30    
Exhibit 10(ii)

or (B) (x) adequate and reasonable means do not exist for determining the LIBOR Rate for any requested Interest Period with respect to a proposed LIBOR Rate Loan or in connection with an existing or proposed Base Rate Loan and (y) the circumstances described in Section 3.03(c)(i) do not apply (in each case with respect to this clause (i), “Impacted Loans”), or (ii) the Administrative Agent or the Required Lenders determine that for any reason the LIBOR Rate for any requested Interest Period with respect to a proposed LIBOR Rate Loan does not adequately and fairly reflect the cost to such Lenders of funding such LIBOR Rate Loan, the Administrative Agent will promptly so notify the Borrower and each Lender. Thereafter, (x) the obligation of the Lenders to make or maintain LIBOR Rate Loans shall be suspended, (to the extent of the affected LIBOR Rate Loans or Interest Periods), and (y) in the event of a determination described in the preceding sentence with respect to the LIBOR Rate component of the Base Rate, the utilization of the LIBOR Rate component in determining the Base Rate shall be suspended, in each case until the Administrative Agent (or, in the case of a determination by the Required Lenders described in clause (ii) of Section 3.03(a), until the Administrative Agent upon instruction of the Required Lenders) revokes such notice. Upon receipt of such notice, the Borrower may revoke any pending request for a Borrowing of, conversion to or continuation of LIBOR Rate Loans (to the extent of the affected LIBOR Rate Loans or Interest Periods) or, failing that, will be deemed to have converted such request into a request for a Borrowing of Base Rate Loans in the amount specified therein.
(b)    Notwithstanding the foregoing, if the Administrative Agent has made the determination described in clause (i) of Section 3.03(a), the Administrative Agent, in consultation with the Borrower and Required Lenders, may establish an alternative interest rate for the Impacted Loans, in which case, such alternative rate of interest shall apply with respect to the Impacted Loans until (i) the Administrative Agent revokes the notice delivered with respect to the Impacted Loans under clause (i) of the first sentence of Section 3.03(a), (ii) the Administrative Agent or the Required Lenders notify the Administrative Agent and the Borrower that such alternative interest rate does not adequately and fairly reflect the cost to such Lenders of funding the Impacted Loans, or (iii) any Lender determines that any Law has made it unlawful, or that any Governmental Authority has asserted that it is unlawful, for such Lender or its applicable Lending Office to make, maintain or fund Loans whose interest is determined by reference to such alternative rate of interest or to determine or charge interest rates based upon such rate or any Governmental Authority has imposed material restrictions on the authority of such Lender to do any of the foregoing and provides the Administrative Agent and the Borrower written notice thereof.
(c)    Notwithstanding anything to the contrary in this Agreement or any other Loan Documents, if the Administrative Agent determines (which determination shall be conclusive absent manifest error), or the Borrower or Required Lenders notify the Administrative Agent (with, in the case of the Required Lenders, a copy to the Borrower) that the Borrower or Required Lenders (as applicable) have determined, that:
(i)    adequate and reasonable means do not exist for ascertaining the LIBOR Rate for any requested Interest Period, including, without limitation, because the LIBOR Screen Rate is not available or published on a current basis and such circumstances are unlikely to be temporary; or
(ii)    the administrator of the LIBOR Screen Rate or a Governmental Authority having jurisdiction over the Administrative Agent has made a public statement identifying a specific date after which the LIBOR Rate or the LIBOR Screen Rate shall no longer be made available, or used for determining the interest rate of loans, provided that, at the time of such statement, there is no successor administrator that is satisfactory to the Administrative Agent, that will continue to provide the LIBOR Rate after such specific date (such specific date, the “Scheduled Unavailability Date”); or

31    
Exhibit 10(ii)

(iii)    syndicated loans currently being executed, or that include language similar to that contained in this Section 3.03, are being executed or amended (as applicable) to incorporate or adopt a new benchmark interest rate to replace the LIBOR Rate,
then, reasonably promptly after such determination by the Administrative Agent or receipt by the Administrative Agent of such notice, as applicable, the Administrative Agent and the Borrower may amend this Agreement to replace the LIBOR Rate with (x) one or more SOFR-Based Rates or (y) another alternate benchmark rate giving due consideration to any evolving or then existing convention for similar U.S. dollar denominated syndicated credit facilities for such alternative benchmarks and, in each case, including any mathematical or other adjustments to such benchmark giving due consideration to any evolving or then existing convention for similar U.S. dollar denominated syndicated credit facilities for such benchmarks, which adjustment or method for calculating such adjustment shall be published on an information service as selected by the Administrative Agent from time to time in its reasonable discretion and may be periodically updated (the “Adjustment;” and any such proposed rate, a “LIBOR Successor Rate”), and any such amendment shall become effective at 5:00 p.m. on the fifth Business Day after the Administrative Agent shall have posted such proposed amendment to all Lenders and the Borrower unless, prior to such time, Lenders comprising the Required Lenders have delivered to the Administrative Agent written notice that such Required Lenders (A) in the case of an amendment to replace the LIBOR Rate with a rate described in clause (x), object to the Adjustment; or (B) in the case of an amendment to replace the LIBOR Rate with a rate described in clause (y), object to such amendment; provided that for the avoidance of doubt, in the case of clause (A), the Required Lenders shall not be entitled to object to any SOFR-Based Rate contained in any such amendment. Such LIBOR Successor Rate shall be applied in a manner consistent with market practice; provided that to the extent such market practice is not administratively feasible for the Administrative Agent, such LIBOR Successor Rate shall be applied in a manner as otherwise reasonably determined by the Administrative Agent.

If no LIBOR Successor Rate has been determined and the circumstances under clause (i) above exist or the Scheduled Unavailability Date has occurred (as applicable), the Administrative Agent will promptly so notify the Borrower and each Lender.  Thereafter, (x) the obligation of the Lenders to make or maintain LIBOR Rate Loans shall be suspended, (to the extent of the affected LIBOR Rate Loans or Interest Periods), and (y) the LIBOR Rate component shall no longer be utilized in determining the Base Rate.  Upon receipt of such notice, the Borrower may revoke any pending request for a Borrowing of, conversion to or continuation of LIBOR Rate Loans (to the extent of the affected LIBOR Rate Loans or Interest Periods) or, failing that, will be deemed to have converted such request into a request for a Borrowing of Base Rate Loans (subject to the foregoing clause (y)) in the amount specified therein.

Notwithstanding anything else herein, any definition of LIBOR Successor Rate shall provide that in no event shall such LIBOR Successor Rate be less than 0.75% per annum for purposes of this Agreement.

In connection with the implementation of a LIBOR Successor Rate, the Administrative Agent will have the right to make LIBOR Successor Rate Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such LIBOR Successor Rate Conforming Changes will become effective without any further action or consent of any other party to this Agreement.

For purposes hereof:

“LIBOR Successor Rate Conforming Changes” means, with respect to any proposed LIBOR Successor Rate, any conforming changes to the definition of Base Rate, Interest Period, timing and frequency

32    
Exhibit 10(ii)

of determining rates and making payments of interest and other technical, administrative or operational matters as may be appropriate, in the discretion of the Administrative Agent, to reflect the adoption and implementation of such LIBOR Successor Rate and to permit the administration thereof by the Administrative Agent in a manner substantially consistent with market practice (or, if the Administrative Agent determines that adoption of any portion of such market practice is not administratively feasible or that no market practice for the administration of such LIBOR Successor Rate exists, in such other manner of administration as the Administrative Agent determines is reasonably necessary in connection with the administration of this Agreement).

“Relevant Governmental Body” means the Federal Reserve Board and/or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Federal Reserve Board and/or the Federal Reserve Bank of New York for the purpose of recommending a benchmark rate to replace the LIBOR Rate in loan agreements similar to this Agreement.

“SOFR” with respect to any day means the secured overnight financing rate published for such day by the Federal Reserve Bank of New York, as the administrator of the benchmark (or a successor administrator) on the Federal Reserve Bank of New York’s website (or any successor source) and, in each case, that has been selected or recommended by the Relevant Governmental Body.

“SOFR-Based Rate” means SOFR or Term SOFR.

“Term SOFR” means the forward-looking term rate for any period that is approximately (as determined by the Administrative Agent”) as long as any of the Interest Period options set forth in the definition of “Interest Period” and that is based on SOFR and that has been selected or recommended by the Relevant Governmental Body, in each case as published on an information service as selected by the Administrative Agent from time to time in its reasonable discretion.

3.04    Increased Cost and Reduced Return; Capital Adequacy; Reserves on LIBOR Rate Loans.
(a)    If the Administrative Agent or any Lender reasonably determines (which determination shall be made in good faith (and not on an arbitrary or capricious basis) and consistent with similarly situated customers of the applicable Lender or the Administrative Agent under agreements having provisions similar to this Section 3.04 after consideration of such factors as such Lender or the Administrative Agent then reasonably determines to be relevant) that as a result of any Change in Law there shall be any increase in the cost to such Lender of agreeing to make or making, funding or maintaining Loans or (as the case may be), or a reduction in the amount received or receivable by such Lender in connection with any of the foregoing including, without limitation, as a result of the Administrative Agent or such Lender becoming subject to any taxes, duties, levies, imposts, deductions, assessments, fees, reserves, special deposits, liquidity or similar requirements (including any compulsory loan requirement, insurance charge or other assessment), withholdings or similar charges and liabilities on its loans, loan principal, letters of credit, commitments, or other obligations, or its deposits, reserves, other liabilities or capital attributable thereto (excluding for purposes of this subsection (a) any such increased costs or reduction in amount resulting from (v) any taxes described in clauses (ii), (iii), (iv), (vi) and (vii) of Section 3.01(a), (w) any taxes imposed by FATCA (including taxes on any passthru payments made by the Borrower, the Administrative Agent, any Lender, any Participant or any of their respective successors or assigns), (x) Taxes imposed on payments hereunder or Other Taxes (as to which Section 3.01 shall govern), (y) changes in the basis of taxation of overall net income or overall gross income by the United States or any foreign jurisdiction or any political subdivision of either thereof under the Laws of which such Lender is organized

33    
Exhibit 10(ii)

or has its Lending Office or is otherwise treated as doing business in such jurisdiction and (z) reserve requirements contemplated by Section 3.04(f)), then from time to time upon demand of the Administrative Agent or such Lender (with a copy of such demand to the Administrative Agent), the Borrower shall pay to the Administrative Agent or such Lender such additional amounts as will compensate the Administrative Agent or such Lender for such increased cost or reduction.
(b)    If any Lender reasonably determines (which determination shall be made in good faith (and not on an arbitrary or capricious basis) and consistent with similarly situated customers of the applicable Lender under agreements having provisions similar to this Section 3.04 after consideration of such factors as such Lender then reasonably determines to be relevant) that any Change in Law regarding capital adequacy or liquidity, or compliance by such Lender (or its Lending Office) therewith, has the effect of reducing the rate of return on the capital of such Lender or any corporation controlling such Lender as a consequence of such Lender’s obligations hereunder (taking into consideration its policies with respect to capital adequacy and liquidity and such Lender’s desired return on capital), then from time to time upon demand of such Lender (with a copy of such demand to the Administrative Agent), the Borrower shall pay to such Lender such additional amounts as will compensate such Lender for such reduction.
(c)    If any Lender requests compensation by the Borrower under the foregoing provisions of this Section 3.04, the Borrower may, by notice to such Lender (with a copy to the Administrative Agent), suspend the obligation of such Lender to make or continue Loans of the Type with respect to which such compensation is requested, or to convert Loans of any other Type into Loans of such Type, until the event or condition giving rise to such request ceases to be in effect; provided, such suspension shall not affect the right of such Lender to receive the compensation so requested.
(d)    Failure or delay on the part of any Lender to demand compensation pursuant to the foregoing provisions of this Section 3.04 shall not constitute a waiver of such Lender’s right to demand such compensation; provided that the Borrower shall not be required to compensate a Lender pursuant to the foregoing provisions of this Section 3.04 for any increased costs or reductions incurred more than 60 days prior to the date that such Lender notifies the Borrower of the Change in Law giving rise to such increased costs or reductions and of such Lender’s intention to claim compensation therefor; provided further that, if the Change in Law giving rise to such increased costs or reductions is retroactive, then the 60-day period referred to above shall be extended to include the period of retroactive effect thereof.
(e)    Each Lender agrees to designate a different Lending Office if such designation will avoid the need for compensation under this Section 3.04 and will not, in the good faith judgment of such Lender, otherwise be materially disadvantageous to such Lender.
(f)    The Borrower shall, to the extent not provided for in the calculation of the LIBOR Rate, pay to each Lender, (i) as long as such Lender shall be required to maintain reserves with respect to liabilities or assets consisting of or including Eurocurrency funds or deposits (currently known as “Eurocurrency liabilities”), additional interest on the unpaid principal amount of each LIBOR Rate Loan equal to the actual costs of such reserves allocated to such Loan by such Lender (as determined by such Lender in good faith, which determination shall be conclusive), and (ii) as long as such Lender shall be required to comply with any reserve ratio requirement or analogous requirement of any other central banking or financial regulatory authority imposed in respect of the maintenance of the Commitments or the funding of the LIBOR Rate Loans, such additional costs (expressed as a percentage per annum and rounded upwards, if necessary, to the nearest five decimal places) equal to the actual costs allocated to such Commitment or Loan by such Lender (as determined by such Lender in good faith, which determination shall be conclusive), which in each case shall be due and payable on each date on which

34    
Exhibit 10(ii)

interest is payable on such Loan; provided the Borrower shall have received at least 10 days’ prior notice (with a copy to the Administrative Agent) of such additional interest or costs from such Lender. If a Lender fails to give notice 10 days prior to the relevant Interest Payment Date, such additional interest or costs shall be due and payable 10 days from receipt of such notice.
3.05    Funding Losses. Upon demand of any Lender (with a copy to the Administrative Agent) from time to time, the Borrower shall promptly compensate such Lender for and hold such Lender harmless from any loss, cost or expense reasonably incurred by it as a result of:
(a)    any continuation, conversion, payment or prepayment of any LIBOR Rate Loan on a day other than the last day of the Interest Period for such Loan (whether voluntary, mandatory, automatic, by reason of acceleration, or otherwise);
(b)    any failure by the Borrower (for a reason other than the failure of such Lender to make a Loan) to repay, prepay, borrow, continue or convert any LIBOR Rate Loan on the date required hereunder or the date or in the amount specified in a notice given by the Borrower; or;
(c)    the assignment of any LIBOR Rate Loan other than on the last day of the Interest Period applicable thereto as a result of a request by the Borrower pursuant to Section 10.16;
including any loss or expense arising from the liquidation or reemployment of funds obtained by it to maintain such Loan or from fees payable to terminate the deposits from which such funds were obtained.
For purposes of calculating amounts payable by the Borrower to the Lenders under this Section 3.05, each Lender shall be deemed to have funded each LIBOR Rate Loan made by it at the rate used in determining the LIBOR Rate for such Loan by a matching deposit or other Borrowing in the London interbank market for a comparable amount and for a comparable period, whether or not such LIBOR Rate Loan was in fact so funded.
3.06    Survival. All of the Borrower’s obligations under Sections 3.01, 3.02 and 3.04 shall survive termination of the Aggregate Commitments, repayment, satisfaction or discharge of all other Obligations hereunder, resignation or replacement of the Administrative Agent and any assignment of rights by, or the replacement of, a Lender.

ARTICLE IV    
CONDITIONS PRECEDENT TO BORROWINGS
4.01    Conditions of Effectiveness of this Agreement. The effectiveness of this Agreement is subject to satisfaction (or waiver) of the following conditions precedent:
(a)    Unless waived by all the Lenders (or by the Administrative Agent with respect to immaterial matters, the Administrative Agent’s receipt of the following, each of which shall be originals or facsimiles or electronic copies (including “PDF” and “TIF” files) (facsimiles and electronic copies followed promptly by originals) unless otherwise specified, each properly executed by a Responsible Officer of the Borrower, as applicable, each dated the Closing Date (or, in the case of certificates of governmental officials, a recent date before the Closing Date) and each in form and substance reasonably satisfactory to the Administrative Agent and each of the Lenders:

35    
Exhibit 10(ii)

(i)    executed counterparts of this Agreement, sufficient in number for distribution to the Administrative Agent, each Lender and the Borrower;
(ii)    Notes executed by the Borrower in favor of each Lender requesting such a Note;
(iii)    a copy of the resolutions of the board of directors (or other governing body) of the Borrower authorizing the transactions contemplated hereby, certified as of the Closing Date by the Secretary, an Assistant Secretary or other appropriate officer or director of the Borrower;
(iv)    a certificate of the Secretary, Assistant Secretary or other appropriate officer or director of the Borrower certifying the names and true signatures of the officers of the Borrower authorized to execute, deliver and perform, as applicable, this Agreement and all other Loan Documents to be delivered by it hereunder;
(v)    the Organization Documents of the Borrower as in effect on the Closing Date, certified by the Secretary, Assistant Secretary or other appropriate officer of the Borrower as of the Closing Date;
(vi)    a good standing certificate for the Borrower from the appropriate Governmental Authority of its jurisdiction of incorporation;
(vii)    a certificate signed by a Responsible Officer of the Borrower, dated as of the Closing Date, certifying that: (A) the representations and warranties of the Borrower contained in Article V or in any other Loan Documents are true and correct in all material respects (or in all respects in the case of any representation and warranty qualified by materiality or “Material Adverse Effect”) on and as of the Closing Date, except to the extent that such representations and warranties specifically refer to an earlier date, in which case they shall have been true and correct in all material respects (or in all respects in the case of any representation and warranty qualified by materiality or “Material Adverse Effect”) as of such earlier date; (B) no Default or Event of Default exists, or will result from the Borrowings made on the Closing Date or the application of the proceeds thereof; and (C) there has not occurred since the date of the Audited Financial Statements, a material adverse change in the business, assets, or financial condition of the Borrower and its Subsidiaries taken as a whole, other than (x) any material adverse change that has been publicly disclosed in the Borrower’s filings with the SEC prior to April 30, 2020 or (y) any material adverse change as a result of the Coronavirus Disease 2019 (COVID-19);
(viii)    copies of the current Issuer Ratings;
(ix)    opinions of in-house and outside counsels to the Borrower in substantially the forms delivered in connection with the closing of the Existing Credit Agreement; and
(x)    such other certificates or documents as the Administrative Agent or the Required Lenders reasonably may require.
(b)    Any fees required to be paid on or before the Closing Date shall have been paid.
(c)    Unless waived by the Administrative Agent, the Borrower shall have paid all fees, charges and disbursements of counsel to the Administrative Agent required to be paid by it to the extent invoiced prior to or on the Closing Date.

36    
Exhibit 10(ii)

Without limiting the generality of the provisions of Section 9.03, for purposes of determining compliance with the conditions specified in this Section 4.01, each Lender that has signed this Agreement shall be deemed to have consented to, approved or accepted or to be satisfied with, each document or other matter required thereunder to be consented to or approved by or acceptable or satisfactory to a Lender unless the Administrative Agent shall have received notice from such Lender prior to the proposed Closing Date specifying its objection thereto.
4.02    Conditions to all Borrowings. The obligation of each Lender to honor any Loan Notice (other than a Loan Notice requesting only a conversion of Loans to the other Type or a continuation of Loans) is subject to the following conditions precedent:
(a)    The representations and warranties of the Borrower contained in Article V or in any other Loan Documents (other than those representations and warranties in Sections 5.01(b)(i), 5.01(c), 5.01(d), all of Sections 5.06 and 5.08, the last sentence of Section 5.09 and all of Section 5.10) shall be true and correct in all material respects (or in all respects in the case of any representation and warranty qualified by materiality or “Material Adverse Effect”) on and as of the date of such Borrowing, except that to the extent that such representations and warranties specifically refer to an earlier date, in which case they shall be true and correct in all material respects (or in all respects in the case of any representation and warranty qualified by materiality or “Material Adverse Effect”) as of such earlier date.
(b)    No Default or Event of Default shall exist, or would result from such proposed Borrowing.
(c)    The Administrative Agent shall have received a Loan Notice in accordance with the requirements hereof.
Each Loan Notice (other than a Loan Notice requesting only a conversion of Loans to the other Type or a continuation of Loans) submitted by the Borrower shall be deemed to be a representation and warranty by the Borrower that the conditions specified in Sections 4.02(a) and (b) have been satisfied on and as of the date of the applicable Borrowing and shall be deemed a making of the representations and warranties described in Section 4.02(a).

ARTICLE V    
REPRESENTATIONS AND WARRANTIES
The Borrower represents and warrants to the Administrative Agent and the Lenders that:
5.01    Existence, Qualification and Power; Compliance with Laws. The Borrower (a) is duly organized or formed, validly existing and in good standing under the Laws of the jurisdiction of its incorporation or organization, (b) (i) has all requisite power and authority and all governmental licenses, authorizations, consents and approvals to own its assets and carry on its business and (ii) has all requisite power and authority and legal right to execute and deliver, and perform its obligations under, the Loan Documents to which it is a party, (c) is duly qualified and is licensed and in good standing under the Laws of each jurisdiction where its ownership, lease or operation of properties or the conduct of its business requires such qualification or license, and (d) is in compliance with all Laws, except in each case referred to in clause (b)(i), clause (c) or clause (d), to the extent that failure to do so would not reasonably be expected to have a Material Adverse Effect.
5.02    Authorization; No Contravention. The execution, delivery and performance by the Borrower of each Loan Document to which it is a party have been duly authorized by all necessary corporate

37    
Exhibit 10(ii)

or other organizational action, and do not and will not (a) contravene the terms of any of its Organization Documents; (b) conflict with or result in any breach or contravention of, or the creation of any Lien under, any Contractual Obligation to which the Borrower is a party or any order, injunction, writ or decree of any Governmental Authority or arbitral award to which the Borrower or its property is subject; or (c) violate any Law, except in each case referred to in clause (b) and clause (c) for any such violation, breach or contravention which would not reasonably be expected to have a Material Adverse Effect.
5.03    Governmental and Third-Party Authorization. No approval, consent, exemption, authorization, or other action by, or notice to, or filing with, any Governmental Authority is necessary or required in connection with the execution, delivery or performance by the Borrower of this Agreement or any other Loan Document to which it is a party except such as have been obtained or made.
5.04    Binding Effect. This Agreement has been, and each other Loan Document, when delivered hereunder, will have been, duly executed and delivered by the Borrower. This Agreement constitutes, and each other Loan Document to which the Borrower is party when so delivered will constitute, a legal, valid and binding obligation of the Borrower, enforceable against the Borrower in accordance with its terms, except as may be limited by bankruptcy, solvency, reorganization, moratorium or similar law relating to or limiting creditor’s rights generally or by equitable principles relating to enforceability.
5.05    Financial Statements. The Audited Financial Statements (i) were prepared in accordance with GAAP (except as otherwise expressly noted therein) consistently applied throughout the period covered thereby; and (ii) fairly present in all material respects the financial condition of the Borrower and its Subsidiaries as of the date thereof and their results of operations for the period covered thereby in accordance with GAAP (except as otherwise expressly noted therein) consistently applied throughout the period covered thereby.
5.06    Litigation. There are no actions, suits, proceedings, claims or disputes pending or, to the knowledge of the Borrower, threatened or contemplated, at law, in equity, in arbitration or before any Governmental Authority, by or against the Borrower or any Subsidiary of the Borrower or against any of their properties or revenues that would reasonably be expected to have a Material Adverse Effect.
5.07    No Default. No Default or Event of Default has occurred and is continuing or would result from the consummation of the transactions contemplated by this Agreement or any other Loan Document.
5.08    Environmental Compliance. Neither the Borrower nor any Material Subsidiary has any liability under Environmental Laws that would reasonably be expected to have a Material Adverse Effect.
5.09    Taxes. The Borrower and its Subsidiaries have filed all Federal, state and other material tax returns and reports required to be filed, and have paid all Federal and state income taxes and other material taxes, assessments, fees and other governmental charges levied or imposed upon them or their properties, income or assets otherwise due and payable, except those which are being contested in good faith by appropriate proceedings diligently conducted and for which adequate reserves have been provided in accordance with GAAP, and except as would not reasonably be expected to have a Material Adverse Effect. There is no proposed tax assessment against the Borrower or any of its Subsidiaries that would reasonably be expected to have a Material Adverse Effect.
5.10    ERISA Compliance.

38    
Exhibit 10(ii)

(a)    Each Plan is in compliance with the applicable provisions of ERISA, the Code and other Federal or state Laws, except to the extent of any noncompliance which would not reasonably be likely to result in a Material Adverse Effect. Each Plan that is intended to qualify under Section 401(a) of the Code has received a favorable determination letter (or opinion or advisory letter) from the IRS or an application for such a letter is currently being processed by the IRS with respect thereto or the remedial amendment period for such Plan under Section 401(b) of the Code has not yet expired and, to the best knowledge of the Borrower, nothing has occurred (i) which has not been remedied which would, or (ii) as to which the Borrower does not intend to commence and complete all necessary and required remedial measures within statutorily or regulatory prescribed periods of time for such remedies to be undertaken so as to, prevent, or cause the loss of, such qualification. The Borrower and each ERISA Affiliate have made all required contributions to each Plan subject to Section 412 and Section 430 of the Code, and no application for a funding waiver or an extension of any amortization period pursuant to Section 412 of the Code has been made with respect to any Plan. Each trust related to a Plan has been determined by the IRS to be exempt from federal income tax under Section 501(a) of the Code.
(b)    There are no pending or, to the best knowledge of the Borrower, threatened claims, actions or lawsuits, or action by any Governmental Authority, with respect to any Plan that would reasonably be expected to have a Material Adverse Effect. There has been no prohibited transaction or violation of the fiduciary responsibility rules with respect to any Plan that has resulted or would reasonably be expected to result in a Material Adverse Effect.
(c)    (i) No ERISA Event has occurred or is reasonably expected to occur that would reasonably be expected to result in any obligation in excess of $100,000,000; (ii) no Pension Plan has any Unfunded Pension Liability that would reasonably be expected to have a Material Adverse Effect; (iii) neither the Borrower nor any ERISA Affiliate has incurred, or reasonably expects to incur, any liability under Title IV of ERISA with respect to any Pension Plan (other than premiums due and not delinquent under Section 4007 of ERISA) that would reasonably be expected to result in any obligation in excess of $100,000,000 and has met all applicable requirements under the Pension Funding Rules; (iv) neither the Borrower nor any ERISA Affiliate has incurred, or reasonably expects to incur, any liability (and no event has occurred which, with the giving of notice under Section 4219 of ERISA, would result in such liability) under Sections 4201 or 4243 of ERISA with respect to a Multiemployer Plan that would reasonably be expected to result in any obligation in excess of $100,000,000; (v) neither the Borrower nor any ERISA Affiliate has engaged in a transaction that could be subject to Sections 4069 or 4212(c) of ERISA; (vi) no Pension Plan has been terminated by the plan administrator thereof nor by the PBGC, and no event or circumstance has occurred or exists that could reasonably be expected to cause the PBGC to institute proceedings under Title IV of ERISA to terminate any Pension Plan; and (vii) as of the most recent valuation date for any Pension Plan, the funding target attainment percentage (as defined in Section 430(d)(2) of the Code) is 60% or higher and neither the Borrower nor any ERISA Affiliate knows or has any reason to know of any facts or circumstances that could reasonably be expected to cause any Plan to be subject to the special funding rules for plans in an at risk, endangered or critical status (as described in Sections 430, 431 or 432 of the Code or Sections 303, 304 or 305 of ERISA.
(d)    Neither the Borrower nor any ERISA Affiliate maintains or contributes to, or has any unsatisfied obligation to contribute to, or liability under, any active or terminated Pension Plan other than on the Closing Date, those listed on Schedule 5.10(d) hereto.
5.11    Margin Regulations; Investment Company Act; Anti-Corruption Laws and Sanctions.

39    
Exhibit 10(ii)

(a)    The Borrower is not engaged nor will the Borrower engage, principally or as one of its important activities, in the business of purchasing or carrying margin stock (within the meaning of Regulation U issued by the FRB), or extending credit for the purpose of purchasing or carrying margin stock. Following the application of the proceeds of each Borrowing, not more than 25% of the value of the assets (either of the Borrower only or of the Borrower and its Subsidiaries on a consolidated basis) subject to the provisions of Section 7.01 or subject to any restriction contained in any agreement or instrument between the Borrower and any Lender or any Affiliate of any Lender relating to Indebtedness and within the scope of Section 8.01(e) will be margin stock.
(b)    None of the Borrower, any Person Controlling the Borrower or any Subsidiary is or is required to be registered as an “investment company” under the Investment Company Act of 1940.
(c)    The Borrower has implemented and maintains in effect policies and procedures designed to ensure compliance by the Borrower, its Subsidiaries and their respective directors, officers and employees with Anti-Corruption Laws and applicable Sanctions, and the Borrower and its Subsidiaries and, to the knowledge of the Borrower, its directors, officers and employees, are in compliance with Anti-Corruption Laws and applicable Sanctions in all material respects. None of (a) the Borrower, any Subsidiary or, to the knowledge of the Borrower or such Subsidiary, any of their respective directors, officers or employees, or (b) to the knowledge of the Borrower, any agent of the Borrower or any Subsidiary that will in each case act in any capacity in connection with or benefit from the credit facility established hereby, is a Sanctioned Person. No Borrowing, use of proceeds or other transactions contemplated by the Loan Documents will violate Anti-Corruption Laws or applicable Sanctions.
5.12    Disclosure. The statements, information and reports (other than information of a general economic or industry-specific nature) provided by a Responsible Officer of the Borrower in any Loan Document or furnished to the Administrative Agent or any Lender by a Responsible Officer of the Borrower in connection with the preparation of any Loan Document, when taken as a whole (in each case as timely modified or supplemented by the Borrower), do not contain any untrue statement of a material fact or omit any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, except to the extent that any inaccuracies, individually or in the aggregate, would not reasonably be likely to have a Material Adverse Effect; provided that with respect to projected financial information, the Borrower represents only that such information was prepared in good faith based upon assumptions believed by it to be reasonable at the time of preparation (it being understood that projections are not to be viewed as facts and that actual results may differ significantly from such projections).
5.13    Affected Financial Institutions. The Borrower is not an Affected Financial Institution.
ARTICLE VI    
AFFIRMATIVE COVENANTS
So long as any Lender shall have any Commitment hereunder or any Loan or other Obligation shall remain unpaid or unsatisfied, the Borrower shall and shall (except in the case of the covenants set forth in Sections 6.01, 6.02, 6.03, 6.05 (which covenant shall apply solely to the Borrower), 6.10 (other than with respect to Material Subsidiaries) and 6.11) cause each Subsidiary to:
6.01    Financial Statements. Deliver to the Administrative Agent (for further delivery to each Lender):

40    
Exhibit 10(ii)

(a)    as soon as available, but in any event within 90 days after the end of each fiscal year of the Borrower (or, if earlier, 15 days after the date required to be filed with the SEC), a consolidated balance sheet of the Borrower and its Subsidiaries as at the end of such fiscal year, and the related consolidated statements of income or operations, shareholders’ equity and cash flows for such fiscal year, setting forth in each case in comparative form the figures for the previous fiscal year, all in reasonable detail and prepared in accordance with GAAP, audited and accompanied by a report and opinion of an independent certified public accountant of nationally recognized standing, which report and opinion shall be prepared in accordance with generally accepted auditing standards and shall not be subject to any qualifications or exceptions as to the scope of the audit or the going concern status of the Borrower; and
(b)    as soon as available, but in any event within 45 days after the end of each of the first three fiscal quarters of each fiscal year of the Borrower (or, if earlier, 5 days after the date required to be filed with the SEC) (commencing with the fiscal quarter ended June 30, 2020), a consolidated balance sheet of the Borrower and its Subsidiaries as at the end of such fiscal quarter, and the related consolidated statements of income or operations, shareholders’ equity and cash flows for such fiscal quarter and for the portion of the Borrower’s fiscal year then ended, setting forth in each case in comparative form the figures for the corresponding fiscal quarter of the previous fiscal year and the corresponding portion of the previous fiscal year, all in reasonable detail and certified by a Responsible Officer as fairly presenting in all material respects the financial condition, results of operations, shareholders’ equity and cash flows of the Borrower and its Subsidiaries in accordance with GAAP, subject only to normal year-end audit adjustments and the absence of footnotes.
6.02    Certificates; Other Information. Deliver to the Administrative Agent (for further delivery to each Lender):
(a)    concurrently with the delivery of the financial statements referred to in Sections 6.01(a) and (b), a duly completed Compliance Certificate signed by a Responsible Officer of the Borrower;
(b)    promptly after the same are available, copies of each annual report, proxy or financial statement sent to the stockholders of the Borrower generally and not otherwise required to be delivered to the Administrative Agent pursuant hereto, and copies of all annual, regular, periodic and special reports and registration statements which the Borrower files with the SEC under Section 13 or 15(d) of the Securities Exchange Act of 1934, and not otherwise required to be delivered to the Administrative Agent pursuant hereto;
(c)    promptly such additional information regarding the business, financial or corporate affairs of the Borrower or any Subsidiary as the Administrative Agent, at the reasonable request of any Lender, may from time to time request; and
(d)    promptly following any request therefor, provide information and documentation reasonably requested by the Administrative Agent or any Lender for purposes of compliance with applicable “know your customer” and anti-money-laundering rules and regulations, including, without limitation, the Patriot Act and the Beneficial Ownership Regulation.
Documents required to be delivered pursuant to Section 6.01(a) or (b) or Section 6.02(b) may be delivered electronically and if so delivered, shall be deemed to have been delivered on the earlier of the date (i) on which the Borrower posts such documents, or provides a link thereto on the Borrower’s website on the Internet at the website address listed on Schedule 10.02; (ii) on which such documents are posted to the SEC’s website (www.sec.gov) or (iii) on which such documents are posted on the Borrower’s behalf on

41    
Exhibit 10(ii)

IntraLinks/IntraAgency or any other Internet or intranet website, if any, to which each Lender and the Administrative Agent have access (whether a commercial, third-party website or whether sponsored by the Administrative Agent); provided that, in the case of documents required to be delivered pursuant to Section 6.01(a) or (b), the Borrower shall deliver electronic copies of such documents to the Administrative Agent if any Lender requests that the Borrower deliver such copies until a request to cease delivering copies is given by the Administrative Agent at the request of such Lender. The Administrative Agent shall have no obligation to request the delivery of or to maintain copies of the documents referred to above, and in any event shall have no responsibility to monitor compliance by the Borrower with any such request for delivery, and each Lender shall be solely responsible for requesting delivery to it or maintaining its copies of such documents.
The Borrower hereby acknowledges that (a) the Administrative Agent and/or the Arranger will make available to the Lenders materials and/or information provided by or on behalf of the Borrower hereunder (collectively, “Borrower Materials”) by posting the Borrower Materials on IntraLinks, Syndtrak, ClearPar, or a substantially similar electronic transmission system (the “Platform”) and (b) certain of the Lenders (each, a “Public Lender”) may have personnel who do not wish to receive material non-public information with respect to the Borrower or its Affiliates, or the respective securities of any of the foregoing, and who may be engaged in investment and other market-related activities with respect to such Persons’ securities. The Borrower hereby agrees that (w) no Borrower Materials shall be made available by the Administrative Agent or the Arranger to Public Lenders unless the Borrower has clearly and conspicuously marked such Borrower Materials “PUBLIC” which, at a minimum, shall mean that the word “PUBLIC” shall appear prominently on the first page thereof; (x) by marking Borrower Materials “PUBLIC,” the Borrower shall be deemed to have authorized the Administrative Agent, the Arranger and the Lenders to treat such Borrower Materials as not containing any material non-public information with respect to the Borrower or its securities for purposes of United States Federal and state securities laws (provided, however, that to the extent such Borrower Materials constitute Information, they shall be treated as set forth in Section 10.07); (y) all Borrower Materials marked “PUBLIC” are permitted to be made available through a portion of the Platform designated “Public Side Information;” and (z) the Administrative Agent and the Arranger shall be entitled to treat any Borrower Materials that are not marked “PUBLIC” as being suitable only for posting on a portion of the Platform not designated “Public Side Information.” For the avoidance of doubt, the Borrower shall be under no any obligation to mark any Borrower Materials “PUBLIC.”
6.03    Notices. Promptly after a Responsible Officer of the Borrower obtains actual knowledge, notify the Administrative Agent of:
(a)    the occurrence of any Default or Event of Default; and
(b)    any announcement by Moody’s or S&P of any change in an Issuer Rating.
Each notice delivered pursuant to Section 6.03(a) shall be accompanied by a statement of a Responsible Officer of the Borrower setting forth details of the occurrence referred to therein and stating what action the Borrower has taken and proposes to take with respect thereto.
6.04    Payment of Taxes. Pay and discharge as the same shall become due and payable, all its material tax liabilities, assessments and governmental charges or levies upon it or its properties or assets that, if not paid, could reasonably be expected to result in a Material Adverse Effect before the same shall become delinquent or in default, except where (a) the validity or amount thereof is being contested in good faith by appropriate proceedings, (b) the Borrower or such Subsidiary has set aside on its books adequate reserves with respect thereto in accordance with GAAP and (c) the failure to make payment pending such contest could not reasonably be expected to result in a Material Adverse Effect.

42    
Exhibit 10(ii)

6.05    Preservation of Existence, Etc. Preserve, renew and maintain in full force and effect its legal existence and good standing under the Laws of the jurisdiction of its organization, except that the Borrower may effect or enter into transactions not prohibited by Section 7.03 or 7.04.
6.06    Maintenance of Properties. (a) Maintain, preserve and protect all of its properties and equipment necessary in the operation of its business in good working order and condition, ordinary wear and tear excepted; and (b) make all necessary repairs thereto and renewals and replacements thereof except in each case referred to in clause (a) and (b) to the extent that the failure to do so would not reasonably be expected to have a Material Adverse Effect.
6.07    Maintenance of Insurance. Maintain with financially sound and reputable insurance companies, associations or captive insurance companies, insurance in such amounts and covering such risks as is consistent with sound business practice in the industry.
6.08    Compliance with Laws. (a) Comply in all material respects with the requirements of all Laws applicable to it or to its business or property, except in such instances in which (i) such requirement of Law is being contested in good faith by appropriate proceedings diligently conducted or a bona fide dispute exists with respect thereto; or (ii) the failure to comply therewith would not reasonably be expected to have a Material Adverse Effect and (b) maintain in effect and enforce policies and procedures designed to ensure compliance by the Borrower, its Subsidiaries and their respective directors, officers and employees with Anti-Corruption Laws and applicable Sanctions.
6.09    Books and Records. Maintain books of record and account containing entries that are full, true and correct in all material respects of all material dealings and transactions in relation to its business and activities in order to permit the preparation of the Borrower’s consolidated financial statements in accordance with GAAP.
6.10    Inspection Rights. When an Event of Default has occurred and is continuing, permit representatives and independent contractors of the Administrative Agent, upon reasonable prior notice, at reasonable times and at reasonable intervals, to visit and inspect any of its properties, to examine its corporate, financial and operating records, and make copies thereof or abstracts therefrom, and to discuss its affairs, finances and condition with its officers and, if a Senior Officer of the Borrower is present, its independent public accountants.
6.11    Use of Proceeds. Use the proceeds of the Borrowings for working capital, capital expenditures, acquisitions and other general corporate purposes not in contravention of any Law or of any Loan Document. The Borrower will not request any Borrowing, shall not use and shall procure that its Subsidiaries and its or their respective directors, officers and employees shall not use, the proceeds of any Borrowing (i) in furtherance of an offer, payment, promise to pay, or authorization of the payment or giving of money, or anything else of value, to any Person in violation of any Anti-Corruption Laws, (ii) for the purpose of funding, financing or facilitating any activities, business or transaction of or with any Sanctioned Person, or in any Sanctioned Country or (iii) in any manner that would result in the violation of any Sanctions applicable to any party hereto.
ARTICLE VII    
NEGATIVE COVENANTS
So long as any Lender shall have any Commitment hereunder, or any Loan or other Obligation shall remain unpaid or unsatisfied, the Borrower shall not and shall not (except in the case of the covenant set

43    
Exhibit 10(ii)

forth in Section 7.03, which covenant shall apply solely to the Borrower) permit any Subsidiary to, directly or indirectly:
7.01    Liens. Create, incur, assume or suffer to exist, any Lien upon any of its property, assets or revenues, whether now owned or hereafter acquired, other than the following:
(a)    Liens created or arising pursuant to any Loan Document;
(b)    Liens existing on the date hereof and listed on Schedule 7.01 and, if the obligation secured by such Lien is modified, refinanced, refunded, extended, renewed or replaced, any Lien securing such modified, refinanced, refunded, extended, renewed or replaced obligation; provided that (i) the property covered thereby shall not be changed in category or scope and (ii) such Lien shall secure only those modifications, refinancings, refundings, extensions, renewals and replacements of the secured obligations that do not increase the outstanding principal amount thereof plus any accrued interest, premium, fee and reasonable out-of-pocket expenses payable in connection with any such modification, refinancing, refunding, extension, renewal or replacement;
(c)    Liens for taxes, assessments, levies or governmental charges of any Governmental Authority, in each case not yet overdue by more than 60 days or which are being contested in good faith (and, if necessary, by appropriate proceedings) for which adequate reserves with respect thereto have been established in accordance with GAAP;
(d)    Liens imposed by law or which arise by operation of law and which are incurred in the ordinary course of business, such as of landlords, carriers’, warehousemen’s, mechanics’, materialmen’s, repairmen’s and mechanics’ Liens, which are not overdue for a period of more than 60 days or which are being contested in good faith (and, if necessary, by appropriate proceedings) for which adequate reserves with respect thereto have been established in accordance with GAAP;
(e)    Liens incurred and pledges or deposits made in the ordinary course of business in connection with workers’ compensation, unemployment insurance and other social security laws or regulations, other than any Lien imposed by ERISA;
(f)    Liens incurred and pledges or deposits made to secure the performance of bids, trade contracts, tenders, leases, statutory obligations, surety, customs and appeal bonds, performance bonds, customer deposits and other obligations of a similar nature incurred in the ordinary course of business;
(g)    easements, zoning restrictions, rights-of-way, leases, subleases and similar charges, minor defects or irregularities in title, restrictions, encroachments, imperfections and other similar encumbrances on the real property of such Person imposed by law or arising in the ordinary course of business which could not be expected to have a Material Adverse Effect;
(h)    statutory and common law rights of set-off and other similar rights and remedies as to deposits of cash, securities, commodities and other funds in favor of banks, other depositary institutions, securities or commodities intermediaries or brokerage, including, without limitation, Liens arising under the general terms and conditions (Algemene Bank Voorwaarden) of any member of the Dutch Bankers’ Association (Nederlandse Vereniging van Banken);

44    
Exhibit 10(ii)

(i)    Liens of a collecting bank arising in the ordinary course of business under Section 4-210 of the Uniform Commercial Code in effect in the relevant jurisdiction (or Section 4-208 in the case of the New York Uniform Commercial Code) and covering only the items being collected upon;
(j)    Liens of sellers of goods to the Borrower or a Subsidiary arising under Article 2 of the Uniform Commercial Code in effect in the relevant jurisdiction or similar provisions of applicable law in the ordinary course of business;
(k)    any interest or title of a lessor, licensor or sublessor under any lease, license or sublease (other than a capital lease) entered into by the Borrower or a Subsidiary in the ordinary course of business;
(l)    Liens solely on any cash earnest money deposits made by the Borrower or any of its Subsidiaries in connection with any letter of intent or purchase agreement entered into by it;
(m)    Liens incurred in connection with the purchase or shipping of goods or assets on the related assets and proceeds thereof in favor of the seller or shipper of such goods or assets;
(n)    Liens arising from filing UCC financing statements relating solely to operating leases;
(o)    Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in connection with the importation of goods;
(p)    any zoning or similar law or right reserved to or vested in any governmental office or agency to control or regulate the use of any real property;
(q)    Liens securing obligations (other than obligations representing Indebtedness for borrowed money) under operating, reciprocal easement or similar agreements entered into in the ordinary course of business of the Borrower and its Subsidiaries;
(r)    leases or subleases of personal property of the Borrower or a Subsidiary or licenses of patents, trademarks and other intellectual property rights of the Borrower or any of its Subsidiaries that could not reasonably be expected to have a Material Adverse Effect;
(s)    Liens consisting of an agreement to sell, transfer or dispose of any asset (to the extent such sale, transfer or disposition is not prohibited by this Agreement);
(t)    Liens on accounts receivable (and related supporting obligations and books and records and the proceeds thereof) subject to a Permitted Securitization Transaction;
(u)    Liens in respect of judgments that do not constitute an Event of Default under Section 8.01(h);
(v)    Liens on any property acquired, constructed or improved by the Borrower or any Subsidiary to secure or provide for the payment of all or any part of the purchase price of such property or the cost of such construction or improvement (or Liens securing obligations to finance the development, construction, lease, repairs, additions or improvements to property (real or personal) whether through the direct purchase of such assets or through the purchase of equity interests in a Person owning such assets), including Liens securing capital leases, tax retention and other synthetic lease obligations and purchase

45    
Exhibit 10(ii)

money obligations; provided that such Liens shall attach only to the asset acquired in connection with the incurrence of such obligations and any proceeds and products thereof;
(w)    Liens securing Indebtedness (including Indebtedness committed to the Borrower or any Subsidiary but not advanced) or other obligations in aggregate outstanding principal amount not to exceed 20% of Consolidated Net Worth as of the most recently ended fiscal quarter of the Borrower; and
(x)    any Lien existing on any property or asset prior to the acquisition thereof by the Borrower or any Subsidiary or existing on any property or asset of any Person that becomes a Subsidiary after the date hereof prior to the time such Person becomes a Subsidiary; provided that (i) such Lien is not created in contemplation of or in connection with such acquisition or such Person becoming a Subsidiary, as the case may be, (ii) the property covered thereby is not changed in category or scope after such acquisition or after such Person becoming a Subsidiary and (iii) such Lien shall secure only those obligations which it secures on the date of such acquisition or the date such Person becomes a Subsidiary, as the case may be, and any modification, refinancing, refunding, extension, renewal or replacement thereof that do not increase the outstanding principal amount thereof plus any accrued interest, premium, fee and reasonable out-of-pocket expenses payable in connection with any such refinancing, refunding, extension, renewal or replacement.
7.02    Subsidiary Indebtedness. Allow or permit any Subsidiary to create, incur, assume or suffer to exist any Indebtedness in an aggregate outstanding principal amount which exceeds 20% of Consolidated Net Worth (measured as of the most recently ended fiscal quarter of the Borrower for which financial statements have been delivered to the Administrative Agent and the Lenders pursuant to Section 6.01 (provided that, for the avoidance of doubt, no Default or Event of Default shall be deemed to have occurred if such aggregate outstanding principal amount of Indebtedness shall not at a later time exceed 20% of Consolidated Net Worth so long as, at the time of the creation, incurrence, assumption or initial existence thereof, such Indebtedness was permitted to be incurred)), other than the following:
(a)    (i) Indebtedness owing to the Borrower or to any other Subsidiary of the Borrower and (ii) guaranties of any Indebtedness of any Subsidiary owing to the Borrower or to any other Subsidiary;
(b)    guaranties in the ordinary course of business of the obligations of suppliers, customers, franchisees and licensees of such Subsidiary;
(c)    Indebtedness incurred by any Subsidiary arising from agreements providing for indemnification, adjustment of purchase price, non-compete, consulting, deferred compensation or similar obligations, or from guaranties or letters of credit, surety bonds or performance bonds securing the performance of such Subsidiary pursuant to such agreements, in connection with acquisitions or dispositions of any business, assets or Subsidiary of such Subsidiary;
(d)    Indebtedness owed to any Person (including obligations in respect of letters of credit) which finances worker’s compensation, health, disability, life insurance or other employee benefits or property, casualty or liability insurance or captive insurance, or which may be deemed to exist pursuant to reimbursement or indemnification obligations to such Person;
(e)    (i) Indebtedness that may be deemed to exist pursuant to any guaranties, performance, surety, statutory, appeal or similar obligations incurred in the ordinary course of business and (ii) Indebtedness of any Subsidiary in respect of performance bonds, bid bonds, appeal bonds, surety bonds and similar obligations to the extent any such obligations constitute indebtedness;

46    
Exhibit 10(ii)

(f)    Indebtedness in respect of netting services, overdraft protections and otherwise in connection with a demand, time, savings, passbook or like account with a bank, savings and loan association, credit union or like organization, other than an account evidenced by a negotiable certificate of deposit and Indebtedness arising from the honoring by a bank or other financial institution of a check, draft or similar instrument of a Subsidiary drawn against insufficient funds in the ordinary course of business;
(g)    Indebtedness pursuant to a Permitted Securitization Transaction;
(h)    Indebtedness outstanding on the date hereof and listed on Schedule 7.02 and any refinancings, refundings, renewals, extensions or replacements thereof that do not increase the outstanding principal amount thereof, plus any accrued interest, premium, fees, costs and expenses payable in connection with any such refinancing, refunding, renewal or extension;
(i)    Indebtedness incurred to finance the acquisition, construction or improvement of any property (or Indebtedness to finance the development, construction, lease, repairs, additions or improvements to property (real or personal) whether through the direct purchase of such assets or through the purchase of equity interests in a Person owning such assets), including capital leases, tax retention and other synthetic lease obligations and purchase money obligations; provided that any such Indebtedness shall be secured only by the property acquired in connection with the incurrence of such Indebtedness and any proceeds and products thereof;
(j)    obligations (contingent or otherwise) of any Subsidiary existing or arising under any Swap Contract, provided that such obligations are (or were) entered into by such Subsidiary in the ordinary course of business for the purpose of directly mitigating risks associated with liabilities, commitments, investments, assets, or property held or reasonably anticipated by such Subsidiary, or changes in the value of securities issued by such Subsidiary, and not for purposes of speculation; and
(k)    Acquired Indebtedness and any modifications, refinancings, refundings, extensions, renewals and replacements thereof which do not increase the outstanding principal amount thereof plus interest, premium, fees and expenses.
7.03    Fundamental Changes. Merge or consolidate with or into any other Person if, immediately after giving effect to such merger or consolidation, (a) a Default or an Event of Default exists or (b) the Borrower is not the continuing or surviving Person (unless the Person formed by such merger or consolidation (i) assumes, by an assumption agreement with terms reasonably satisfactory to the Required Lenders, all of the Obligations of the Borrower under the Loan Documents and (ii) is organized in the United States, Ireland, the Netherlands or in any other jurisdiction approved by the Lenders).
7.04    Dispositions. Convey, transfer, lease or otherwise Dispose of (whether in one transaction or in a series of transactions) all or substantially all of the assets of the Borrower and its Subsidiaries, taken as a whole, to or in favor of any other Person.
7.05    Leverage Ratio. Permit the Leverage Ratio to be greater than 4.5 to 1.0 at the end of any fiscal quarter of the Borrower; provided that the Borrower may, only once during the term of this Agreement, in connection with an Acquisition for which the aggregate consideration paid or to be paid in respect thereof exceeds $500,000,000, elect to increase the maximum Leverage Ratio permitted hereunder by 0.5 to 1.0 for a period of four consecutive fiscal quarters commencing with the fiscal quarter in which such Acquisition occurs (any such election in respect of the maximum Leverage Ratio pursuant to this Section 7.05 being referred to as an “Acquisition Holiday”).

47    
Exhibit 10(ii)


ARTICLE VIII    
EVENTS OF DEFAULT AND REMEDIES
8.01    Events of Default. Any of the following shall constitute an Event of Default:
(a)    Non-Payment. The Borrower fails to pay (i) when and as required to be paid herein, any amount of principal of any Loan, or (ii) within three Business Days after the same becomes due, any interest on any Loan, or any facility, utilization or other fee due hereunder, or (iii) within three Business Days after the same becomes due, any other amount payable hereunder or under any other Loan Document; or
(b)    Specific Covenants. The Borrower fails to perform or observe any term, covenant or agreement contained in any of Section 6.03(a), 6.05, 6.11, 7.03, 7.04 or 7.05 that applies to it; or
(c)    Other Defaults. The Borrower fails to perform or observe any other covenant or agreement (not specified in subsection (a) or (b) above) contained in any Loan Document which is not remedied within thirty (30) days after a Senior Officer receives written notice from the Administrative Agent or the Required Lenders; or
(d)    Representations and Warranties. Any representation, warranty, certification or statement of fact made by the Borrower herein, in any other Loan Document, or in any document delivered in connection herewith or therewith shall be incorrect in any material respect when made; or
(e)    Cross-Default; Cross-Acceleration. (i) The Borrower or any Subsidiary fails to make any payment when due (whether by scheduled maturity, required prepayment, acceleration, demand, or otherwise) in respect of any Material Indebtedness and such failure shall continue after the applicable grace period, if any, specified in the agreement or instrument relating to such Material Indebtedness, the effect of which such failure to pay is to cause, or to permit the holder or holders of such Material Indebtedness (or a trustee or agent on behalf of such holder or holders) to cause, with the giving of notice if required, such Material Indebtedness to be demanded or to become due or to be repurchased or redeemed (automatically or otherwise) prior to its stated maturity, (ii) the Borrower or any Subsidiary fails to observe or perform any other agreement or instrument evidencing any Material Indebtedness, or any other event occurs, in each case the effect of which failure or other event is to cause such Material Indebtedness to be demanded or to become due or to be repurchased or redeemed (automatically or otherwise), in full, prior to its stated maturity; provided that, if the holders of such Material Indebtedness must elect to have it repurchased or redeemed, then this clause (ii) shall apply only if holders sufficient to make the Material Indebtedness become repurchased or redeemed in full make such election ; or (iii) there occurs under any Swap Contract an Early Termination Date (as defined in such Swap Contract) resulting from (A) any event of default under such Swap Contract as to which the Borrower or any Subsidiary is the Defaulting Party (as defined in such Swap Contract) or (B) any Termination Event (as so defined) under such Swap Contract as to which the Borrower or any Subsidiary is an Affected Party (as so defined) and, in either event, the Swap Termination Value owed by the Borrower or such Subsidiary as a result thereof is greater than $100,000,000; or
(f)    Insolvency Proceedings, Etc. The Borrower or any Material Subsidiary of the Borrower institutes or consents to the institution of any proceeding under any Debtor Relief Law, or makes an assignment for the benefit of creditors; or applies for or consents to the appointment of any receiver, trustee, custodian, conservator, examiner, liquidator, rehabilitator or similar officer for it or for all or

48    
Exhibit 10(ii)

substantially all of its property; or any receiver, trustee, custodian, conservator, examiner, liquidator, rehabilitator or similar officer is appointed without the application or consent of such Person and the appointment continues undischarged or unstayed for 60 calendar days; or any proceeding under any Debtor Relief Law relating to any such Person or to all or substantially all of its property is instituted without the consent of such Person and continues undismissed or unstayed for 60 calendar days, or an order for relief is entered in any such proceeding; or
(g)    Inability to Pay Debts. The Borrower or any Material Subsidiary of the Borrower becomes unable or admits in writing its inability or fails generally to pay its debts as they become due; or
(h)    Judgments. There is entered against the Borrower or any Material Subsidiary of the Borrower one or more final judgments with respect to which all appeals have been exhausted or are time-barred for the payment of money in an aggregate amount exceeding the Threshold Amount (to the extent not covered by independent third-party insurance or captive insurance as to which the insurer does not dispute coverage) and (A) enforcement proceedings are commenced by any creditor upon such judgment or order, or (B) there is a period of 60 consecutive days during which such judgments or orders shall not have been paid, vacated, discharged, stayed or bonded; or
(i)    Change of Control. There occurs any Change of Control with respect to the Borrower.
8.02    Remedies Upon Event of Default. If any Event of Default occurs and is continuing, the Administrative Agent shall, at the request of, or may, with the consent of, the Required Lenders, take any or all of the following actions:
(i)    declare the commitment of each Lender to make Loans to be terminated, whereupon such commitments and obligation shall be terminated;
(ii)    declare the unpaid principal amount of all outstanding Loans, all interest accrued and unpaid thereon, and all other amounts owing or payable hereunder or under any other Loan Document to be immediately due and payable, without presentment, demand, protest or other notice of any kind, all of which are hereby expressly waived by the Borrower; and
(iii)    exercise on behalf of itself and the Lenders all rights and remedies available to it and the Lenders under the Loan Documents or applicable law;
provided, however, that upon the occurrence of any event specified in subsection (f) or (g) of Section 8.01 (with respect to the Borrower), the obligation of each Lender to make Loans shall automatically terminate and the unpaid principal amount of all outstanding Loans and all interest and other amounts as aforesaid shall automatically become due and payable, in each case without further act of the Administrative Agent or any Lender.
8.03    Application of Funds. After the exercise of remedies provided for in Section 8.02 (or after the Loans have automatically become immediately due and payable as set forth in the proviso to Section 8.02), any amounts received on account of the Obligations in respect of the Loan Documents shall, subject to the provisions of Section 2.12, be applied by the Administrative Agent in the following order:
First, to payment of that portion of the Obligations constituting fees, indemnities, expenses and other amounts (including fees, charges and disbursements of counsel to the Administrative Agent and amounts payable under Article III) required hereunder to be paid to the Administrative Agent in its capacity as such;

49    
Exhibit 10(ii)

Second, to payment of that portion of the Obligations constituting fees, indemnities and other amounts (other than principal and interest) required hereunder to be paid to the Lenders (including fees, charges and disbursements of counsel to the respective Lenders and amounts payable under Article III), ratably among them in proportion to the amounts described in this clause Second payable to them;
Third, to payment of that portion of the Obligations constituting accrued and unpaid interest on the Loans and other Obligations, ratably among the Lenders in proportion to the respective amounts described in this clause Third payable to them;
Fourth, to payment of that portion of the Obligations constituting unpaid principal of the Loans, ratably among the Lenders in proportion to the respective amounts described in this clause Fourth held by them; and
Last, the balance, if any, after all of the Obligations (other than unasserted indemnification or other contingent obligations) have been paid in full, to the Borrower or as otherwise required by Law.
ARTICLE IX    
ADMINISTRATIVE AGENT
9.01    Appointment and Authorization of Administrative Agent. Each of the Lenders hereby irrevocably appoints Bank of America to act on its behalf as the Administrative Agent hereunder and under the other Loan Documents and authorizes the Administrative Agent to take such actions on its behalf and to exercise such powers as are delegated to the Administrative Agent by the terms hereof or thereof, together with such actions and powers as are reasonably incidental thereto. The provisions of this Article are solely for the benefit of the Administrative Agent and the Lenders, and the Borrower shall not have rights as a third party beneficiary of any of such provisions. It is understood and agreed that the use of the term “agent” herein or in any other Loan Documents (or any other similar term) with reference to the Administrative Agent is not intended to connote any fiduciary or other implied (or express) obligations arising under agency doctrine of any applicable Law. Instead such term is used as a matter of market custom, and is intended to create or reflect only an administrative relationship between contracting parties.
9.02    Rights as a Lender. The Person serving as the Administrative Agent hereunder shall have the same rights and powers in its capacity as a Lender as any other Lender and may exercise the same as though it were not the Administrative Agent and the term “Lender” or “Lenders” shall, unless otherwise expressly indicated or unless the context otherwise requires, include the Person serving as the Administrative Agent hereunder in its individual capacity as a Lender. Such Person and its Affiliates may accept deposits from, lend money to, own securities of, act as the financial advisor or in any other advisory capacity for and generally engage in any kind of business with the Borrower or any Subsidiary or other Affiliate thereof as if such Person were not the Administrative Agent hereunder and without any duty to account therefor to the Lenders.
9.03    Exculpatory Provisions. The Administrative Agent shall not have any duties or obligations except those expressly set forth herein and in the other Loan Documents, and its duties hereunder shall be administrative in nature. Without limiting the generality of the foregoing, the Administrative Agent:
(a)    shall not be subject to any fiduciary or other implied duties in connection with the arranging and other services regarding this Agreement and the administration of the Loan Documents and the transactions contemplated thereby, regardless of whether a Default has occurred and is continuing (it being understood that, for the avoidance of doubt, the foregoing shall not apply with respect to any transactions other than the transactions under this Agreement or the transactions contemplated hereby,

50    
Exhibit 10(ii)

including, without limitation, other corporate transactions, other financial matters and custodial relationships between the Person acting as Administrative Agent (and not in its capacity as Administrative Agent), the Borrower or the Borrower’s Affiliates, and except as otherwise agreed to in writing by such Persons);
(b)    shall not have any duty to take any discretionary action or exercise any discretionary powers, except discretionary rights and powers expressly contemplated hereby or by the other Loan Documents that the Administrative Agent is required to exercise as directed in writing by the Required Lenders (or such other number or percentage of the Lenders as shall be expressly provided for herein or in the other Loan Documents); provided that the Administrative Agent shall not be required to take any action that, in its opinion or the opinion of its counsel, may expose the Administrative Agent to liability or that is contrary to any Loan Document or applicable law, including for the avoidance of doubt any action that may be in violation of the automatic stay under any Debtor Relief Law or that may effect a forfeiture, modification or termination of property of a Defaulting Lender in violation of any Debtor Relief Law; and
(c)    shall not, except as expressly set forth herein and in the other Loan Documents, have any duty to disclose, and shall not be liable for the failure to disclose, any information relating to the Borrower or any of its Affiliates that is communicated to or obtained by the Person serving as the Administrative Agent or any of its Affiliates in any capacity.
The Administrative Agent shall not be liable for any action taken or not taken by it (i) with the consent or at the request of the Required Lenders (or such other number or percentage of the Lenders as shall be necessary, or as the Administrative Agent shall believe in good faith shall be necessary, under the circumstances as provided in Sections 10.01 and 8.02) except, in each case for this clause (i), to the extent of its gross negligence or willful misconduct or (ii) in the absence of its own gross negligence or willful misconduct as determined by a court of competent jurisdiction by final and nonappealable judgment. The Administrative Agent shall be deemed not to have knowledge of any Default unless and until notice describing such Default is given to the Administrative Agent by the Borrower or a Lender.
The Administrative Agent shall not be responsible for or have any duty to ascertain or inquire into (i) any statement, warranty or representation made in or in connection with this Agreement or any other Loan Document, (ii) the contents of any certificate, report or other document delivered hereunder or thereunder or in connection herewith or therewith, (iii) the performance or observance of any of the covenants, agreements or other terms or conditions set forth herein or therein or the occurrence of any Default, (iv) the validity, enforceability, effectiveness or genuineness of this Agreement, any other Loan Document or any other agreement, instrument or document or (v) the satisfaction of any condition set forth in Article IV or elsewhere herein, other than to confirm receipt of items expressly required to be delivered to the Administrative Agent.
9.04    Reliance by Administrative Agent. The Administrative Agent shall be entitled to rely upon, and shall not incur any liability for relying upon, any written notice, request, certificate, consent, statement, instrument, document or other writing (including any electronic message, Internet or intranet website posting or other distribution) reasonably believed by it to be genuine and to have been signed, sent or otherwise authenticated by the proper Person. The Administrative Agent also may rely upon any statement made to it orally or by telephone and believed by it to have been made by the proper Person, and shall not incur any liability for relying thereon. In determining compliance with any condition hereunder to the making of a Loan that by its terms must be fulfilled to the satisfaction of a Lender, the Administrative Agent may presume that such condition is satisfactory to such Lender unless the Administrative Agent shall have received notice to the contrary from such Lender prior to the making of such Loan. The

51    
Exhibit 10(ii)

Administrative Agent may consult with legal counsel (who may be counsel for the Borrower), independent accountants and other experts selected by it, and shall not be liable for any action taken or not taken by it in accordance with the advice of any such counsel, accountants or experts.
9.05    Delegation of Duties. The Administrative Agent may perform any and all of its duties and exercise its rights and powers hereunder or under any other Loan Document by or through any one or more sub-agents appointed by the Administrative Agent. The Administrative Agent and any such sub-agent or Affiliate may perform any and all of its duties and exercise its rights and powers by or through their respective Related Parties. The exculpatory provisions of this Article shall apply to any such sub-agent and Affiliate and to the Related Parties of the Administrative Agent and any such sub-agent and Affiliate, and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as Administrative Agent. The Administrative Agent shall not be responsible for the negligence or misconduct of any sub-agents except to the extent that a court of competent jurisdiction determines in a final and nonappealable judgment that the Administrative Agent acted with gross negligence or willful misconduct in the selection of such sub-agents.
9.06    Resignation of Administrative Agent. The Administrative Agent may at any time give notice of its resignation to the Lenders and the Borrower. Upon receipt of any such notice of resignation, the Required Lenders shall have the right, with the consent of the Borrower (so long as no Event of Default has occurred and is continuing), to appoint a successor, which shall be a bank with an office in the United States, or an Affiliate of any such bank with an office in the United States. If no such successor shall have been so appointed by the Required Lenders with the consent of the Borrower (if required) and shall have accepted such appointment within 30 days after the retiring Administrative Agent gives notice of its resignation (or such earlier day as shall be agreed by the Required Lenders and, to the extent the consent of the Borrower is required for such appointment, the Borrower) (the “Resignation Effective Date”), then the retiring Administrative Agent may on behalf of the Lenders appoint a successor Administrative Agent meeting the qualifications set forth above; provided that if the Administrative Agent shall notify the Borrower and the Lenders that no qualifying Person has accepted such appointment, then such resignation shall nonetheless become effective in accordance with such notice and (1) the retiring Administrative Agent shall be discharged from its duties and obligations hereunder and under the other Loan Documents (except that in the case of any collateral security held by the Administrative Agent on behalf of the Lenders under any of the Loan Documents, the retiring Administrative Agent shall continue to hold such collateral security until such time as a successor Administrative Agent is appointed) and (2) except for any indemnity payments or other amounts then owed to the retiring Administrative Agent, all payments, communications and determinations provided to be made by, to or through the Administrative Agent shall instead be made by or to each Lender directly, until such time as the Required Lenders, with the consent of the Borrower (so long as no Event of Default has occurred and is continuing), appoint a successor Administrative Agent as provided for above in this Section. Upon the acceptance of a successor’s appointment as Administrative Agent hereunder, such successor shall succeed to and become vested with all of the rights, powers, privileges and duties of the retiring (or retired) Administrative Agent (other than as provided in Section 3.06 and other than any rights to indemnity payments or other amounts owed to the retiring or removed Administrative Agent as of the Resignation Effective Date), and the retiring Administrative Agent shall be discharged from all of its duties and obligations hereunder or under the other Loan Documents (if not already discharged therefrom as provided above in this Section). The fees payable by the Borrower to a successor Administrative Agent shall be the same as those payable to its predecessor unless otherwise agreed between the Borrower and such successor. After the retiring Administrative Agent’s resignation hereunder and under the other Loan Documents, the provisions of this Article and Section 10.04 shall continue in effect for the benefit of such retiring Administrative Agent, its sub‑agents and their respective Related Parties in

52    
Exhibit 10(ii)

respect of any actions taken or omitted to be taken by any of them while the retiring Administrative Agent was acting as Administrative Agent.
9.07    Non-Reliance on Administrative Agent and Other Lenders. Each Lender acknowledges that it has, independently and without reliance upon the Administrative Agent or any other Lender or any of their Related Parties and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Agreement. Each Lender also acknowledges that it will, independently and without reliance upon the Administrative Agent or any other Lender or any of their Related Parties and based on such documents and information as it shall from time to time deem appropriate, continue to make its own decisions in taking or not taking action under or based upon this Agreement, any other Loan Document or any related agreement or any document furnished hereunder or thereunder.
9.08    No Other Duties, Etc. Anything herein to the contrary notwithstanding, none of the Joint Lead Arrangers, Joint Bookrunners or Co-Documentation Agents listed on the cover page hereof shall have any powers, duties or responsibilities under this Agreement or any of the other Loan Documents, except in its capacity, as applicable, as a Lender hereunder. None of the Joint Lead Arrangers, Joint Bookrunners or Co-Documentation Agents listed on the cover page hereof shall have or be deemed to have any fiduciary relationship with any Lender.
9.09    Administrative Agent May File Proofs of Claim. In case of the pendency of any proceeding under any Debtor Relief Law or any other judicial proceeding relative to the Borrower, the Administrative Agent (irrespective of whether the principal of any Loan shall then be due and payable as herein expressed or by declaration or otherwise and irrespective of whether the Administrative Agent shall have made any demand on the Borrower) shall be entitled and empowered, by intervention in such proceeding or otherwise:
(a)    to file and prove a claim for the whole amount of the principal and interest owing and unpaid in respect of the Loans and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Lenders and the Administrative Agent (including any claim for the reasonable compensation, expenses, disbursements and advances of the Lenders and the Administrative Agent and their respective agents and counsel and all other amounts due the Lenders and the Administrative Agent under Sections 2.07 and 10.04) allowed in such judicial proceeding; and
(b)    to collect and receive any monies or other property payable or deliverable on any such claims and to distribute the same;
and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any such judicial proceeding is hereby authorized by each Lender to make such payments to the Administrative Agent and, in the event that the Administrative Agent shall consent to the making of such payments directly to the Lenders, to pay to the Administrative Agent any amount due for the reasonable compensation, expenses, disbursements and advances of the Administrative Agent and its agents and counsel, and any other amounts due the Administrative Agent under Sections 2.07 and 10.04.
Nothing contained herein shall be deemed to authorize the Administrative Agent to authorize or consent to or accept or adopt on behalf of any Lender any plan of reorganization, arrangement, adjustment or composition affecting the Obligations or the rights of any Lender to authorize the Administrative Agent to vote in respect of the claim of any Lender in any such proceeding.


53    
Exhibit 10(ii)

ARTICLE X    
MISCELLANEOUS
10.01    Amendments, Etc. Subject to Section 3.03, no amendment or waiver of any provision of this Agreement or any other Loan Document, and no consent to any departure by the Borrower therefrom, shall be effective unless in a writing signed by the Required Lenders (or the Administrative Agent with the consent of the Required Lenders) and the Borrower, and delivered to the Administrative Agent, and each such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given; provided, however, that no such amendment, waiver or consent shall:
(a)    in the case of the initial Borrowing, waive any condition set forth in Section 4.02(a) or (b), without the written consent of each Lender;
(b)    extend or increase the Commitment of any Lender (or reinstate any Commitment of any Lender terminated pursuant to Section 8.02(i)) without the written consent of such Lender;
(c)    extend or postpone any date fixed by this Agreement or any other Loan Document for any payment of principal, interest, fees or other amounts due to the Administrative Agent or any Lender hereunder (including the Maturity Date) or under any other Loan Document without the written consent of such Lender (or, in the case of the Administrative Agent, such Person);
(d)    reduce the principal of, or the rate of interest specified herein on, any Loan owed to any Lender, or (subject to clause (iv) of the proviso below) any fees or other amounts payable hereunder or under any other Loan Document to any Lender without the written consent of such Lender; provided, however, that only the consent of the Required Lenders shall be necessary to amend the definition of “Default Rate” or to waive any obligation of the Borrower to pay interest at the Default Rate;
(e)    change any provision of this Section or the definition of “Required Lenders” or any other provision hereof specifying the number or percentage of Lenders required to amend, waive or otherwise modify any rights hereunder or make any determination or grant any consent hereunder, without the written consent of each Lender;
(f)    amend Section 8.03 or the definition of “Applicable Percentage” in a manner that would alter the pro rata sharing of payments required thereby or otherwise under this Agreement without the written consent of each Lender; or
(g)    amend Section 2.02(a) (solely with respect to funding procedures relating to LIBOR Rate Loans);
and, provided further, that (i) no amendment, waiver or consent shall, unless in writing and signed by the Administrative Agent in addition to the Required Lenders or each directly-affected Lender, as the case may be, directly affect the rights or duties of the Administrative Agent under this Agreement or any other Loan Document; and (ii) the Fee Letter may be amended, or rights or privileges thereunder waived, in a writing executed only by the respective parties thereto. Notwithstanding anything to the contrary herein, no Defaulting Lender shall have any right to approve or disapprove any amendment, waiver or consent hereunder (and any amendment, waiver or consent which by its terms requires the consent of all Lenders or each affected Lender may be effected with the consent of the applicable Lenders other than Defaulting Lenders), except that (x) the Commitment of any Defaulting Lender may not be increased or extended nor the principal amount owed to such Lender reduced or the final maturity thereof extended without the consent of such Lender and

54    
Exhibit 10(ii)

(y) any waiver, amendment or modification requiring the consent of all Lenders or each affected Lender that by its terms affects any Defaulting Lender more adversely than other affected Lenders or any modification of this sentence shall require the consent of such Defaulting Lender.
For the avoidance of doubt and notwithstanding any provision herein to the contrary, this Agreement (including, without limitation, this Section 10.01) may be amended (or amended and restated) with the written consent of the Required Lenders (or the Administrative Agent on behalf of the Required Lenders) and the Borrower (i) to add one or more additional tranches of loans (including additional revolving credit or term loan facilities) to this Agreement and to permit the extensions of credit from time to time outstanding hereunder (or under such amended and restated agreement) and the accrued interest and fees in respect thereof to share ratably (or on a basis subordinated to the existing facilities hereunder) in the benefits of this Agreement and the other Loan Documents with the then-outstanding obligations of the Borrower hereunder, and (ii) in connection with the foregoing, to include, as appropriate, the Lenders providing such additional tranches of loans in any required vote or action required to be approved by the Required Lenders or by any other number, percentage or class of Lenders hereunder.
10.02    Notices; Effectiveness; Electronic Communication.
(a)    Notices Generally. Except in the case of notices and other communications expressly permitted to be given by telephone (and except as provided in subsection (b) below), all notices and other communications provided for herein shall be in writing and shall be delivered by hand or overnight courier service, mailed by certified or registered mail or sent by telecopier as follows, and all notices and other communications expressly permitted hereunder to be given by telephone shall be made to the applicable telephone number, as follows:
(i)    if to the Borrower or the Administrative Agent, to the address, telecopier number, electronic mail address or telephone number specified for such Person on Schedule 10.02;
(ii)    if to any other Lender, to the address, telecopier number, electronic mail address or telephone number specified in its Administrative Questionnaire (including, as appropriate, notices delivered solely to the Person designated by a Lender on its Administrative Questionnaire then in effect for the delivery of notices that may contain material non-public information relating to the Borrower).
Notices and other communications sent by hand or overnight courier service, or mailed by certified or registered mail, shall be deemed to have been given when received; notices and other communications sent by telecopier shall be deemed to have been given when sent (except that, if not given during normal business hours for the recipient, shall be deemed to have been given at the opening of business on the next Business Day for the recipient). Notices and other communications delivered through electronic communications to the extent provided in subsection (b) below, shall be effective as provided in such subsection (b).
(b)    Electronic Communications. Notices and other communications to the Lenders hereunder may be delivered or furnished by electronic communication (including e-mail FpML messaging, and Internet or intranet websites) pursuant to the procedures approved by the Administrative Agent and notified to the Borrower; provided that the foregoing shall not apply to notices to any Lender pursuant to Article II if such Lender has notified the Administrative Agent that it is incapable of receiving notices under such Article by electronic communication. The Administrative Agent and the Borrower agrees to accept notices and other communications to it hereunder by electronic communications pursuant to procedures approved by it, provided that approval of such procedures may be limited to particular notices or communications.

55    
Exhibit 10(ii)

Unless the Administrative Agent otherwise prescribes, (i) notices and other communications sent to an e-mail address shall be deemed received upon the sender’s receipt of an acknowledgement from the intended recipient (such as by the “return receipt requested” function, as available, return e-mail or other written acknowledgement), and (ii) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed receipt by the intended recipient at its e-mail address as described in the foregoing clause (i) of notification that such notice or communication is available and identifying the website address therefor; provided that, for both clauses (i) and (ii), if such notice, email or other communication is not sent during the normal business hours of the recipient, such notice, email or communication shall be deemed to have been sent at the opening of business on the next business day for the recipient.
(c)    The Platform. THE PLATFORM IS PROVIDED “AS IS” AND “AS AVAILABLE.” THE AGENT PARTIES (AS DEFINED BELOW) DO NOT WARRANT THE ACCURACY OR COMPLETENESS OF THE BORROWER MATERIALS OR THE ADEQUACY OF THE PLATFORM, AND EXPRESSLY DISCLAIM LIABILITY FOR ERRORS IN OR OMISSIONS FROM THE BORROWER MATERIALS. NO WARRANTY OF ANY KIND, EXPRESS, IMPLIED OR STATUTORY, INCLUDING ANY WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT OF THIRD PARTY RIGHTS OR FREEDOM FROM VIRUSES OR OTHER CODE DEFECTS, IS MADE BY ANY AGENT PARTY IN CONNECTION WITH THE BORROWER MATERIALS OR THE PLATFORM. In no event shall the Administrative Agent or any of its Related Parties (collectively, the “Agent Parties”) have any liability to the Borrower, any Lender or any other Person for losses, claims, damages, liabilities or expenses of any kind (whether in tort, contract or otherwise) arising out of the Borrower’s or the Administrative Agent’s transmission of Borrower Materials or notices through the Platform, any other electronic platform or electronic messaging service, or through the Internet, except to the extent that such losses, claims, damages, liabilities or expenses are determined by a court of competent jurisdiction by a final judgment, with respect to which all appeals have been exhausted or abandoned, to have resulted from the gross negligence or willful misconduct of such Agent Party; provided, however, that in no event shall any Agent Party have any liability to the Borrower, any Lender or any other Person for indirect, special, incidental, consequential or punitive damages (as opposed to direct or actual damages).
(d)    Change of Address, Etc. Each of the Borrower and the Administrative Agent may change its address, telecopier, e-mail address or telephone number for notices and other communications hereunder by notice to the other parties hereto. Each other Lender may change its address, telecopier, e-mail address or telephone number for notices and other communications hereunder by notice to the Borrower and the Administrative Agent. In addition, each Lender agrees to notify the Administrative Agent from time to time to ensure that the Administrative Agent has on record (i) an effective address, contact name, telephone number, telecopier number and e-mail address to which notices and other communications may be sent and (ii) accurate wire instructions for such Lender. Furthermore, each Public Lender agrees to cause at least one individual at or on behalf of such Public Lender to at all times have selected the “Private Side Information” or similar designation on the content declaration screen of the Platform in order to enable such Public Lender or its delegate, in accordance with such Public Lender’s compliance procedures and applicable Law, including United States Federal and state securities Laws, to make reference to Borrower Materials that are not made available through the “Public Side Information” portion of the Platform and that may contain material non-public information with respect to the Borrower or its securities for purposes of United States Federal or state securities laws.
(e)    Reliance by Administrative Agent and Lenders. The Administrative Agent and the Lenders shall be entitled to rely and act upon any notices (including telephonic notices and Loan Notices)

56    
Exhibit 10(ii)

purportedly given by the Borrower even if (i) such notices were not made in a manner specified herein, were incomplete or were not preceded or followed by any other form of notice specified herein, or (ii) the terms thereof, as understood by the recipient, varied from any confirmation thereof. The Borrower shall indemnify the Administrative Agent, each Lender and the Related Parties of each of them from all losses, costs, expenses and liabilities resulting from the reliance by such Person on each notice purportedly given by the Borrower. All telephonic notices to and other telephonic communications with the Administrative Agent may be recorded by the Administrative Agent, and each of the parties hereto hereby consents to such recording.
10.03    No Waiver; Cumulative Remedies; Enforcement. No failure by any Lender or the Administrative Agent to exercise, and no delay by any such Person in exercising, any right, remedy, power or privilege hereunder shall operate as a waiver thereof; nor shall any single or partial exercise of any right, remedy, power or privilege hereunder preclude any other or further exercise thereof or the exercise of any other right, remedy, power or privilege. The rights, remedies, powers and privileges herein provided are cumulative and not exclusive of any rights, remedies, powers and privileges provided by law.
Notwithstanding anything to the contrary contained herein or in any other Loan Document, the authority to enforce rights and remedies hereunder and under the other Loan Documents against the Borrower shall be vested exclusively in, and all actions and proceedings at law in connection with such enforcement shall be instituted and maintained exclusively by, the Administrative Agent in accordance with Section 8.02 for the benefit of all the Lenders; provided, however, that the foregoing shall not prohibit (a) the Administrative Agent from exercising on its own behalf the rights and remedies that inure to its benefit (solely in its capacity as Administrative Agent) hereunder and under the other Loan Documents, (b) any Lender from exercising set-off rights in accordance with Section 10.08 (subject to the terms of Section 2.11) or (c) any Lender from filing proofs of claim or appearing and filing pleadings on its own behalf during the pendency of a proceeding relative to the Borrower under any Debtor Relief Law; and provided, further, that if at any time there is no Person acting as Administrative Agent hereunder and under the other Loan Documents, then (i) the Required Lenders shall collectively have the rights otherwise ascribed to the Administrative Agent pursuant to Section 8.02 and (ii) in addition to the matters set forth in clauses (b) and (c) of the preceding proviso and subject to Section 2.11, any Lender may, with the consent of the Required Lenders, enforce any rights and remedies available to it and as authorized by the Required Lenders.
10.04    Expenses; Indemnity; Damage Waiver.
(a)    Costs and Expenses. The Borrower shall pay (i) all reasonable and documented out of pocket expenses incurred by the Administrative Agent and its Affiliates (including the reasonable and documented fees, charges and disbursements of counsel for the Administrative Agent), in connection with the preparation, negotiation, execution, delivery and administration (including, without limitation, the exercise of the Administrative Agent’s rights under Section 6.10) of this Agreement and the other Loan Documents or any amendments, modifications or waivers of the provisions hereof or thereof to the extent requested by the Borrower (whether or not the transactions contemplated hereby or thereby shall be consummated) and (ii) all reasonable and documented out of pocket expenses incurred by the Administrative Agent or any Lender (including the reasonable and documented fees, charges and disbursements of any counsel for the Administrative Agent or any Lender), if an Event of Default exists, in connection with the enforcement of its rights or remedies (A) under this Agreement and the other Loan Documents, including its rights under this Section or (B) in connection with the Loans made hereunder. Notwithstanding the foregoing, the costs and expenses of counsel required to be paid by the Borrower in connection with the preparation, negotiation, execution and delivery of the Loan Documents and occurring on or before the Closing Date shall be limited as set forth in the Fee Letter. For the avoidance of doubt

57    
Exhibit 10(ii)

and notwithstanding the foregoing provisions on this Section 10.04(a), no payment shall be required for costs and expenses that are taxes, duties, levies, imposts, deductions, assessments, fees or similar charges or liabilities with respect thereto other than amounts that represent losses, claims, damages, liabilities or related expenses arising from any claim other than for taxes, duties, levies, imposts, deductions, assessments, fees or similar charges or liabilities with respect thereto.
(b)    Indemnification by the Borrower. The Borrower shall indemnify the Administrative Agent (and any sub-agent thereof) and each Lender, and each Related Party of any of the foregoing Persons (each such Person being called an “Indemnitee”) against, and hold each Indemnitee harmless from, any and all losses, claims, damages, liabilities and related expenses (including the reasonable and documented fees, charges and disbursements of any counsel for any Indemnitee), incurred by any Indemnitee or asserted against any Indemnitee by any third party or by the Borrower arising out of, in connection with, or as a result of (i) the execution or delivery of this Agreement, any other Loan Document or any agreement or instrument contemplated hereby or thereby, the performance by the parties hereto of their respective obligations hereunder or thereunder, the consummation of the transactions contemplated hereby or thereby, or, in the case of the Administrative Agent (and any sub-agent thereof) and its Related Parties only, the administration of this Agreement and the other Loan Documents (including in respect of any amounts required to be paid by the Borrower pursuant to Section 3.01), (ii) any Loan or the use or proposed use of the proceeds therefrom, or (iii) any actual or prospective claim, litigation, investigation or proceeding relating to any of the foregoing, whether based on contract, tort or any other theory, whether brought by a third party or by the Borrower, and regardless of whether any Indemnitee is a party thereto, IN ALL CASES, WHETHER OR NOT CAUSED BY OR ARISING, IN WHOLE OR IN PART, OUT OF THE COMPARATIVE, CONTRIBUTORY OR SOLE NEGLIGENCE OF THE INDEMNITEE; provided that such indemnity shall not, as to any Indemnitee, be available to the extent that such losses, claims, damages, liabilities or related expenses (x) are determined by a court of competent jurisdiction in a final judgment, with respect to which all appeals have been exhausted or abandoned, to have resulted from the gross negligence or willful misconduct of such Indemnitee, (y) result from a claim brought by the Borrower against an Indemnitee for breach in bad faith of such Indemnitee’s obligations hereunder or under any other Loan Document, if the Borrower has obtained a final judgment, with respect to which all appeals have been exhausted or abandoned, in its favor on such claim as determined by a court of competent jurisdiction or (z) result from any dispute solely among Indemnitees (not arising as a result of any act or omission by the Borrower or any of its Subsidiaries) other than claims against the Administrative Agent, any Co-Documentation Agent, any Joint Lead Arranger or any Joint Bookrunner in its capacity as, or in fulfilling its role as, the Administrative Agent, a Co‑Documentation Agent, a Joint Lead Arranger or a Joint Bookrunner or any similar role under this Agreement. For the avoidance of doubt and notwithstanding the foregoing provisions of this Section 10.04(b), no indemnity shall be available to any Indemnitee to the extent that any losses, claims, damages, liabilities or related expenses are taxes, duties, levies, imposts, deductions, assessments, fees or similar charges, or liabilities with respect thereto (collectively, “Applicable Taxes”) other than any Applicable Taxes that represent losses, claims, damages, liabilities or related expenses arising from any non-Applicable Tax claim.
(c)    Reimbursement by Lenders. To the extent that the Borrower for any reason fails to indefeasibly pay any amount required under subsection (a) or (b) of this Section to be paid by it to the Administrative Agent (or any sub-agent thereof) or any Related Party of any of the foregoing, each Lender severally agrees to pay to the Administrative Agent (or any such sub-agent) or such Related Party, as the case may be, such Lender’s Applicable Percentage (determined as of the time that the applicable unreimbursed expense or indemnity payment is sought) of such unpaid amount; provided that the unreimbursed expense or indemnified loss, claim, damage, liability or related expense, as the case may be, was incurred by or asserted against the Administrative Agent (or any such sub-agent) in its capacity

58    
Exhibit 10(ii)

as such, or against any Related Party of any of the foregoing acting for the Administrative Agent (or any such sub-agent) in connection with such capacity. The obligations of the Lenders under this subsection (c) are subject to the provisions of Section 2.10(d).
(d)    Waiver of Consequential Damages, Etc. The Borrower agrees that no Indemnitee shall have any liability (whether direct or indirect, in contract or tort or otherwise) to it or its Subsidiaries or Affiliates or to its or their respective equity holders or creditors arising out of, or related to or in connection with any aspect of this Agreement, any other Loan Document or any agreement or instrument contemplated hereby or thereby, the transactions contemplated hereby or thereby, any Loan or the use of the proceeds thereof, except to the extent of direct, as opposed to special, indirect, consequential or punitive, damages determined in a final judgment, with respect to which all appeals have been exhausted or abandoned, by a court of competent jurisdiction to have resulted from the gross negligence or willful misconduct of such Indemnitee or any of its officers, directors, employees, agents or advisors or such Indemnitee’s breach in bad faith of its obligations under this Agreement or the other Loan Documents. No Indemnitee referred to in subsection (b) above shall be liable for any damages arising from the use by unintended recipients of any information or other materials distributed to such unintended recipients by such Indemnitee through telecommunications, electronic or other information transmission systems in connection with this Agreement or the other Loan Documents or the transactions contemplated hereby or thereby other than for direct or actual damages resulting from (i) the gross negligence or willful misconduct of such Indemnitee or its Related Parties as determined by a final judgment, with respect to which all appeals have been exhausted or abandoned, by a court of competent jurisdiction or (ii) a claim brought by the Borrower against such Indemnitee for breach in bad faith of such Indemnitee’s obligations hereunder or under any other Loan Document, if the Borrower has obtained a final judgment, with respect to which all appeals have been exhausted or abandoned, in its favor on such claim as determined by a court of competent jurisdiction.
(e)    Payments. All amounts due under this Section shall be payable not later than ten Business Days after demand therefor.
(f)    Survival. The agreements in this Section 10.04 shall survive the resignation of the Administrative Agent, the replacement of any Lender, the termination of the Aggregate Commitments and the repayment, satisfaction or discharge of all the other Obligations.
10.05    Payments Set Aside. To the extent that any payment by or on behalf of the Borrower is made to the Administrative Agent or any Lender, or the Administrative Agent or any Lender exercises its right of set-off, and such payment or the proceeds of such set-off or any part thereof is subsequently invalidated, declared to be fraudulent or preferential, set aside or required (including pursuant to any settlement entered into by the Administrative Agent or such Lender in its discretion) to be repaid to a trustee, receiver or any other party, in connection with any proceeding under any Debtor Relief Law or otherwise, then (a) to the extent of such recovery, the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not been made or such set-off had not occurred, and (b) each Lender severally agrees to pay to the Administrative Agent upon demand its applicable share (without duplication) of any amount so recovered from or repaid by the Administrative Agent, plus interest thereon from the date of such demand to the date such payment is made at a rate per annum equal to the applicable Overnight Rate from time to time in effect, in the applicable currency of such recovery or payment. The obligations of the Lenders under clause (b) of the preceding sentence shall survive the payment in full of the Obligations and the termination of this Agreement.
10.06    Successors and Assigns.

59    
Exhibit 10(ii)

(a)    Successors and Assigns Generally. The provisions of this Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors and assigns permitted hereby, except that the Borrower may not assign or otherwise transfer any of its rights or obligations hereunder without the prior written consent of the Administrative Agent and each Lender (except that the Borrower may effect or enter into transactions not prohibited by Section 7.03) and no Lender may assign or otherwise transfer any of its rights or obligations hereunder except (i) to an assignee in accordance with the provisions of subsection (b) of this Section, (ii) by way of participation in accordance with the provisions of subsection (d) of this Section, or (iii) by way of pledge or assignment of a security interest subject to the restrictions of subsection (f) of this Section (and any other attempted assignment or transfer by any party hereto shall be null and void). Nothing in this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby, Participants to the extent provided in subsection (d) of this Section and, to the extent expressly contemplated hereby, the Related Parties of each of the Administrative Agent and the Lenders) any legal or equitable right, remedy or claim under or by reason of this Agreement.
(b)    Assignments by Lenders. Any Lender may at any time assign to one or more assignees all or a portion of its rights and obligations under this Agreement (including all or a portion of its Commitment and the Loans at the time owing to it); provided that any such assignment shall be subject to the following conditions:
(i)    Minimum Amounts.
(A)    in the case of an assignment of the entire remaining amount of the assigning Lender’s Commitment and the Loans at the time owing to it or in the case of an assignment to a Lender, an Affiliate of a Lender or an Approved Fund, no minimum amount need be assigned; and
(B)    in any case not described in subsection (b)(i)(A) of this Section, the aggregate amount of the Commitment (which for this purpose includes Loans outstanding thereunder) or, if the Commitment is not then in effect, the principal outstanding balance of the Loans of the assigning Lender subject to each such assignment, determined as of the date the Assignment and Assumption with respect to such assignment is delivered to the Administrative Agent or, if “Trade Date” is specified in the Assignment and Assumption, as of the Trade Date, shall not be less than $5,000,000 unless each of the Administrative Agent and, so long as no Event of Default has occurred and is continuing, the Borrower otherwise consents (each such consent not to be unreasonably withheld or delayed); provided, however, that concurrent assignments to members of an Assignee Group and concurrent assignments from members of an Assignee Group to a single Eligible Assignee (or to an Eligible Assignee and members of its Assignee Group) will be treated as a single assignment for purposes of determining whether such minimum amount has been met.
(ii)    Proportionate Amounts. Each partial assignment shall be made as an assignment of a proportionate part of all the assigning Lender’s rights and obligations under this Agreement with respect to the Loans or the Commitment assigned.
(iii)    Required Consents.
(A)    the consent of the Borrower (such consent not to be unreasonably withheld or delayed, it being understood that the Borrower may withhold its approval if it reasonably

60    
Exhibit 10(ii)

believes that an assignment would result in the incurrence of increased costs payable by the Borrower under this Agreement) shall be required unless (1) an Event of Default has occurred and is continuing at the time of such assignment or (2) such assignment is to a Lender, an Affiliate of a Lender or an Approved Fund; provided that the Borrower shall be deemed to have consented to any such assignment unless it shall object thereto by written notice to the Administrative Agent within five (5) Business Days after having received notice thereof; and
(B)    the consent of the Administrative Agent (such consent not to be unreasonably withheld or delayed) shall be required if such assignment is to a Person that is not a Lender, an Affiliate of such Lender or an Approved Fund with respect to such Lender.
(iv)    Assignment and Assumption. The parties to each assignment shall execute and deliver to the Administrative Agent an Assignment and Assumption, together with a processing and recordation fee in the amount of $3,500; provided, however, that the Administrative Agent may, in its sole discretion, elect to waive such processing and recordation fee in the case of any assignment; and provided further that the Borrower shall not in any event be required to pay any portion of such fee unless the Borrower requests that a Lender be replaced pursuant to the provisions of Section 10.16. The assignee, if it is not a Lender, shall deliver to the Administrative Agent an Administrative Questionnaire.
(v)    No Assignment to Certain Persons. No such assignment shall be made (A) to the Borrower or any of the Borrower’s Affiliates or Subsidiaries, or (B) to any Defaulting Lender or any of its Subsidiaries, or any Person who, upon becoming a Lender hereunder, would constitute any of the foregoing Persons described in this clause (B), or (C) to a natural person (or to a holding company, investment vehicle or trust for, or owned and operated for the primary benefit of a natural Person).
(vi)    Certain Additional Payments. In connection with any assignment of rights and obligations of any Defaulting Lender hereunder, no such assignment shall be effective unless and until, in addition to the other conditions thereto set forth herein, the parties to the assignment shall make such additional payments to the Administrative Agent in an aggregate amount sufficient, upon distribution thereof as appropriate (which may be outright payment, purchases by the assignee of participations or subparticipations, or other compensating actions, including funding, at the request of the Borrower, the applicable pro rata share of Loans previously requested but not funded by the Defaulting Lender, to each of which the applicable assignee and assignor hereby irrevocably consent), to (x) pay and satisfy in full all payment liabilities then owed by such Defaulting Lender to the Administrative Agent or any Lender hereunder (and interest accrued thereon) and (y) acquire (and fund as appropriate) its full pro rata share of all Loans in accordance with its Applicable Percentage. Notwithstanding the foregoing, in the event that any assignment of rights and obligations of any Defaulting Lender hereunder shall become effective under applicable Law without compliance with the provisions of this paragraph, then the assignee of such interest shall be deemed to be a Defaulting Lender for all purposes of this Agreement until such compliance occurs.
Subject to acceptance and recording thereof by the Administrative Agent pursuant to subsection (c) of this Section, from and after the effective date specified in each Assignment and Assumption, the assignee thereunder shall be a party to this Agreement and, to the extent of the interest assigned by such Assignment and Assumption, have the rights and obligations of a Lender under this Agreement, and the assigning Lender thereunder shall, to the extent of the interest assigned by such Assignment and Assumption, be released from its obligations under this Agreement (and, in the case of an Assignment and Assumption covering all of the

61    
Exhibit 10(ii)

assigning Lender’s rights and obligations under this Agreement, such Lender shall cease to be a party hereto) but shall continue to be entitled to the benefits of Sections 3.01, 3.04, 3.05, and 10.04 with respect to facts and circumstances occurring prior to the effective date of such assignment; provided that, except to the extent otherwise expressly agreed by the affected parties, no assignment by a Defaulting Lender will constitute a waiver or release of any claim of any party hereunder arising from that Lender’s having been a Defaulting Lender. Upon request, the Borrower (at its expense) shall execute and deliver a Note to the assignee Lender. Any assignment or transfer by a Lender of rights or obligations under this Agreement that does not comply with this subsection shall be treated for purposes of this Agreement as a sale by such Lender of a participation in such rights and obligations in accordance with subsection (d) of this Section.
(c)    Register. The Administrative Agent, acting solely for this purpose as a non‑fiduciary agent of the Borrower (and such agency being solely for tax purposes), shall maintain at the Administrative Agent’s Office a copy of each Assignment and Assumption delivered to it (or the equivalent thereof in electronic form) and a register for the recordation of the names and addresses of the Lenders, and the Commitments of, and principal amounts (and stated interest) of the Loans owing to, each Lender pursuant to the terms hereof from time to time (the “Register”). The entries in the Register shall be conclusive absent manifest error, and the Borrower, the Administrative Agent and the Lenders shall treat each Person whose name is recorded in the Register pursuant to the terms hereof as a Lender hereunder for all purposes of this Agreement, notwithstanding notice to the contrary. The Register shall be available for inspection by the Borrower and any Lender, at any reasonable time and from time to time upon reasonable prior notice. This Section 10.06(c) shall be construed so that all Loans are at all times maintained in “registered form” within the meaning of Section 163(f), 871(h)(2), and 881(c)(2) of the Code and Sections 5f.103-1(c) and 1.871-14 of the United States Treasury Regulations.
(d)    Participations. Any Lender may at any time, without the consent of, or notice to, the Borrower or the Administrative Agent, sell participations to any Person (other than a natural Person, or a holding company, investment vehicle or trust for, or owned and operated for the primary benefit of a natural Person, a Defaulting Lender or the Borrower or any of the Borrower’s Affiliates or Subsidiaries) (each, a “Participant”) in all or a portion of such Lender’s rights and/or obligations under this Agreement (including all or a portion of its Commitment and/or the Loans owing to it); provided that (i) such Lender’s obligations under this Agreement shall remain unchanged, (ii) such Lender shall remain solely responsible to the other parties hereto for the performance of such obligations, (iii) the Borrower, the Administrative Agent and the Lenders shall continue to deal solely and directly with such Lender in connection with such Lender’s rights and obligations under this Agreement and (iv) such Lender shall remain the holder of its Loans and owner of its interest in the Credit Agreement for all purposes hereunder.
Any agreement or instrument pursuant to which a Lender sells such a participation shall provide that such Lender shall retain the sole right to enforce this Agreement and to approve any amendment, modification or waiver of any provision of this Agreement; provided that such agreement or instrument may provide that such Lender will not, without the consent of the Participant, agree to any amendment, waiver or other modification described in the first proviso to Section 10.01 that directly affects such Participant. Subject to subsection (e) of this Section, the Borrower agrees that each Participant shall be (without duplication of amounts paid to a participating Lender) entitled to the benefits of Sections 3.01, 3.04 and 3.05 (subject to the requirements and limitations with respect thereto) to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to subsection (b) of this Section; provided that such Participant (A) agrees to be subject to the provisions of Sections 3.04 and 10.16 as if it were an assignee under paragraph (b) of this Section and (B) shall not be entitled to receive any greater payment under Sections 3.01 or 3.04, with respect to any participation, than the Lender from whom it acquired the applicable participation would have been entitled to receive, except to the extent such entitlement to receive a greater

62    
Exhibit 10(ii)

payment which (i) would accrue to such Participant if it were deemed to be a “Lender” under Sections 3.01 or 3.04 (and subject to the requirements and limitations with respect thereto) and (ii) results from a Change in Law for which a Participant would be entitled to compensation under Sections 3.01 or 3.04 (in accordance with the immediately preceding clause (i)) that occurs after the Participant acquired the applicable participation. Each Lender that sells a participation agrees, at the Borrower’s request and expense, to use reasonable efforts to cooperate with the Borrower to effectuate the provisions of Section 3.04 with respect to any Participant. To the extent permitted by law, each Participant also shall be entitled to the benefits of Section 10.08 as though it were a Lender; provided such Participant agrees to be subject to Section 2.11 as though it were a Lender. Each Lender that sells a participation shall, acting solely for this purpose as a non-fiduciary agent of the Borrower (and such agency being solely for tax purposes), maintain a register on which it enters the name and address of each Participant and the principal amounts (and stated interest) of each Participant’s interest in the Loans or other obligations under the Loan Documents (the “Participant Register”); provided that no Lender shall have any obligation to disclose all or any portion of the Participant Register (including the identity of any Participant or any information relating to a Participant’s interest in any Commitments, Loans or its other obligations under any Loan Document) to any Person except to the extent that such disclosure is necessary to establish that such Commitment, Loan or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations. The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat each Person whose name is recorded in the Participant Register as the owner of such participation for all purposes of this Agreement notwithstanding any notice to the contrary. For the avoidance of doubt, the Administrative Agent (in its capacity as Administrative Agent) shall have no responsibility for maintaining a Participant Register. This Section 10.06(d) shall be construed so that all Loans are at all times maintained in “registered form” within the meaning of Section 163(f), 871(h)(2), and 881(c)(2) of the Code and Sections 5f.103-1(c) and 1.871-14 of the United States Treasury Regulations.
(e)    Limitations upon Participant Rights. A Participant that would be a Foreign Lender if it were a Lender shall not be entitled to the benefits of Section 3.01 unless the Borrower is notified of the participation sold to such Participant and such Participant agrees, for the benefit of the Borrower, to comply with Section 10.15 as though it were a Lender.
(f)    Certain Pledges. Any Lender may at any time pledge or assign a security interest in all or any portion of its rights under this Agreement (including under its Note, if any) to secure obligations of such Lender, including any pledge or assignment to secure obligations to a Federal Reserve Bank or other central banking authority; provided that no such pledge or assignment shall release such Lender from any of its obligations hereunder or substitute any such pledgee or assignee for such Lender as a party hereto.
10.07    Treatment of Certain Information; Confidentiality. Each of the Administrative Agent and the Lenders agrees to maintain the confidentiality of the Information (as defined below), except that Information may be disclosed (a) on a confidential, need-to-know basis, to its Affiliates and to its and its Affiliates’ directors, officers, employees and agents, including accountants, legal counsel and other advisors (it being understood that the Persons to whom such disclosure is made will be informed of the confidential nature of such Information and instructed to keep such Information confidential), (b) to the extent required or requested by any regulatory authority purporting to have jurisdiction over it (including any self-regulatory authority, such as the National Association of Insurance Commissioners), (c) to the extent required by applicable laws or regulations or by any subpoena or similar legal process, (d) to any other party to this Agreement, (e) in connection with the exercise of any remedies hereunder or under any other Loan Document or any action or proceeding relating to this Agreement or any other Loan Document or the enforcement of rights hereunder or thereunder, (f) subject to an agreement containing provisions

63    
Exhibit 10(ii)

substantially the same as those of this Section, to (i) any Eligible Assignee of or Participant in, or any prospective Eligible Assignee of or Participant in, any of its rights or obligations under this Agreement or (ii) any actual or prospective counterparty (or its advisors) to any swap or derivative transaction (including, without limitation, credit insurance providers) relating to the Borrower and its obligations, (g) with the consent of the Borrower, or (h) to the extent such Information (x) becomes publicly available other than as a result of a breach of this Section or (y) becomes available to the Administrative Agent, any Lender or any of their respective Affiliates on a nonconfidential basis from a source other than the Borrower. In addition, the Administrative Agent and the Lenders may disclose the existence of this Agreement and information about this Agreement to market data collectors, similar service providers to the lending industry, and service providers to the Administrative Agent and the Lenders in connection with the administration and management of this Agreement, the other Loan Documents, the Commitments and the Borrowings. For purposes of this Section, “Information” means all information received from the Borrower relating to the Borrower or any of its businesses, other than any such information that is available to the Administrative Agent or any Lender on a nonconfidential basis prior to disclosure by the Borrower. Any Person required to maintain the confidentiality of Information as provided in this Section shall be considered to have complied with its obligation to do so if such Person has exercised the same degree of care to maintain the confidentiality of such Information as such Person would accord to its own confidential information.
Each of the Administrative Agent and the Lenders acknowledges that (a) the Information may include material non-public information concerning the Borrower, (b) it has developed compliance procedures regarding the use of material non-public information and (c) it will handle such material non-public information in accordance with applicable Law, including United States Federal and state securities Laws.
10.08    Set-off. In addition to any other rights and remedies that such Lender may have, upon the occurrence and during the continuance of an Event of Default, each Lender and each of their respective Affiliates is hereby authorized at any time and from time to time, without prior notice to the Borrower, any such notice being waived by the Borrower, to the fullest extent permitted by applicable law, to set off and apply any and all deposits (general or special, time or demand, provisional or final, in whatever currency) at any time held and other obligations (in whatever currency) at any time owing by such Lender to or for the credit or the account of the Borrower against any and all of the obligations of the Borrower now or hereafter existing under this Agreement or any other Loan Document to such Lender, irrespective of whether or not such Lender shall have made any demand under this Agreement or any other Loan Document and although such obligations of the Borrower may be contingent or unmatured or are owed to a branch or office of such Lender different from the branch or office holding such deposit or obligated on such indebtedness; provided that in the event that any Defaulting Lender shall exercise any such right of set-off hereunder, (x) all amounts so set off shall be paid over immediately to the Administrative Agent for further application in accordance with the provisions of Section 2.12 and, pending such payment, shall be segregated by such Defaulting Lender from its other funds and deemed held in trust for the benefit of the Administrative Agent and the Lenders, and (y) the Defaulting Lender shall provide promptly to the Administrative Agent a statement describing in reasonable detail the Obligations owing to such Defaulting Lender as to which it exercised such right of set-off. Each Lender agrees promptly to notify the Borrower and the Administrative Agent after any such set-off and application made by such Lender; provided, however, that the failure to give such notice shall not affect the validity of such set-off and application.
10.09    Interest Rate Limitation. Notwithstanding anything to the contrary contained in any Loan Document, the interest paid or agreed to be paid under the Loan Documents shall not exceed the maximum rate of non-usurious interest permitted by applicable Law (the “Maximum Rate”). If the Administrative Agent or any Lender shall receive interest in an amount that exceeds the Maximum Rate, the excess interest shall be applied to the principal of the Loans or, if it exceeds such unpaid principal, refunded to the Borrower.

64    
Exhibit 10(ii)

In determining whether the interest contracted for, charged, or received by the Administrative Agent or a Lender exceeds the Maximum Rate, such Person may, to the extent permitted by applicable Law, (a) characterize any payment that is not principal as an expense, fee, or premium rather than interest, (b) exclude voluntary prepayments and the effects thereof, and (c) amortize, prorate, allocate, and spread in equal or unequal parts the total amount of interest throughout the contemplated term of the Obligations.
10.10    Counterparts; Integration; Effectiveness. This Agreement may be executed in counterparts (and by different parties hereto in different counterparts), each of which shall constitute an original, but all of which when taken together shall constitute a single contract. This Agreement, the other Loan Documents, and any separate letter agreements with respect to fees payable to the Administrative Agent, constitute the entire contract among the parties relating to the subject matter hereof and supersede any and all previous agreements and understandings, oral or written, relating to the subject matter hereof. Except as provided in Section 4.01, this Agreement shall become effective when it shall have been executed by the Administrative Agent and when the Administrative Agent shall have received counterparts hereof that, when taken together, bear the signatures of each of the other parties hereto. Delivery of an executed counterpart of a signature page of this Agreement by telecopy or other electronic imaging means shall be effective as delivery of a manually executed counterpart of this Agreement.
10.11    Survival of Representations and Warranties. All representations and warranties made hereunder and in any other Loan Document or other document delivered pursuant hereto or thereto or in connection herewith or therewith shall survive the execution and delivery hereof and thereof. Such representations and warranties have been or will be relied upon by the Administrative Agent and each Lender, regardless of any investigation made by the Administrative Agent or any Lender or on their behalf and notwithstanding that the Administrative Agent or any Lender may have had notice or knowledge of any Default or Event of Default at the time of any Borrowing, and shall survive in full force and effect until payment in full of all Obligations (other than indemnification and other contingent obligations).
10.12    Severability. If any provision of this Agreement or the other Loan Documents is held to be illegal, invalid or unenforceable, (a) the legality, validity and enforceability of the remaining provisions of this Agreement and the other Loan Documents shall not be affected or impaired thereby and (b) the parties shall endeavor in good faith negotiations to replace the illegal, invalid or unenforceable provisions with valid provisions the economic effect of which comes as close as possible to that of the illegal, invalid or unenforceable provisions. The invalidity of a provision in a particular jurisdiction shall not invalidate or render unenforceable such provision in any other jurisdiction. Without limiting the foregoing provisions of this Section 10.12, if and to the extent that the enforceability of any provisions in this Agreement relating to Defaulting Lenders shall be limited by Debtor Relief Laws, as determined in good faith by the Administrative Agent, then such provisions shall be deemed to be in effect only to the extent not so limited.
10.13    No advisory or Fiduciary Responsibility. In connection with all aspects of each transaction contemplated hereby (including in connection with any amendment, waiver or other modification hereof or of any other Loan Document), the Borrower acknowledges and agrees, and acknowledges its Affiliates’ understanding, that: (i) (A) the arranging and other services regarding this Agreement provided by the Administrative Agent, the Lenders and the Arranger are arm’s-length commercial transactions between the Borrower and its Affiliates, on the one hand, and the Administrative Agent and the Arranger, on the other hand, (B) the Borrower has consulted its own legal, accounting, regulatory and tax advisors to the extent it has deemed appropriate, and (C) the Borrower is capable of evaluating, and understands and accepts, the terms, risks and conditions of the transactions contemplated hereby and by the other Loan Documents; (ii) (A) in connection with the arranging and other services regarding this Agreement and the administration of the Loan Documents and the transactions contemplated thereby, the Administrative Agent, each Lender

65    
Exhibit 10(ii)

and the Arranger, as applicable, each is and has been acting solely as a principal and has not been, is not and will not be acting as an advisor, agent or fiduciary for the Borrower or any of its Affiliates or any other Person (it being understood that the foregoing shall not apply with respect to any other transactions, including, without limitation, other corporate transactions, other financial matters and custodial relationships between such parties, and except as otherwise agreed to by the relevant parties) and (B) neither the Administrative Agent nor any Lender nor the Arranger has any obligation to the Borrower or any of its Affiliates with respect to the transactions contemplated hereby except those obligations expressly set forth herein and in the other Loan Documents; and (iii) the Administrative Agent, the Lenders and the Arranger and their respective Affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Borrower and its Affiliates, and neither the Administrative Agent nor any Lender nor the Arranger has any obligation to disclose any of such interests to the Borrower or its Affiliates. To the fullest extent permitted by law, the Borrower hereby waives and releases any claims that it may have against the Administrative Agent, the Lenders and the Arranger with respect to any breach or alleged breach of agency or fiduciary duty in connection with any aspect of any transaction contemplated hereby except to the extent provided otherwise in clause (ii) above.
10.14    Electronic Execution of Assignments and Certain Other Documents. The words “execute,” “execution,” “signed,” “signature,” and words of like import in or related to any document to be signed in connection with this Agreement and the transactions contemplated hereby (including without limitation Assignment and Assumptions, amendments or other modifications, Loan Notices, waivers and consents) shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act; provided that, notwithstanding anything contained herein to the contrary, the Administrative Agent is under no obligation to agree to accept electronic signatures in any form or in any format unless expressly agreed to by the Administrative Agent pursuant to procedures approved by it.
10.15    Tax Forms.
(a)    Any Foreign Lender that is entitled to an exemption from or reduction of withholding Tax with respect to payments made under any Loan Document shall deliver to the Borrower and the Administrative Agent (in such number of copies as shall be requested by the recipient) on or prior to the date on which such Foreign Lender becomes a Lender under this Agreement (and from time to time thereafter upon the request of the Borrower or the Administrative Agent, but only if such Foreign Lender is legally entitled to do so), whichever of the following is applicable:
(i)    duly completed copies of IRS Form W-8BEN or IRS Form W-8BEN-E claiming eligibility for exemption from United States Federal withholding tax under an income tax treaty to which the United States is a party,
(ii)    duly completed copies of IRS Form W-8ECI,
(iii)    in the case of a Foreign Lender claiming the benefits of the exemption for portfolio interest under section 881(c) of the Code, (x) a certificate to the effect that such Foreign Lender is not (A) a “bank” within the meaning of section 881(c)(3)(A) of the Code, (B) a “10 percent shareholder” of the Borrower within the meaning of section 881(c)(3)(B) of the Code, or (C) a

66    
Exhibit 10(ii)

“controlled foreign corporation” described in section 881(c)(3)(C) of the Code and (y) duly completed copies of IRS Form W-8BEN or IRS Form W-8BEN-E,
(iv)    IRS Form W-8IMY and all required supporting documentation, or
(v)    any other form prescribed by applicable law as a basis for claiming exemption from United States Federal withholding tax duly completed together with such supplementary documentation as may be prescribed by applicable law to permit the Borrower to determine the withholding or deduction required to be made.
Without limiting the obligations of the Lenders set forth above regarding delivery of certain forms and documents to establish each Lender’s status for U.S. withholding tax purposes, each Lender agrees promptly to deliver to the Administrative Agent or the Borrower, as the Administrative Agent or the Borrower shall reasonably request, on or prior to the Closing Date, and in a timely fashion thereafter, such other documents and forms required by any relevant taxing authorities under the Laws of any other jurisdiction, duly executed and completed by such Lender to the extent that it may legally do so, as are required under such Laws to confirm such Lender’s entitlement to any available exemption from, or reduction of, applicable withholding taxes in respect of all payments to be made to such Lender outside of the U.S. by the Borrower pursuant to this Agreement or otherwise to establish such Lender’s status for withholding tax purposes in such other jurisdiction.
(b)    Upon the request of the Administrative Agent, each Lender that is a “United States person” within the meaning of Section 7701(a)(30) of the Code shall deliver to the Administrative Agent two duly signed completed copies of IRS Form W-9. If such Lender fails to deliver such forms, then the Administrative Agent may withhold from any interest payment to such Lender an amount equivalent to the applicable back-up withholding tax imposed by the Code, without reduction.
(c)    If a payment made to a Lender or a Participant under any Loan Document would be subject to U.S. Federal withholding Tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Code, as applicable), such Lender shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Code) and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender’s obligations under FATCA or to determine the amount to deduct and withhold from such payment. Solely for purposes of this Section 10.15(c), “FATCA” shall include any amendments made to FATCA after the date of this Agreement.
10.16    Replacement of Lenders. If any Lender requests compensation under Section 3.04, or if the Borrower is required to pay any additional amount to any Lender or any Governmental Authority for the account of any Lender pursuant to Section 3.01, or if any Lender gives notice under Section 3.02, or if any Lender is a Restricted Lender (as defined below), or if any Lender is a Defaulting Lender, or if any other circumstance exists hereunder that gives the Borrower the right to replace a Lender as a party hereto, then the Borrower may, at its sole expense and effort, upon notice to such Lender and the Administrative Agent, require such Lender to assign and delegate, without recourse (in accordance with and subject to the restrictions contained in, and consents required by, Section 10.06), all of its interests, rights and obligations

67    
Exhibit 10(ii)

under this Agreement and the related Loan Documents to an Eligible Assignee that shall assume such obligations (which assignee may be another Lender, if a Lender accepts such assignment); provided that:
(a)    the Borrower shall have paid to the Administrative Agent the assignment fee specified in Section 10.06(b);
(b)    such Lender shall have received payment of an amount equal to 100% of the outstanding principal of its Loans, accrued interest thereon, accrued fees and all other amounts payable to it hereunder and under the other Loan Documents (including any amounts under Section 3.05) from the assignee (to the extent of such outstanding principal and accrued interest and fees) or the Borrower (in the case of all other amounts);
(c)    in the case of any such assignment resulting from a claim for compensation under Section 3.04 or payments required to be made pursuant to Section 3.01, such assignment will result in a reduction in such compensation or payments thereafter;
(d)    in the case of any such assignment by a Restricted Lender, the assignee must have approved in writing the substance of the amendment, waiver or consent which caused the assignor to be a Restricted Lender; and
(e)    such assignment does not conflict with applicable Laws.
A Lender shall not be required to make any such assignment or delegation if, prior thereto, as a result of a waiver by such Lender or otherwise, the circumstances entitling the Borrower to require such assignment and delegation cease to apply. Each party hereto agrees that an assignment required pursuant to this Section 10.16 may be effected pursuant to an Assignment and Assumption executed by the Borrower and the assignee and acknowledged by the Administrative Agent, and that the Lender required to make such assignment need not be a party thereto.
For the purposes of this Section 10.16, a “Restricted Lender” means a Lender that fails to approve an amendment, waiver or consent requested by the Borrower pursuant to Section 10.01 that has received the written approval of not less than the Required Lenders but also requires the approval of such Lender.
10.17    Governing Law; Jurisdiction; Etc.
(a)    GOVERNING LAW. THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS AND ANY CLAIMS, CONTROVERSY, DISPUTE OR CAUSE OF ACTION (WHETHER IN CONTRACT OR TORT OR OTHERWISE) BASED UPON, ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT (EXCEPT, AS TO ANY OTHER LOAN DOCUMENT, AS EXPRESSLY SET FORTH THEREIN) AND THE TRANSACTIONS CONTEMPLATED HEREBY AND THEREBY SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAW OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF NEW YORK.
(b)    SUBMISSION TO JURISDICTION. EACH PARTY HERETO IRREVOCABLY AND UNCONDITIONALLY SUBMITS, FOR ITSELF AND ITS PROPERTY, TO THE EXCLUSIVE JURISDICTION OF THE COURTS OF THE STATE OF NEW YORK SITTING IN NEW YORK COUNTY, BOROUGH OF MANHATTAN, AND OF THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF NEW YORK, AND ANY APPELLATE COURT FROM ANY

68    
Exhibit 10(ii)

THEREOF, IN ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT, OR FOR RECOGNITION OR ENFORCEMENT OF ANY JUDGMENT, AND EACH OF THE PARTIES HERETO IRREVOCABLY AND UNCONDITIONALLY AGREES THAT ALL CLAIMS IN RESPECT OF ANY SUCH ACTION OR PROCEEDING MAY BE HEARD AND DETERMINED IN SUCH NEW YORK STATE COURT OR, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, IN SUCH FEDERAL COURT. EACH OF THE PARTIES HERETO AGREES THAT A FINAL JUDGMENT IN ANY SUCH ACTION OR PROCEEDING SHALL BE CONCLUSIVE AND MAY BE ENFORCED IN OTHER JURISDICTIONS BY SUIT ON THE JUDGMENT OR IN ANY OTHER MANNER PROVIDED BY LAW. NOTHING IN THIS AGREEMENT OR IN ANY OTHER LOAN DOCUMENT SHALL AFFECT ANY RIGHT THAT ANY PARTY HERETO MAY OTHERWISE HAVE TO BRING ANY ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT AGAINST ANY OTHER PARTY HERETO OR ITS PROPERTIES IN THE COURTS OF ANY JURISDICTION.
(c)    WAIVER OF VENUE. EACH PARTY HERETO IRREVOCABLY AND UNCONDITIONALLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY OBJECTION THAT IT MAY NOW OR HEREAFTER HAVE TO THE LAYING OF VENUE OF ANY ACTION OR PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT IN ANY COURT REFERRED TO IN PARAGRAPH (b) OF THIS SECTION. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, THE DEFENSE OF AN INCONVENIENT FORUM TO THE MAINTENANCE OF SUCH ACTION OR PROCEEDING IN ANY SUCH COURT.
(d)    SERVICE OF PROCESS. EACH PARTY HERETO IRREVOCABLY CONSENTS TO SERVICE OF PROCESS IN THE MANNER PROVIDED FOR NOTICES IN SECTION 10.02. NOTHING IN THIS AGREEMENT WILL AFFECT THE RIGHT OF ANY PARTY HERETO TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY APPLICABLE LAW.
10.18    Waiver of Jury Trial. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER LOAN DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS SECTION.
10.19    USA PATRIOT Act Notice. Each Lender that is subject to the Act (as hereinafter defined) and the Administrative Agent (for itself and not on behalf of any Lender) hereby notifies the Borrower that pursuant to the requirements of the Patriot Act, it is required to obtain, verify and record information that identifies the Borrower, which information includes the name and address of the Borrower and other information that will allow such Lender or the Administrative Agent, as applicable, to identify the Borrower in accordance with the Patriot Act. The Borrower shall, promptly following a request by the Administrative Agent or any Lender, provide all documentation and other information that the Administrative Agent or

69    
Exhibit 10(ii)

such Lender requests in order to comply with its ongoing obligations under applicable “know your customer” and anti-money laundering rules and regulations, including the Patriot Act.
10.20    Acknowledgement and Consent to Bail-In of Affected Financial Institutions. Solely to the extent any Lender that is an Affected Financial Institution is a party to this Agreement and notwithstanding anything to the contrary in any Loan Document or in any other agreement, arrangement or understanding among any such parties, each party hereto acknowledges that any liability of any Lender that is an Affected Financial Institution arising under any Loan Document, to the extent such liability is unsecured, may be subject to the Write-Down and Conversion Powers of the Relevant Resolution Authority and agrees and consents to, and acknowledges and agrees to be bound by:
(a)    the application of any Write-Down and Conversion Powers by the Relevant Resolution Authority to any such liabilities arising hereunder which may be payable to it by any Lender that is an Affected Financial Institution; and
(b)    the effects of any Bail-In Action on any such liability, including, if applicable:
(i)    a reduction in full or in part or cancellation of any such liability;
(ii)    a conversion of all, or a portion of, such liability into shares or other instruments of ownership in such Affected Financial Institution, its parent undertaking, or a bridge institution that may be issued to it or otherwise conferred on it, and that such shares or other instruments of ownership will be accepted by it in lieu of any rights with respect to any such liability under this Agreement or any other Loan Document; or
(iii)    the variation of the terms of such liability, as deemed necessary by the Relevant Resolution Authority, to give effect to the exercise of the Write-Down and Conversion Powers of the Relevant Resolution Authority.
10.21    ENTIRE AGREEMENT. THIS AGREEMENT AND THE OTHER LOAN DOCUMENTS REPRESENT THE FINAL AGREEMENT AMONG THE PARTIES AND MAY NOT BE CONTRADICTED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OF THE PARTIES. THERE ARE NO UNWRITTEN ORAL AGREEMENTS AMONG THE PARTIES.
10.22    Acknowledgement Regarding Any Supported QFCs.    To the extent that the Loan Documents provide support, through a guarantee or otherwise, for any Swap Contract or any other agreement or instrument that is a QFC (such support, “QFC Credit Support”, and each such QFC, a “Supported QFC”), the parties acknowledge and agree as follows with respect to the resolution power of the Federal Deposit Insurance Corporation under the Federal Deposit Insurance Act and Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act (together with the regulations promulgated thereunder, the “U.S. Special Resolution Regimes”) in respect of such Supported QFC and QFC Credit Support (with the provisions below applicable notwithstanding that the Loan Documents and any Supported QFC may in fact be stated to be governed by the laws of the State of New York and/or of the United States or any other state of the United States):
(a)    In the event a Covered Entity that is party to a Supported QFC (each, a “Covered Party”) becomes subject to a proceeding under a U.S. Special Resolution Regime, the transfer of such Supported QFC and the benefit of such QFC Credit Support (and any interest and obligation in or under such

70    
Exhibit 10(ii)

Supported QFC and such QFC Credit Support, and any rights in property securing such Supported QFC or such QFC Credit Support) from such Covered Party will be effective to the same extent as the transfer would be effective under the U.S. Special Resolution Regime if the Supported QFC and such QFC Credit Support (and any such interest, obligation and rights in property) were governed by the laws of the United States or a state of the United States. In the event a Covered Party or a BHC Act Affiliate of a Covered Party becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under the Loan Documents that might otherwise apply to such Supported QFC or any QFC Credit Support that may be exercised against such Covered Party are permitted to be exercised to no greater extent than such Default Rights could be exercised under the U.S. Special Resolution Regime if the Supported QFC and the Loan Documents were governed by the laws of the United States or a state of the United States. Without limitation of the foregoing, it is understood and agreed that rights and remedies of the parties with respect to a Defaulting Lender shall in no event affect the rights of any Covered Party with respect to a Supported QFC or any QFC Credit Support.
(b)    As used in this Section 10.22, the following terms have the following meanings:
“BHC Act Affiliate” of a party means an “affiliate” (as such term is defined under, and interpreted in accordance with, 12 U.S.C. 1841(k)) of such party.
“Covered Entity” means any of the following: (i) a “covered entity” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 252.82(b); (ii) a “covered bank” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 47.3(b); or (iii) a “covered FSI” as that term is defined in, and interpreted in accordance with, 12 C.F.R. § 382.2(b).
“Default Right” has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. §§ 252.81, 47.2 or 382.1, as applicable.
“QFC” has the meaning assigned to the term “qualified financial contract” in, and shall be interpreted in accordance with, 12 U.S.C. 5390(c)(8)(D).

[Signature pages follow.]

71    
Exhibit 10(ii)


IN WITNESS WHEREOF, the parties hereto have caused this Credit Agreement to be duly executed as of the date first above written.
STRYKER CORPORATION

By: /s/ JEANNE M. BLONDIA    
Name: Jeanne M. Blondia
Title: Vice President, Finance and Treasurer




72    



BANK OF AMERICA, N.A., as Administrative Agent
By: /s/ MOLLIE S. CANUP    
Name: Mollie S. Canup    
Title: Vice President    

STRYKER CORPORATION
364-DAY CREDIT AGREEMENT
Signature Page



BANK OF AMERICA, N.A., as a Lender
By: /s/ YINGHUA ZHANG    
Name: Yinghua Zhang    
Title: Director    

STRYKER CORPORATION
364-DAY CREDIT AGREEMENT
Signature Page



WELLS FARGO BANK, NATIONAL ASSOCIATION, as a Lender
By: /s/ ANDREA S. CHEN    
Name: Andrea S. Chen    
Title: Managing Director    

STRYKER CORPORATION
364-DAY CREDIT AGREEMENT
Signature Page



JPMORGAN CHASE BANK, N.A., as a Lender
By: /s/ HELEN D. DAVIS    
Name: Helen D. Davis    
Title: Authorized Officer    

STRYKER CORPORATION
364-DAY CREDIT AGREEMENT
Signature Page



BNP PARIBAS, as a Lender
By: /s/ BRENDAN HENEGHAN    
Name: Brendan Heneghan    
Title: Director    
By: /s/ CHRISTOPHER SKED    
Name: Christopher Sked    
Title: Managing Director    


STRYKER CORPORATION
364-DAY CREDIT AGREEMENT
Signature Page



CITIBANK, N.A., as a Lender
By: /s/ PRANJAL GAMBHIR    
Name: Pranjal Gambhir    
Title: Vice President    


STRYKER CORPORATION
364-DAY CREDIT AGREEMENT
Signature Page



GOLDMAN SACHS BANK USA, as a Lender
By: /s/ ANNIE CARR    
Name: Annie Carr    
Title: Authorized Signatory    


STRYKER CORPORATION
364-DAY CREDIT AGREEMENT
Signature Page
 EX-31.1 4 ex31i-331202010q.htm EXHIBIT 31.1 Exhibit


Exhibit 31(i)

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER
PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002

I, Kevin A. Lobo, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 of Stryker Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:
May 1, 2020
/s/ KEVIN A. LOBO
 
 
Kevin A. Lobo
 
 
Chairman and Chief Executive Officer


 EX-31.2 5 ex31ii-331202010q.htm EXHIBIT 31.2 Exhibit


Exhibit 31(ii)

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT OF 2002

I, Glenn S. Boehnlein, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 of Stryker Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting.

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.


Date:
May 1, 2020
/s/ GLENN S. BOEHNLEIN
 
 
Glenn S. Boehnlein
 
 
Vice President, Chief Financial Officer


 EX-32.1 6 ex32i-331202010q.htm EXHIBIT 32.1 Exhibit


Exhibit 32(i)
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Stryker Corporation (the "Company") for the quarter ended March 31, 2020 (the "Report"), I, Kevin A. Lobo, Chairman and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 

(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:
May 1, 2020
/s/ KEVIN A. LOBO
 
 
Kevin A. Lobo
 
 
Chairman and Chief Executive Officer







 EX-32.2 7 ex32ii-331202010q.htm EXHIBIT 32.2 Exhibit


Exhibit 32(ii)
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Stryker Corporation (the "Company") for the quarter ended March 31, 2020 (the "Report"), I, Glenn S. Boehnlein, Vice President, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 

(1)
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date:
May 1, 2020
/s/ GLENN S. BOEHNLEIN
 
 
Glenn S. Boehnlein
 
 
Vice President, Chief Financial Officer




 EX-101.SCH 8 syk-20200331.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 2106100 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) link:presentationLink link:calculationLink link:definitionLink 2406402 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Details) link:presentationLink link:calculationLink link:definitionLink 2306301 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables) link:presentationLink link:calculationLink link:definitionLink 2112100 - Disclosure - Acquisitions link:presentationLink link:calculationLink link:definitionLink 2412403 - Disclosure - Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets (Details) link:presentationLink link:calculationLink link:definitionLink 2412404 - Disclosure - Acquisitions (Future Amortization Expense) (Details) link:presentationLink link:calculationLink link:definitionLink 2412402 - Disclosure - Acquisitions (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2312301 - Disclosure - Acquisitions (Tables) link:presentationLink link:calculationLink link:definitionLink 2101100 - Disclosure - Basis Of Presentation link:presentationLink link:calculationLink link:definitionLink 2201201 - Disclosure - Basis Of Presentation (Policies) link:presentationLink link:calculationLink link:definitionLink 1003000 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 1003501 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 1005000 - Statement - Consolidated Statements Of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1002000 - Statement - Consolidated Statements of Comprehensive Income (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1001000 - Statement - Consolidated Statements Of Earnings (Unaudited) link:presentationLink link:calculationLink link:definitionLink 1004000 - Statement - Consolidated Statements Of Shareholders' Equity (Unaudited) link:presentationLink link:calculationLink link:definitionLink 2111100 - Disclosure - Contingencies and Commitments link:presentationLink link:calculationLink link:definitionLink 2411403 - Disclosure - Contingencies and Commitments - Leases (Details) link:presentationLink link:calculationLink link:definitionLink 2411402 - Disclosure - Contingencies and Commitments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2311301 - Disclosure - Contingencies and Commitments (Tables) link:presentationLink link:calculationLink link:definitionLink 2114100 - Disclosure - Debt and Credit Facilities link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Debt and Credit Facilities (Details) link:presentationLink link:calculationLink link:definitionLink 2414402 - Disclosure - Debt and Credit Facilities (Details) link:presentationLink link:calculationLink link:definitionLink 2314301 - Disclosure - Debt and Credit Facilities (Tables) link:presentationLink link:calculationLink link:definitionLink 2107100 - Disclosure - Derivative Instruments link:presentationLink link:calculationLink link:definitionLink 2407402 - Disclosure - Derivative Instruments (Forward Currency Exchange Contracts) (Details) link:presentationLink link:calculationLink link:definitionLink 2407404 - Disclosure - Derivative Instruments (Income Statement Location) (Details) link:presentationLink link:calculationLink link:definitionLink 2407403 - Disclosure - Derivative Instruments (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2307301 - Disclosure - Derivative Instruments (Tables) link:presentationLink link:calculationLink link:definitionLink 0001000 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 2108100 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 2408403 - Disclosure - Fair Value Measurements (Assets and Liabilities Measured At Fair Value On A Recurring Basis Using Unobservable Inputs (Level 3)) (Details) link:presentationLink link:calculationLink link:definitionLink 2408404 - Disclosure - Fair Value Measurements (Narrative) (Details) link:presentationLink link:calculationLink link:definitionLink 2308301 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 2408402 - Disclosure - Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details) link:presentationLink link:calculationLink link:definitionLink 2117100 - Disclosure - Income Taxes link:presentationLink link:calculationLink link:definitionLink 2417401 - Disclosure - Income Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 2104100 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 2404403 - Disclosure - Revenue Recognition - Disaggregated Sales Analysis (Details) link:presentationLink link:calculationLink link:definitionLink 2404402 - Disclosure - Revenue Recognition - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 2304301 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 2118100 - Disclosure - Segment Information link:presentationLink link:calculationLink link:definitionLink 2418402 - Disclosure - Segment Information (Sales And Other Financial Information By Business Segment) (Details) link:presentationLink link:calculationLink link:definitionLink 2318301 - Disclosure - Segment Information (Tables) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 9 syk-20200331_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 10 syk-20200331_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 11 syk-20200331_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Fair Value Disclosures [Abstract] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Investments Classified by Contractual Maturity Date Investments Classified by Contractual Maturity Date [Table Text Block] Derivative Instruments and Hedging Activities Disclosure [Abstract] Schedule of Derivative Instruments in Statement of Financial Position, Fair Value Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block] Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block] Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract] Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Income Statement [Abstract] Net sales Revenues Cost of sales Cost of Revenue Gross profit Gross Profit Research, development and engineering expenses Research and Development Expense Selling, general and administrative expenses Selling, General and Administrative Expense Recall charges Product Liability Accrual, Period Expense Amortization of intangible assets Amortization of Intangible Assets Total operating expenses Operating Expenses Operating income Operating Income (Loss) Other income (expense), net Nonoperating Income (Expense) Earnings before income taxes Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest Income taxes Income Tax Expense (Benefit) Net earnings Net Income (Loss) Attributable to Parent Net earnings per share of common stock: Earnings Per Share [Abstract] Basic Earnings Per Share, Basic Diluted Earnings Per Share, Diluted Weighted-average shares outstanding (in millions): Weighted Average Number of Shares Outstanding, Diluted [Abstract] Basic Weighted Average Number of Shares Outstanding, Basic Effect of dilutive employee stock compensation Weighted Average Number Diluted Shares Outstanding Adjustment Diluted Weighted Average Number of Shares Outstanding, Diluted Cash dividends declared per share of common stock (in dollars per share) Common Stock, Dividends, Per Share, Declared Long-term Debt, Unclassified [Abstract] Debt And Credit Facilities Debt Disclosure [Text Block] Organization, Consolidation and Presentation of Financial Statements [Abstract] Basis of Presentation Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Measurements, Recurring and Nonrecurring [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Fair Value, Inputs, Level 2 Fair Value, Inputs, Level 2 [Member] Derivative Instrument [Axis] Derivative Instrument [Axis] Derivative Contract [Domain] Derivative Contract [Domain] Interest Rate Swap Interest Rate Swap [Member] Foreign Exchange Contract Foreign Exchange Contract [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Foreign currency exchange forward contracts Foreign Currency Contracts, Liability, Fair Value Disclosure Due in one year or less Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value Due after one year through three years Available for sale Securities, Debt Maturities, After One Through Three Years, Fair Value This item represents the fair value of debt securities which are expected to mature after one through three years of the balance sheet date and which are categorized neither as held-to-maturity nor trading securities. Revenue Recognition [Abstract] Schedule of Disaggregated Revenue Disaggregation of Revenue [Table Text Block] Schedule of Long-term Debt Instruments Schedule of Debt [Table Text Block] Income Tax [Abstract] Income Tax [Abstract] Effective income tax rate reconciliation, percent Effective Income Tax Rate Reconciliation, Percent Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Segments [Axis] Segments [Axis] Segments [Domain] Segments [Domain] Orthopaedics Orthopaedics [Member] Orthopaedics [Member] MedSurg MedSurg [Member] MedSurg Equipment [Member] Neurotechnology and Spine Neurotechnology And Spine [Member] Neurotechnology And Spine [Member] Product and Service [Axis] Product and Service [Axis] Product and Service [Domain] Product and Service [Domain] Knees Knees [Member] Knees [Member] Hips Hips [Member] Hips [Member] Trauma and Extremities Trauma and Extremities [Member] Trauma and Extremities [Member] Other Other Orthopaedics [Domain] Other Orthopaedics [Domain] Instruments Instruments [Member] Instruments [Member] Endoscopy Endoscopy [Member] Endoscopy [Member] Medical Medical [Member] Medical [Member] Sustainability Sustainability [Member] Sustainability [Member] Neurotechnology Neurotechnology [Member] Neurotechnology [Member] Spine Spine [Member] Spine [Member] Geographical [Axis] Geographical [Axis] Geographical [Domain] Geographical [Domain] United States UNITED STATES International Non-US [Member] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Document and Entity Information [Abstract] Document and Entity Information [Abstract] Document Information [Table] Document Information [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Common Stock Common Stock [Member] Senior Unsecured Notes 1.125% due 2021 Senior Unsecured Notes, 1.125% Due 2021 [Member] Senior Unsecured Notes, 1.125% Due 2021 [Member] Senior Unsecured Notes 2.125% due 2027 Senior Unsecured Notes, 2.125% Due 2027 [Member] Senior Unsecured Notes, 2.125% Due 2027 [Member] Senior Unsecured Notes 2.625% due 2030 Senior Unsecured Notes, 2.625% Due 2030 [Member] Senior Unsecured Notes, 2.625% Due 2030 Senior Unsecured Notes Variable due 2020 Senior Unsecured Notes, Variable Interest Rate, Due November 2020 [Member] Senior Unsecured Notes, Variable Interest Rate, Due November 2020 [Member] Document Information [Line Items] Document Information [Line Items] Document Type Document Type Document Quarterly Report Document Quarterly Report Document Period End Date Document Period End Date Document Transition Report Document Transition Report Entity File Number Entity File Number Entity Registrant Name Entity Registrant Name Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, State or Province Entity Address, State or Province Entity Address, Postal Zip Code Entity Address, Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Title of each class Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Shell Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Amendment Flag Amendment Flag Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Entity Central Index Key Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Segment Reporting [Abstract] Sales and Other Financial Information by Business Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Business Combinations [Abstract] Schedule of Business Acquisitions, by Acquisition Schedule of Business Acquisitions, by Acquisition [Table Text Block] Schedule of Finite-Lived Intangible Assets, Future Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Income Taxes Income Tax Disclosure [Text Block] Fair Value Measurements Fair Value Disclosures [Text Block] Fair Value, Measurements, Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 3 Fair Value, Inputs, Level 3 [Member] Schedule of Gain (Loss) on Investments, Including Marketable Securities and Investments Held at Cost, Reported Amounts, by Category [Axis] Debt Security Category [Axis] Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain] Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain] Available-for-sale marketable securities: Available-for-sale Securities [Member] Investment Type [Axis] Investment Type [Axis] Investments [Domain] Investments [Domain] Corporate and asset-backed debt securities Asset-backed Securities [Member] United States agency debt securities US Government Agencies Debt Securities [Member] United States Treasury debt securities US Treasury Securities [Member] Certificates of deposit Certificates of Deposit [Member] Foreign currency exchange forward contracts Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Trading marketable securities Debt Securities, Trading Assets Assets [Abstract] Available-for-sale securities, current Available-for-sale Securities, Current Derivative asset Derivative Asset Investments Fair Value Disclosure Assets, Fair Value Disclosure Deferred compensation arrangements Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Plan Liabilities Fair Value, Liabilities Measured on Recurring Basis, Deferred Compensation Plan Liabilities Liabilities Liabilities [Abstract] Contingent consideration: Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract] Beginning Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Additions Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances Change in estimate Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) Settlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Ending Total liabilities measured at fair value Financial and Nonfinancial Liabilities, Fair Value Disclosure Derivative [Table] Derivative [Table] Hedging Relationship [Axis] Hedging Relationship [Axis] Hedging Relationship [Domain] Hedging Relationship [Domain] Cash Flow Hedging [Member] Cash Flow Hedging [Member] Net Investment Hedging [Member] Net Investment Hedging [Member] Hedging Designation [Axis] Hedging Designation [Axis] Hedging Designation [Domain] Hedging Designation [Domain] Net Investment Designated as Hedging Instrument [Member] Non-Designated Not Designated as Hedging Instrument [Member] Balance Sheet Location [Axis] Balance Sheet Location [Axis] Balance Sheet Location [Domain] Balance Sheet Location [Domain] Other current assets Other Current Assets [Member] Other noncurrent assets Other Noncurrent Assets [Member] Other current liabilities Other Current Liabilities [Member] Other noncurrent liabilities Other Noncurrent Liabilities [Member] Derivative [Line Items] Derivative [Line Items] Notional Amount Derivative, Notional Amount1 Derivative, Notional Amount Maximum term in days Maximum Remaining Maturity of Foreign Currency Derivatives Derivative assets Derivative Asset, Fair Value, Gross Asset Derivative liabilities Derivative Liability, Fair Value, Gross Liability Derivative, Fair Value, Net Derivative, Fair Value, Net Statement of Financial Position [Abstract] Current assets Assets, Current [Abstract] Cash and cash equivalents Marketable securities Accounts receivable, less allowance of $100 ($88 in 2019) Accounts Receivable, Net, Current Inventories: Inventory, Net [Abstract] Materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves Work in process Inventory, Work in Process, Net of Reserves Finished goods Inventory, Finished Goods, Net of Reserves Total inventories Inventory, Net Prepaid expenses and other current assets Prepaid Expense, Current Total current assets Assets, Current Property, plant and equipment: Property, Plant and Equipment [Abstract] Land, buildings and improvements Land, Buildings and Improvements, Gross Land, Buildings and Improvements, Gross Machinery and equipment Machinery and Equipment, Gross Total property, plant and equipment Property, Plant and Equipment, Gross Less accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Property, plant and equipment, net Property, Plant and Equipment, Net Goodwill Goodwill Other intangibles, net Intangible Assets, Net (Excluding Goodwill) Noncurrent deferred income tax assets Deferred Income Tax Assets, Net Other noncurrent assets Other Assets, Noncurrent Total assets Assets Liabilities and shareholders' equity Liabilities and Equity [Abstract] Current liabilities Liabilities, Current [Abstract] Accounts payable Accounts Payable, Trade, Current Accrued compensation Employee-related Liabilities, Current Income taxes Accrued Income Taxes, Current Dividends payable Dividends Payable, Current Accrued expenses and other liabilities Other Liabilities, Current Current maturities of debt Debt, Current Total current liabilities Liabilities, Current Long-term debt, excluding current maturities Long-term Debt, Excluding Current Maturities Income taxes Accrued Income Taxes, Noncurrent Other noncurrent liabilities Other Liabilities, Noncurrent Total liabilities Liabilities Shareholders' equity Stockholders' Equity Attributable to Parent [Abstract] Common stock, $0.10 par value Common Stock, Value, Outstanding Additional paid-in capital Additional Paid in Capital, Common Stock Retained earnings Retained Earnings (Accumulated Deficit) Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Total shareholders' equity Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Total liabilities and shareholders' equity Liabilities and Equity Statement of Cash Flows [Abstract] Operating activities Net Cash Provided by (Used in) Operating Activities [Abstract] Net earnings Adjustments to reconcile net earnings to net cash provided by operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Depreciation Depreciation Amortization of intangible assets Amortization Share-based compensation Share-based Compensation Sale of inventory stepped-up to fair value at acquisition Sale of Inventory, Stepped-Up to Fair Value at Acquisition Sale of Inventory, Stepped-Up to Fair Value at Acquisition Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] Accounts receivable Increase (Decrease) in Accounts Receivable Inventories Increase (Decrease) in Inventories Accounts payable Increase (Decrease) in Accounts Payable, Trade Accrued expenses and other liabilities Increase (Decrease) in Accrued Liabilities Recall-related payments Change in accrual for recall expenses Change in accrual for recall expenses Income taxes Increase (Decrease) in Income Taxes Payable Other, net Increase (Decrease) in Other Operating Assets and Liabilities, Net Net cash provided by operating activities Net Cash Provided by (Used in) Operating Activities Investing activities Net Cash Provided by (Used in) Investing Activities [Abstract] Acquisitions, net of cash acquired Payments to Acquire Businesses, Net of Cash Acquired Purchases of marketable securities Payments to Acquire Marketable Securities Proceeds from sales of marketable securities Proceeds from Sale and Maturity of Marketable Securities Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities Financing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Proceeds (payments) on short-term borrowings, net Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less Payments on long-term debt Repayments of Long-term Debt Dividends paid Payments of Dividends Repurchases of common stock Payments for Repurchase of Common Stock Cash paid for taxes from withheld shares Excess Tax Benefit from Share-based Compensation, Financing Activities Other financing, net Proceeds from (Payments for) Other Financing Activities Net cash provided by (used in) financing activities Net Cash Provided by (Used in) Financing Activities Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Change in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash and cash equivalents at beginning of period Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash and cash equivalents at end of period Contract liabilities Contract with Customer, Liability Segment Information Segment Reporting Disclosure [Text Block] Remainder of 2020 Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year 2021 Finite-Lived Intangible Assets, Amortization Expense, Year Two 2022 Finite-Lived Intangible Assets, Amortization Expense, Year Three 2023 Finite-Lived Intangible Assets, Amortization Expense, Year Four 2024 Finite-Lived Intangible Assets, Amortization Expense, Year Five Commitments and Contingencies Disclosure [Abstract] Loss Contingencies [Table] Loss Contingencies [Table] Range [Axis] Range [Axis] Range [Domain] Range [Domain] Minimum Minimum [Member] Maximum Maximum [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Estimate of possible loss Loss Contingency, Estimate of Possible Loss Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Marketable Securities Accumulated Net Investment Gain (Loss) Attributable to Parent [Member] Pension Plans Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Hedges Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member] Financial Statement Translation Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] AOCI Attributable to Parent, Net of Tax [Roll Forward] AOCI Attributable to Parent, Net of Tax [Roll Forward] Accumulated Other Comprehensive Income (Loss), Net of Tax at beginning of period OCI Other Comprehensive Income (Loss), before Reclassifications, Net of Tax Income taxes Other Comprehensive Income (Loss) before Reclassifications, Tax Cost of sales Other (income) expense Income taxes Net OCI Other Comprehensive Income (Loss), Net of Tax Accumulated Other Comprehensive Income (Loss), Net of Tax at end of period Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table] Derivative Instruments, Gain (Loss) [Table] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Cost of sales Cost of Sales [Member] Other income (expense), net Other Nonoperating Income (Expense) [Member] Derivative Instruments, Gain (Loss) [Line Items] Derivative Instruments, Gain (Loss) [Line Items] Net currency exchange rate gains (losses) Foreign Currency Transaction Gain (Loss), before Tax Derivative Instruments Derivative Instruments and Hedging Activities Disclosure [Text Block] Gain on sale of marketable securities Marketable Securities, Gain (Loss) Allowance for doubtful accounts receivable Allowance for Doubtful Accounts Receivable, Current Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Right-of-use assets Operating Lease, Right-of-Use Asset Lease liabilities, current Operating Lease, Liability, Current Lease liabilities, non-current Operating Lease, Liability, Noncurrent Other information Lease, Cost [Abstract] Weighted-average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Weighted-average discount rate Operating Lease, Weighted Average Discount Rate, Percent Operating lease cost Operating Lease, Cost Accrued Expenses Accrued Liabilities [Member] Designated as Hedging Instrument Statement [Line Items] Statement [Line Items] Notional amount Derivative, fair value Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value Cash flow hedge gain (loss) to be reclassified within twelve months Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months Other Income Net Investment Hedge Gain (Loss) to be Reclassified within Twelve Months Net Investment Hedge Gain (Loss) to be Reclassified within Twelve Months Notional amount terminated Derivative Notional Amount Terminated Derivative Notional Amount Terminated Pretax losses recorded in AOCI Derivative Assets (Liabilities), at Fair Value, Net Statement of Stockholders' Equity [Abstract] Statement [Table] Statement [Table] Total Stryker shareholders' equity Parent [Member] Additional Paid-In Capital Additional Paid-in Capital [Member] Retained Earnings Retained Earnings [Member] Accumulated Other Comprehensive Income (Loss) AOCI Attributable to Parent [Member] Non-controlling interest Noncontrolling Interest [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Beginning balance Beginning balance (in shares) Common Stock, Shares, Outstanding Issuance of common stock under stock compensation and benefit plans Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Issuance of common stock under stock option and benefit plans (in shares) Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures Repurchase of common stock Stock Repurchased and Retired During Period, Value Repurchase of common stock (in shares) Stock Repurchased and Retired During Period, Shares Share-based compensation Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition Net earnings (loss) Cash dividends declared Dividends, Cash Other comprehensive income (loss) Ending balance Ending balance (in shares) Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Operating Segments Operating Segments [Member] Corporate and other Corporate, Non-Segment [Member] Segment Reconciling Items Segment Reconciling Items [Member] Business Segments [Axis] Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Segment operating income Acquisition and integration-related charges Business Combination, Integration Related Costs Amortization of intangible assets Restructuring-related charges Restructuring Charges Medical device regulations European Medical Devices Regulation European Medical Devices Regulation Recall-related matters Regulatory and legal matters Regulatory and Legal Regulatory and Legal Matters Schedule of Business Acquisitions, by Acquisition [Table] Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Mobius Mobius [Member] Mobius [Member] OrthoSpace, Ltd. OrthoSpace, Ltd. [Member] OrthoSpace, Ltd. [Member] Wright Wright [Member] Wright [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Aggregate purchase price of acquisitions Business Combination, Consideration Transferred Future milestone payments Business Combination, Contingent Consideration, Future Milestone Payments Business Combination, Contingent Consideration, Future Milestone Payments Consideration transferred (in dollars per share) Business Combination, Consideration Transferred, Price Per Share Business Combination, Consideration Transferred, Price Per Share Acquisitions, net of cash acquired Par value of ordinary shares of acquiree (in dollars per share) Business Combination, Par Value of Ordinary Shares of Acquiree Business Combination, Par Value of Ordinary Shares of Acquiree Revenue Recognition Revenue from Contract with Customer [Text Block] Lease, Cost Lease, Cost [Table Text Block] Accumulated Other Comprehensive (Loss) Income (AOCI) Comprehensive Income (Loss) Note [Text Block] Statement of Comprehensive Income [Abstract] Other comprehensive income (loss), net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Marketable securities Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax Pension plans Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax Unrealized gains (losses) on designated hedges Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax Financial statement translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Total other comprehensive income (loss), net of tax Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Line of Credit Facility [Table] Line of Credit Facility [Table] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Revolving Credit Facility Revolving Credit Facility [Member] Subsequent Event Type [Axis] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Subsequent Event Subsequent Event [Member] Debt Instrument [Axis] Debt Instrument [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Commercial Paper Commercial Paper [Member] Senior Unsecured Notes 4.375% due 2020 Senior Unsecured Notes 4.375% Due 2020 [Member] Senior Unsecured Notes Four Point Three Seven Five Percent Due Two Thousand Twenty [Member] Senior Unsecured Notes 2.625% due 2021 Senior Unsecured Notes 2.625% due 2021 [Member] [Domain] Senior Unsecured Notes 2.625% due 2021 [Member] [Domain] Senior Unsecured Notes 3.375% due 2024 Senior Unsecured Notes 3.375% due 2024 [Member] Senior Unsecured Notes 3.375% due 2024 [Member] Senior Unsecured Notes 0.250% due 2024 Senior Unsecured Notes 0.250% due 2024 [Member] Senior Unsecured Notes 0.250% due 2024 [Member] Senior Unsecured Notes 3.375% due 2025 Senior Unsecured Notes 3.375% due 2025 [Member] [Member] Senior Unsecured Notes 3.375% due 2025 [Member] Senior Unsecured Notes 3.50% due 2026 Senior Unsecured Notes 3.50% due 2026 [Member] [Domain] Senior Unsecured Notes 3.50% due 2026 [Member] [Domain] Senior Unsecured Notes 3.650% due 2028 Senior Unsecured Notes 3.650% due 2028 [Domain] Senior Unsecured Notes 3.650% due 2028 [Domain] Senior Unsecured Notes 0.750% due 2029 Senior Unsecured Notes 0.750% due 2029 [Member] Senior Unsecured Notes 0.750% due 2029 [Member] Senior Unsecured Notes 1.000% due 2031 Senior Unsecured Notes 1.000% due 2031 [Member] Senior Unsecured Notes 1.000% due 2031 [Member] Senior Unsecured Notes 4.100% due 2043 Senior Unsecured Notes 4.10% due 2043 [Member] Senior Unsecured Notes 4.10% due 2043 [Member] Senior Unsecured Notes 4.375% due 2044 Senior Unsecured Notes 4.375% due 2044 [Member] Senior Unsecured Notes 4.375% due 2044 [Member] Senior Unsecured Notes 4.625% due 2046 Senior Unsecured Notes 4.625% due 2046 [Member] [Domain] [Domain] Senior Unsecured Notes 4.625% due 2046 [Member] [Domain] [Domain] Credit Agreement Credit Agreement [Member] Credit Agreement [Member] Commercial paper Short-term Debt Debt instrument, maturity Debt Instrument, Term Amounts outstanding under commercial paper program Commercial Paper Stated interest rate Debt Instrument, Interest Rate, Stated Percentage Maturity Date Debt Instrument, Maturity Date Unsecured Debt Unsecured Debt Other Long-term Debt Other Long-term Debt Total debt Debt, Long-term and Short-term, Combined Amount Less current maturities of debt Total long-term debt Unamortized debt issuance costs Unamortized Debt Issuance Expense Available secured borrowing capacity Line of Credit Facility, Remaining Borrowing Capacity Fair value of senior unsecured notes Debt Instrument, Fair Value Disclosure Debt instrument, repurchased face amount Debt Instrument, Repurchased Face Amount Leverage ratio Debt Instrument, Covenant, Leverage Ratio Debt Instrument, Covenant, Leverage Ratio Line of credit facility, maximum borrowing capacity Line of Credit Facility, Maximum Borrowing Capacity Acquisitions Business Combination Disclosure [Text Block] New Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Accounting Pronouncements Recently Adopted Accounting Pronouncements Recently Adopted [Policy Text Block] Accounting Pronouncements Recently Adopted [Policy Text Block] Contingencies and Commitments Commitments and Contingencies Disclosure [Text Block] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Customer relationship Customer Relationships [Member] Developed technology and patents Developed Technology Rights [Member] In-process research and development Internally Developed Software [Member] Internally Developed Software [Member] Non-compete agreements Noncompete Agreements [Member] Accounts receivable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Inventory Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory Other assets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets Contingent consideration Business Combination, Contingent Consideration, Liability Other liabilities Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities Intangible assets acquired Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles Assets and liabilities acquired, net Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Weighted-average life of intangible assets Acquired Finite-lived Intangible Assets, Weighted Average Useful Life EX-101.PRE 12 syk-20200331_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 13 exhibit10ii.jpg begin 644 exhibit10ii.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_X1#R17AI9@ 34T *@ @ ! $[ ( M - (2H=I 0 ! (6)R= $ : 0T.H< < @, /@ M &UL;G,Z9&,](FAT=' Z M+R]P=7)L+F]R9R]D8R]E;&5M96YT#IX;7!M971A/@T*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" * M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" \/WAP86-K970@ M96YD/2=W)S\^_]L 0P '!04&!00'!@4&" <'" H1"PH)"0H5#Q ,$1@5&AD8 M%1@7&QXG(1L=)1T7&"(N(B4H*2LL*QH@+S,O*C(G*BLJ_]L 0P$'" @*"0H4 M"PL4*AP8'"HJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ*BHJ M*BHJ*BHJ*BHJ*BHJ_\ $0@ )0!\ P$B (1 0,1 ?_$ !\ $% 0$! 0$! M ! @,$!08'" D*"__$ +40 (! P,"! ,%!00$ !?0$" P $ M$042(3%!!A-180'EZ@X2%AH>( MB8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R;GZ.GJ\?+S]/7V]_CY^O_$ !\! ,! 0$! 0$! 0$ ! M @,$!08'" D*"__$ +41 (! @0$ P0'!00$ $"=P ! @,1! 4A,08205$' M87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)BH*#A(6&AXB)BI*3E)66 MEYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+CY.7F MY^CIZO+S]/7V]_CY^O_: P# 0 "$0,1 #\ ^D:**1@64@,5)& 1U% "T5YO MX0U+6-9T?Q-=:QXJOK==,UJ]LHY8[>U'EQ1-A2083DX_.NI/BBPTF[L]&UV\ M8:L]FT[$6LGER^6@,K*X3:<=< YYZ4 ;]%<1K_C"2S\0^#I;2[:'2-7FG6X2 M:U9'=5MW=.' =26"\8!/ [UIWOBO2;KP[%J-CKJ6=O)=I +@P%CO$H5HBC#* ML3E.0"": .DHKA5\/:@#;HKG_!GBN'QAH1 MU*"VGMU^T31!)HF7A)GC!R1@DA,D G!.#5?7-6U*Q\?>%]/MYXUL-1:Y6XB\ MK+L4A++\Q/ SZ =.M '445R$FNW^L^.-9T#2;K[&-%LH9I)!&KF6:;>44[@< M(%0$XP3NZC',&@^/E\4:/X9.GJL-]KMJUTZ_>%M''@2L/4[R$&>YR;7;1;[Q!&=>4?V?!&TT9M_P#CPW*^')Q\^=I..VWWJO/XD&EZ3H>KR7RW MVEW_ -G@DN3%Y9)FP(Y@,+-"U?QEID%O M MSDT^>>74H_M,#" O;/&,$2?,-S#ISCK6/>>'/$4_A+6K*/0;CS[GQ4NHPQFX M@^: 7,F"[@UNVMTA/G(%C9(V0K*" M<@9;JH;C-4=*\):CH'BCP9#;VTMWI^BZ+/83WV^-1O;R=IVEMV/W;= <<5Z% M10!RGPZT?4O#_A=M*U6V6)X+RZ=)%E#"59+B20, .@PXZ\YSQZIXCL-2N?'W MA2]L]-FN+.PDN6NIUDC41B2$HO#,&//H#7644 01R* .%ETC6?^$D\>7*Z M/.T&J:?;P6+B:']^Z1RJPP7RO+CEL=ZH:]HM_<_!GPWX8N+9K;5)6TVT:$NK M&-HGC>0Y4D8"Q.<@]!7IPX%1?9H3=BY,8,P38'/)5@H EHHH DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9 end GRAPHIC 14 strykerlogoa74.jpg begin 644 strykerlogoa74.jpg M_]C_X 02D9)1@ ! 0$ 2 !( #_[@ .061O8F4 9 !_^$-M$5X:68 M $U- "H ( 0 P " M% 020! " % 1B2D0 " S P "2D@ " S P "@ 0 # M ?__ "@ @ $ 0 N2@ P $ 0 ,@ ,C Q-3HP-SHQ M-B Q,CHP,3HP, R,#$U.C W.C$V(#$R.C Q.C P 8! P # 0 & M !&@ % 0 7P!&P % 0 80!* # 0 " " 0 $ M 0 8P" @ $ 0 #" 2 $ !( ?_8_^T #$%D M;V)E7T-- +_[@ .061O8F4 9( !_]L A ," @("0@,"0D,$0L*"Q$5 M#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P, M# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P, M# P,# P,# P,# P,# P,# P,# P,# S_P 1" K * # 2( A$! Q$!_]T M! *_\0!/P 04! 0$! 0$ P ! @0%!@<("0H+ 0 !!0$! 0$! M 0 ! (#! 4&!P@)"@L0 $$ 0,"! (%!P8(!0,,,P$ A$#!"$2 M,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;& MUN;V-T=79W>'EZ>WQ]?G]Q$ @(! @0$ P0%!@<'!@4U 0 "$0,A,1($05%A M<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&EJ:VQM;F]B7I[?'_]H # ,! (1 Q$ /P#U5)5NI9^/TWI^1U#))%&+6ZVR(DA@ MW;6;BWWN^BQ>+9G^-7Z[=1S7'ICQB5:FO%HI9<0T'3U'WU7/L>UOTWL]*O\ MX*M)3[DDO"?^?W^,[_N1?_[!T_\ O*E_S^_QG?\ 5)3O?63Z\ M?6C!^O[^CXN;Z> ,G&K%/I5'VV-H=8WU'U.M]WJ/_P (O6%\S9_5.LY76CU+ M.ZMK';V!C:?T#6,9]%E?^#79=!^NW^,3(Z[T[&S;[CBW9=%60UV M+4P>F^QC+6N>W'8YGL=^\DI]G27B/UB_QB_73"^L74L'$Z@6T49=U5%?H4.( M:VQS*V;G4.>[V_O*DW_&A]?:+&/NS=[09].S'I#71RT[*:[/\QZ2GWM)>4]; M_P 8?U@S/JC@_6#H]XP+JLAV%U.AM;+6FPL;=3=5]HKN=71M9_GW>C^F]+U% MU/\ BT^LV9]8OJ^Z[J-@MSL:]]-KX:TN:0VZJPUU-8QGML]'Z'^!24]:O//\ M:OUKZ_\ 5Z[IK>D97V9N0VXVCTZ[-Q8:MG\_7;M^F[Z*H?XS/K[UWH_7V=-Z M+EC'930UV2!778?4>7/#7>O7;MVT>D_V_P"D6-_C//43TKZLOZI:Z[/LQK;, ME[FM80^ST+34:Z6LK;Z._P!'Z/YB2GU;ZK9N3G_5SIN;EO\ 5RKZG^ ME_2^DDI]=27GOU[_ ,:+>AY3ND]&K9DY]8C)OLDUU./%36M+?7OV_P Y[_3I M_P"%L]6NGBA]?/\ &:[&/46WWG#$SD#$J]$:_P"E^S>DDI]W27GGU$_QI-ZU MDLZ3UMM>/G60,;(9+:[7?Z%[7%WHY#O\'_@K_P";_16>E7=2_P :'US^LO0> MOX^'TG,^S8]F(RUS/2J?+S9?6YVZ^JU_T*F)*?4$EX$?\9G^,%K=YZ@X-T.X MXU$:\?\ :=>B?XN/K_?]9O6Z?U%C&=0QJQ:+*P0VVL$5O>YGN;78RQU>_P#, M?ZOZ.M)3_]#OOK;TN_J_U;ZCT['UOOI<*6R!N>W])77N<6M;ZCV;/U_\[4O7_K-_C#Z)]6>H,Z?U"G)? M<^IMP=2QCF[7.?6!-EU3MWZ+]UK=BX[WP.&[W MW.=M24YO_CX=3_\ *NC_ +GC_0^A6DIV_KB3_XZKS.HR\.#\&8R M]T7@_P#C#?;T[_&+D9ME1O0>G_XW/JUU#/Q ML"C'S&W9EU=%9?76&AUCFU,+RW(=[-SO+Z3/6?\ Y51_Z?&_ M^W07OR2GS;IG^+OJG3OJ7UWI&<^F^_, OQ1C.QW[U=5.QW_'JQ_C MR_I'1_ZF1^6A)3YYU/K.?U-F)5E/FG H9C8M31#&,8 W=M_TMSF[[K/S_P#B MV55L]P_Q>7]&K^I6/?TFO:RMCG9;)!L.2T?K/K.;^>_:WTMW_:;[.L7HWU!Z M;U#_ !;LQ:&@9_4:V9KH[_P B MN:ZOT[J/U$^M@>VMME=+W68;K6[Z[J'[F;+-S1N=Z3_1O_T=O\W_ (*U=MC_ M .-7ZCOI8[)Z/95<0/48RFBQH/@RUUE+GM_ZU6DI\RZIU2K*ZN_J?3\9O3"Y M[;64T..VNQL$OH,,]/\ 2-]5K/\ !_F+J/\ &WE?;.M],RR-OVCI=%NWPWV9 M#X_Z2](^JO7OJI]:_M8Z=TX5C#]/U?M%%39]7U-FSTW7?Z%^[[W+D?\7W^ M+SK?U8ZW9U#/NQK*;,9](;0^QSMSGU6"1932W;^B_>7;="_Y#Z=_X5I_\]L5 MY)3_ /_1ZSZS_P"+OHGUGZ@SJ&?=DUW,J;2&T/K:W:US[ 8LIM=N_2_O+)_\ M97ZJ_P#9=^DDI\_\ _&5^JO\ W*S_ /MRK_WE6]]7?J#]6_J[ M:,C!H=9F-!#WV[JJF/71))*<7ZQ_5#H7UDK:.IT;K:QM MJR*SLM8"9AKQ[7M_D6LLK6#T_P#Q1?5KI^?C9]&3FNNQ+J[ZP^RHM+JW-M8' MAN.UVSG;4W9MI_=7 MF/UB^L'4?K;U>K*NQJVY;V,QJZL5CIL.YWI^QSKK++GNM]/_ +;8O6_KK_RK M5_XFOYAO_+G])^G;_-?]U/W/^&]=2^I?]/M_\3?T/^\/^>_Z[_P22F_]0/JW M9]7/JY3AY C,N<SU-ZE]:OJ/TGZU/QG]1MR M*CB!XK%#F-!W["[?ZM5W^C71))*:G2NG4=+Z=C=.QW.=3B5MJK=807%K1M&\ MM:QN[^PN:Z[_ (KOJWUSJ=W4\A^3CWY$&UN.ZMK"X#;ZFRRFWWO_ ,(NP224 MYN=]7^E]3Z;7TWJM7[0IK:UOJ7_SIV[-J:3I6RRLM']7U*+'_YSUWJ22GG_ *J?4KI7U4^U?LZV^W[9Z?J?:',= M'I>ILV>E53_IG[E7^M'^+SHOUGZA7U#J%V37;52*&MH)BTXM9)KQZVU,+M26L 8W=Q[O:C)))*?_9_^T5=%!H;W1O M'1E96Y":71B;V]L MP.$))3009 $ M'CA"24T#\P "0 0 X0DE-)Q H 0 ! M.$))30/U !( "]F9@ ! &QF9@ & ! "]F9@ ! *&9F@ & M ! #( ! %H & ! #4 ! "T & !.$))30/X M !P #_____________________________ ^@ ____________ M_________________P/H /____________________________\#Z M #_____________________________ ^@ #A"24T$" $ $ M ) "0 X0DE-!!X 0 .$))300: -= !@ M R N0 4 ', = !R 'D :P!E '( 7P!L &\ 9P!O #( M, Q #4 7P!W &4 8@ $ 0 M "Y ,@ 0 0 M 0 &YU;&P " !F)O=6YD'1)D%L:6=N96YU;0 ]%4VQI8V5(;W)Z06QI9VX '9&5F875L= EV M97)T06QI9VYE;G5M #T53;&EC959E7!E96YU;0 !%%4VQI8V5"1T-O;&]R5'EP90 !.;VYE M "71O<$]U='-E=&QO;F< "FQE9G1/=71S971L;VYG M QB;W1T;VU/=71S971L;VYG MR:6=H=$]U='-E=&QO;F< M #A"24T$* # (_\ #A"24T$$0 0$ .$))3004 M $ SA"24T$# ,/ $ "@ *P > %"@ , M( 8 '_V/_M Q!9&]B95]#30 "_^X #D%D;V)E &2 ?_; (0 # @( M" D(# D)#!$+"@L1%0\,# \5&!,3%1,3&!$,# P,# P1# P,# P,# P,# P, M# P,# P,# P,# P,# P,# $-"PL-#@T0#@X0% X.#A04#@X.#A01# P,# P1 M$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P,_\ $0@ *P"@ M P$B (1 0,1 ?_= 0 "O_$ 3\ $% 0$! 0$! , 0($!08' M" D*"P$ 04! 0$! 0$ 0 " P0%!@<("0H+$ !! $# @0"!0<& M" 4###,! (1 P0A$C$%05%A$R)Q@3(&%)&AL4(C)!52P6(S-'*"T4,')9)3 M\.'Q8W,U%J*R@R9$DU1D1<*C=#87TE7B9?*SA,/3=>/S1B>4I(6TE<34Y/2E MM<75Y?569G:&EJ:VQM;F]C='5V=WAY>GM\?7Y_<1 (" 0($! ,$!08'!P8% M-0$ A$#(3$2!$%187$B$P4R@9$4H;%"(\%2T? S)&+A7U M5F9VAI:FML;6YO8G-T=79W>'EZ>WQ__: P# 0 "$0,1 #\ ]525;J6?C]-Z M?D=0R211BUNMLB)(8-VUFXM][OHL7BV9_C5^NW47NK:QV]@8VG] UC&?197_@UV70?KM_C$R. MN].QLV^XXMV715D-=BU,'IOL8RUKGMQV.9['?O)*?9TEXC]8O\8OUTPOK%U+ M!Q.H%M%&7=517Z%#B&MLT&?3LQZ0UTDI][27E/6_\ &']8,SZHX/U@Z/>,"ZK(=A=3H;6RUIL+&W4W5?:* M[G5T;6?Y]WH_IO2]1=3_ (M/K-F?6+ZONNZC8+<[&O?3:^&M+FD-NJL-=36, M9[;/1^A_@4E/6KSS_&K]:^O_ %>NZ:WI&5]F;D-N-H].NS<6&K9_/UV[?IN^ MBJ'^,SZ^]=Z/U]G3>BY8QV4T-=D@5UV'U'ESPUWKUV[=M'I/]O\ I%C?XSSU M$]*^K+^J6NNS[,:VS)>YK6$/L]"TU&NEK*V^CO\ 1^C^8DI]6^JV;DY_U! M'_&9_C!:W>>H.#=#N.-1&O'_ &G7HG^+CZ_W_6;UNG]18QG4,:L6BRL$-MK! M%;WN9[FUV,L=7O\ S'^K^CK24__0[[ZV]+OZO]6^H].Q];[Z7"EL@;GM_25U M[G%K6^H]FSW+P_ZI_6SJ'U-S\LC$9;9:/1OIO!98QU;C[=W\Y7M?_.U+U_ZS M?XP^B?5GJ#.G]0IR7W/J;<'4L8YNUSGU@39=4[=^B_=7-9O^,K_%QU"WU\_H MUF5= 'JW8N.]\#AN]]SG;4E.;_X^'4__ "KH_P"W'_W+HOJG_C8Z?US.KZ;G MXW[/RKR&8[P_?58\_P""W%M;J;'_ .!;^D]3_2?0WXX^O7^*F?\ Q/\ _LEC M?^E5PMK\?JOUN:[ZOX[L.K*RZ_L5$@%A+F[7>T[*OTGZ78QWIX_T/H5I*=OZ MXD_^.J\SJ,O#@_!F,O=%X/\ XPWV]._QBY&;947-99C9%;3+0]K*Z?HO@_GU M/JWKT'I_^-SZM=0S\; HQ\QMV9=7167UUAH=8YM3"\MR'>S<[W)*?.+/_P J MH_\ 3XW_ -N@O8?KKT&_ZP_5S)Z7B^DW)M-;J7W2&M++&6/=N8RU['>BVROV M,_/7CUG_ .54?^GQO_MT%[\DI\VZ9_B[ZIT[ZE]=Z1G/IOOS +\48SG.FRD> MK4S]+73_ #EM;&+"_P 2O5!C]=3ZSG]39B593YIP*&8V+4T0QC& M-W;?]+F]0_P 6[,6AH&?U&MF:W)?H?M :XX['.]WZ"MMC\?\ MXNZ^W^=L7+?XK_K%;T#ZPV=$ZCNJQL]_V>VNP$>EDM/IU;F0=N]_ZK=_UOU? MYA)3R>!U1E/66]4ZECMZI^D===1D_ MT;_]';_-_P""M7;8_P#C5^H[Z6.R>CV57$#U&,IHL:#X,M=92Y[?^M5I*?,N MJ=4JRNKOZGT_&;TPN>VUE-#CMKL;!+Z##/3_ $C?5:S_ ?YBZC_ !MY7VSK M?3,LC;]HZ71;M\-]F0^/^DO2/JKU[ZJ?6O[6.G=.%8P_3]7[114V?5]39L]- MUW^A?NW+S[_'4 /K3B " ,"L #_CLI)3ZKA8_P!L^JN/BD-?]HP&5%K_ *)W MTAD6?2]GN]RY'_%]_B\ZW]6.MV=0S[L:RFS&?2&T/L<[24_P#_T>L^L_\ B[Z)]9^H,ZAGW9-=S*FTAM#ZVMVM M<^P&+*;7;OTO[RR?_&5^JO\ W*S_ /MRK_WF7?I)*?/_ /QE?JK_ -RL_P#[ MU[?Y%K+*U@]/\ \47U:Z?GXV?1DYKK ML2ZN^L/LJ+2ZMS;6!X;CM=LW-_>7<))*>0=_BQZ [ZP?M_U\O[7]K&=LWU^G MZ@L^T;-OH>IZ6_\ X7^VNO2224^>_P",+_&'UCZK]:IZ?@T8UM5N,V]SKVO+ MMSK+JH'IVU-V;:?W5YC]8OK!U'ZV]7JRKL:MN6]C,:NK%8Z;#N=Z?L0(S+G'(RP"' 6/#6^F'-]OZ*IE5;MGL]3> MI?6KZC])^M3\9_4;*Q0YC0=^PNW^K5=_HUT222FITKIU'2^G8W3L=S MG4XE;:JW6$%Q:T;1O+6L;N_L+FNN_P"*[ZM]GZGVAS'1Z7J;-GI54_Z9^Y5_K1_B\Z+]9^H5]0ZA=DUVU4BAK: M',:W:UUEHMM3"[4EK &-W<>[VHR2 M22G_V3A"24T$(0 70 $! #P!! &0 ;P!B &4 ( !0 &@ ;P!T M &\ &UL;G,Z&UL;G,Z>&UP/2)H='1P.B\O;G,N M861O8F4N8V]M+WAA<"\Q+C O(B!X;6QN&UL;G,Z&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B('AM;&YS.G-T M179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O&UP.DUO9&EF>41A=&4](C(P,34M,#DM,CA4 M,3$Z-3DZ,S&UP34TZ1&5R:79E9$9R;VT@&UP+FEI9#HW,35B9C(P92TY,3=A+30U.6$M.3,P-"UC9F0R964W960Y,S0B M('-T4F5F.F1O8W5M96YT240](GAM<"YD:60Z,D4Y,SA%034R,S S,3%%-4%" M.#1"-D8P,D4R-S$X14,B('-T4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#TB>&UP M+F1I9#HR13DS.$5!-3(S,#,Q,44U04(X-$(V1C R13(W,3A%0R(O/@T*"0D) M/'AM<$U-.DAI&UP+FEI M9#HW,35B9C(P92TY,3=A+30U.6$M.3,P-"UC9F0R964W960Y,S0B('-T179T M.G=H96X](C(P,34M,#DM,CA4,3$Z-3DZ,S&UP+FEI9#IA M-F0X93!C,RTU.3(T+30T.&,M.3(W92TT,C8P9&1A,S$R9#&UP;65T83X-"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" * M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @ M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(#P_>'!A8VME="!E;F0] M)W7J%AH>(B8J4E9:7F)F:I*6FIZBIJK2UMK>XN;K$Q<;'R,G*U-76 MU]C9VN3EYN?HZ>KT]?;W^/GZ_\0 'P$ 8# 0$! !@4$ P<" M" $) H+_\0 M1$ @$# @0$ P4$! 0&!@5M 0(#$00A$@4Q!@ B$T%1!S)A M%'$(0H$CD152H6(6,PFQ),'10W+P%^&"-"624QAC1/&BLB8U&50V160G"G.# MDT9TPM+B\E5E=58WA(6CL\/3X_,I&I2DM,34Y/25I;7%U>7U*$=79CAVAI:F MML;6YO9G=X>7I[?'U^?W2%AH>(B8J+C(V.CX.4E9:7F)F:FYR=GI^2HZ2EIJ M>HJ:JKK*VNKZ_]T ! !=_]H # ,! (1 Q$ /P#?X]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=?_]#?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]UJ2_\*J_YG'SA_EM[1^$^4^%O=O\ H8KNW-Q]\T'8 M4_\ HVZB[$_O!2;+QG4U1MJ+Q=K[!WU#B?X;-N:N.JA6F:;SVE+A(PGNO=:; M_P#T%'?SU_\ O.;_ -EF^'G_ -S[[]U[KW_04=_/7_[SF_\ 99OAY_\ <^^_ M=>ZM._DF_P __P#FX?+G^:/\1OCG\AOEG_I!Z:[/WAO#%;YV=_H'^,^U/XY0 M8KJO?FY*"#^\.R.F=M;JQG@S6%IIM5'74[MX]#$QLZM[KW7TK/?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7R*-X_\*?OYYF*W=NG%T'S M@\%#C=QYR@HH/]EI^($OAI*/)U5/31>6;H"2:3QPQ@:G9F-KDD\^_=>Z3G_0 M4=_/7_[SF_\ 99OAY_\ <^^_=>Z]_P!!1W\]?_O.;_V6;X>?_<^^_=>Z^B9_ MPGO^7'R%^;:VEM6D^PPN-AAU04,;RZ-0LQ]U[JZ[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U__T=_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6AE_PN M/_X\+^6__P"'?\HO_=-T1[]U[KYZGOW7NO>_=>ZN^_X3>_\ ;[7X$?\ B0.P M?_?(=H>_=>Z^QU[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_ M=>Z^!MV#_P ?[O?_ ,.__OW7NMC[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U__TM_CW[KW7O?NO=>] M^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6AE_PN/_X\+^6__P"'?\HO_=-T M1[]U[KYZGOW7NO>_=>ZN^_X3>_\ ;[7X$?\ B0.P?_?(=H>_=>Z^QU[]U[KW MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=> MZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWO MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^!MV#_P ?[O?_ ,._ M_OW7NMC[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U__T]_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O? MNO=>]^Z]U[W[KW6AE_PN/_X\+^6__P"'?\HO_=-T1[]U[KYZGOW7NO>_=>ZN M^_X3>_\ ;[7X$?\ B0.P?_?(=H>_=>Z^QU[]U[KWOW7NO>_=>Z][]U[KWOW7 MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][ M]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NO>_=>Z^!MV#_P ?[O?_ ,.__OW7NMC[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U__U-_CW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]TC]]=A; ZNVW7;R[,WQL M_KK:&,"G);JWUN;"[1VWCPP8J:[.;@KZ]_P!!1W\BC_O.;_V6;YA__<^^ M_=>Z]_T%'?R*/^\YO_99OF'_ /<^^_=>Z]_T%'?R*/\ O.;_ -EF^8?_ -S[ M[]U[KW_04=_(H_[SF_\ 99OF'_\ <^^_=>Z]_P!!1W\BC_O.;_V6;YA__<^^ M_=>Z]_T%'?R*/^\YO_99OF'_ /<^^_=>Z]_T%'?R*/\ O.;_ -EF^8?_ -S[ M[]U[KW_04=_(H_[SF_\ 99OF'_\ <^^_=>Z]_P!!1W\BC_O.;_V6;YA__<^^ M_=>Z]_T%'?R*/^\YO_99OF'_ /<^^_=>ZU)?^%5?\U;X$_S)-H_"?%_"WOC_ M $SUW4>X^^:_L*#_ $7]S==_W?I-Z8SJ:GVU+Y>U^N]BPY;^)3;9KAIH6J6A M\%Y0@>,O[KW6F_[]U[KWOW7NK3OY)OR/Z8^(W\T?XC?(SY#;R_T?=-=8;PWA ME=\[Q_N[NO=?\#H,KU7OS;=!/_=[9&#W+NK)^?-9JFATT=#4.ODUL!&KLONO M=?2L_P"@H[^11_WG-_[+-\P__N???NO=>_Z"COY%'_>_Z"COY%'_>_Z"COY%'_ 'G-_P"RS?,/_P"Y]]^Z M]U<-\9?DSTA\QNC=A_)+XX;V_P!(O2W9E/G*K9&\_P"[>[MH_P ;@VYN?-;- MS+_W=WW@-L;KQOV>Y-NUE-:KH:'R1AHG1V]U[HL'S@_FS?R_?Y;^?V#M? MYG]_?Z&L[VAA\UG]BT/^BONOL/\ CF)V]6T6.S%7]SU3UQOFCQGV=9D(4\=9 M)3RR:[HK*&(]U[HC'_04=_(H_P"\YO\ V6;YA_\ W/OOW7NO?]!1W\BC_O.; M_P!EF^8?_P!S[[]U[KW_ $%'?R*/^\YO_99OF'_]S[[]U[KW_04=_(H_[SF_ M]EF^8?\ ]S[[]U[KW_04=_(H_P"\YO\ V6;YA_\ W/OOW7NLD7_"HG^15-(D M2?.>,,[!5,OQK^7T$8)_U>_*7JC.Y&=R E+CL)VO#LG+5]8]^(887E(!.FP/OW7NK.Z& MNHLG1TN1QM92Y#'U]/#5T-?0U$571UE)41K+3U5+50/)!44\\3AD=&*LI!!( M]^Z]U*]^Z]U[W[KW5,'?O_"A/^4'\7NY.POC]WQ\M*KK_M[JK<,^UM^;.J_C MQ\J,S+@\W3PP5+4Z9C;72&:V]EZ6:EJ8IH*JAJZFDJ(9$DBE=&#'W7N@@_Z" MCOY%'_>_Z"COY%'_>Q-IU71_R2V5%GLO2XK(9J3'KN7?W3 MNUMI8^IEH,7,85JZ^#[B8+#%KFDCC?W7NKE/?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U6)\U?YRG\MG^7=V9M[IWYB?)2FZB[*W3LBA['PFUH^JN\.Q*JIV7DLYGM MMX_.5%9U5UGOC%XR.LS6UZ^&.&JGAJ6^V9Q'H*LWNO=$\_Z"COY%'_>_Z"COY%'_>]^Z]U];K_A)__P!N2OCE_P") ^1'_O[][^_=>ZV/O?NO M=>]^Z]U[W[KW17OEY\T?C!\#.GZKOKY:]N87ISJRESN'VPFXVGLK";EWEN?+314\U0\&.Q]5+!14T]5*$IJ>:6/W7NJHO\ H*._ MD4?]YS?^RS?,/_[GWW[KW7O^@H[^11_WG-_[+-\P_P#[GWW[KW7O^@H[^11_ MWG-_[+-\P_\ [GWW[KW2BVA_PI?_ )*/8&Z]M;$V/\Q,QNW>>\\]B-K;3VMM M[XK?,S+9[<>Y,]7P8O"X/"XNB^/,U7DZO:5@ MZJXU ,H8!E9& 87&I'"NC6/((!'Y]^Z]UR]^Z]U[W[KW7O?NO=(/L;M3K#I[ M;53O/MSL?8?5NSZ(Z:S=?8V[]O;(VU2-I9[5.=W-D<9BX#H0GU2C@$^_=>ZJ M)[>_X48_R7.EJFJH-R?._K/=.1IC(B4O4.W^QN[*:KEC)!CI<]U/LS>&UR'( M],CUR0L/H_(]^Z]T2W-?\*]_Y.&*J7@H=V?(;B\I!32#G]Q%W%F M\!5A./[42MS]/K;W7NEELK_A6?\ R5]UU,-/F^[^U.MTE.DU>]?C_P!HUE-" M20!YO]'V#WW4 &_U6-@!];>_=>ZM)^/'\V/^6M\K*NAQ70OS:^.^^=QY1XX\ M;LN7L3#[1[!R#R6TK1=>;XDVUOBIY8 Z,>VEB ;$@>_=>ZL)]^Z]U[W[KW7O M?NO=>]^Z]U[W[KW7O?NO=5.?+G^>/_*W^"7<^3^/?RK^4'^BSM_#X/ ;DR.T M?]"GR(WQ]MA=ST7\0P=9_'^N.I-W[8F^^H_7XXZUI8OI(J-Q[]U[HLG_ $%' M?R*/^\YO_99OF'_]S[[]U[KW_04=_(H_[SF_]EF^8?\ ]S[[]U[KW_04=_(H M_P"\YO\ V6;YA_\ W/OOW7NO?]!1W\BC_O.;_P!EF^8?_P!S[[]U[KW_ $%' M?R*/^\YO_99OF'_]S[[]U[J70_\ "H#^1=D*J*DI_G321RS,%1Z[XZ_+7&4H M)(4&6MR70U)10+<\EY% ')-O?NO='IZ'_FR_RT?DU746(Z2^_=> MZ][]U[KWOW7NO>_=>Z__U=_CW[KW7O?NO=>]^Z]U[W[KW35G<[A-KX3,;FW- MF<5MW;FWL7D,YG]P9W(4F)PF#PN)I):_*9C,96OFIZ'&8O&T,$DU1432)%#$ MC.[!03[]U[K0E_FX?\+ *S"9W=/0_P#*MQN%KDQ<]9A,W\O]]X*+-4%760LT M,\W1G7>:@.,KJ*FF6T6>W'3U--5C7X,4T/@K9/=>ZTZ]T ?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7 MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z^P MS_PF6_[<<_!'_M0=W?\ P3?=7OW7NM8+_A<%_P S]^ W_B'^Z/\ WM-F>_=> MZT8_?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO='_ /A9_-(^>O\ +YS] M%E_BO\DNPM@8.GK%J\AUG691]U]/[AO*'J8\]U9N<939=5/5QEXS614D.2@6 M1C!4PN=8]U[KZ+_\E7_A3;T5_,?R^W/CG\D\+M[XW?,/)I#0[;H:;)3KT[WI MD] #4O6F4S=549/:V]*F0'Q[9RE3535(T_8UU=*TD$'NO=;37OW7NOF ?\+* M_BC_ *(OYBG6OR_=>Z&_XS=X;A^,WR+Z(^1.T_*=Q]&]O===L8B"*7 MPFMJ]@[LQ.YTQLK'T-2Y1<::>9&!22&5E<%20?=>Z^['LK>&WNP]F[2W_M'( MQ9?:F^=L8'>&V,M ;P9/;VYL529K"Y&$W-XJW&UL4B_X-[]U[I3>_=>Z][]U M[KWOW7NO>_=>Z^-M_P *(?E!_LUO\W[YB[OH,C]_M/K/?D7QYV4(Y?/1TV'Z M*H(.OLV^.F!99J#-;^Q.9RD;J2C_ 'Y9"5(/OW7NJ4/?NO=>]^Z]UPXN]^PUEA\^/7:71M-+V,E#EX[-KQFZ-SX/&X M206LS915) )(]U[K[,WOW7NO@;=@_P#'^[W_ /#OW+_[N:WW[KW20]^Z]U[W M[KW7UNO^$G__ &Y*^.7_ (D#Y$?^_OWO[]U[K8^]^Z]U[W[KW0<=O]N]:]!= M7[\[I[BWCAM@=7]9;8RN\-\;QS]0:?%X' 8>G:IK*N8HLD]3.X41T]- DE35 M5#I##')+(B-[KW7Q\OYW?\X#LK^;;\HJO>9.9VE\:.K:C+[;^-_4];.$;#[< MJ*B-,CO_ '=24\TU#-V1V#]E#45[(TD=!2QT^/BDE2F-1/[KW5+?OW7NO>_= M>Z][]U[KZ3/_ EK_D1?[+MM3;?\R+Y<[-\/?F_L":WXU=:[DH--9TQU]N*@ M>,]F9_'U<>NA[.[ PM64H(&59<)@IV\EJRNEAH?=>ZW7_?NO=>]^Z]T2GYR? MS#OB)_+GZKD[;^6?;^"ZZPU4*N':>UTU9KL7L7*TD:.^$Z^V+C?+GMRUJO-$ ML\T<:4% )DDK:BFA)E'NO=?/_P#YAO\ PL3^8/>-=G-C_ W9F,^)75TDE11T MG8^YJ+!=@_(/<% 6:):R^2I\IUQUP*VE7R-W?4=@=_]Q=F]U[WJC*)=U=I[YW+OO.K%*_D:EI\CN7)9*HHZ%" $IXF M2&-5"HJJH ]U[H(_?NO=>]^Z]U[W[KW7O?NO=6X_!O\ GE_S-?Y?E9AJ/I/Y M*;KW+UMB6@C/1W<]36]K=05&.@"@8C'[=W'7-E=D4ZWYOY4_P#PJF^'7SJR&V^G/DO18_X<_)+,24F*Q4.Y]P1UO1/9&;GT4\-+ MLSLC(QT#[2SF5JK^##[AC@!>2*FI]^ MZ]U\G3_A7+_V^;[,_P#$(="?^\;[]U[K62]^Z]U[W[KW7O?NO=>]^Z]U[W[K MW7O?NO=>]^Z]U;I\!?YX_P#,B_ETY7"T_2G?^XMV=5XR6G6KZ![DK,GV3TY7 M8V%U:3&XO;^7R*Y78(J HUU&V:[#53:0'D=+H?=>Z^E/_)R_GW_%O^;7MQMG MXZ%>D/EAMK#')[V^/6Y\U3Y"7+X^E11D-W]1[D:#'#?^T:=C>JB^WI\KB2;5 M5,(#!5U'NO=7N^_=>Z][]U[KWOW7NO_6W^/?NO=>]^Z]U[W[KW7O?NO=?.<_ MX5I?SG=S;Z[-SG\KCXY[NJ<5UAUS)0/\L]R8"ND@E[$[%9*?*T'31K*1E\FS M>OH)()\W )&6MS[_ &LZ)_"F$_NO=:-7OW7NO>_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7 MNO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NOL,_\)EO^W'/P1_[4'=W_ ,$W MW5[]U[K6"_X7!?\ ,_?@-_XA_NC_ -[39GOW7NM&/W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=2\?D*_$U]%E,76U>-R>-JZ;(8[(X^IFHZ_' MU]',E11UM%64[QU%+5TM1&LD\L\F3^7/Q=AP&W>QLO5/&E?VSUYE8JBEV)VZ\9$?GW!4/C)\9N/Q!U&2I MXJQS$,G# GNO=!U_PKP^*/\ I[_E5UO<^&QOW>[_ (A]K;/[42HIX?-D'Z^W MA4#J[L#&0BS,M!'/NK$YFK86*0X/63I5K^Z]U\J+W[KW7O?NO=>]^Z]U]@[_ M (30_*#_ &:'^3M\6JS(9'^(;LZ'Q^=^,F[QY?,U#+T[7)C=B4;N3K\G^A[( M;:F8, 09B!<6)]U[J^KW[KW7O?NO=>]^Z]T6CYF_(;$_$SXE?)+Y,YDTQI.C M.E.Q^S*>EJF"Q9;,[5VMDLGMW +=D#U.XL_#34,*W77-4*MQ>_OW7NOA99S- M9;_=>ZW\_P#A$?\ %+75?,OYO9K&\00[6^+O764:&X+U#8[M3M^F M65Q97B2'9971Z^!MV#_P ?[O?_ ,.__OW7NMC[W[KW6.::&FAEJ M*B6*"G@BDFGGFD6*&&&)2\LLLKE4CBC1268D 7/OW7NOEL_\*9/YZ\OS[[0 MKOAM\7MVRM\,NF]SG^]&Z<)5LM'\D>T_=>ZW+O^$O/\B+_ &;+>^"_F$?+39OG M^,76>XFFZ+Z\W'0:L?W]V9MNO*/N?+T%7'X\IU)UUF*4J\;*U+GZ]U\H M7Y6?+?Y$?-ON?<_?_P G>T-Q=J]F[IF83Y;.5(7'X/%)/-/0[7VA@*98<+M# M:.)-0XI,9CX*>DAULP36[NWNO=%P]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW6Y!_((_X4T;\^)>8V7\0_GYN_-]A?%*KEH=L]>]T9N6NSV_/ MCBKE:7&4&7Q&4H99Z+(XS)4,Z303PN\4T3J MZ,5(/OW7NG3W[KW7O?NO=?)T_P"%JI>M/D)LC&LRTNU^W-N4-! M/E:O$TTTDM1%M3>N*R%+F\4&>;P4U=]H\LE12SD>Z]U;%[]U[KWOW7NO_]?? MX]^Z]U[W[KW7O?NO=%@^:WR.Q7Q"^(GR4^3^7BIZJGZ*Z6[#[)HL;5,4AS>> MVUMNOK=L;Z^&=O?>FZ.R-Z;O[$WQFJS<> M]=^[HS^]-W[AR,@ER&>W1NG+5>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M?89_X3+?]N.?@C_VH.[O_@F^ZO?NO=:P7_"X+_F?OP&_\0_W1_[VFS/?NO=: M,?OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[J\#_A.G\N M\G\/?YN'Q4W#_$Y*#97=V[H/C%V72^;[>CR.V>\*V@VO@'R'QWWHJG:G>/4_8'5&>E,*SO1X[? MNULIMJ;(TR,5TUN,&2%13NI5XYXD965@"/=>Z^%)V/L#='5'8>_.K=[X]L3O M3K7>>Z-@;NQ3EB^,W1L[.5VW<_CV+*C%J/*XZ6,W4&Z_0>_=>Z1GOW7NO>_= M>ZWV_P#A$9\H/M=T_-/X8Y?(W3-839?R8V#C&ET+%48"LAZP[6JDC9K2S5T& M>V>/2 RI2,3<6T^Z]U]!WW[KW7O?NO=>]^Z]UJD_\+!_E!_H6_E94G1^*R/V M^Y?EIW5LG8-31Q2^&L?KSKJ5NV=WY"%U(D--'N/:^WL?4*O$D64*-=&8'W7N MOE>^_=>Z][]U[KWOW7NOLJ?\)[OBE_LH/\HWX@[$R.-_AV\NQMB?[,'V )(? M!72[E[SJ7W_CZ7*PZ5:+)[;V3E,1AI48:T_AH5O4#[]U[JZ3W[KW7P-NP?\ MC_=[_P#AW[E_]W-;[]U[I(>_=>Z][]U[KZW7_"3_ /[_=>ZT/O^%4O\]W^Y>.WC_*\^(6\K;OS5%+A/F%VEMJOLVUL%7P6 MJ?CWMS*4_=>Z][]U[J M^[^0A_)>WI_-E^2*UN\Z3-;:^'/2V5Q64[]W_2>>@FW-4L4K\9TML;) +KWE MO"G3575,1(P6(9ZN0BHEH(*OW7NOKN["V'LOJW9&TNMNN=L8796P=A[8J8PSTF&H*J6-9)EBBD]U[KXS/R4^1_<7RY[R[(^1G?N\:_??;':NXZ MK_=>Z WW[ MKW7O?NO=>]^Z]T[8+ 9W=&7H-O[9PN6W%GLK.M+B\)@L=69?+Y*J8$K34&-Q M\-165D[!20D:,QM]/?NO='_VC_*'_FG;ZQD6:VQ_+N^9M=B:B,34F0J?CIVG MB*2M@9!(L]!-FMLX]*^"13Z7AUHQX!)]^Z]T"'='P:^:?QQHILIW_P#$CY*] M+8>G_P YG>T>C^RMCX KJ""2'/;CVUC\/40EV"AXYV0MQ>_OW7NBL^_=>Z][ M]U[KWOW7NO>_=>ZWN?\ A)O_ #LLGM3=FW?Y67R>W=)6;+W;45$7P[WMN"N+ M2;2W=.\U;6= UU?5-9MN[O=I:C:X=PU)EM>,B\JU]%#2^Z]U]#_W[KW7O?NO M=?)T_P"%9/I[^8OO3XKY/*NFQ_EYU/G(\? MB'FT0-VUTG0Y3L+:V4C60F,.O7B[LIG5 KS/-"23XE4^Z]U]0CW[KW7O?NO= M?__0W^/?NO=>]^Z]U[W[KW6N;_PJR[!K=C?R4/DAC*":2GF[)WKT/U])-%J$ M@HI^X=H;NR,(=2-$=;0;0EIY+\-%*R_VO?NO=?(Y]^Z]U[W[KW7O?NO=?37_ M .$T_P#(B^+W7GP^ZA^IJW S;SWAMTTV_T3=5_\^TZ__P#0-VY_];??NO=>_P!$W5?_ #[3K_\ ] W;G_UM M]^Z]U[_1-U7_ ,^TZ_\ _0-VY_\ 6WW[KW7O]$W5?_/M.O\ _P! W;G_ -;? M?NO=>_T3=5_\^TZ__P#0-VY_];??NO=>_P!$W5?_ #[3K_\ ] W;G_UM]^Z] MU[_1-U7_ ,^TZ_\ _0-VY_\ 6WW[KW7O]$W5?_/M.O\ _P! W;G_ -;??NO= M>_T3=5_\^TZ__P#0-VY_];??NO=:,'_"V[:&T]L=7_R]9-M;7V[MYZS?OR*2 MK?!X3&XEZI(=O=0M"M2U!34YG6(R,5#7"EC;ZGW[KW7SYO?NO=>]^Z]U=A_P MG/QF-S/\Z?X(8S,8^ARN-J]_;_2JQ^2I*>NH:E$Z3[-E1:BDJHY8)E65%8!E M(# 'ZCW[KW7V"/\ 1-U7_P ^TZ__ /0-VY_];??NO=>_T3=5_P#/M.O_ /T# M=N?_ %M]^Z]U[_1-U7_S[3K_ /\ 0-VY_P#6WW[KW7O]$W5?_/M.O_\ T#=N M?_6WW[KW2QQF*Q>$H8,7AL;08C&4H<4N.QE'3T%#3"65YY!!24L<5/"))I6= MM*B[,2>2??NO=?.R_P"%P7_,_?@-_P"(?[H_][39GOW7NM&/W[KW7O?NO=72 M_P#">/ISJCY ?SBOAQU%WAUULWMGJ[=]=W@FZ>ONP-OXW=6T-PIA?C7W)N/$ M+F,#EZ>JQU>N-S^'I:R 21MXZFGCD6S("/=>Z^I)_P ,R_RF/^]<'PP_])YZ MT_\ L>]^Z]U(@_DW?RG*?5X_Y;WPH;7:_G^-W555;3>VG[G;$VCZ\Z;7_/T] M^Z]TU[A_DK_RDMSXNJP^2_ER?#RFI*R&2&6;;W16P]HY1$D&EFIR_E]\.H,_C/C/O_ 'I%UWO[ MJK.9C);IEZ:WWEL?DLOM2NVON3,3UVX\CUYNNCP]73,F5J*JJQ>3AB3[N>.O MAAI?=>ZU"O?NO=>]^Z]TI]D[LRNPMY[1WS@IFI\WLO<^ W9AIT8H\&5VYE:3 M,8^97'*M'5T:,#^"/?NO=??$QM?3Y7'8_*4C%J3)45+7TS'3=J>L@CJ(6.AF M6YCD'T)'^/OW7NOD@?\ "ICXH_[+#_-][MSV*QO\/V9\H<#M7Y-;8\<.F!\G MO:*MV[V86G0"*6NK>V-H9O(2IQ(D=?$6!U*[^Z]UKI^_=>Z][]U[JZC_ (3S M?*#_ &5#^;W\.-Z5^1_A^T^QNP&^/N]A)+X**HPG>U!4==8F7)S$A8<=@M\9 MG$961V(1#CPSD*#[]U[K[*'OW7NO>_=>Z][]U[KYB_\ PL[^4'^D_P#F#=.? M&7%9'[G _%KHVER.;HA*3_#NSN]J^GW=GH7A4E%\O6^W]H3*QLY\QXTV)]U[ MK3O]^Z]U[W[KW1R/Y>?Q@K?FA\XOBQ\7*2"HFH^Y^ZMD;4W/)2%Q48_8 RT6 M5[(S<1B(DU8#8&-R5=P5-J?ZCZCW7NON2T%!18NAHL9C:2FH,=CJ2GH,?0T< M,=/245%1PI3TM)2T\2K%!34T$:HB* JJH %A[]U[J7[]U[KX&W8/_'^[W_\ M#OW+_P"[FM]^Z]TD/?NO=>]^Z]U];K_A)_\ ]N2OCE_XD#Y$?^_OWO[]U[I+ M_P#"C3^>+B/Y8W1[=$]#Y['5WSA[TVW5C9L<34U=_H)Z_KS4XNM[EW!0N)HC MGIYX9J7:M%4)XJG(12UDRRTU"]-5>Z]U\G[,9C+;AR^4S^?RF1SF=SF1KLQF MLUEZVIR66R^6R=3+6Y+*93(UDDU97Y'(5D[RSSRN\DLKLS$L2??NO=-WOW7N MO>_=>Z/_ /RTOY=7>7\SWY4[*^,O25$U&,BZY_LWL:MH9ZO;/4?6..JZ6+)X%F^U6I2GQU#Y8I,IE*BGI$>,RF1/=>Z^RA\*_AOT;\!_C=UO\ %WX] M;:7;W7G76*6G-74B";<6\MRU@2;Z][]U[KY./_ J=_F0U_P V/YB.Y>C]F9^2LZ!^%55G>G-I MT=)4L^*W!VU#5P1=W;X>)6:&:J3=&-3;M-(K21-0X".>(K]U+J]U[K65]^Z] MU[W[KW7:J6(5069B%55!)8DV '))/OW7NMT3^3K_P )+NSODU@MJ?(O^8KD M]W=!=,9N"ASNT/C_ ("./$=Z]A8>=8ZNCR&^:[)TM5%U!MG)PLFFC>FGW'50 MM)JCQ1$$\ONO=;^_Q/\ @/\ #7X-;4@V?\4/CGU?TMCTHXJ&OS&V-NP3;XW' M#"JJDF\.Q[WKHJF?&]V_'O!XG:$D^8E#RK5;_ .M:&.AV!V'35=85>MEGI:3.3HI2 M+*4Y8M[]U[KYH_\ -(_E%_++^4]VY!L+OW 4^?Z\W74US]1]\[.@K:CK7L[& MT9$DL%+4U,8J=L[SQM.Z'(X*OT5E*3Y(FJ:-X*N;W7NJM_?NO=>]^Z]T[8#/ MYO:F=PNZ-LY?(X#LGQV7PF;P]9#D<3E\7D*5XJJAR.-KZ>. M:":-EDBE164@@'W[KW7VAOY*W\PVB_F:?R]>E_D;7U-#_I5H*6HZM[_Q="L, M,>*[JV%3T-)NBK6CIQX-]^Z]UK)>_=>Z][]U[K:F_X20_%_XY_*WY\]_;$^3' M1_5W?.R\#\0-T;MPNUNV-EX+?.!Q6YZ;N?I/#T^?H,9N"BKJ2ER\&*S-73+. MBB18:F1 ;.P/NO=?0C_X9E_E,?\ >N#X8?\ I//6G_V/>_=>ZE0?R(ZGW#"LBLODH=U=7KM#]^Z]U:5_)%WY6]?(_+3I_8]^Z]U_]'?X]^Z]U[W[KW7O?NO=:Q7_"NO M"5>5_DT=@UU-&SP[:[WZ&S=>R_2&DGW14[<21^#Z379^!/QZF'^L?=>Z^3Y[ M]U[KWOW7NO>_=>Z^TI_(T^2>P?E'_*B^$&]]AY+'U3[(Z"ZYZ,WUBJ*:$S[8 M['Z.VGA^M=W87(4*,TV*>HJ]O)D:.&4*[XNOI9UU1S1NWNO=6R>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K1"_X7%_\ MRM_EV?\ A_\ R/\ _>=Z>]^Z]U\\3W[KW7O?NO=7??\ ";W_ +?:_ C_ ,2! MV#_[Y#M#W[KW7V.O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U\Z/\ X7!?\S]^ W_B M'^Z/_>TV9[]U[K1C]^Z]U[W[KW5]W_"83_M^=\%?^UA\@_\ X%'O;W[KW7V" MO?NO=>]^Z]U[W[KW5 7_ J'V]09_P#D8Y9\965-.6'/CG8?GW[KW7R!/?NO=>]^Z]U[W[KW7WNNJ7>3J[K: M21F=WV#LYW=V+.[MMW',S,S$EF8FY)Y)]^Z]UIJ_\+6/BC_?;XK_ !B^8F#Q MOES'1':>8ZDWM54T7[W]P>Z,5%DL-D\I-I]6/V]OG8=/1TXO=)]PM8'62/=> MZ^;?[]U[KWOW7NG+#9C*;>S&*S^#KZG%YK!Y*AS&'R='(8:S'93&545;CZ^D MF7U15-)5P))&PY5E!]^Z]U]TGX5?(C%_+;XB?&KY-8EJ80=Y=)]<=DUM+2D& M+%9[ZX221PQR332) M%%$C22RR,J1QQHI9Y)'8A41%!))( ]^Z]U\.K^97\G)/F5\^_ES\FEK7K\/ MVSWGOK-;-GD9G>/K?&963;?6%$SM^LXWKO"XNFN ?%P%%@/=>Z(_P"_=>Z] M[]U[K<>_X1A?%'_2A\\^ZOE7F<;]SM_XL=--@=MULD5A1]I]\U-?MG%55-.X M*NT'6>V]UT\R)ZU^^B)(# /[KW7TVO?NO=>]^Z]U\#;L'_C_ '>__AW[E_\ M=S6^_=>Z2'OW7NO>_=>Z^C+_ "O/YJ?3_P#*;_X3/='=W;X./W1VKNG?_P F M-K?'OIYJ[[?)]G=BCN/>LL9JD@<5M!L/:*U$5;N#)* M-2F."-FK:NCAF]U[ MK0(^1_R*[@^6?>'9/R*[ZWCD-]]L=K;DJ]S[NW%7G2LE3.$@HL7BJ)#]OA]N MX#&00T.-H( E-04%/#3PJL<:@>Z]T"/OW7NO>_=>Z%WH3HCMCY.]R=== ]&[ M-RF_^V.U=S4&T]E;4Q$:M4Y'*5Q9Y)ZFHD9*7&8?%444M9D*ZH>.DH*&GFJ: MB2.&)W7W7NOL3_R:?Y3/4_\ *5^*V+ZFVY_"]V=X;[3%[I^1O<-/2,E5OS?< M5)(L.%PL]3%%7TO7.Q$K)J+!4;K%Z'GK98UJZVI+>Z]U;I[]U[KWOW7NB._S M+/E5'\(_@/\ +#Y3K-3PYGJ'IG=>9V7]VJ/25/9>8ITVKU9CZM9 5:ER?8^> MQ=-(+,=$ILK'@^Z]U\/7(Y'(9C(5^6RU;5Y+*92LJLCDLC7U$M779#(5L[U- M96UE5.SS5-755$K222.Q9W8DDD^_=>ZA^_=>Z][]U[K>>_X27_R6=J=S52?S M/OD[M*FW#LG8^[JS!_$S8F?HDJL)N/?NT:[[?Z^BU[]U[KWOW7NO>_=>Z][]U[KWOW7NBM_,WX<]$_ M/3XZ=A_&/Y%;3I]U==]@XN2 3HE.FX=G;DIXIO[O;]V3E9X*AL%O/:E=+]Q1 M52JRDZX9DFIIIX9/=>Z^+=\^_A?V9_+Y^7/=7Q([7TU>Y.IMTOC\9N2GI9:/ M&;YV5E::GS>Q=^8>&1YC%C]W;4R-)6>'R2/1S224TC>:&0#W7NB>>_=>Z][] MU[K=1_X1]^Z]U[W[KW6FG_PMCV]05/\N_XO;LDAB;*87YH8/;U'4&,&>*@W/T=W3DLE M#'+;4D4]1M&E9U'#&-2?TCW[KW7S,_?NO=>]^Z]T?_\ E._]O3?Y:?\ XO\ M_#?_ ."*ZY]^Z]U]OGW[KW7O?NO=?__2W^/?NO=>]^Z]U[W[KW53W\\[X[9' MY3?RD_G3U%A*"3*;C?I/)=D;8QM/#YZ[);EZ0S.&[JPF)QB#UG(YNOV E%" M1K:HT$Z6/OW7NOBT>_=>Z][]U[KWOW7NK$_Y?G\U;YP?RQ]UYS4QTE!EHX;PK5"%GC M;W7NKU*?_A:)_-9A@CBDZB^"U7(BA6J:CJ;NU9YC_JY%I/D?2TP8_P"T1H/\ M/?NO==S?\+1OYK$B%$Z?^"M.Q(M+#U-W>SBQN0!/\D9X['\W4^_=>ZB?]!GO M\U[_ )]?\(/_ $4?<'_W0GOW7NO?]!GO\U[_ )]?\(/_ $4?<'_W0GOW7NO? M]!GO\U[_ )]?\(/_ $4?<'_W0GOW7NLU/_PM"_FMPRK))U/\&JM!]8*CJ7NA M8G_X,:7Y%TTP_P!@X]^Z]T:#J/\ X6\?)W%5E+_IX^$/0V_: O&M:>H]_P#8 M/4E8L9($LU*N\D[LA=T!U+&Y4,1I+K?4/=>ZOX^'/_"M+^5=\FJ_$;5[5S^_ M_AYOG)R14BQ]Z82DJ>M)\C*RVBI.U]E5F?PF*QZJQ+5NXJ;;U,I4AF'IU>Z] MULN[4W9M7?>V\+O'8^YMO[RVAN3'T^6V[NK:F9QVXMMY_%5:>2ER>%SF(J:S M&93'U*_=>Z][]U[K0^_P"%QDJ#K'^73"6M+)OOY)RH MMCRD.W^F4D:]K#2TRC^O/OW7NOGD>_=>Z][]U[J[[_A-[_V^U^!'_B0.P?\ MWR':'OW7NOL=>_=>Z][]U[KWOW7NO>_=>Z][]U[KYT?_ N"_P"9^_ ;_P 0 M_P!T?^]ILSW[KW6C'[]U[KWOW7NK[O\ A,)_V_.^"O\ VL/D'_\ H][>_=> MZ^P5[]U[KWOW7NO>_=>ZH@_X4T_]N.?G=_VH.D?_ ()OI7W[KW7QYO?NO=>] M^Z]U[W[KW7WN.IO^95]:?^(_V;_[SF-]^Z]T3G^:U\4U^;7\NCY??&>#'KE- MP]B=+[FGV!1F,2>3M/9*P;_ZIMP75?\ 2+M;&!RGK\9:UR;>_=>Z^(>RLC,C MJR.C%65@5964V964V*LI%B#]/?NO=]^Z]U]3K_A'G\H/],_\ *XRG M165R/W&Y/B7W7O+9%)122^:JBZY[,D':^T:^5V8R"";=.XMR4,"'A(L:%7T@ M*ONO=;7WOW7NJJOYWGR@_P!D_P#Y5/S7[GH\C_#-S#IK-=:[#JHI?'74^_NZ M*BDZEVED<:@.N:LV_EMY)D](!TQ43NPT(Q'NO=?%<]^Z]U[W[KW7O?NO=?5_ M_P"$E'Q2_P!EY_E-;3[0S&-^RWE\MNRMZ]VU\E1%HR,6S,;4Q=:==8^1K -C M*G#;+FSE&+MZ,ZS7]6E?=>ZV>??NO=>]^Z]U\#;L'_C_ '>__AW[E_\ =S6^ M_=>Z2'OW7NO>_=>Z5^?W_O;=.W-B[/W%NC-9C:O66)S&#Z_V]75TTV'VAB]P M[FR^\L]2X*@+?;4(S.Y\[55E2ZKY)I9!K8JD87W7NDA[]U[KWOW7NO>_=>ZV M_?\ A&]\@/C=UA\_>RNI.UMF;Z^GW[]U[KWOW7NO>_=>ZU+_^ M%DW<]5U[_*LVAUACJMHJGO[Y0]:[3S-&KE/N]H;(V[O;M"ND< _N)2[OVE@? M21;4X;ZJ/?NO=?+7]^Z]U[W[KW7O?NO=;0'Q8_X5B?S _A[\<^F/B_T_\?/@ MI%UOT=U_@.O=K3Y[K+OFJW%EJ3"4BQ5>X]SUF(^2V#Q5=NK=&3>?(Y2HIJ*C M@GR%5-)'!$K"-?=>Z'W_ *#5OYIO_/@_@!_Z*SY%?_=5>_=>Z]_T&K?S3?\ MGP?P _\ 16?(K_[JKW[KW7O^@U;^:;_SX/X ?^BL^17_ -U5[]U[KW_0:M_- M-_Y\'\ /_16?(K_[JKW[KW7O^@U;^:;_ ,^#^ '_ **SY%?_ '57OW7NO?\ M0:M_--_Y\'\ /_16?(K_ .ZJ]^Z]U17_ #/_ .:+W;_-A[JV;W[\@NL^ANON MP]G=]^Z]U9Q_)@[NJOCO_-:^ G:-/5M04U+\F>MMDYZL M5RGVVT.V\NO4F]I7*\M$FT-\5Q=?[:W7\^_=>Z^V![]U[KY.G_"N7_M\WV9_ MXA#H3_WC??NO=:R7OW7NO>_=>ZW'/^$4/_;R7Y*_^*/[O_\ ?\] >_=>Z^FY M[]U[KWOW7NO>_=>ZT\O^%K7_ &['^.W_ (O?U_\ _ _?)/W[KW7S%/?NO=>] M^Z]T?_\ E._]O3?Y:?\ XO\ _#?_ ."*ZY]^Z]U]OGW[KW7O?NO=?__3W^/? MNO=>]^Z]U[W[KW6.6**>*2">..:&:-XIH9462*6*12DDZ^--_/=_EG[@_EC?/WLWK3'8&JH^@>T\EENVOC1G4IY!B*KK3<>4FJ)MC MPU87P'-=49>HDP=7"6%0::"DK'1(JZ#5[KW5,GOW7NO>_=>Z][]U[KWOW7NO M>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>ZML_E=?SG_ )H?RJ=_T&2Z M6WK5[QZ2R&7BK.Q/C5OK)U]=U7O*DFD492KP](6J)>O-[3P"\.=Q*15'FCB% M9%74J-22>Z]U]9;^7'_,9^.O\SSXV;<^1WQYSDC4<\B8+L/KW,RTR;WZEW_3 MTE/59;9&\:&G=D6I@2H6:CK8KTF3HI(ZB!BK%4]U[H^WOW7NM#+_ (7'_P#' MA?RW_P#P[_E%_P"Z;HCW[KW7SU/?NO=>]^Z]U=]_PF]_[?:_ C_Q('8/_OD. MT/?NO=?8Z]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7SH_^%P7_,_?@-_XA_NC_P![ M39GOW7NM&/W[KW7O?NO=7W?\)A/^WYWP5_[6'R#_ /@4>]O?NO=?8*]^Z]U[ MW[KW7O?NO=%U^67Q7Z;^;/Q\[%^+_P @<'D]R=0=J4VWZ3>6%P^?RNU\E70[ M8W;@-[8A:;.X2II,I0&'<&VJ25C%(ID1"C75F!]U[JCO_H$S_DI_\^([0_\ M2@^V_P#[)/?NO=>_Z!,_Y*?_ #XCM#_TH/MO_P"R3W[KW7O^@3/^2G_SXCM# M_P!*#[;_ /LD]^Z]UL>87$T6 P^)P6,C>+&X7&4&)Q\3R/,\=%C:6*CI(WED M+22ND$*@LQ)8BYY]^Z]TY>_=>Z^+/_/%^*/^R9?S4_F5TQ08W^&;0J.U\EVG MUS3Q0^+'Q=>]ST]-VCMG&8IK!9J':]/NIL-J%],V.D1B65O?NO=5/^_=>Z][ M]U[K<'_X1D_*#_1;_,.[;^-&5R/VV!^5/1M?4X6A,NG^(]G]%UE1O3;Z+$Q" MOX.M\SO"0D>L:!QIU$>Z]U]/'W[KW6CO_P +9OE!_=CXZ_$?X@8?(Z*_MKM# M='>&\Z2FETSQ[7ZCP*[5VM19- P+XW<&Y>R:FIA6Q#5&!U&QC%_=>Z^UL7+-&A9143T>+1Y3_=>Z^!MV#_P ?[O?_ M ,._]^Z]U[W[KW7O?NO=+7K;L7>O4 M'8>QNUNMMQ9#:/876N[MO;ZV1NC%2"+);>W7M3+4FZ^UA_*J^?^R?YF/P>Z9^56U?X?0;AW'B/[L]O[/H)C(-@=T;5 MAIJ+L#:C1R225,-!_$)$R.*,Q$U1A,A15# &:P]U[JQ/W[KW7O?NO=:(W_"X MK/U%-U1_+OVLLC"ES/8?R+S\T5VTO4;:VWU'CJ:0@#06BCW7* 2;C6;?4V]U M[KYX'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z][]U[KWOW7NEYU9N*IVAV=UQNVCD,-9M??FT-Q4LP<1F*IPFX,=DH) M!(2!&4EI@=5^+7]^Z]U][SW[KW7R=/\ A7+_ -OF^S/_ !"'0G_O&^_=>ZUD MO?NO=>]^Z]UN.?\ "*'_ +>2_)7_ ,4?W?\ ^_YZ ]^Z]U]-SW[KW7O?NO=> M]^Z]T1WY\?R[?BW_ #+>I=K](_+3:6?WEU]L_L7&=J8+&[=WEN/9%93[RQ&V MMU[2HJZ7*;9KJ"NJ::/";TKXS3NYB9Y%Z]U4G_ - F?\E/_GQ':'_I M0?;?_P!DGOW7NO?] F?\E/\ Y\1VA_Z4'VW_ /9)[]U[H2NF?^$QG\HGH/N# MJCO7K7I?L;%=C=+=E;%[:V!DZ[O/L_+T6.WKUSNC%[PVK7UF*R&X)J#)TM'G M<-!))3SH\,R*4=2K$>_=>ZV!/?NO=>]^Z]U__]3?X]^Z]U[W[KW7O?NO=>]^ MZ]U6W_-(_E@_'[^:Q\:,MT!W;3RX+/XN>IW)T[V]A:&EJ]X=0[_^T:FI\]B4 MJ'@7+[?RD86FS6&EEBI\K1 20545)5TWNO=?)*_F/\ \JKYA_RNNUZGKOY* M]>5D.UM+F*$$-+ M3B)XI9/=>ZK@]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW5VW\A#^:'N+^6#\\=A;RS.X*JE^-W<^2P?57R9V])42?P?^ MY.6R7V^&[)-(7\"YWJ/,5_\ %8:@(U0V-.0HHRJUTA]^Z]U]CZ*6*>*.>"2. M:&:-)89HG62*6*10\_=>ZT-O^%Q_P#QX7\M_P#\._Y1 M?^Z;HCW[KW7SU/?NO=>]^Z]U=]_PF]_[?:_ C_Q('8/_ +Y#M#W[KW7V.O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U\Z/_A<%_P S]^ W_B'^Z/\ WM-F>_=>ZT8_ M?NO=>]^Z]U?=_P )A/\ M^=\%?\ M8?(/_X%'O;W[KW7V"O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7SR_^%MGQ1_A?87P\^;6#QMJ M;=^V=S_&KL7(11>*&+,;0K:OL?JUJET&BHR&:Q.Y-T1EVM((,1&EV55">Z]U MH=^_=>Z][]U[H['\M[Y-3?#;YZ?$KY-_>2T.*ZB[SV'N#=\L)=99^NJO,0X+ MLW'(R>I3ENO6.>">-)H)X766&:&50\ MF&2V[05.]^PAX%8QQUM#V3OW+8Z9_UNN/0,;*JK[KW6N#[]U[KWOW7N MMD?_ (2G_%+_ &97^;OU1N_+8W[_ &9\5MG;R^1FX/-#>D.=P=/2[*ZUB$[# M1'DJ+L7>V.RU.@];KB92!I1RONO=?6Q]^Z]U[W[KW7O?NO=? V[!_P"/]WO_ M .'?N7_W_=>Z][]U[IVSN SNULM6X#..MQV0AIZRED>"57 =%)1@?H1[]U[II]^Z]U[W[K MW6U/_P )2_YHO^R5_-H?%OM'<7V'QW^:.2P6S/+D:KQXC8G?U.[T'5N[0TSF M#'T6\I*Q]LY)D5!+)6XZHJ)!#C^/=>Z^JC[]U[KWOW7NM%?_ (7"[5J:SI'^ M7[O=(F-'M[M3O;:L\X12L=3O':/7F7I(B]M2M-%L68@ V(C-_H/?NO=?.O\ M?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z] MU[W[KW7O?NO="=TEM2KWYW-U'L:@1Y:[>?9VPMJ44<=_))5[BW5B:L '^/OW7NOO5>_=>Z^3I_PKE_[?-]F?^(0Z$_]XWW[KW6LE[]U[KWOW7NM MQS_A%#_V\E^2O_BC^[__ '_/0'OW7NOIN>_=>Z][]U[KWOW7NO>_=>Z][]U[ MKWOW7NO>_=>Z][]U[KWOW7NO_]7?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW2 [0 MZIZQ[MV-G^L>X^O=E=I]=;JI#0[DV-V#MG#[OVIFZ4D,L63P.>HZ[&U?BD > M,O&6C/"[:JX>V^ MH::HG8RSSIL3?=;3[RI@TQNE/1;KHJ&%#HB@1 H7W7NJ+>S_ /A$K\Y,/6U MZ<^6_P 5>P<7&[_;5'8M'VSU/E:B(,=!;&;=V7W#003NG.@US(&XUD<^_=>Z M!'_H#"_FO?\ /T/A!_Z-SN#_ .Y[]^Z]U[_H#"_FO?\ /T/A!_Z-SN#_ .Y[ M]^Z]U[_H#"_FO?\ /T/A!_Z-SN#_ .Y[]^Z]U[_H#"_FO?\ /T/A!_Z-SN#_ M .Y[]^Z]U[_H#"_FO?\ /T/A!_Z-SN#_ .Y[]^Z]U'JO^$9'\V.GIY9H>Q?A M1721HS)24O;W:R5$[ 7$<35O0E'2!V^@\DJ+_4CW[KW5$?SU_EC?-7^6GOC# M[)^773>3V"FZDK9MC;WQF1QF[.MM^P8XQ"O.U=[[?J:W#U.0H%J(GJ<=4-39 M6DCFB>>FB66,M[KW1!O?NO=>]^Z]U[W[KW7V@OY#7R1R/RK_ )1OP>[6SM?) MDMT4?4_=>Z MUJ/^%Q__ !X7\M__ ,._Y1?^Z;HCW[KW7SU/?NO=>]^Z]U=]_P )O?\ M]K\ M"/\ Q('8/_OD.T/?NO=?8Z]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7SH_P#A<%_S M/WX#?^(?[H_][39GOW7NM&/W[KW7O?NO=7W?\)A/^WYWP5_[6'R#_P#@4>]O M?NO=?8*]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=46_ M\*0OBC_LVG\H+Y4X+&XW^([SZ3P-!\FMB:8?N)Z;)=)RS;AW>U' H,L]=DNI MIMQT$*1_N-)6 -^AO=>Z^.S[]U[KWOW7NO>_=>Z^RQ_*2^=>V.UOY)_QU^8 M?86;\M'U!\7,Y!W3EI9D:OBR?Q9PN=V;V)F\IY6 @KLU3]W<7:_=V]I_N=Y=Q=D[Y[2W94!VD$VY-_[GRFZ\Y(LC@. MZ-DLM*02 ;>_=>Z#/W[KW7O?NO=?2F_X17?%+^X/P_\ DC\O,WC?!F_D-VWC M>M=GU51%JDDZZZ/Q=0U3DL;.1^U1YKL#?65HZA5(\DN"C+7T);W7NMU+W[KW M7O?NO=>]^Z]U\#;L'_C_ '>__AW[E_\ =S6^_=>Z2'OW7NO>_=>Z][]U[K;_ M /\ A+]_(Q_V=3LO&_.[Y2[/-1\3.G-SWZNV7N&AOC/D/VSMVK#%JNBJD\>7 MZGZWR<(;)ZE-)F,Q&F-/GAI\I ONO='._P"%CG\K@;?W%LS^:/U#MP1X?=L*,5AS^+I4VODJAS'%'4T>'10TM7(WOW7N MM#+W[KW7O?NO=98)YZ6>&IIII:>IIY8YZ>H@D>&>">%Q)%-#+&5DBEBD4,K* M05(N.??NO=?8@_X3W?S/H/YG'P!V9N?>>ZU<_P#A7KT-5=N_ MRA,[O_'4355=\:^^^H^X*F2"(R528#-39WI7,( H,AHHYNV*:JJ 55*02-9 M8RP]U[KY2?OW7NO>_=>Z][]U[KZ:'\E[^3?_ "0/Y@7\M7XO?(O<'PXVQNKM M"OV+3[#[RR*=S_(:@KI.ZNMW.T=_9'+X?"]P4&+P=9NW(8U,_%2T]/3TZ466 M@:&)(7C4>Z]U:3_T#+?R.?\ O!' ?^CN^3?_ -NKW[KW4.7_ (3$?R,IG,C_ M 4Q@9K7$7?WRJITX M%!WG'$O YL!<^_=>ZQ_] P?\C#_O!6@_]*%^6'_V M]O?NO=>_Z!@_Y&'_ '@K0?\ I0ORP_\ M[>_=>Z]_P! P?\ (P_[P5H/_2A? MEA_]O;W[KW7O^@8/^1A_W@K0?^E"_+#_ .WM[]U[KW_0,'_(P_[P5H/_ $H7 MY8?_ &]O?NO=>_Z!@_Y&'_>"M!_Z4+\L/_M[>_=>Z]_T#!_R,/\ O!6@_P#2 MA?EA_P#;V]^Z]TM>M?\ A./_ "8.H>Q=@]L]>_"O&X'?_5^]=J]B;'SDG>/R M8S<>&WALK.T&Y=LY:3#;@[GRN!RZ8[-8R"8TM=2U-'4!-$T4D;,A]U[J[KW[ MKW7R=/\ A7+_ -OF^S/_ !"'0G_O&^_=>ZUDO?NO=>]^Z]UN.?\ "*'_ +>2 M_)7_ ,4?W?\ ^_YZ ]^Z]U]-SW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U__];?X]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5,?\ PH*^-.PODU_*(^:^ M(WMC_=>Z^-'[]U[KWOW7NO>_=>Z^J[_ ,(]LY69;^3[24%2\C0[8^3O M=V#QRN&"QT=12;(W*Z1$@!HSD-PSM<7&IB/J"/?NO=5F?\+CR/[A?RWQ<7.[ MOE$0/R0,-T/Z^>K[]U[KWOW7NKO/^$W[I'_.S^ [.ZHI["WZ M@+L%!>3I+LZ.- 20-4DC!5'U)( Y]^Z]U]CSW[KW7O?NO=>]^Z]U[W[KW7O? MNO=?.C_X7!?\S]^ W_B'^Z/_ 'M-F>_=>ZT8_?NO=>]^Z]U?=_PF$_[?G?!7 M_M8?(/\ ^!1[V]^Z]U]@KW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]TU9W!XC<^$S.V]P8^ER^!W#BLA@\WBJV,3463Q&6I)J#)8^KB/ M$M+6T=0\_=>ZV/OA?_-!_ MT'_\)^OYF?PEGW%]COKL3NSI_ ]1TTU5>KJMH_(RAJJ3O/'8ZG#>4X7&['Z# MKXZA1IBCJMSJYU&1E/NO=:X/OW7NO>_=>ZYQQR32)%$CRRRNL<<<:L\DDCL% M1$106=W8@ 7)]^Z]U]O_P#E<_%:/X3_ ,O3XB?&*2@CQV=ZPZ5VI#ONFB18 MT_TH[I@DWOVM.JJ+Z*KLCAFIL>'$BT%+%59"2. M9*3[>?W7NOL)]4=5==]&]:;&Z=ZDVCAMA=9=:[8Q&S=C[.P%-]KB=O["/*8FHEBF&/S^!K1%78ZK53)1U]-#.EGC4CW7N MOB5?.[X==F? 3Y:=V_$SMB!FW1U#O"KP]'G$I9*3'[UV?6QQ9;8V_L-%(TA7 M$;TVE7T>1A0NST_W!ADM+%(H]U[HH_OW7NO>_=>ZN^_D _S.JK^6'\_MB[ZW M9F:BC^.?='V/3OR/H6DD./H-F9S)0G ]E/3 NGW_ %3N5XLHTJQR5+8@Y&DA MLU83[]U[K[&=+54M=2TU=0U-/64593PU5'64LT=12U5+41K-3U--40L\4]// M$X9'4E64@@D'W[KW1?OEQ\>-L_+;XO?(#XR;O:*' =[=1;\ZQJLA+!]P<)5; MLV[78O$[DIXKC57[9R\\&0IB.5J*9"/I[]U[KX9/:'6^\>F^RNP>H^Q,//M[ M?W5V]MT]>;VP-4"*C#;LV9G*[;NX<9-J527HPWI(JO)U'3?8<$46(PW<^ M'Q%.)IZW%-C5CH-STE+&:RKQD%-40K//C8*2H]U[KZP&S=Y;2[$VGMO?FPMS M8'>>R=XX3&[DVGNW:^5HL[MSZ][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z^3I_PKE_[?-]F?^(0Z$_\ >-]^Z]UK)>_=>Z][]U[K<<_X10_]O)?D MK_XH_N__ -_ST![]U[KZ;GOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7N MO>_=>Z][]U[K_]??X]^Z]TVY3,X?!TZ5>:RN-P]+),M/'4Y2NIZ]_I# MV!_SW&S_ /T)L+_]6^_=>Z]_I#V!_P ]QL__ -";"_\ U;[]U[KW^D/8'_/< M;/\ _0FPO_U;[]U[KW^D/8'_ #W&S_\ T)L+_P#5OOW7NO?Z0]@?\]QL_P#] M";"__5OOW7NO?Z0]@?\ /<;/_P#0FPO_ -6^_=>Z]_I#V!_SW&S_ /T)L+_] M6^_=>Z]_I#V!_P ]QL__ -";"_\ U;[]U[KW^D/8'_/<;/\ _0FPO_U;[]U[ MKW^D/8'_ #W&S_\ T)L+_P#5OOW7NL-1V5US2PRU-5O_ &334\*&2:>HW5@H M88HU%V>662O5(T4?4D@#W[KW6G5_PIU_GH_&7;/Q%[,^ _Q;[;V?W1WM\@*2 MGV3VKF^LMP8[=FT.GNJQD:6MWECEH3@QAH)IJBBH*NLJ* MS[61:-*KW7NOFI>_=>Z][]U[KWOW7NOK._\ "2KKVMV3_)>Z?S]9 \"]K]N] M]=A4>M=+345+V!7=:QSZ2 P267KMRA/ZDLP])'OW7NJO/^%P6S*VNZ$^ O8< M<#-CMK]O=U;,JJG1=8JW?FS-E9R@@,NGT-40=<5+!;C5XB;'3Q[KW7SI??NO M=>]^Z]T8'XI?(W?7Q"^2G1_R>ZU%++O?HOLO:G9&#H<@95QF:?;F4@K*[;F7 M,!%1_!MS8Q9L?6>,K)]K4R:&5K$>Z]U]=3X*?S^/Y9'SLV%MS.;=^277'2G9 M]?CJ0[GZ*[\WEM_K#?\ MO<#PHU?AL//NRLPV![&HJ>4EH:_ 5%;%) 5:5*> M7R01>Z]U;%C>VNJLS3K5X?LSK[*TKHDB5.-WGMRNIWCD%XW6:ER4L;(X%P0; M'\>_=>ZP/\ GN-G_P#H387_ .K??NO=>_TA[ _Y[C9__H387_ZM]^Z] MTI:'(4&4I(:_&5M)D:&H#F"MH:F&KI)Q'(T3F&HIWDAD"2HRG239@1]1[]U[ MKYUW_"X+_F?OP&_\0_W1_P"]ILSW[KW6C'[]U[KWOW7NK[O^$PG_ &_.^"O_ M &L/D'_\"CWM[]U[K[!7OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO> M_=>Z][]U[KWOW7NOE^_\+*?BC_HA_F+=]^Z]U[W[KW7O?N MO=6V?R+/BE_LY/\ -:^&O4%?C?XGM#&=J8_MSL6&:'RXZ3872E/4=HYW&9;T ML$Q^Z6VO#A2>"TN21006!'NO=?:,]^Z]U[W[KW7O?NO=>]^Z]U\#;L'_ (_W M>_\ X=^Y?_=S6^_=>Z2'OW7NO>_=>Z^L_P#\)+-M;>PG\ESI;,8?!XG%Y7>' M:G?NZ]ULL^_=>Z][]U[K3,_X5\_RN?]F"^-VW_YAO4VW?NNW/BOB?[O]T4^,I=> M0W=\Z^9U[]U[KWOW7 MNO>_=>Z^IU_PD]_FB?[./\+Y/B/VEN+[_P"07POQ>%VSC)3*[Y^.U0?X M=UMN%#*RRUM5U[)"=L5_C5A!24^*EF=IJX^_=>ZVOO?NO=?- _X6"?RR:[HW MY-[=_F(=9;>=>I/E%-0[5[D..I2*':'R%V[A?#1Y2L$02"CI.V]E8=:J,JI, MN8P^3FF?R540;W7NM,;W[KW7O?NO=>]^Z]U>#_*B_GY?-G^5+74^S]C9:C[I M^,]7DY&3(];S8:&4@1SY>KP=7*AU&D2S!?=>ZO1V+\G_C3VCCJ?,=9_(?HSL7$ MU:1R4N4V+VUL'=V.J8Y0&BDIZW;^X,A33)(I!4JQ!!X]^Z]T(?\ I#V!_P ] MQL__ -";"_\ U;[]U[KW^D/8'_/<;/\ _0FPO_U;[]U[KW^D/8'_ #W&S_\ MT)L+_P#5OOW7NO?Z0]@?\]QL_P#]";"__5OOW7NE)C\CC\M215^+KZ/)4,_D M$-;CZJ"LI)O%(\,OBJ:=Y(9/'+&RM8FS*0>1[]U[J9[]U[KWOW7NO>_=>Z^3 MI_PKE_[?-]F?^(0Z$_\ >-]^Z]UK)>_=>Z][]U[K<<_X10_]O)?DK_XH_N__ M -_ST![]U[KZ;GOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][ M]U[K_]#?X]^Z]UJ!?\+5O^W670?_ (O_ -6?_ Z_*KW[KW7S!/?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW3]M7:^X=\;HVWLK:.'KMP[LW?GL/M?;& QD)J,EG-P[@R%/ MB<+A\?3K9IZ[)Y*KBAB0HZ1Z M6V+L?<%=16%)E]Z4.%IZC?F?IP%4"+<&]:JOKAQ?_*.;GGW[KW52_P#PJ2^* M^0^3_P#)\[RKMO8R7+[M^-.X]G_*# 4<$9>7^'=>-E,!V16%E5G2'#=0;UW# MD'X(;[0 V^H]U[KY%/OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NOL,_ M\)EO^W'/P1_[4'=W_P $WW5[]U[K6"_X7!?\S]^ W_B'^Z/_ 'M-F>_=>ZT8 M_?NO=>]^Z]U?=_PF$_[?G?!7_M8?(/\ ^!1[V]^Z]U]@KW[KW7O?NO=>]^Z] MU[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW6K#_ ,*\OBC_ *>OY5M5 MW1AL;]WN_P"(?;&S^TEJ((?-D&Z\WG4#JW?^,A4*S"A2JW3B,Q5L+%(<)K)T MJWOW7NOE2^_=>Z][]U[KWOW7NO>_=>Z][]U[K?+_ .$27Q2_B.^OF+\VLWC; MT^UMN[6^,_761EB\D,N4W364?97:H@9QHIZ[$8W;VU$#K>0P921;JK$/[KW7 MT+??NO=>]^Z]U[W[KW7O?NO=? V[!_X_W>__ (=^Y?\ W_=>Z9-R[;P&\MN9 M_:&Z\-CMQ;6W5A,KMOH"+%/$6]U[JJ#W[KW7O?NO=6!_P K MSY[[Z_EJ_-KI?Y7[,^_R&+V?G!A.TMGT4XA'8/3VYGAQW8>S9%EDCI)*RKP_ M^5XQY]4-)FJ.CJBI, ]^Z]U]KCJSL[8O=76FP.X.L-Q4&[NN>T-G;Z"GY??%'I[YO_ !O[ M8^+?>^"_CO6O;FV*C;^6$'@3+X'(QR19#;F\-M5=1#418_=6SMPTE-D\;.T< MB1U=*FM)(]:-[KW7QD/YDG\O#O7^61\I]\?&3O'&R32XB9\UUQV%1T-12[7[ M;ZTKZJHCVUO_ &O),94$-?% T-?1B667%Y.&HHY69X2S>Z]T0GW[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U]>K_ (2R_P#;C'X8?]K# MY*__ 5W=_OW7NM@[W[KW7O?NO=>]^Z]U\G3_A7+_P!OF^S/_$(="?\ O&^_ M=>ZUDO?NO=>]^Z]UN.?\(H?^WDOR5_\ %']W_P#O^>@/?NO=?3<]^Z]U[W[K MW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_1W^/?NO=:@7_"U;_M MUET'_P"+_P#5G_P.ORJ]^Z]U\P3W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]UN\?\ "37^ M3!N3M+M?;W\S_P"16TJC&]/=49"KF^*^WL]1/"_9W:]&\^/E[9BI:I09=E]6 MRB48NH"::SZ^D![]U[IHW!@,)NS 9O:VYL50YW;FY<1DL! MN#"92FCK,9F<)F:*;'97%9&DF5H:JAR%!4R0S1N"KQN5(L??NO=?&5_G6?RN M=]?RJ_FIO;IZJQF6J^B=\UN6W[\9=_U<<]11;JZMKL@7@V[599P8JG>O6LU6 MF(S<3%)VDCAK?$E-7TK/[KW51'OW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K[ M#/\ PF6_[<<_!'_M0=W?_!-]U>_=>ZU@O^%P7_,_?@-_XA_NC_WM-F>_=>ZT M8_?NO=>]^Z]U?=_PF$_[?G?!7_M8?(/_ .!1[V]^Z]U]@KW[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW0)_)3H[;'R:^//>/QVW MHJ_W5[QZF[ ZISLK0K.]'0;\VME-M2Y*F0E2M;BSD14T[J5>.>)&4A@"/=>Z M^%+V-L'<_578.^^K][8]\1O/K?>6Y]@[NQ4FK7C-S[/S==M[/X]]2HVNBRN. MEC-U!NOT'OW7ND;[]U[KWOW7NO>_=>Z][]U[K[%7_"<#XI?[*7_*"^*> R6- M_AV\^Z=O5WR8WUJB,$]5D^[9HMR;1-9 P$L%=C.J$V[CYD?UK)1D$*?2ONO= M7G>_=>Z][]U[KWOW7NO>_=>Z^!MV#_Q_N]__ []R_\ NYK??NO=)#W[KW7O M?NO=?6Z_X2?_ /;DKXY?^) ^1'_O[][^_=>ZV/O?NO=>]^Z]U[W[KW6N'_PI MH_E<_P##A_P*S&_NM]N_Q3Y-_$B'<';'52T%+YLUO/90H8)NV^J:<1I)45<^ MX]OXF+)XRGC1YJC-X:DIH]"U4Q/NO=?)#]^Z]U[W[KW7O?NO=?1)_P"$7\K_ +=W%Y-R];4^<[6^+M5E*J\V4Z^KZ]J_L_JZBDG9!)4;-W!D M#G\=3J99Y:')Y&P2GQR@>Z]UO7^_=>ZK-_FF_P J_P"./\UWX[UG2O=] <#O M# '(9CI?NO!XZEJM\=/[RJZ>*)LEBC-)3?QK:V;^UAAS>#FFCI*:(U^*JEI\KC&E05,"+)#)+[KW5>7OW7NO>_=>Z][]U[KWO MW7NO>_=>Z][]U[KWOW7NO>_=>Z^O5_PEE_[<8_##_M8?)7_X*[N_W[KW6P=[ M]U[KWOW7NO>_=>Z^3I_PKE_[?-]F?^(0Z$_]XWW[KW6LE[]U[KWOW7NMQS_A M%#_V\E^2O_BC^[__ '_/0'OW7NOIN>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW M7NO>_=>Z][]U[KWOW7NO_]+?X]^Z]UJ!?\+5O^W670?_ (O_ -6?_ Z_*KW[ MKW7S!/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=#Y\>_BO\DOECO.GZ]^-/1G:/>.\)Y8(Y<1UMLW-[H. M,CJ'T)79^OQU)+C-MXE#S+6Y":FI(4!:215!(]U[K>(_E)_\(_*[$YW:_>O\ MU'*8:J@QDU'FL-\0=@YZ/,4M;61,DT-/WAV/A*C^&U-#3RH?-@]MU%3!5C09 MZ]UON;>V[@-HX#";4VI@\/MG:^VL3C\#MS;FW\;1X; X#!XBDBH, M5AL+B,=#38_%XK&4,"0T]/!&D,,2*B*% 'OW7NGCW[KW7O?NO=$6_F%_R[/C M/_,S^/>:^/'R8VH^4PTTLF8V/O?!M34'8'56]$I9::@WKL+.S4U4,?E*=)3' M44\T<]!D:8M3U<$T+%??NO=?+W_F9?\ ";W^8;_+QSNXMRX/KW-?*7XW4<]5 M58?O+I/;F2SU5BL'&TCI+VIUICCEMW=_=>Z][]U[KWOW7NOL,_\ M"9;_ +<<_!'_ +4'=W_P3?=7OW7NM8+_ (7!?\S]^ W_ (A_NC_WM-F>_=>Z MT8_?NO=>]^Z]U?=_PF$_[?G?!7_M8?(/_P"!1[V]^Z]U]@KW[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?'Z_X4W]*[4Z M1_G0_+>@V:::'%=DU?7_ '578ZG\>O&[K[2Z^VYN7? JO';_ "G-;SGK\KR% M;1D%O?\ 4WNO=4&>_=>Z][]U[KWOW7NC?? +XK9[YN?-+XT?%/;\=69>Z^V] MJ[3SE90JSU.$V,M9_%^QMT(JAF*;3V!C,GDWL/T4A]^Z]U]R;!X3$;9PF'VW M@,?2XC [?Q>/PF$Q5#&(:+&8C%4D-!C]^Z]U[W[KW7P-NP?^/]WO\ ^'?N7_W_=>Z][]U[KWOW7NOD MA_\ "FC^5S_PWA\],IXT2"#"9FDIH];4LQ'NO=:X?OW7NO>_=>Z'KXN_(_L_X@_( M?I_Y-=-9?^"]E=+;YPV^-L5+F7[*MEQLQ3);?S,,$D,E9MS=6%GJ<9DZ;4HJ ML?5S0DV<^_=>Z^VU\*/EKUA\ZOBQTI\K^H*L3;)[EV50;DBQLE3#59#:FX(V MEQF\-C9N6 +$<_L;=E#6XJMT#QM44C-&3&R,?=>Z-)[]U[H"_D;\9N@OEUU1 MN+H_Y*]4[/[CZLW1&!E=I;RQHK::.KCCECI,SA:^%Z?+[:W)C/,S4>4QM129 M&BD.N":-N??NO=:%_P#,@_X1G=C; MY7VE\H?COVYT;F/N9*2C?L+9.:PF#SO5+M?=,M*^U]V41\;::G&5E73OI M;2YL;>Z]T67W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U]>K_ (2R_P#;C'X8 M?]K#Y*__ 5W=_OW7NM@[W[KW7O?NO=>]^Z]U\G3_A7+_P!OF^S/_$(="?\ MO&^_=>ZUDO?NO=>]^Z]UN.?\(H?^WDOR5_\ %']W_P#O^>@/?NO=?3<]^Z]U M[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=?_3W^/?NO=% ^:O MP*^)W\Q+JS =*?,7JG_3!UEM?L#%=I8+;7]^>R>O_L=]X3;FZMIXS._QGJW> M.R=P5/VVW][92G^UFJY*-_NM;Q-)'$\?NO=5@?\ 0+C_ "*/^\&?_9F?F'_] MT%[]U[KW_0+C_(H_[P9_]F9^8?\ ]T%[]U[KW_0+C_(H_P"\&?\ V9GYA_\ MW07OW7NO?] N/\BC_O!G_P!F9^8?_P!T%[]U[KW_ $"X_P BC_O!G_V9GYA_ M_=!>_=>Z]_T"X_R*/^\&?_9F?F'_ /=!>_=>Z]_T"X_R*/\ O!G_ -F9^8?_ M -T%[]U[KW_0+C_(H_[P9_\ 9F?F'_\ =!>_=>Z]_P! N/\ (H_[P9_]F9^8 M?_W07OW7NO?] N/\BC_O!G_V9GYA_P#W07OW7NO?] N/\BC_ +P9_P#9F?F' M_P#=!>_=>Z]_T"X_R*/^\&?_ &9GYA__ '07OW7NAUZN_P"$_?\ )HZ?K*:O MVC_+[Z-RE122))".SH=V]VTVN,W0RT7<^Z-_452 ?J)(W!_-_?NO=6M;%Z]V M#U?MNAV;UIL?:'7>T,6&7&;4V+MK"[2VWCE:P84.#P%%C\72!@HOXXEO;W[K MW2O]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=$;^07\LO^7M\J:^MS7R#^&7Q MR[0W-D6D:MWIGNJ]J0[_ *EI?\X9.P,3C\=O0ZSR?\O_ %<_47]^Z]U7UE_^ M$Q7\C/-U;UM9\%,5#-(Q9DQ'?ORHV_2 FP.B@P/>6-H8EXX"Q@#W[KW35_T" MX_R*/^\&?_9F?F'_ /=!>_=>Z]_T"X_R*/\ O!G_ -F9^8?_ -T%[]U[KW_0 M+C_(H_[P9_\ 9F?F'_\ =!>_=>ZN&^,OQFZ0^'/1NP_C;\<-D_Z.NENLZ?.4 MNR-F?WDW=N[^"0;CW/FMY9E/[Q;[S^Y]UY+[SK\/FL!L6N_TJ=U]>?P/$[AK:+(YB MD^VZI['V-1Y/[RLQ\+^2LCJ)8]%D95+ ^Z]T1C_H%Q_D4?\ >#/_ +,S\P__ M +H+W[KW7O\ H%Q_D4?]X,_^S,_,/_[H+W[KW0^?&#^0A_*:^&G>FQ?DI\;/ MBC_HX[KZTDW#+LG>G^G3Y*;P_@LFZMIYW8^>;^[F_>X]T[3R7W^U]S5U+:KH M)Q%Y_)'HF2.1/=>ZN"]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=$:_F5?,#) M? ;X-_(;Y?8C8M#V7DNC]JXC<=+L7)9Z?;%%N)\GO';>UFI*C/4N+S4^.2&/ M/&8.M+,6,06P#7'NO=:5'_0<7VI_WKMZ_P#_ $H[U=N8RCQF.@>6:2&AI(E>21PTC>Z]T7GW[KW7O?N MO=>]^Z]UOD_\(N_Y?=7EMZ]Y?S(]^X1DPNTL?7?'GX_S5U/Z*[=6]^Z M]U[W[KW5!N0_X3 _R,\K7UV4K_@_YZ[)5E37UL_^S+?+^+S5=9,]14R^*'O^ M.&/R32$Z455%[ <>_=>ZA_] N/\BC_O!G_V9GYA_P#W07OW7NO?] N/\BC_ M +P9_P#9F?F'_P#=!>_=>ZMO^)_Q'^/7P>Z2VY\<_BYU]_HPZ:VED-Q97;VS MO[U[WWK_ ^OW7G*[Z][]U[KWOW7NO>_=>Z*'\S_@9\2OYA?6&(Z;^8G3N-[EZ\P&[J#?>"P]5 MN7?&S*_#;KQN.RF(ILOB]T]<[GV?NV@=L9FJF":**N2"IBE*RHX"V]U[JKW_ M *!#/_LS/S#_^Z"]^Z]U[_H%Q_D4?]X,_^S,_,/\ ^Z"]^Z]U[_H% MQ_D4?]X,_P#LS/S#_P#N@O?NO=6@_"_X'_%C^7MUAE^F/B'UODNJ>L,WNZOW MW6[0JNS.V>RZ]T;WW[KW7O?NO=>]^Z]TR[AVWM[=V&K]N;KP.%W/M[*PFFR>"W#BZ'-8;) M4[$$P5^+R4%315D)(!*2(R\?3W[KW58G;'\CK^47W555-?OK^7S\:HJZL9I* MRNV%L.GZBK:N9V+R5-35]2U&R*B>JEZ*Y4?\ "7G^174S M23R?!B%7D8LRT_R1^7=)""?^.=/2]^PT\2_X*H'OW7NL/_0+C_(H_P"\&?\ MV9GYA_\ W07OW7NO?] N/\BC_O!G_P!F9^8?_P!T%[]U[KW_ $"X_P BC_O! MG_V9GYA__=!>_=>Z]_T"X_R*/^\&?_9F?F'_ /=!>_=>ZM[^+'Q6Z&^%71>R M_C7\9=B?Z-.E.O9-RR[/V7_>C>6\OX1)O#=F_=>Z]_T"X_R*/^\&?_ M &9GYA__ '07OW7NCC_"?^3A_+@_EU]D[E[>^''QS_T/=B;PV/6=;[BW#_I= M[W[!_B.RZ_/;?W/5X;^$]I=G[WP=)Y1']U[JS?W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U_]3?X]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW5*'_"C'_MRG\^_P#Q&&T__?N==^_=>Z^- MM[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[HTWPJ^('F/BITU0-1[ Z8V70;6QM5/%#%DMQ94O-DMT[S MSHIP('W%O?=-?69;(,@$9K*R30%32H]U[HS'OW7NO>_=>Z][]U[KWOW7NO>_ M=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K MWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_= M>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KW MOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[K__U=_CW[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z M]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=4H?\*,?^W*?S[_ /$8;3_]^YUW[]U[ MKXVWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[H;/CQ\<>\OECVWM/HKXZ=9;J M[:[6WM6I1X':&TL>U95LGDC2KRV5JY&AQNW]N8F.42U^4KYJ;'T%.&EJ)HHU M9A[KW7UC/Y#?\COK[^4ATQ6[EWI48/L+YE=OX6@B[D[+Q\33X?:&$$E/DH>G M>L:FK@AK(]FXK)0QS9&N9(:C<&1A2HF2."GH::E]U[K8 ]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U__6W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW M7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^ MZ]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7 MO?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U5Y_.D^.OQ=F9VJIO[P;VSFV]K8SQ8 MK$U$NNLKJ>-O'I#%V53[KW7S2/\ H%Q_GK_]X,_^S,_#S_[H+W[KW7O^@7'^ M>O\ ]X,_^S,_#S_[H+W[KW7O^@7'^>O_ -X,_P#LS/P\_P#N@O?NO=>_Z!=^-&QNM*:20(V6WM M\BNAJ_'PJ2 99(^N-_\ 8&5,:@W.BF=K?0$\>_=>ZN6^)G_")/?59D<9F_G' M\P-KX+#1312Y/KOXOX#)[DS.3I6TN],G:W9^&VWC]NUD8]+%=IY>,DG2]@&; MW7NMT/X+_P MKX9?RX>O9>O/B3TMM_KN+*14J[OWM4&;<79W8%32#5'5[X[! MS+U6XLW''.[RP40FBQ="\KBDI:=&*>_=>Z/1[]U[KWOW7NO>_=>Z][]U[KWO MW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z M][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW M7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z] M[]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7NO>_=>Z][]U[KWOW7 MNO_7W^/?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?N MO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[ MW[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO M=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W M[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO= M>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[ MKW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=> M]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[K JW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7O?NO=>]^Z]U[W[KW7__9 end XML 15 R32.htm IDEA: XBRL DOCUMENT v3.20.1
Derivative Instruments (Income Statement Location) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Foreign Exchange Contract    
Derivative Instruments, Gain (Loss) [Line Items]    
Net currency exchange rate gains (losses) $ (3) $ 0
Foreign Exchange Contract | Cost of sales    
Derivative Instruments, Gain (Loss) [Line Items]    
Net currency exchange rate gains (losses) (3) 2
Foreign Exchange Contract | Other income (expense), net    
Derivative Instruments, Gain (Loss) [Line Items]    
Net currency exchange rate gains (losses) (7) (2)
Net Investment Hedging [Member] | Other income (expense), net    
Derivative Instruments, Gain (Loss) [Line Items]    
Net currency exchange rate gains (losses) $ 7 $ 0
XML 16 R36.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies and Commitments (Narrative) (Details)
$ in Millions
Mar. 31, 2020
USD ($)
Minimum  
Loss Contingencies [Line Items]  
Estimate of possible loss $ 290
Maximum  
Loss Contingencies [Line Items]  
Estimate of possible loss $ 535
XML 17 R19.htm IDEA: XBRL DOCUMENT v3.20.1
Revenue Recognition (Tables)
 3 Months Ended
Mar. 31, 2020
Revenue Recognition [Abstract]  
Schedule of Disaggregated Revenue
We disaggregate our net sales by product line and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.
Net Sales by Product Line
 
 
 
Three Months
 
2020
2019
Orthopaedics:
 
 
Knees
$
432

$
439

Hips
316

336

Trauma and Extremities
392

396

Other
82

79

 
$
1,222

$
1,250

MedSurg:
 
 
Instruments
$
513

$
461

Endoscopy
455

470

Medical
587

531

Sustainability
67

65

 
$
1,622

$
1,527

Neurotechnology and Spine:
 
 
Neurotechnology
$
483

$
469

Spine
261

270

 
$
744

$
739

Total
$
3,588

$
3,516

Net Sales by Geography
 
 
 
 
 
 
Three Months 2020
 
Three Months 2019
 
United States
International
 
United States
International
Orthopaedics:
 
 
 
 
 
Knees
$
322

$
110

 
$
320

$
119

Hips
201

115

 
213

123

Trauma and Extremities
260

132

 
254

142

Other
69

13

 
63

16

 
$
852

$
370

 
$
850

$
400

MedSurg:
 
 
 
 
 
Instruments
$
410

$
103

 
$
365

$
96

Endoscopy
364

91

 
376

94

Medical
454

133

 
416

115

Sustainability
66

1

 
64

1

 
$
1,294

$
328

 
$
1,221

$
306

Neurotechnology and Spine:
 
 
 
 
 
Neurotechnology
$
301

$
182

 
$
300

$
169

Spine
196

65

 
208

62

 
$
497

$
247

 
$
508

$
231

Total
$
2,643

$
945

 
$
2,579

$
937
XML 18 R15.htm IDEA: XBRL DOCUMENT v3.20.1
Debt and Credit Facilities
 3 Months Ended
Mar. 31, 2020
Long-term Debt, Unclassified [Abstract]  
Debt And Credit Facilities DEBT AND CREDIT FACILITIES
We have lines of credit issued by various financial institutions that are available to fund our day-to-day operating needs. Certain of our credit facilities require us to comply with financial and other covenants. We were in compliance with all covenants on March 31, 2020.
Our commercial paper program allows us to have a maximum of $1,500 in commercial paper outstanding with maturities up to 397 days from the date of issuance. On March 31, 2020 there were no amounts outstanding under our commercial paper program.
Summary of Total Debt
March 2020
 
December 2019
Senior unsecured notes:
 
 
 
 
Rate
 
Due
 
 
 
 
4.375%
 
January 15, 2020
$
—

 
$
500

 
Variable
 
November 30, 2020
328

 
333

 
2.625%
 
March 15, 2021
749

 
749

 
1.125%
 
November 30, 2023
599

 
609

 
3.375%
 
May 15, 2024
588

 
587

 
0.250%
 
December 3, 2024
923

 
938

 
3.375%
 
November 1, 2025
746

 
746

 
3.500%
 
March 15, 2026
991

 
991

 
2.125%
 
November 30, 2027
815

 
829

 
3.650%
 
March 7, 2028
596

 
596

 
0.750%
 
March 1, 2029
869

 
884

 
2.625%
 
November 30, 2030
700

 
712

 
1.000%
 
December 3, 2031
809

 
823

 
4.100%
 
April 1, 2043
392

 
391

 
4.375%
 
May 15, 2044
395

 
395

 
4.625%
 
March 15, 2046
981

 
981

Other
26

 
26

Total debt
$
10,507

 
$
11,090

Less current maturities of debt
1,103

 
859

Total long-term debt
$
9,404

 
$
10,231

 
 
 
 

 
March 2020
 
December 2019
Unamortized debt issuance costs
$
56

 
$
58

Available secured borrowing capacity
$
1,403

 
$
1,403

Fair value of senior unsecured notes
$
10,904

 
$
11,910


The fair value of the senior unsecured notes was estimated using quoted interest rates, maturities and amounts of borrowings based on quoted active market prices and yields that took into account the underlying terms of the debt instruments. Substantially all of our debt is classified within Level 2 of the fair value hierarchy.
In January 2020 we repaid $500 of senior unsecured notes with a coupon of 4.375% that were due on January 15, 2020.
On April 30, 2020 we amended our primary credit facility. The principal change was to increase the leverage ratio financial covenant from 3.5:1 to 4.5:1 at the end of each fiscal quarter ending on or prior to June 30, 2021.
On April 30, 2020 we entered into a credit agreement that provides for up to $1,500 of borrowings in U.S. Dollars pursuant to a 364-day revolving credit facility, which matures on April 29, 2021 and is available for working capital and general corporate purposes.
XML 19 R11.htm IDEA: XBRL DOCUMENT v3.20.1
Derivative Instruments
 3 Months Ended
Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]  
Derivative Instruments DERIVATIVE INSTRUMENTS
We use operational and economic hedges, foreign currency exchange forward contracts, net investment hedges (both derivative and non-derivative financial instruments) and interest rate derivative instruments to manage the impact of currency exchange and interest rate fluctuations on earnings, cash flow and equity. We do not enter into derivative instruments for speculative purposes. We are exposed to potential credit loss in the event of nonperformance by our counterparties on our outstanding derivative instruments but do not anticipate nonperformance by any of our counterparties. Should a counterparty default, our maximum loss exposure is the asset balance of the instrument. We have not changed our hedging strategies, accounting practices or objectives from those disclosed in our Annual Report on Form 10-K for 2019.
Foreign Currency Hedges
March 2020
Cash Flow
Net Investment
Non-Designated
Total
Gross notional amount
$
837

$
1,094

$
5,275

$
7,206

Maximum term in days
 
 
 
1555

Fair value:
 
 
 
 
Other current assets
$
30

$
—

$
100

$
130

Other noncurrent assets
5

105

—

110

Other current liabilities
(2
)
—

(27
)
(29
)
Other noncurrent liabilities
—

—

—

—

Total fair value
$
33

$
105

$
73

$
211


December 2019
Cash Flow
Net Investment
Non-Designated
Total
Gross notional amount
$
801

$
1,113

$
6,174

$
8,088

Maximum term in days
 
 
 
1646

Fair value:
 
 
 
 
Other current assets
$
5

$
—

$
180

$
185

Other noncurrent assets
1

40

—

41

Other current liabilities
(10
)
—

(11
)
(21
)
Other noncurrent liabilities
(2
)
—

—

(2
)
Total fair value
$
(6
)
$
40

$
169

$
203


In December 2019 and November 2018 we designated the issuance of €2,400 and €2,250 of senior unsecured notes as net investment hedges to selectively hedge portions of our investment in certain international subsidiaries. The currency effects of our euro-denominated senior unsecured notes are reflected in AOCI within shareholders' equity where they offset gains and losses recorded on our net investment in international subsidiaries. On March 31, 2020 the total after tax gain amount in AOCI related to these designated net investment hedges was $83.
In July 2019 we entered into €1.0 billion in certain forward currency contracts and designated these as net investment hedges to hedge a portion of our investments in certain of our entities with functional currencies denominated in Euros.
Net Currency Exchange Rate Gains (Losses)
 
 
Three Months
Derivative instrument
Recorded in:
2020
2019
Cash Flow
Cost of sales
$
(3
)
$
2

Net Investment
Other income (expense), net
7

—

Non-Designated
Other income (expense), net
(7
)
(2
)
 
Total
$
(3
)
$
—


Pretax gains (losses) on derivatives designated as cash flow of $26 and net investment hedges of $27 recorded in AOCI are expected to be reclassified to cost of sales and other income (expense) in earnings within 12 months as of March 31, 2020. This cash flow hedge reclassification is primarily due to the sale of inventory that includes previously hedged purchases. A component of the AOCI amounts related to net investment hedges is reclassified over the life of the hedge instruments as we elected to exclude the initial value of the component related to the spot-forward difference from the effectiveness assessment.
Interest Rate Hedges
In conjunction with our offering of senior unsecured notes in November 2019 we terminated cash flow hedges with gross notional amounts of €600 designated as forward starting interest rate swaps of our interest rates, the impact of which will be recognized over time as a benefit within interest expense. Pretax gains recorded in AOCI related to closed interest rate hedges of $6 are expected to be reclassified to other income (expense) in earnings within 12 months of March 31, 2020.
On March 31, 2020 we had interest rate swap agreements with notional amounts of $750 designated as forward starting interest rate swaps in anticipation of future debt issuances. Pretax losses of $62 were recorded in AOCI as of March 31, 2020. Upon the probable issuance of the debt, these amounts will be released to interest expense over the term of the debt. The cash flow effect of these hedges is recorded in cash flow from operations.
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.20.1
Basis Of Presentation
 3 Months Ended
Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Basis of Presentation BASIS OF PRESENTATION
General Information
Management believes the accompanying unaudited Consolidated Financial Statements contain all adjustments, including normal recurring items, considered necessary to fairly present the financial position of Stryker Corporation and its consolidated subsidiaries (the "Company," "we," us" or "our") on March 31, 2020 and the results of operations for the three months 2020. The results of operations included in these Consolidated Financial Statements may not necessarily be indicative of our annual results. These statements should be read in conjunction with our Annual Report on Form 10-K for 2019.
Certain prior year amounts have been reclassified to conform with current year presentation of segment results.
New Accounting Pronouncements Not Yet Adopted
We evaluate all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB) for consideration of their applicability. ASUs not included in our disclosures were assessed and determined to be either not applicable or are not expected to have a material impact on our Consolidated Financial Statements.
Accounting Pronouncements Recently Adopted
On January 1, 2020 we adopted ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard replaces the incurred loss impairment methodology with a methodology that reflects expected credit losses for accounts receivables, loans and other financial instruments. The adoption of this update did not have a material impact on our Consolidated Financial Statements.
XML 21 R4.htm IDEA: XBRL DOCUMENT v3.20.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2020
Dec. 31, 2019
Current assets    
Cash and cash equivalents $ 3,964 $ 4,337
Marketable securities 84 88
Accounts receivable, less allowance of $100 ($88 in 2019) 2,646 2,893
Inventories:    
Materials and supplies 738 677
Work in process 187 178
Finished goods 2,434 2,427
Total inventories 3,359 3,282
Prepaid expenses and other current assets 683 760
Total current assets 10,736 11,360
Property, plant and equipment:    
Land, buildings and improvements 1,419 1,263
Machinery and equipment 3,357 3,451
Total property, plant and equipment 4,776 4,714
Less accumulated depreciation 2,169 2,147
Property, plant and equipment, net 2,607 2,567
Goodwill 9,025 9,069
Other intangibles, net 4,107 4,227
Noncurrent deferred income tax assets 1,537 1,575
Other noncurrent assets 1,428 1,369
Total assets 29,440 30,167
Current liabilities    
Accounts payable 736 675
Accrued compensation 430 955
Income taxes 227 171
Dividends payable 216 213
Accrued expenses and other liabilities 1,450 1,527
Current maturities of debt 1,103 859
Total current liabilities 4,162 4,400
Long-term debt, excluding current maturities 9,404 10,231
Income taxes 1,026 1,068
Other noncurrent liabilities 1,733 1,661
Total liabilities 16,325 17,360
Shareholders' equity    
Common stock, $0.10 par value 38 37
Additional paid-in capital 1,676 1,628
Retained earnings 12,024 11,748
Accumulated other comprehensive loss (623) (606)
Total shareholders' equity 13,115 12,807
Total liabilities and shareholders' equity $ 29,440 $ 30,167
XML 22 R42.htm IDEA: XBRL DOCUMENT v3.20.1
Income Taxes (Details)
 3 Months Ended
Mar. 31, 2020
Rate
Mar. 31, 2019
Rate
Income Tax [Abstract]    
Effective income tax rate reconciliation, percent 16.40% 14.20%
XML 23 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 24 R27.htm IDEA: XBRL DOCUMENT v3.20.1
Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
Mar. 31, 2020
Dec. 31, 2019
Revenue Recognition [Abstract]    
Contract liabilities $ 361 $ 313
XML 25 R23.htm IDEA: XBRL DOCUMENT v3.20.1
Contingencies and Commitments (Tables)
 3 Months Ended
Mar. 31, 2020
Commitments and Contingencies Disclosure [Abstract]  
Lease, Cost
Leases
March
 
December
2020
 
2019
Right-of-use assets
$
393

 
$
384

Lease liabilities, current
$
89

 
$
86

Lease liabilities, non-current
$
306

 
$
301

 
 
 
 
Other information
 
 
 
Weighted-average remaining lease term
5.9 years

 
6.2 years

Weighted-average discount rate
3.09
%
 
3.34
%
 
Three Months
 
2020
 
2019
Operating lease cost
$
36

 
34
XML 26 R43.htm IDEA: XBRL DOCUMENT v3.20.1
Segment Information (Sales And Other Financial Information By Business Segment) (Details) - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Segment Reporting Information [Line Items]    
Net sales $ 3,588 $ 3,516
Segment operating income 635 528
Amortization of intangible assets (118) (114)
Recall-related matters 6 (13)
Orthopaedics    
Segment Reporting Information [Line Items]    
Net sales 1,222 1,250
MedSurg    
Segment Reporting Information [Line Items]    
Net sales 1,622 1,527
Neurotechnology and Spine    
Segment Reporting Information [Line Items]    
Net sales 744 739
Operating Segments    
Segment Reporting Information [Line Items]    
Net sales 3,588 3,516
Segment operating income 999 1,013
Operating Segments | Orthopaedics    
Segment Reporting Information [Line Items]    
Net sales 1,222 1,250
Segment operating income 392 437
Operating Segments | MedSurg    
Segment Reporting Information [Line Items]    
Net sales 1,622 1,527
Segment operating income 401 377
Operating Segments | Neurotechnology and Spine    
Segment Reporting Information [Line Items]    
Net sales 744 739
Segment operating income 206 199
Corporate and other    
Segment Reporting Information [Line Items]    
Segment operating income (137) (132)
Segment Reconciling Items    
Segment Reporting Information [Line Items]    
Acquisition and integration-related charges (37) (138)
Amortization of intangible assets (118) (114)
Restructuring-related charges (54) (56)
Medical device regulations (24) (7)
Recall-related matters 6 (13)
Regulatory and legal matters $ 0 $ (25)
ZIP 27 0000310764-20-000069-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000310764-20-000069-xbrl.zip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end XML 28 R26.htm IDEA: XBRL DOCUMENT v3.20.1
    Segment Information (Tables)
    		 3 Months Ended
    Mar. 31, 2020
    Segment Reporting [Abstract]  
    Sales and Other Financial Information by Business Segment
     
    Three Months
     
    2020
    2019
    Orthopaedics
    $
    1,222

    $
    1,250

    MedSurg
    1,622

    1,527

    Neurotechnology and Spine
    744

    739

    Net sales
    $
    3,588

    $
    3,516

    Orthopaedics
    $
    392

    $
    437

    MedSurg
    401

    377

    Neurotechnology and Spine
    206

    199

    Segment operating income
    $
    999

    $
    1,013

    Items not allocated to segments:
     
     
    Corporate and other
    (137
    )
    (132
    )
    Acquisition and integration-related charges
    (37
    )
    (138
    )
    Amortization of intangible assets
    (118
    )
    (114
    )
    Restructuring-related charges
    (54
    )
    (56
    )
    Medical device regulations
    (24
    )
    (7
    )
    Recall-related matters
    6

    (13
    )
    Regulatory and legal matters
    —

    (25
    )
    Consolidated operating income
    $
    635

    $
    528

    XML 29 R22.htm IDEA: XBRL DOCUMENT v3.20.1
    Fair Value Measurements (Tables)
    		 3 Months Ended
    Mar. 31, 2020
    Fair Value Disclosures [Abstract]  
    Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis
    Assets Measured at Fair Value
    March
    December
    2020
    2019
    Cash and cash equivalents
    $
    3,964

    $
    4,337

    Trading marketable securities
    127

    149

    Level 1 - Assets
    $
    4,091

    $
    4,486

    Available-for-sale marketable securities:
     
     
    Corporate and asset-backed debt securities
    $
    32

    $
    32

    United States agency debt securities
    3

    2

    United States Treasury debt securities
    45

    49

    Certificates of deposit
    4

    5

    Total available-for-sale marketable securities
    $
    84

    $
    88

    Foreign currency exchange forward contracts
    240

    226

    Interest rate swap asset
    —

    17

    Level 2 - Assets
    $
    324

    $
    331

    Total assets measured at fair value
    $
    4,415

    $
    4,817


    Liabilities Measured at Fair Value
    March
    December
    2020
    2019
    Deferred compensation arrangements
    $
    127

    $
    149

    Level 1 - Liabilities
    $
    127

    $
    149

    Foreign currency exchange forward contracts
    $
    29

    $
    23

    Interest rate swap liability
    62

    —

    Level 2 - Liabilities
    $
    91

    $
    23

    Contingent consideration:
     
     
    Beginning
    $
    306

    $
    117

    Additions
    —

    298

    Change in estimate
    —

    (10
    )
    Settlements
    —

    (99
    )
    Ending
    $
    306

    $
    306

    Level 3 - Liabilities
    $
    306

    $
    306

    Total liabilities measured at fair value
    $
    524

    $
    478
    Investments Classified by Contractual Maturity Date
    Fair Value of Available for Sale Securities by Maturity
     
    March 2020
    December 2019
    Due in one year or less
    $
    46

    $
    50

    Due after one year through three years
    $
    38

    $
    38
    XML 30 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.1 html 320 286 1 false 84 0 false 7 false false R1.htm 0001000 - Document - Document and Entity Information Sheet http://www.stryker.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 1001000 - Statement - Consolidated Statements Of Earnings (Unaudited) Sheet http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited Consolidated Statements Of Earnings (Unaudited) Statements 2 false false R3.htm 1002000 - Statement - Consolidated Statements of Comprehensive Income (Unaudited) Sheet http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited Consolidated Statements of Comprehensive Income (Unaudited) Statements 3 false false R4.htm 1003000 - Statement - Consolidated Balance Sheets Sheet http://www.stryker.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 4 false false R5.htm 1003501 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.stryker.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 5 false false R6.htm 1004000 - Statement - Consolidated Statements Of Shareholders' Equity (Unaudited) Sheet http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited Consolidated Statements Of Shareholders' Equity (Unaudited) Statements 6 false false R7.htm 1005000 - Statement - Consolidated Statements Of Cash Flows (Unaudited) Sheet http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited Consolidated Statements Of Cash Flows (Unaudited) Statements 7 false false R8.htm 2101100 - Disclosure - Basis Of Presentation Sheet http://www.stryker.com/role/BasisOfPresentation Basis Of Presentation Notes 8 false false R9.htm 2104100 - Disclosure - Revenue Recognition Sheet http://www.stryker.com/role/RevenueRecognition Revenue Recognition Notes 9 false false R10.htm 2106100 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) Sheet http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAoci Accumulated Other Comprehensive (Loss) Income (AOCI) Notes 10 false false R11.htm 2107100 - Disclosure - Derivative Instruments Sheet http://www.stryker.com/role/DerivativeInstruments Derivative Instruments Notes 11 false false R12.htm 2108100 - Disclosure - Fair Value Measurements Sheet http://www.stryker.com/role/FairValueMeasurements Fair Value Measurements Notes 12 false false R13.htm 2111100 - Disclosure - Contingencies and Commitments Sheet http://www.stryker.com/role/ContingenciesAndCommitments Contingencies and Commitments Notes 13 false false R14.htm 2112100 - Disclosure - Acquisitions Sheet http://www.stryker.com/role/Acquisitions Acquisitions Notes 14 false false R15.htm 2114100 - Disclosure - Debt and Credit Facilities Sheet http://www.stryker.com/role/DebtAndCreditFacilities Debt and Credit Facilities Notes 15 false false R16.htm 2117100 - Disclosure - Income Taxes Sheet http://www.stryker.com/role/IncomeTaxes Income Taxes Notes 16 false false R17.htm 2118100 - Disclosure - Segment Information Sheet http://www.stryker.com/role/SegmentInformation Segment Information Notes 17 false false R18.htm 2201201 - Disclosure - Basis Of Presentation (Policies) Sheet http://www.stryker.com/role/BasisOfPresentationPolicies Basis Of Presentation (Policies) Policies 18 false false R19.htm 2304301 - Disclosure - Revenue Recognition (Tables) Sheet http://www.stryker.com/role/RevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.stryker.com/role/RevenueRecognition 19 false false R20.htm 2306301 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables) Sheet http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociTables Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables) Tables http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAoci 20 false false R21.htm 2307301 - Disclosure - Derivative Instruments (Tables) Sheet http://www.stryker.com/role/DerivativeInstrumentsTables Derivative Instruments (Tables) Tables http://www.stryker.com/role/DerivativeInstruments 21 false false R22.htm 2308301 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.stryker.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.stryker.com/role/FairValueMeasurements 22 false false R23.htm 2311301 - Disclosure - Contingencies and Commitments (Tables) Sheet http://www.stryker.com/role/ContingenciesAndCommitmentsTables Contingencies and Commitments (Tables) Tables http://www.stryker.com/role/ContingenciesAndCommitments 23 false false R24.htm 2312301 - Disclosure - Acquisitions (Tables) Sheet http://www.stryker.com/role/AcquisitionsTables Acquisitions (Tables) Tables http://www.stryker.com/role/Acquisitions 24 false false R25.htm 2314301 - Disclosure - Debt and Credit Facilities (Tables) Sheet http://www.stryker.com/role/DebtAndCreditFacilitiesTables Debt and Credit Facilities (Tables) Tables http://www.stryker.com/role/DebtAndCreditFacilities 25 false false R26.htm 2318301 - Disclosure - Segment Information (Tables) Sheet http://www.stryker.com/role/SegmentInformationTables Segment Information (Tables) Tables http://www.stryker.com/role/SegmentInformation 26 false false R27.htm 2404402 - Disclosure - Revenue Recognition - Narrative (Details) Sheet http://www.stryker.com/role/RevenueRecognitionNarrativeDetails Revenue Recognition - Narrative (Details) Details 27 false false R28.htm 2404403 - Disclosure - Revenue Recognition - Disaggregated Sales Analysis (Details) Sheet http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails Revenue Recognition - Disaggregated Sales Analysis (Details) Details 28 false false R29.htm 2406402 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Details) Sheet http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails Accumulated Other Comprehensive (Loss) Income (AOCI) (Details) Details http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociTables 29 false false R30.htm 2407402 - Disclosure - Derivative Instruments (Forward Currency Exchange Contracts) (Details) Sheet http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails Derivative Instruments (Forward Currency Exchange Contracts) (Details) Details http://www.stryker.com/role/DerivativeInstrumentsTables 30 false false R31.htm 2407403 - Disclosure - Derivative Instruments (Narrative) (Details) Sheet http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails Derivative Instruments (Narrative) (Details) Details http://www.stryker.com/role/DerivativeInstrumentsTables 31 false false R32.htm 2407404 - Disclosure - Derivative Instruments (Income Statement Location) (Details) Sheet http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails Derivative Instruments (Income Statement Location) (Details) Details http://www.stryker.com/role/DerivativeInstrumentsTables 32 false false R33.htm 2408402 - Disclosure - Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details) Sheet http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details) Details http://www.stryker.com/role/FairValueMeasurementsTables 33 false false R34.htm 2408403 - Disclosure - Fair Value Measurements (Assets and Liabilities Measured At Fair Value On A Recurring Basis Using Unobservable Inputs (Level 3)) (Details) Sheet http://www.stryker.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details Fair Value Measurements (Assets and Liabilities Measured At Fair Value On A Recurring Basis Using Unobservable Inputs (Level 3)) (Details) Details http://www.stryker.com/role/FairValueMeasurementsTables 34 false false R35.htm 2408404 - Disclosure - Fair Value Measurements (Narrative) (Details) Sheet http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails Fair Value Measurements (Narrative) (Details) Details http://www.stryker.com/role/FairValueMeasurementsTables 35 false false R36.htm 2411402 - Disclosure - Contingencies and Commitments (Narrative) (Details) Sheet http://www.stryker.com/role/ContingenciesAndCommitmentsNarrativeDetails Contingencies and Commitments (Narrative) (Details) Details http://www.stryker.com/role/ContingenciesAndCommitmentsTables 36 false false R37.htm 2411403 - Disclosure - Contingencies and Commitments - Leases (Details) Sheet http://www.stryker.com/role/ContingenciesAndCommitmentsLeasesDetails Contingencies and Commitments - Leases (Details) Details 37 false false R38.htm 2412402 - Disclosure - Acquisitions (Narrative) (Details) Sheet http://www.stryker.com/role/AcquisitionsNarrativeDetails Acquisitions (Narrative) (Details) Details http://www.stryker.com/role/AcquisitionsTables 38 false false R39.htm 2412403 - Disclosure - Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets (Details) Sheet http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets (Details) Details http://www.stryker.com/role/AcquisitionsTables 39 false false R40.htm 2412404 - Disclosure - Acquisitions (Future Amortization Expense) (Details) Sheet http://www.stryker.com/role/AcquisitionsFutureAmortizationExpenseDetails Acquisitions (Future Amortization Expense) (Details) Details http://www.stryker.com/role/AcquisitionsTables 40 false false R41.htm 2414402 - Disclosure - Debt and Credit Facilities (Details) Sheet http://www.stryker.com/role/DebtAndCreditFacilitiesDetails Debt and Credit Facilities (Details) Details http://www.stryker.com/role/DebtAndCreditFacilitiesTables 41 false false R42.htm 2417401 - Disclosure - Income Taxes (Details) Sheet http://www.stryker.com/role/IncomeTaxesDetails Income Taxes (Details) Details http://www.stryker.com/role/IncomeTaxes 42 false false R43.htm 2418402 - Disclosure - Segment Information (Sales And Other Financial Information By Business Segment) (Details) Sheet http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails Segment Information (Sales And Other Financial Information By Business Segment) (Details) Details http://www.stryker.com/role/SegmentInformationTables 43 false false All Reports Book All Reports syk10q3312020.htm ex10iamendcreditagreement.htm ex10ii364creditagreement.htm ex31i-331202010q.htm ex31ii-331202010q.htm ex32i-331202010q.htm ex32ii-331202010q.htm syk-20200331.xsd syk-20200331_cal.xml syk-20200331_def.xml syk-20200331_lab.xml syk-20200331_pre.xml strykerlogoa74.jpg http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/us-gaap/2018-01-31 http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/country/2017-01-31 true true XML 31 R33.htm IDEA: XBRL DOCUMENT v3.20.1
    Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 12 Months Ended
    Mar. 31, 2020
    Dec. 31, 2019
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Cash and cash equivalents $ 3,964 $ 4,337
    Assets    
    Available-for-sale securities, current 84 88
    Investments Fair Value Disclosure 4,415 4,817
    Contingent consideration:    
    Total liabilities measured at fair value 524 478
    Fair Value, Inputs, Level 1    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Cash and cash equivalents 3,964 4,337
    Trading marketable securities 127 149
    Assets    
    Investments Fair Value Disclosure 4,091 4,486
    Deferred compensation arrangements 127 149
    Contingent consideration:    
    Total liabilities measured at fair value 127 149
    Fair Value, Inputs, Level 2    
    Assets    
    Investments Fair Value Disclosure 324 331
    Contingent consideration:    
    Total liabilities measured at fair value 91 23
    Fair Value, Inputs, Level 2 | Foreign currency exchange forward contracts    
    Assets    
    Derivative asset 240 226
    Liabilities    
    Foreign currency exchange forward contracts 29 23
    Fair Value, Inputs, Level 2 | Interest Rate Swap    
    Assets    
    Derivative asset 0 17
    Liabilities    
    Foreign currency exchange forward contracts 62 0
    Fair Value, Inputs, Level 2 | Available-for-sale marketable securities:    
    Assets    
    Available-for-sale securities, current 84 88
    Fair Value, Inputs, Level 2 | Available-for-sale marketable securities: | Corporate and asset-backed debt securities    
    Assets    
    Available-for-sale securities, current 32 32
    Fair Value, Inputs, Level 2 | Available-for-sale marketable securities: | United States agency debt securities    
    Assets    
    Available-for-sale securities, current 3 2
    Fair Value, Inputs, Level 2 | Available-for-sale marketable securities: | United States Treasury debt securities    
    Assets    
    Available-for-sale securities, current 45 49
    Fair Value, Inputs, Level 2 | Available-for-sale marketable securities: | Certificates of deposit    
    Assets    
    Available-for-sale securities, current 4 5
    Fair Value, Inputs, Level 3    
    Contingent consideration:    
    Beginning 306 117
    Additions 0 298
    Change in estimate 0 (10)
    Settlements 0 (99)
    Ending 306 306
    Total liabilities measured at fair value $ 306 $ 306
    XML 32 R37.htm IDEA: XBRL DOCUMENT v3.20.1
    Contingencies and Commitments - Leases (Details) - USD ($)
    $ in Millions
    		 3 Months Ended 12 Months Ended
    Mar. 31, 2020
    Dec. 31, 2019
    Commitments and Contingencies Disclosure [Abstract]    
    Right-of-use assets $ 393 $ 384
    Lease liabilities, current 89 86
    Lease liabilities, non-current $ 306 $ 301
    Other information    
    Weighted-average remaining lease term 5 years 10 months 24 days 6 years 2 months 12 days
    Weighted-average discount rate 3.09% 3.34%
    Operating lease cost $ 36 $ 34
    XML 33 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 34 R14.htm IDEA: XBRL DOCUMENT v3.20.1
    Acquisitions
    		 3 Months Ended
    Mar. 31, 2020
    Business Combinations [Abstract]  
    Acquisitions ACQUISITIONS
    We acquire stock in companies and various assets that continue to support our capital deployment and product development strategies. The aggregate purchase price of our acquisitions, net of cash acquired was $23 and $308 in the three months 2020 and 2019.
    In October 2019 we completed the acquisition of Mobius Imaging and Cardan Robotics for net cash consideration of $360 and future regulatory and commercial milestone payments of up to $130. Mobius Imaging is a leader in point-of-care imaging technology focused on integrating advanced imaging technologies into medical workflow. Cardan Robotics is working to develop innovative robotics and navigation technology systems for surgical and interventional radiology procedures. Mobius Imaging and Cardan Robotics (Mobius) are part of our Spine business within Neurotechnology and Spine. For income tax purposes the acquisition was treated as an asset purchase. Goodwill attributable to the acquisition is deductible for tax purposes.
    In March 2019 we completed the acquisition of OrthoSpace, Ltd. (OrthoSpace) for net cash consideration of $110 and future regulatory milestone payments of up to $110. OrthoSpace is a medical device company specializing in orthopaedic biodegradable technology for the treatment of irreparable rotator cuff tears. OrthoSpace is part of our Endoscopy business within MedSurg. Goodwill attributable to the acquisition is not deductible for tax purposes.
    In November 2019 we announced a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. (Wright) for $30.75 per share, or an aggregate purchase price of approximately $5.4 billion (including convertible notes). Pursuant to the agreement, on December 13, 2019 our wholly owned subsidiary, Stryker B.V., commenced a tender offer to purchase all of the outstanding ordinary shares, par value €0.03 per share, of Wright at a price of $30.75 per share, without interest, but subject to any applicable withholding of taxes. We expect the acquisition to close in the second half of 2020, subject to the expiration of the waiting period (and any extension thereof) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the receipt of other required approvals and clearances under applicable antitrust laws and other customary conditions. Wright is a global medical device company focused on extremities and biologics. Following closing, we plan to integrate
    Wright into our Trauma and Extremities business within Orthopaedics.
    Purchase price allocations for our significant acquisitions are presented below:
    Purchase Price Allocation of Acquired Net Assets
     
    2019
     
    Mobius
     
    OrthoSpace
    Tangible assets:
     
     
     
    Accounts receivable
    $
    3

     
    $
    1

    Inventory
    6

     
    1

    Other assets
    2

     
    1

    Contingent consideration
    (4
    )
     
    —

    Other liabilities
    (10
    )
     
    (29
    )
    Intangible assets:
     
     
     
    Customer relationship
    7

     
    —

    Developed technology and patents
    59

     
    120

    In-process research and development
    98

     
    —

    Non-compete agreements
    9

     
    —

    Goodwill
    303

     
    114

    Purchase price, net of cash acquired
    $
    473

     
    $
    208

    Weighted-average life of intangible assets
    12

     
    18


    The purchase price allocation for Mobius is based on preliminary valuations, primarily related to intangible assets that are subject to change within the measurement period. The purchase price allocation for OrthoSpace was finalized in 2020.
    Estimated Amortization Expense
    Remainder of 2020
    2021
    2022
    2023
    2024
    $
    341

    $
    440

    $
    438

    $
    417

    $
    386
    XML 35 R10.htm IDEA: XBRL DOCUMENT v3.20.1
    Accumulated Other Comprehensive (Loss) Income (AOCI)
    		 3 Months Ended
    Mar. 31, 2020
    Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
    Accumulated Other Comprehensive (Loss) Income (AOCI) ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME (AOCI)
    Three Months 2020
    Marketable Securities
    Pension Plans
    Hedges
    Financial Statement Translation
    Total
    Beginning
    $
    (3
    )
    $
    (179
    )
    $
    47

    $
    (471
    )
    $
    (606
    )
    OCI
    1

    (6
    )
    (39
    )
    55

    11

    Income taxes
    —

    —

    11

    (37
    )
    (26
    )
    Reclassifications to:
     
     
     
     
     
    Cost of sales
    —

    —

    3

    —

    3

    Other (income) expense
    (1
    )
    3

    (1
    )
    (7
    )
    (6
    )
    Income taxes
    —

    (1
    )
    —

    2

    1

    Net OCI
    $
    —

    $
    (4
    )
    $
    (26
    )
    $
    13

    $
    (17
    )
    Ending
    $
    (3
    )
    $
    (183
    )
    $
    21

    $
    (458
    )
    $
    (623
    )

    Three Months 2019
    Marketable Securities
    Pension Plans
    Hedges
    Financial Statement Translation
    Total
    Beginning
    $
    (4
    )
    $
    (137
    )
    $
    50

    $
    (540
    )
    $
    (631
    )
    OCI
    1

    (6
    )
    (19
    )
    94

    70

    Income taxes
    —

    1

    6

    (9
    )
    (2
    )
    Reclassifications to:
     
     
     
     
     
    Cost of sales
    —

    —

    (2
    )
    —

    (2
    )
    Other (income) expense
    —

    1

    —

    —

    1

    Income taxes
    —

    —

    (1
    )
    —

    (1
    )
    Net OCI
    $
    1

    $
    (4
    )
    $
    (16
    )
    $
    85

    $
    66

    Ending
    $
    (3
    )
    $
    (141
    )
    $
    34

    $
    (455
    )
    $
    (565
    )
    XML 36 R18.htm IDEA: XBRL DOCUMENT v3.20.1
    Basis Of Presentation (Policies)
    		 3 Months Ended
    Mar. 31, 2020
    Organization, Consolidation and Presentation of Financial Statements [Abstract]  
    New Accounting Pronouncements Not Yet Adopted
    New Accounting Pronouncements Not Yet Adopted
    We evaluate all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB) for consideration of their applicability. ASUs not included in our disclosures were assessed and determined to be either not applicable or are not expected to have a material impact on our Consolidated Financial Statements.
    Accounting Pronouncements Recently Adopted
    Accounting Pronouncements Recently Adopted
    On January 1, 2020 we adopted ASU 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments. The standard replaces the incurred loss impairment methodology with a methodology that reflects expected credit losses for accounts receivables, loans and other financial instruments. The adoption of this update did not have a material impact on our Consolidated Financial Statements.
    XML 37 R1.htm IDEA: XBRL DOCUMENT v3.20.1
    Document and Entity Information
    		 3 Months Ended
    Mar. 31, 2020
    shares
    Document Information [Line Items]  
    Document Type 10-Q
    Document Quarterly Report true
    Document Period End Date Mar. 31, 2020
    Document Transition Report false
    Entity File Number 001-13149
    Entity Registrant Name STRYKER CORP
    Entity Incorporation, State or Country Code MI
    Entity Tax Identification Number 38-1239739
    Entity Address, Address Line One 2825 Airview Boulevard
    Entity Address, City or Town  Kalamazoo,
    Entity Address, State or Province MI
    Entity Address, Postal Zip Code 49002
    City Area Code (269)
    Local Phone Number 385-2600
    Entity Current Reporting Status Yes
    Entity Interactive Data Current Yes
    Entity Filer Category Large Accelerated Filer
    Entity Small Business false
    Entity Emerging Growth Company false
    Entity Shell Company false
    Entity Common Stock, Shares Outstanding 375,378,477
    Amendment Flag false
    Document Fiscal Year Focus 2020
    Document Fiscal Period Focus Q1
    Entity Central Index Key 0000310764
    Current Fiscal Year End Date --12-31
    Common Stock  
    Document Information [Line Items]  
    Title of each class Common Stock, $.10 Par Value
    Trading Symbol SYK
    Security Exchange Name NYSE
    Senior Unsecured Notes 1.125% due 2021  
    Document Information [Line Items]  
    Title of each class 1.125% Notes due 2023
    Trading Symbol SYK23
    Security Exchange Name NYSE
    Senior Unsecured Notes 2.125% due 2027  
    Document Information [Line Items]  
    Title of each class 2.125% Notes due 2027
    Trading Symbol SYK27
    Security Exchange Name NYSE
    Senior Unsecured Notes 2.625% due 2030  
    Document Information [Line Items]  
    Title of each class 2.625% Notes due 2030
    Trading Symbol SYK30
    Security Exchange Name NYSE
    Senior Unsecured Notes Variable due 2020  
    Document Information [Line Items]  
    Title of each class Floating Rate Notes due 2020
    Trading Symbol SYK20A
    Security Exchange Name NYSE
    XML 38 syk10q3312020_htm.xml IDEA: XBRL DOCUMENT 0000310764 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.125Due2027Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes1.125Due2021Member 2020-01-01 2020-03-31 0000310764 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.625Due2030Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotesVariableInterestRateDueNovember2020Member 2020-01-01 2020-03-31 0000310764 2020-03-31 0000310764 2019-01-01 2019-03-31 0000310764 2019-12-31 0000310764 us-gaap:NoncontrollingInterestMember 2020-03-31 0000310764 us-gaap:RetainedEarningsMember 2019-03-31 0000310764 us-gaap:CommonStockMember 2018-12-31 0000310764 us-gaap:RetainedEarningsMember 2018-12-31 0000310764 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000310764 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000310764 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000310764 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0000310764 us-gaap:CommonStockMember 2019-03-31 0000310764 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0000310764 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000310764 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000310764 us-gaap:CommonStockMember 2020-03-31 0000310764 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000310764 us-gaap:CommonStockMember 2019-12-31 0000310764 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000310764 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000310764 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0000310764 us-gaap:NoncontrollingInterestMember 2019-03-31 0000310764 2019-03-31 0000310764 us-gaap:RetainedEarningsMember 2020-03-31 0000310764 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000310764 us-gaap:RetainedEarningsMember 2019-12-31 0000310764 us-gaap:ParentMember 2020-03-31 0000310764 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000310764 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000310764 us-gaap:ParentMember 2019-03-31 0000310764 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000310764 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000310764 2018-12-31 0000310764 syk:NeurotechnologyMember us-gaap:NonUsMember syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 syk:NeurotechnologyMember country:US syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 syk:SustainabilityMember us-gaap:NonUsMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 us-gaap:NonUsMember syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 us-gaap:NonUsMember syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 country:US syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:InstrumentsMember us-gaap:NonUsMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:SpineMember country:US syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 country:US syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:OtherOrthopaedicsDomain country:US syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:InstrumentsMember country:US syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:MedicalMember us-gaap:NonUsMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:KneesMember us-gaap:NonUsMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:TraumaandExtremitiesMember country:US syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:HipsMember us-gaap:NonUsMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:KneesMember country:US syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:SpineMember us-gaap:NonUsMember syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 syk:OtherOrthopaedicsDomain country:US syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:InstrumentsMember us-gaap:NonUsMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:EndoscopyMember country:US syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 country:US syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 syk:EndoscopyMember us-gaap:NonUsMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:EndoscopyMember us-gaap:NonUsMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 country:US syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:SustainabilityMember us-gaap:NonUsMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:KneesMember us-gaap:NonUsMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 us-gaap:NonUsMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:TraumaandExtremitiesMember country:US syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:SpineMember country:US syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 syk:SpineMember us-gaap:NonUsMember syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 syk:InstrumentsMember country:US syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 country:US syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:MedicalMember country:US syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 us-gaap:NonUsMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 us-gaap:NonUsMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 country:US 2019-01-01 2019-03-31 0000310764 country:US 2020-01-01 2020-03-31 0000310764 us-gaap:NonUsMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:OtherOrthopaedicsDomain us-gaap:NonUsMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:EndoscopyMember country:US syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:HipsMember country:US syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 country:US syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 syk:NeurotechnologyMember country:US syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 syk:NeurotechnologyMember us-gaap:NonUsMember syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 syk:HipsMember us-gaap:NonUsMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 us-gaap:NonUsMember 2020-01-01 2020-03-31 0000310764 syk:MedicalMember us-gaap:NonUsMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 us-gaap:NonUsMember 2019-01-01 2019-03-31 0000310764 syk:OtherOrthopaedicsDomain us-gaap:NonUsMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:SustainabilityMember country:US syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:MedicalMember country:US syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:HipsMember country:US syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:TraumaandExtremitiesMember us-gaap:NonUsMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:KneesMember country:US syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:TraumaandExtremitiesMember us-gaap:NonUsMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:SustainabilityMember country:US syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:HipsMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:HipsMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:EndoscopyMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:OtherOrthopaedicsDomain syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:TraumaandExtremitiesMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:SpineMember syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 syk:SustainabilityMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 syk:EndoscopyMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:InstrumentsMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:NeurotechnologyMember syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 syk:MedicalMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:MedicalMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:KneesMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 syk:InstrumentsMember syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:TraumaandExtremitiesMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 syk:MedsurgMember 2019-01-01 2019-03-31 0000310764 syk:SustainabilityMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 syk:KneesMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:SpineMember syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 syk:OtherOrthopaedicsDomain syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 syk:NeurotechnologyMember syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-03-31 0000310764 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-03-31 0000310764 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000310764 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-01-01 2020-03-31 0000310764 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-12-31 0000310764 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-01-01 2020-03-31 0000310764 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-12-31 0000310764 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000310764 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2020-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000310764 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000310764 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2020-01-01 2020-03-31 0000310764 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-12-31 0000310764 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2020-03-31 0000310764 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-03-31 0000310764 us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-01-01 2019-03-31 0000310764 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-01-01 2019-03-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0000310764 us-gaap:AccumulatedTranslationAdjustmentMember 2018-12-31 0000310764 us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember us-gaap:AccumulatedTranslationAdjustmentMember 2019-01-01 2019-03-31 0000310764 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-03-31 0000310764 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2019-03-31 0000310764 us-gaap:AccumulatedTranslationAdjustmentMember 2019-03-31 0000310764 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2018-12-31 0000310764 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2019-01-01 2019-03-31 0000310764 us-gaap:AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember 2019-03-31 0000310764 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2018-12-31 0000310764 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2018-12-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember 2019-01-01 2019-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-03-31 0000310764 us-gaap:NetInvestmentHedgingMember us-gaap:OtherNonoperatingIncomeExpenseMember 2020-01-01 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember 2020-01-01 2020-03-31 0000310764 us-gaap:NetInvestmentHedgingMember us-gaap:OtherNonoperatingIncomeExpenseMember 2019-01-01 2019-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2019-01-01 2019-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:CostOfSalesMember 2020-01-01 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2020-03-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:NetInvestmentHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2020-03-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000310764 us-gaap:ForeignExchangeContractMember 2019-01-01 2019-12-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000310764 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:OtherCurrentLiabilitiesMember us-gaap:ForeignExchangeContractMember us-gaap:CashFlowHedgingMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-12-31 0000310764 us-gaap:ForeignExchangeContractMember 2019-12-31 0000310764 us-gaap:OtherNoncurrentAssetsMember us-gaap:ForeignExchangeContractMember 2019-12-31 0000310764 us-gaap:OtherCurrentAssetsMember us-gaap:ForeignExchangeContractMember us-gaap:NondesignatedMember 2019-12-31 0000310764 us-gaap:AccruedLiabilitiesMember us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-01-01 2019-12-31 0000310764 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2018-11-30 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2020-01-01 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-07-31 0000310764 us-gaap:InterestRateSwapMember us-gaap:DesignatedAsHedgingInstrumentMember 2019-11-30 0000310764 us-gaap:FairValueInputsLevel2Member 2019-12-31 0000310764 us-gaap:FairValueInputsLevel3Member 2020-03-31 0000310764 us-gaap:FairValueInputsLevel3Member 2019-12-31 0000310764 us-gaap:FairValueInputsLevel3Member 2020-01-01 2020-03-31 0000310764 us-gaap:FairValueInputsLevel2Member 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member 2020-03-31 0000310764 us-gaap:FairValueInputsLevel1Member 2019-12-31 0000310764 us-gaap:FairValueInputsLevel1Member 2020-03-31 0000310764 us-gaap:ForeignExchangeContractMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000310764 us-gaap:FairValueInputsLevel3Member 2018-12-31 0000310764 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2019-12-31 0000310764 us-gaap:FairValueInputsLevel3Member 2019-01-01 2019-12-31 0000310764 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel2Member 2020-03-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:AssetBackedSecuritiesMember 2019-12-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:CertificatesOfDepositMember 2020-03-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:USTreasurySecuritiesMember 2020-03-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:CertificatesOfDepositMember 2019-12-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:USTreasurySecuritiesMember 2019-12-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember 2020-03-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2019-12-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:USGovernmentAgenciesDebtSecuritiesMember 2020-03-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember 2019-12-31 0000310764 us-gaap:FairValueInputsLevel2Member us-gaap:AvailableforsaleSecuritiesMember us-gaap:AssetBackedSecuritiesMember 2020-03-31 0000310764 srt:MinimumMember 2020-03-31 0000310764 srt:MaximumMember 2020-03-31 0000310764 2019-01-01 2019-12-31 0000310764 syk:WrightMember 2019-12-13 2019-12-13 0000310764 syk:WrightMember 2019-11-01 2019-11-30 0000310764 syk:MobiusMember 2019-10-01 2019-10-31 0000310764 syk:OrthoSpaceLtd.Member 2019-03-01 2019-03-31 0000310764 syk:OrthoSpaceLtd.Member 2019-12-31 0000310764 syk:OrthoSpaceLtd.Member us-gaap:DevelopedTechnologyRightsMember 2019-12-31 0000310764 syk:MobiusMember 2019-12-31 0000310764 syk:MobiusMember 2019-01-01 2019-12-31 0000310764 syk:MobiusMember us-gaap:DevelopedTechnologyRightsMember 2019-12-31 0000310764 syk:OrthoSpaceLtd.Member us-gaap:CustomerRelationshipsMember 2019-12-31 0000310764 syk:MobiusMember us-gaap:NoncompeteAgreementsMember 2019-12-31 0000310764 syk:OrthoSpaceLtd.Member 2019-01-01 2019-12-31 0000310764 syk:MobiusMember syk:InternallyDevelopedSoftwareMember 2019-12-31 0000310764 syk:OrthoSpaceLtd.Member us-gaap:NoncompeteAgreementsMember 2019-12-31 0000310764 syk:MobiusMember us-gaap:CustomerRelationshipsMember 2019-12-31 0000310764 syk:OrthoSpaceLtd.Member syk:InternallyDevelopedSoftwareMember 2019-12-31 0000310764 us-gaap:RevolvingCreditFacilityMember 2020-03-31 0000310764 us-gaap:RevolvingCreditFacilityMember syk:CreditAgreementMember us-gaap:SubsequentEventMember 2020-04-30 0000310764 us-gaap:CommercialPaperMember 2020-01-01 2020-03-31 0000310764 us-gaap:RevolvingCreditFacilityMember syk:CreditAgreementMember us-gaap:SubsequentEventMember 2020-04-30 2020-04-30 0000310764 syk:SeniorUnsecuredNotes4375Due2020Member 2020-01-31 0000310764 us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember 2020-04-30 0000310764 srt:MaximumMember us-gaap:CommercialPaperMember 2020-03-31 0000310764 syk:SeniorUnsecuredNotes1.125Due2021Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.375due2025MemberMember 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.375due2024Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes0.750due2029Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotesVariableInterestRateDueNovember2020Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.625due2021MemberDomain 2019-12-31 0000310764 syk:SeniorUnsecuredNotes4.625due2046MemberDomainDomain 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.125Due2027Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes2.625Due2030Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes410Due2043Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes1.125Due2021Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes1.000due2031Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.50due2026MemberDomain 2020-03-31 0000310764 syk:SeniorUnsecuredNotes4375Due2020Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes4.375due2044Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.625due2021MemberDomain 2020-03-31 0000310764 syk:SeniorUnsecuredNotes0.250due2024Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes3.650due2028Domain 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes1.125Due2021Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotesVariableInterestRateDueNovember2020Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes4.625due2046MemberDomainDomain 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes410Due2043Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.650due2028Domain 2019-12-31 0000310764 syk:SeniorUnsecuredNotes410Due2043Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes2.125Due2027Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.625Due2030Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes4.625due2046MemberDomainDomain 2019-12-31 0000310764 syk:SeniorUnsecuredNotes3.375due2025MemberMember 2019-12-31 0000310764 syk:SeniorUnsecuredNotes0.250due2024Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes4375Due2020Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes3.375due2024Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes0.750due2029Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotesVariableInterestRateDueNovember2020Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes0.250due2024Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes4.375due2044Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes1.000due2031Member 2019-12-31 0000310764 syk:SeniorUnsecuredNotes3.375due2025MemberMember 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.125Due2027Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes1.000due2031Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.625Due2030Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes0.750due2029Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.650due2028Domain 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.50due2026MemberDomain 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.375due2024Member 2020-03-31 0000310764 syk:SeniorUnsecuredNotes2.625due2021MemberDomain 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes3.50due2026MemberDomain 2019-12-31 0000310764 syk:SeniorUnsecuredNotes4375Due2020Member 2020-01-01 2020-03-31 0000310764 syk:SeniorUnsecuredNotes4.375due2044Member 2020-01-01 2020-03-31 0000310764 us-gaap:MaterialReconcilingItemsMember 2019-01-01 2019-03-31 0000310764 us-gaap:MaterialReconcilingItemsMember 2020-01-01 2020-03-31 0000310764 us-gaap:OperatingSegmentsMember syk:NeurotechnologyAndSpineMember 2020-01-01 2020-03-31 0000310764 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-03-31 0000310764 us-gaap:OperatingSegmentsMember syk:MedsurgMember 2020-01-01 2020-03-31 0000310764 us-gaap:OperatingSegmentsMember syk:NeurotechnologyAndSpineMember 2019-01-01 2019-03-31 0000310764 us-gaap:CorporateNonSegmentMember 2020-01-01 2020-03-31 0000310764 us-gaap:OperatingSegmentsMember 2019-01-01 2019-03-31 0000310764 us-gaap:OperatingSegmentsMember 2020-01-01 2020-03-31 0000310764 us-gaap:OperatingSegmentsMember syk:OrthopaedicsMember 2019-01-01 2019-03-31 0000310764 us-gaap:OperatingSegmentsMember syk:OrthopaedicsMember 2020-01-01 2020-03-31 0000310764 us-gaap:OperatingSegmentsMember syk:MedsurgMember 2019-01-01 2019-03-31 pure iso4217:EUR utreg:Rate iso4217:EUR shares shares iso4217:USD iso4217:USD shares false --12-31 Q1 2020 0000310764 88000000 100000000 0.1 0.1 10-Q true 2020-03-31 false 001-13149 STRYKER CORP MI 38-1239739 2825 Airview Boulevard  Kalamazoo, MI 49002 (269) 385-2600 Common Stock, $.10 Par Value SYK NYSE 1.125% Notes due 2023 SYK23 NYSE 2.125% Notes due 2027 SYK27 NYSE 2.625% Notes due 2030 SYK30 NYSE Floating Rate Notes due 2020 SYK20A NYSE Yes Yes Large Accelerated Filer false false false 375378477 3588000000 3516000000 1257000000 1233000000 2331000000 2283000000 254000000 225000000 1330000000 1403000000 -6000000 13000000 118000000 114000000 1696000000 1755000000 635000000 528000000 -45000000 -48000000 590000000 480000000 97000000 68000000 493000000 412000000 1.32 1.10 1.30 1.09 374800000 373300000 4900000 6000000.0 379700000 379300000 0.575 0.52 493000000 412000000 0 1000000 4000000 4000000 -26000000 -16000000 13000000 85000000 -17000000 66000000 476000000 478000000 3964000000 4337000000 84000000 88000000 2646000000 2893000000 738000000 677000000 187000000 178000000 2434000000 2427000000 3359000000 3282000000 683000000 760000000 10736000000 11360000000 1419000000 1263000000 3357000000 3451000000 4776000000 4714000000 2169000000 2147000000 2607000000 2567000000 9025000000 9069000000 4107000000 4227000000 1537000000 1575000000 1428000000 1369000000 29440000000 30167000000 736000000 675000000 430000000 955000000 227000000 171000000 216000000 213000000 1450000000 1527000000 1103000000 859000000 4162000000 4400000000 9404000000 10231000000 1026000000 1068000000 1733000000 1661000000 16325000000 17360000000 38000000 37000000 1676000000 1628000000 12024000000 11748000000 -623000000 -606000000 13115000000 12807000000 29440000000 30167000000 374500000 374400000 900000 1300000 0 1900000 375400000 373800000 37000000 37000000 1000000 38000000 37000000 1628000000 1559000000 -8000000 -48000000 8000000 56000000 35000000 1676000000 1538000000 11748000000 10765000000 493000000 412000000 299000000 217000000 195000000 12024000000 10683000000 -606000000 -631000000 -17000000 66000000 -623000000 -565000000 13115000000 11693000000 0 0 13115000000 11693000000 493000000 412000000 80000000 76000000 118000000 114000000 56000000 35000000 -6000000 13000000 6000000 24000000 -204000000 -50000000 122000000 139000000 63000000 -12000000 -550000000 -166000000 -4000000 -20000000 84000000 9000000 -169000000 83000000 591000000 313000000 23000000 180000000 8000000 20000000 12000000 19000000 144000000 122000000 -163000000 -303000000 4000000 -12000000 500000000 1341000000 215000000 195000000 0 307000000 -56000000 -97000000 -1000000 5000000 -768000000 -1947000000 -33000000 -5000000 -373000000 -1942000000 4337000000 3616000000 3964000000 1674000000 BASIS OF PRESENTATION<div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">General Information</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Management believes the accompanying unaudited Consolidated Financial Statements contain all adjustments, including normal recurring items, considered necessary to fairly present the financial position of Stryker Corporation and its consolidated subsidiaries (the "Company," "we," us" or "our") on </span><span style="font-family:Arial;font-size:9pt;">March 31, 2020</span><span style="font-family:Arial;font-size:9pt;"> and the results of operations for the </span><span style="font-family:Arial;font-size:9pt;">three months 2020</span><span style="font-family:Arial;font-size:9pt;">. The results of operations included in these Consolidated Financial Statements may not necessarily be indicative of our annual results. These statements should be read in conjunction with our Annual Report on Form 10-K for </span><span style="font-family:Arial;font-size:9pt;">2019</span><span style="font-family:Arial;font-size:9pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Certain prior year amounts have been reclassified to conform with current year presentation of segment results.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">New Accounting Pronouncements Not Yet Adopted </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">We evaluate all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB) for consideration of their applicability. ASUs not included in our disclosures were assessed and determined to be either not applicable or are not expected to have a material impact on our Consolidated Financial Statements.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Accounting Pronouncements Recently Adopted </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">On January 1, 2020 we adopted ASU 2016-13, </span><span style="font-family:Arial;font-size:9pt;font-style:italic;">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="font-family:Arial;font-size:9pt;">. The standard replaces the incurred loss impairment methodology with a methodology that reflects expected credit losses for accounts receivables, loans and other financial instruments. The adoption of this update did not have a material impact on our Consolidated Financial Statements.</span></div> <div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">New Accounting Pronouncements Not Yet Adopted </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">We evaluate all Accounting Standards Updates (ASUs) issued by the Financial Accounting Standards Board (FASB) for consideration of their applicability. ASUs not included in our disclosures were assessed and determined to be either not applicable or are not expected to have a material impact on our Consolidated Financial Statements.</span></div> <div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Accounting Pronouncements Recently Adopted </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">On January 1, 2020 we adopted ASU 2016-13, </span><span style="font-family:Arial;font-size:9pt;font-style:italic;">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="font-family:Arial;font-size:9pt;">. The standard replaces the incurred loss impairment methodology with a methodology that reflects expected credit losses for accounts receivables, loans and other financial instruments. The adoption of this update did not have a material impact on our Consolidated Financial Statements.</span></div> REVENUE RECOGNITION<div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Our policies for recognizing sales have not changed from those described in our Annual Report on Form 10-K for </span><span style="font-family:Arial;font-size:9pt;">2019</span><span style="font-family:Arial;font-size:9pt;">.</span></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">We disaggregate our net sales by product line and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:66%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Net Sales by Product Line</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Orthopaedics:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Knees</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>439</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Hips</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>316</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>336</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Trauma and Extremities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>396</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>82</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>79</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,222</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,250</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">MedSurg:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>513</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>461</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Endoscopy</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>455</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>470</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>587</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>531</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Sustainability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>67</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,622</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,527</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Neurotechnology and Spine:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Neurotechnology</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>483</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>469</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Spine</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>261</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>270</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>744</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>739</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>3,588</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>3,516</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Net Sales by Geography</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:Arial;font-size:6pt;font-weight:bold;">United States</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:Arial;font-size:6pt;font-weight:bold;">International</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:Arial;font-size:6pt;font-weight:bold;">United States</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:Arial;font-size:6pt;font-weight:bold;">International</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Orthopaedics:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Knees</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>322</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>110</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>320</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>119</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Hips</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>201</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>115</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>123</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Trauma and Extremities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>260</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>132</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>254</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>142</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>69</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>63</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>852</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>370</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>850</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>400</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">MedSurg:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>410</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>103</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>365</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>96</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Endoscopy</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>364</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>91</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>376</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>454</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>133</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>416</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>115</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Sustainability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>66</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,294</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>328</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,221</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>306</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Neurotechnology and Spine:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Neurotechnology</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>301</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>182</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>300</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>169</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Spine</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>196</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>208</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>62</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>497</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>247</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>508</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>231</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>2,643</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>945</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>2,579</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>937</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;padding-top:8px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-style:italic;font-weight:bold;">Contract Assets and Liabilities </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">On </span><span style="font-family:Arial;font-size:9pt;">March 31, 2020</span><span style="font-family:Arial;font-size:9pt;"> there were no contract assets recorded on our Consolidated Balance Sheets. </span></div><span style="font-family:Arial;font-size:9pt;">Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. We generally satisfy performance obligations within one year from the contract inception date. Our contract liabilities were </span><span style="font-family:Arial;font-size:9pt;"><span>$361</span></span><span style="font-family:Arial;font-size:9pt;"> and </span><span style="font-family:Arial;font-size:9pt;"><span>$313</span></span><span style="font-family:Arial;font-size:9pt;"> on </span><span style="font-family:Arial;font-size:9pt;">March 31, 2020</span><span style="font-family:Arial;font-size:9pt;"> and </span><span style="font-family:Arial;font-size:9pt;">December 31, 2019</span>. <div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">We disaggregate our net sales by product line and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:66%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Net Sales by Product Line</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Orthopaedics:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Knees</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>432</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>439</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Hips</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>316</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>336</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Trauma and Extremities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>396</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>82</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>79</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,222</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,250</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">MedSurg:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>513</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>461</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Endoscopy</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>455</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>470</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>587</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>531</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Sustainability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>67</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,622</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,527</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Neurotechnology and Spine:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Neurotechnology</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>483</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>469</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Spine</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>261</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>270</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>744</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>739</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>3,588</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>3,516</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="14"/></tr><tr><td style="width:40%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Net Sales by Geography</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months 2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:Arial;font-size:6pt;font-weight:bold;">United States</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:Arial;font-size:6pt;font-weight:bold;">International</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:Arial;font-size:6pt;font-weight:bold;">United States</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:6pt;"><span style="font-family:Arial;font-size:6pt;font-weight:bold;">International</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Orthopaedics:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Knees</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>322</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>110</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>320</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>119</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Hips</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>201</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>115</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>213</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>123</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Trauma and Extremities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>260</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>132</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>254</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>142</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>69</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>63</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>852</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>370</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>850</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>400</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">MedSurg:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Instruments</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>410</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>103</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>365</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>96</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Endoscopy</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>364</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>91</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>376</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Medical</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>454</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>133</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>416</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>115</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Sustainability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>66</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>64</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,294</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>328</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,221</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>306</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Neurotechnology and Spine:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Neurotechnology</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>301</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>182</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>300</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>169</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Spine</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>196</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>65</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>208</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>62</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>497</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>247</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>508</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>231</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>2,643</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>945</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>2,579</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>937</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div></div> 432000000 439000000 316000000 336000000 392000000 396000000 82000000 79000000 1222000000 1250000000 513000000 461000000 455000000 470000000 587000000 531000000 67000000 65000000 1622000000 1527000000 483000000 469000000 261000000 270000000 744000000 739000000 3588000000 3516000000 322000000 110000000 320000000 119000000 201000000 115000000 213000000 123000000 260000000 132000000 254000000 142000000 69000000 13000000 63000000 16000000 852000000 370000000 850000000 400000000 410000000 103000000 365000000 96000000 364000000 91000000 376000000 94000000 454000000 133000000 416000000 115000000 66000000 1000000 64000000 1000000 1294000000 328000000 1221000000 306000000 301000000 182000000 300000000 169000000 196000000 65000000 208000000 62000000 497000000 247000000 508000000 231000000 2643000000 945000000 2579000000 937000000 361000000 313000000 ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME (AOCI)<div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months 2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Marketable Securities</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Pension Plans</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Financial Statement Translation</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Beginning</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(179</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>47</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(471</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(606</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">OCI </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(39</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>55</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(37</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Reclassifications to:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Cost of sales</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:Arial;font-size:7.5pt;">Other (income) expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Net OCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(26</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(17</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Ending</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(183</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(458</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(623</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months 2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Marketable Securities</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Pension Plans</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Financial Statement Translation</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Beginning</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(137</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>50</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(540</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(631</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">OCI </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>70</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Reclassifications to:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Cost of sales</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:Arial;font-size:7.5pt;">Other (income) expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Net OCI</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>85</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>66</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Ending</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(141</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>34</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(455</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(565</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months 2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Marketable Securities</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Pension Plans</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Financial Statement Translation</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Beginning</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(179</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>47</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(471</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(606</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">OCI </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(39</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>55</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(37</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Reclassifications to:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Cost of sales</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:Arial;font-size:7.5pt;">Other (income) expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Net OCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(26</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(17</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Ending</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(183</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(458</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(623</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months 2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Marketable Securities</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Pension Plans</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Financial Statement Translation</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Beginning</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(137</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>50</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(540</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(631</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">OCI </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>70</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Reclassifications to:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Cost of sales</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:Arial;font-size:7.5pt;">Other (income) expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Net OCI</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>85</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>66</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Ending</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(141</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>34</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(455</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(565</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> <div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months 2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Marketable Securities</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Pension Plans</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Financial Statement Translation</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Beginning</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(179</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>47</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(471</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(606</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">OCI </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(39</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>55</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(37</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Reclassifications to:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Cost of sales</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:Arial;font-size:7.5pt;">Other (income) expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Net OCI</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(26</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>13</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(17</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Ending</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(183</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>21</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(458</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(623</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"/></tr><tr><td style="width:29%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:11%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:10%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months 2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Marketable Securities</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Pension Plans</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Hedges</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Financial Statement Translation</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Beginning</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(4</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(137</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>50</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(540</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(631</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">OCI </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(6</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(19</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>94</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>70</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(9</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Reclassifications to:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Cost of sales</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7.5pt;"><span style="font-family:Arial;font-size:7.5pt;">Other (income) expense</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Income taxes</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Net OCI</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(16</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>85</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>66</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Ending</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(141</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>34</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(455</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(565</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> -3000000 -179000000 47000000 -471000000 -606000000 1000000 -6000000 -39000000 55000000 11000000 0 0 11000000 -37000000 -26000000 0 0 3000000 0 3000000 -1000000 3000000 -1000000 -7000000 -6000000 0 1000000 0 -2000000 -1000000 0 -4000000 -26000000 13000000 -17000000 -3000000 -183000000 21000000 -458000000 -623000000 -4000000 -137000000 50000000 -540000000 -631000000 1000000 -6000000 -19000000 94000000 70000000 0 1000000 6000000 -9000000 -2000000 0 0 -2000000 0 -2000000 0 1000000 0 0 1000000 0 0 1000000 0 1000000 1000000 -4000000 -16000000 85000000 66000000 -3000000 -141000000 34000000 -455000000 -565000000 DERIVATIVE INSTRUMENTS<div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">We use operational and economic hedges, foreign currency exchange forward contracts, net investment hedges (both derivative and non-derivative financial instruments) and interest rate derivative instruments to manage the impact of currency exchange and interest rate fluctuations on earnings, cash flow and equity. We do not enter into derivative instruments for speculative purposes. We are exposed to potential credit loss in the event of nonperformance by our counterparties on our outstanding derivative instruments but do not anticipate nonperformance by any of our counterparties. Should a counterparty default, our maximum loss exposure is the asset balance of the instrument. We have not changed our hedging strategies, accounting practices or objectives from those disclosed in our Annual Report on Form 10-K for </span><span style="font-family:Arial;font-size:9pt;">2019</span><span style="font-family:Arial;font-size:9pt;">. </span></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Foreign Currency Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:33%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">March 2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Cash Flow</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Net Investment</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Non-Designated</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Gross notional amount</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>837</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,094</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>5,275</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>7,206</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Maximum term in days</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1555</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Fair value:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>130</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other noncurrent assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>105</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>110</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other noncurrent liabilities</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>33</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>105</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>73</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>211</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:33%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">December 2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Cash Flow</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Net Investment</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Non-Designated</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Gross notional amount</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>801</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,113</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>6,174</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>8,088</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Maximum term in days</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1646</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Fair value:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>180</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>185</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other noncurrent assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>40</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other noncurrent liabilities</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>40</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>169</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>203</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In December 2019 and November 2018 we designated the issuance of </span><span style="font-family:Arial;font-size:9pt;"><span>€2,400</span></span><span style="font-family:Arial;font-size:9pt;"> and </span><span style="font-family:Arial;font-size:9pt;"><span>€2,250</span></span><span style="font-family:Arial;font-size:9pt;"> of senior unsecured notes as net investment hedges to selectively hedge portions of our investment in certain international subsidiaries. The currency effects of our euro-denominated senior unsecured notes are reflected in AOCI within shareholders' equity where they offset gains and losses recorded on our net investment in international subsidiaries. On </span><span style="font-family:Arial;font-size:9pt;">March 31, 2020</span><span style="font-family:Arial;font-size:9pt;"> the total after tax gain amount in AOCI related to these designated net investment hedges was </span><span style="font-family:Arial;font-size:9pt;"><span>$83</span></span><span style="font-family:Arial;font-size:9pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In July 2019 we entered into </span><span style="font-family:Arial;font-size:9pt;"><span>€1.0 billion</span></span><span style="font-family:Arial;font-size:9pt;"> in certain forward currency contracts and designated these as net investment hedges to hedge a portion of our investments in certain of our entities with functional currencies denominated in Euros.</span></div><div style="line-height:120%;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-style:italic;font-weight:bold;">Net Currency Exchange Rate Gains (Losses)</span></div><div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:31%;"/><td style="width:39%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Derivative instrument</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Recorded in:</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Cash Flow</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Net Investment</span></div></td><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other income (expense), net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Non-Designated</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other income (expense), net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Pretax gains (losses) on derivatives designated as cash flow of </span><span style="font-family:Arial;font-size:9pt;"><span>$26</span></span><span style="font-family:Arial;font-size:9pt;"> and net investment hedges of </span><span style="font-family:Arial;font-size:9pt;"><span>$27</span></span><span style="font-family:Arial;font-size:9pt;"> recorded in AOCI are expected to be reclassified to cost of sales and other income (expense) in earnings within 12 months as of </span><span style="font-family:Arial;font-size:9pt;">March 31, 2020</span><span style="font-family:Arial;font-size:9pt;">. This cash flow hedge reclassification is primarily due to the sale of inventory that includes previously hedged purchases. A component of the AOCI amounts related to net investment hedges is reclassified over the life of the hedge instruments as we elected to exclude the initial value of the component related to the spot-forward difference from the effectiveness assessment. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Interest Rate Hedges</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In conjunction with our offering of senior unsecured notes in November 2019 we terminated cash flow hedges with gross notional amounts of </span><span style="font-family:Arial;font-size:9pt;"><span>€600</span></span><span style="font-family:Arial;font-size:9pt;"> designated as forward starting interest rate swaps of our interest rates, the impact of which will be recognized over time as a benefit within interest expense. Pretax gains recorded in AOCI related to closed interest rate hedges of </span><span style="font-family:Arial;font-size:9pt;"><span>$6</span></span><span style="font-family:Arial;font-size:9pt;"> are expected to be reclassified to other income (expense) in earnings within 12 months of </span><span style="font-family:Arial;font-size:9pt;">March 31, 2020</span><span style="font-family:Arial;font-size:9pt;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">On </span><span style="font-family:Arial;font-size:9pt;">March 31, 2020</span><span style="font-family:Arial;font-size:9pt;"> we had interest rate swap agreements with notional amounts of </span><span style="font-family:Arial;font-size:9pt;"><span>$750</span></span><span style="font-family:Arial;font-size:9pt;"> designated as forward starting interest rate swaps in anticipation of future debt issuances. Pretax losses of </span><span style="font-family:Arial;font-size:9pt;"><span>$62</span></span><span style="font-family:Arial;font-size:9pt;"> were recorded in AOCI as of </span><span style="font-family:Arial;font-size:9pt;">March 31, 2020</span><span style="font-family:Arial;font-size:9pt;">. Upon the probable issuance of the debt, these amounts will be released to interest expense over the term of the debt. The cash flow effect of these hedges is recorded in cash flow from operations.</span></div> <div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:33%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">March 2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Cash Flow</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Net Investment</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Non-Designated</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Gross notional amount</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>837</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,094</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>5,275</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>7,206</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Maximum term in days</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1555</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Fair value:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>30</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>100</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>130</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other noncurrent assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>105</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>110</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(27</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other noncurrent liabilities</span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>33</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>105</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>73</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>211</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="13"/></tr><tr><td style="width:33%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:15%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:14%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">December 2019</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Cash Flow</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Net Investment</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Non-Designated</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Gross notional amount</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>801</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,113</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>6,174</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>8,088</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Maximum term in days</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1646</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Fair value:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other current assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>180</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>185</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other noncurrent assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>40</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>41</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other current liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(11</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(21</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other noncurrent liabilities</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:middle;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(6</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>40</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>169</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>203</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 837000000 1094000000 5275000000 7206000000 P1555D 30000000 0 100000000 130000000 5000000 105000000 0 110000000 2000000 0 -27000000 29000000 0 0 0 0 33000000 105000000 73000000 211000000 801000000 1113000000 6174000000 8088000000 P1646D 5000000 0 180000000 185000000 1000000 40000000 0 41000000 10000000 0 -11000000 21000000 -2000000 0 0 2000000 -6000000 40000000 169000000 203000000 2400000000 2250000000 83000000 1000000000.0 <div style="line-height:120%;padding-bottom:4px;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:31%;"/><td style="width:39%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:13%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Derivative instrument</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Recorded in:</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Cash Flow</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Cost of sales</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Net Investment</span></div></td><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other income (expense), net</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Non-Designated</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other income (expense), net</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>(3</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-right:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">)</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> -3000000 2000000 7000000 0 -7000000 -2000000 -3000000 0 26000000 27000000 600000000 6000000 750000000 62000000 FAIR VALUE MEASUREMENTS <div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Our policies for managing risk related to foreign currency, interest rates, credit and markets and our process for determining fair value have not changed from those described in our Annual Report on Form 10-K for </span><span style="font-family:Arial;font-size:9pt;">2019</span><span style="font-family:Arial;font-size:9pt;">.</span></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">There were no significant transfers into or out of any level in </span><span style="font-family:Arial;font-size:9pt;">2020</span><span style="font-family:Arial;font-size:9pt;">.</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Assets Measured at Fair Value</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">March</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">December</span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3,964</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>4,337</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Trading marketable securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>127</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>149</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Level 1 - Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>4,091</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>4,486</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Available-for-sale marketable securities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Corporate and asset-backed debt securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">United States agency debt securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">United States Treasury debt securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>45</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Certificates of deposit</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Total available-for-sale marketable securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>84</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>88</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Foreign currency exchange forward contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>240</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>226</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Interest rate swap asset</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Level 2 - Assets</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>324</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>331</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>4,415</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>4,817</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Liabilities Measured at Fair Value</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">March</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">December</span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Deferred compensation arrangements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>127</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>149</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Level 1 - Liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>127</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>149</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Foreign currency exchange forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Interest rate swap liability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>62</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Level 2 - Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>91</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Contingent consideration:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Beginning</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>306</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>117</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>298</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Change in estimate</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(99</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Ending</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>306</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>306</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Level 3 - Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>306</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>306</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total liabilities measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>524</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>478</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:55%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/></tr><tr><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Fair Value of Available for Sale Securities by Maturity</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">March 2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">December 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Due in one year or less</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>50</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Due after one year through three years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">On </span><span style="font-family:Arial;font-size:9pt;">March 31, 2020</span><span style="font-family:Arial;font-size:9pt;"> and </span><span style="font-family:Arial;font-size:9pt;">December 31, 2019</span><span style="font-family:Arial;font-size:9pt;"> the aggregate difference between the cost and fair value of available-for-sale marketable securities was nominal. Interest and marketable securities income recorded in other income (expense), net, was </span><span style="font-family:Arial;font-size:9pt;"><span>$40</span></span><span style="font-family:Arial;font-size:9pt;"> and </span><span style="font-family:Arial;font-size:9pt;"><span>$39</span></span><span style="font-family:Arial;font-size:9pt;"> in the </span><span style="font-family:Arial;font-size:9pt;">three months</span><span style="font-family:Arial;font-size:9pt;"> </span><span style="font-family:Arial;font-size:9pt;">2020</span><span style="font-family:Arial;font-size:9pt;"> and </span><span style="font-family:Arial;font-size:9pt;">2019</span><span style="font-family:Arial;font-size:9pt;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Our investments in available-for-sale marketable securities had a minimum credit quality rating of A2 (Moody's), A (Standard &amp; Poor's) and A (Fitch). We do not plan to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis, which may be maturity. </span></div> <div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Assets Measured at Fair Value</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">March</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">December</span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Cash and cash equivalents</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3,964</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>4,337</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Trading marketable securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>127</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>149</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Level 1 - Assets</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>4,091</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>4,486</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Available-for-sale marketable securities:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Corporate and asset-backed debt securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>32</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">United States agency debt securities</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">United States Treasury debt securities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>45</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>49</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Certificates of deposit</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>4</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>5</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Total available-for-sale marketable securities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>84</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>88</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Foreign currency exchange forward contracts</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>240</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>226</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Interest rate swap asset</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>17</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Level 2 - Assets</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>324</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>331</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total assets measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>4,415</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>4,817</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:justify;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Liabilities Measured at Fair Value</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">March</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">December</span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Deferred compensation arrangements</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>127</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>149</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Level 1 - Liabilities</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>127</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>149</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Foreign currency exchange forward contracts</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>29</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Interest rate swap liability</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>62</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Level 2 - Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>91</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>23</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Contingent consideration:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Beginning</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>306</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>117</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Additions</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>298</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Change in estimate</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Settlements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(99</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Ending</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>306</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>306</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Level 3 - Liabilities</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>306</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>306</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total liabilities measured at fair value</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>524</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>478</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 3964000000 4337000000 127000000 149000000 4091000000 4486000000 32000000 32000000 3000000 2000000 45000000 49000000 4000000 5000000 84000000 88000000 240000000 226000000 0 17000000 324000000 331000000 4415000000 4817000000 127000000 149000000 127000000 149000000 29000000 23000000 62000000 0 91000000 23000000 306000000 117000000 0 298000000 0 10000000 0 99000000 306000000 306000000 306000000 306000000 524000000 478000000 <div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:55%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:20%;"/><td style="width:1%;"/></tr><tr><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Fair Value of Available for Sale Securities by Maturity</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">March 2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">December 2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Due in one year or less</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>46</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>50</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Due after one year through three years</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>38</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 46000000 50000000 38000000 38000000 40000000 39000000 CONTINGENCIES AND COMMITMENTS<div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">We are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor, intellectual property and other matters that are more fully described below. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings, the claimants seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect future operating results. We are self-insured for product liability claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Recall Matters</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In June 2012 we voluntarily recalled our Rejuvenate and ABG II Modular-Neck hip stems and terminated global distribution of these hip products. Product liability lawsuits relating to this voluntary recall have been filed against us. In November 2014 we entered into a settlement agreement to compensate eligible United States patients who had revision surgery prior to November 3, 2014 and in December 2016 the settlement program was extended to patients who had revision surgery prior to December 19, 2016. We continue to offer support for recall-related care and reimburse patients who are not eligible to enroll in the settlement program for testing and treatment services, including any necessary revision surgeries. In addition, there are remaining lawsuits that we will continue to defend against. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In August 2016 and May 2018 we voluntarily recalled certain lot-specific sizes and offsets of LFIT Anatomic CoCr V40 Femoral Heads. Product liability lawsuits and claims relating to this voluntary recall have been filed against us. In November 2018 we entered into a settlement agreement to resolve a significant number of claims and lawsuits related to the recalls. The specific terms of the settlement agreement, including the financial terms, are confidential. </span></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">We have incurred, and expect to incur in the future, costs associated with the defense and settlement of these matters. Based on the </span></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">information that has been received, we have estimated the remaining range of probable loss related to these matters globally to be approximately </span><span style="font-family:Arial;font-size:9pt;"><span>$290</span></span><span style="font-family:Arial;font-size:9pt;"> to </span><span style="font-family:Arial;font-size:9pt;"><span>$535</span></span><span style="font-family:Arial;font-size:9pt;">. We have recorded charges to earnings representing the minimum of the range of probable loss. The final outcomes of these matters are dependent on many factors that are difficult to predict. Accordingly, the ultimate cost related to these matters globally may be materially different than the amount of our current estimate and accruals and could have a material adverse effect on our results of operations and cash flows.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Leases</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">March</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">December</span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Right-of-use assets </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>393</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>384</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Lease liabilities, current </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>89</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>86</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Lease liabilities, non-current </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>306</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>301</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Other information</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Weighted-average remaining lease term </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>5.9 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>6.2 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Weighted-average discount rate</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3.09</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3.34</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Operating lease cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 290000000 535000000 <div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:56%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:19%;"/><td style="width:1%;"/></tr><tr><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:4px;text-align:left;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;font-weight:bold;">Leases</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">March</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">December</span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Right-of-use assets </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>393</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>384</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Lease liabilities, current </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>89</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>86</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Lease liabilities, non-current </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>306</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>301</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:8px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Other information</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Weighted-average remaining lease term </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>5.9 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>6.2 years</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Weighted-average discount rate</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3.09</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">%</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3.34</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">%</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Operating lease cost</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>36</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>34</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 393000000 384000000 89000000 86000000 306000000 301000000 P5Y10M24D P6Y2M12D 0.0309 0.0334 36000000 34000000 ACQUISITIONS<div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">We acquire stock in companies and various assets that continue to support our capital deployment and product development strategies. The aggregate purchase price of our acquisitions, net of cash acquired was </span><span style="font-family:Arial;font-size:9pt;"><span>$23</span></span><span style="font-family:Arial;font-size:9pt;"> and </span><span style="font-family:Arial;font-size:9pt;"><span>$308</span></span><span style="font-family:Arial;font-size:9pt;"> in the </span><span style="font-family:Arial;font-size:9pt;">three months</span><span style="font-family:Arial;font-size:9pt;"> </span><span style="font-family:Arial;font-size:9pt;">2020</span><span style="font-family:Arial;font-size:9pt;"> and </span><span style="font-family:Arial;font-size:9pt;">2019</span><span style="font-family:Arial;font-size:9pt;">. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In October 2019 we completed the acquisition of Mobius Imaging and Cardan Robotics for net cash consideration of </span><span style="font-family:Arial;font-size:9pt;"><span>$360</span></span><span style="font-family:Arial;font-size:9pt;"> and future regulatory and commercial milestone payments of up to </span><span style="font-family:Arial;font-size:9pt;"><span>$130</span></span><span style="font-family:Arial;font-size:9pt;">. Mobius Imaging is a leader in point-of-care imaging technology focused on integrating advanced imaging technologies into medical workflow. Cardan Robotics is working to develop innovative robotics and navigation technology systems for surgical and interventional radiology procedures. Mobius Imaging and Cardan Robotics (Mobius) are part of our Spine business within Neurotechnology and Spine. For income tax purposes the acquisition was treated as an asset purchase. Goodwill attributable to the acquisition is deductible for tax purposes. </span></div><div style="line-height:120%;padding-bottom:4px;padding-top:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In March 2019 we completed the acquisition of OrthoSpace, Ltd. (OrthoSpace) for net cash consideration of </span><span style="font-family:Arial;font-size:9pt;"><span>$110</span></span><span style="font-family:Arial;font-size:9pt;"> and future regulatory milestone payments of up to </span><span style="font-family:Arial;font-size:9pt;"><span>$110</span></span><span style="font-family:Arial;font-size:9pt;">. OrthoSpace is a medical device company specializing in orthopaedic biodegradable technology for the treatment of irreparable rotator cuff tears. OrthoSpace is part of our Endoscopy business within MedSurg. Goodwill attributable to the acquisition is not deductible for tax purposes.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In November 2019 we announced a definitive agreement to acquire all of the issued and outstanding ordinary shares of Wright Medical Group N.V. (Wright) for </span><span style="font-family:Arial;font-size:9pt;"><span>$30.75</span></span><span style="font-family:Arial;font-size:9pt;"> per share, or an aggregate purchase price of approximately </span><span style="font-family:Arial;font-size:9pt;"><span>$5.4 billion</span></span><span style="font-family:Arial;font-size:9pt;"> (including convertible notes). Pursuant to the agreement, on December 13, 2019 our wholly owned subsidiary, Stryker B.V., commenced a tender offer to purchase all of the outstanding ordinary shares, par value </span><span style="font-family:Arial;font-size:9pt;"><span>€0.03</span></span><span style="font-family:Arial;font-size:9pt;"> per share, of Wright at a price of </span><span style="font-family:Arial;font-size:9pt;"><span>$30.75</span></span><span style="font-family:Arial;font-size:9pt;"> per share, without interest, but subject to any applicable withholding of taxes. We expect the acquisition to close in the second half of 2020, subject to the expiration of the waiting period (and any extension thereof) under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the receipt of other required approvals and clearances under applicable antitrust laws and other customary conditions. Wright is a global medical device company focused on extremities and biologics. Following closing, we plan to integrate </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Wright into our Trauma and Extremities business within Orthopaedics.</span></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Purchase price allocations for our significant acquisitions are presented below:</span></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:60%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td colspan="8" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Purchase Price Allocation of Acquired Net Assets</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Mobius</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">OrthoSpace</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Tangible assets:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Inventory</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Contingent consideration</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Intangible assets:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Customer relationship</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Developed technology and patents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>59</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>120</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">In-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>98</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Non-compete agreements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>303</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>114</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Purchase price, net of cash acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>473</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>208</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Weighted-average life of intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">The purchase price allocation for Mobius is based on preliminary valuations, primarily related to intangible assets that are subject to change within the measurement period. The purchase price allocation for OrthoSpace was finalized in 2020.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/></tr><tr><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Estimated Amortization Expense</span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Remainder of 2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2021</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2022</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2023</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2024</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>341</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>440</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>438</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>417</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>386</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 23000000 308000000 360000000 130000000 110000000 110000000 30.75 5400000000 0.03 30.75 <div style="line-height:120%;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"/></tr><tr><td style="width:60%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td colspan="8" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Purchase Price Allocation of Acquired Net Assets</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Mobius</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">OrthoSpace</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Tangible assets:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Accounts receivable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Inventory</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Contingent consideration</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(4</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other liabilities</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(10</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(29</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Intangible assets:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Customer relationship</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>7</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Developed technology and patents</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>59</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>120</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">In-process research and development</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>98</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Non-compete agreements</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>9</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Goodwill</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>303</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>114</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Purchase price, net of cash acquired</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>473</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>208</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Weighted-average life of intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>12</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:3px double #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>18</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:3px double #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 3000000 1000000 6000000 1000000 2000000 1000000 4000000 0 10000000 29000000 7000000 0 59000000 120000000 98000000 0 9000000 0 303000000 114000000 473000000 208000000 P12Y P18Y <div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="15"/></tr><tr><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:18%;"/><td style="width:1%;"/></tr><tr><td colspan="15" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Estimated Amortization Expense</span></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Remainder of 2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2021</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2022</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2023</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2024</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>341</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>440</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>438</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>417</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>386</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 341000000 440000000 438000000 417000000 386000000 DEBT AND CREDIT FACILITIES<div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">We have lines of credit issued by various financial institutions that are available to fund our day-to-day operating needs. Certain of our credit facilities require us to comply with financial and other covenants. We were in compliance with all covenants on </span><span style="font-family:Arial;font-size:9pt;">March 31, 2020</span><span style="font-family:Arial;font-size:9pt;">.</span></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Our commercial paper program allows us to have a maximum of </span><span style="font-family:Arial;font-size:9pt;"><span>$1,500</span></span><span style="font-family:Arial;font-size:9pt;"> in commercial paper outstanding with maturities up to </span><span style="font-family:Arial;font-size:9pt;"><span>397</span></span><span style="font-family:Arial;font-size:9pt;"> days from the date of issuance. On </span><span style="font-family:Arial;font-size:9pt;">March 31, 2020</span><span style="font-family:Arial;font-size:9pt;"> there were </span><span style="font-family:Arial;font-size:9pt;"><span>no</span></span><span style="font-family:Arial;font-size:9pt;"> amounts outstanding under our commercial paper program.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:1%;"/><td style="width:13%;"/><td style="width:2%;"/><td style="width:36%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Summary of Total Debt</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">March 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">December 2019</span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Senior unsecured notes:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;text-decoration:underline;">Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;text-decoration:underline;">Due</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>4.375%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">January 15, 2020</span></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Variable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">November 30, 2020</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>328</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>333</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2.625%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">March 15, 2021</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>749</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>749</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1.125%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">November 30, 2023</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>599</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>609</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3.375%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">May 15, 2024</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>588</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>587</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>0.250%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">December 3, 2024</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>923</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>938</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3.375%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">November 1, 2025</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>746</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>746</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3.500%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">March 15, 2026</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>991</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>991</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2.125%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">November 30, 2027</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>815</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>829</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3.650%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">March 7, 2028</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>596</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>596</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>0.750%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">March 1, 2029</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>869</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>884</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2.625%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">November 30, 2030</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>700</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>712</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1.000%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">December 3, 2031</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>809</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>823</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>4.100%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">April 1, 2043</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>391</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>4.375%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">May 15, 2044</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>395</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>395</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>4.625%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">March 15, 2046</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>981</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>981</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>10,507</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>11,090</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Less current maturities of debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1,103</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>859</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total long-term debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>9,404</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>10,231</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:1%;"/><td style="width:13%;"/><td style="width:2%;"/><td style="width:36%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">March 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">December 2019</span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Unamortized debt issuance costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>58</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Available secured borrowing capacity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1,403</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1,403</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Fair value of senior unsecured notes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>10,904</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>11,910</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">The fair value of the senior unsecured notes was estimated using quoted interest rates, maturities and amounts of borrowings based on quoted active market prices and yields that took into account the underlying terms of the debt instruments. Substantially all of our debt is classified within Level 2 of the fair value hierarchy. </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In January 2020 we repaid </span><span style="font-family:Arial;font-size:9pt;"><span>$500</span></span><span style="font-family:Arial;font-size:9pt;"> of senior unsecured notes with a coupon of </span><span style="font-family:Arial;font-size:9pt;"><span>4.375%</span></span><span style="font-family:Arial;font-size:9pt;"> that were due on January 15, 2020</span><span style="font-family:inherit;font-size:9pt;">.</span><span style="font-family:Arial;font-size:9pt;"> </span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">On April 30, 2020 we amended our primary credit facility. The principal change was to increase the leverage ratio financial covenant from </span><span style="font-family:Arial;font-size:9pt;"><span>3.5</span></span><span style="font-family:Arial;font-size:9pt;">:1 to </span><span style="font-family:Arial;font-size:9pt;"><span>4.5</span></span><span style="font-family:Arial;font-size:9pt;">:1 at the end of each fiscal quarter ending on or prior to June 30, 2021.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">On April 30, 2020 we entered into a credit agreement that provides for up to </span><span style="font-family:Arial;font-size:9pt;"><span>$1,500</span></span><span style="font-family:Arial;font-size:9pt;"> of borrowings in U.S. Dollars pursuant to a </span><span style="font-family:Arial;font-size:9pt;"><span>364</span></span><span style="font-family:Arial;font-size:9pt;">-day revolving credit facility, which matures on April 29, 2021 and is available for working capital and general corporate purposes.</span></div> 1500000000 P397D 0 <div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:1%;"/><td style="width:13%;"/><td style="width:2%;"/><td style="width:36%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><span style="font-family:Arial;font-size:8pt;font-style:italic;font-weight:bold;">Summary of Total Debt</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">March 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">December 2019</span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Senior unsecured notes:</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;text-decoration:underline;">Rate</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;text-decoration:underline;">Due</span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>4.375%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">January 15, 2020</span></span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>500</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Variable</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">November 30, 2020</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>328</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>333</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2.625%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">March 15, 2021</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>749</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>749</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1.125%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">November 30, 2023</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>599</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>609</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3.375%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">May 15, 2024</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>588</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>587</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>0.250%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">December 3, 2024</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>923</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>938</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3.375%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">November 1, 2025</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>746</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>746</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3.500%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">March 15, 2026</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>991</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>991</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2.125%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">November 30, 2027</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>815</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>829</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>3.650%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">March 7, 2028</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>596</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>596</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>0.750%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">March 1, 2029</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>869</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>884</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>2.625%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">November 30, 2030</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>700</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>712</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1.000%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">December 3, 2031</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>809</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>823</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>4.100%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">April 1, 2043</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>391</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>4.375%</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">May 15, 2044</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>395</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>395</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>4.625%</span></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span><span style="white-space:nowrap">March 15, 2046</span></span></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>981</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>981</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Other</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>26</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>10,507</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>11,090</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:12px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Less current maturities of debt</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1,103</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>859</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Total long-term debt</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>9,404</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>10,231</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:3px double #000000;"><div style="overflow:hidden;height:13px;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="11"/></tr><tr><td style="width:1%;"/><td style="width:13%;"/><td style="width:2%;"/><td style="width:36%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/><td style="width:2%;"/><td style="width:1%;"/><td style="width:21%;"/><td style="width:1%;"/></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">March 2020</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">December 2019</span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Unamortized debt issuance costs</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>58</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Available secured borrowing capacity</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1,403</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1,403</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td colspan="4" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Fair value of senior unsecured notes</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>10,904</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>11,910</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 0.04375 2020-01-15 0 500000000 2020-11-30 328000000 333000000 0.02625 2021-03-15 749000000 749000000 0.01125 2023-11-30 599000000 609000000 0.03375 2024-05-15 588000000 587000000 0.00250 2024-12-03 923000000 938000000 0.03375 2025-11-01 746000000 746000000 0.03500 2026-03-15 991000000 991000000 0.02125 2027-11-30 815000000 829000000 0.03650 2028-03-07 596000000 596000000 0.00750 2029-03-01 869000000 884000000 0.02625 2030-11-30 700000000 712000000 0.01000 2031-12-03 809000000 823000000 0.04100 2043-04-01 392000000 391000000 0.04375 2044-05-15 395000000 395000000 0.04625 2046-03-15 981000000 981000000 26000000 26000000 10507000000 11090000000 1103000000 859000000 9404000000 10231000000 56000000 58000000 1403000000 1403000000 10904000000 11910000000 500000000 0.04375 3.5 4.5 1500000000 P364D INCOME TAXES<div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">Our effective tax rates were </span><span style="font-family:Arial;font-size:9pt;"><span>16.4%</span></span><span style="font-family:Arial;font-size:9pt;"> and </span><span style="font-family:Arial;font-size:9pt;"><span>14.2%</span></span><span style="font-family:Arial;font-size:9pt;"> in the </span><span style="font-family:Arial;font-size:9pt;">three months</span><span style="font-family:Arial;font-size:9pt;"> </span><span style="font-family:Arial;font-size:9pt;">2020</span><span style="font-family:Arial;font-size:9pt;"> and </span><span style="font-family:Arial;font-size:9pt;">2019</span><span style="font-family:Arial;font-size:9pt;">. The increase in the effective tax rate for the </span><span style="font-family:Arial;font-size:9pt;">three</span><span style="font-family:Arial;font-size:9pt;"> months was primarily due to a lower tax benefit related to share-based compensation</span><span style="font-family:inherit;font-size:9pt;">.</span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">In March 2020 the Coronavirus Aid, Relief and Economic Security Act (the "CARES Act") was signed into law in the United States. We do not expect the provisions of the CARES Act to have a material impact on our annual effective tax rate or Consolidated Financial Statements in 2020.</span></div> 0.164 0.142 SEGMENT INFORMATION<div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Orthopaedics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1,222</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1,250</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">MedSurg</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1,622</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1,527</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Neurotechnology and Spine</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>744</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>739</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Net sales</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>3,588</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>3,516</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Orthopaedics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>437</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">MedSurg</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>377</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Neurotechnology and Spine</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>206</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>199</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Segment operating income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>999</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,013</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Items not allocated to segments:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Corporate and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(137</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(132</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Acquisition and integration-related charges</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(37</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(138</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Amortization of intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(118</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(114</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Restructuring-related charges</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(54</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Medical device regulations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(24</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Recall-related matters</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Regulatory and legal matters</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Consolidated operating income</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>635</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>528</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><span style="font-family:Arial;font-size:9pt;">There were no significant changes to total assets by segment from information provided in our Annual Report on Form 10-K for </span><span style="font-family:Arial;font-size:9pt;">2019</span><span style="font-family:Arial;font-size:9pt;">.</span></div> <div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"/></tr><tr><td style="width:62%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/><td style="width:1%;"/><td style="width:17%;"/><td style="width:1%;"/></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="6" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Three Months</span></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2020</span></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">2019</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Orthopaedics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1,222</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1,250</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">MedSurg</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1,622</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>1,527</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Neurotechnology and Spine</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>744</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>739</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Net sales</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>3,588</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>3,516</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Orthopaedics</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>392</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">$</span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>437</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">MedSurg</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>401</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>377</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Neurotechnology and Spine</span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>206</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>199</span></span></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Segment operating income</span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>999</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>1,013</span></span></div></td><td style="vertical-align:bottom;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Items not allocated to segments:</span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td><td colspan="3" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"> </span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Corporate and other</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(137</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(132</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Acquisition and integration-related charges</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(37</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(138</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Amortization of intangible assets</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(118</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(114</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Restructuring-related charges</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(54</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(56</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Medical device regulations</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(24</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(7</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Recall-related matters</span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>6</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(13</span></span></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:6px;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">Regulatory and legal matters</span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>—</span></span></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;"><span>(25</span></span></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;">)</span></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">Consolidated operating income</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>635</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;">$</span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:7pt;"><span style="font-family:Arial;font-size:7pt;font-weight:bold;"><span>528</span></span></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><span style="font-family:inherit;font-size:10pt;"><br/></span></div></td></tr></table></div><span style="font-family:inherit;font-size:10pt;"><br/></span></div> 1222000000 1250000000 1622000000 1527000000 744000000 739000000 3588000000 3516000000 392000000 437000000 401000000 377000000 206000000 199000000 999000000 1013000000 -137000000 -132000000 37000000 138000000 118000000 114000000 54000000 56000000 24000000 7000000 -6000000 13000000 0 25000000 635000000 528000000 XML 39 R5.htm IDEA: XBRL DOCUMENT v3.20.1
    Consolidated Balance Sheets (Parenthetical) - USD ($)
    $ in Millions
    Mar. 31, 2020
    Dec. 31, 2019
    Statement of Financial Position [Abstract]    
    Allowance for doubtful accounts receivable $ 100 $ 88
    Common stock, par value (in dollars per share) $ 0.1 $ 0.1
    XML 40 R9.htm IDEA: XBRL DOCUMENT v3.20.1
    Revenue Recognition
    		 3 Months Ended
    Mar. 31, 2020
    Revenue Recognition [Abstract]  
    Revenue Recognition REVENUE RECOGNITION
    Our policies for recognizing sales have not changed from those described in our Annual Report on Form 10-K for 2019.
    We disaggregate our net sales by product line and geographic location for each of our segments as we believe it best depicts how the nature, amount, timing and certainty of our net sales and cash flows are affected by economic factors.
    Net Sales by Product Line
     
     
     
    Three Months
     
    2020
    2019
    Orthopaedics:
     
     
    Knees
    $
    432

    $
    439

    Hips
    316

    336

    Trauma and Extremities
    392

    396

    Other
    82

    79

     
    $
    1,222

    $
    1,250

    MedSurg:
     
     
    Instruments
    $
    513

    $
    461

    Endoscopy
    455

    470

    Medical
    587

    531

    Sustainability
    67

    65

     
    $
    1,622

    $
    1,527

    Neurotechnology and Spine:
     
     
    Neurotechnology
    $
    483

    $
    469

    Spine
    261

    270

     
    $
    744

    $
    739

    Total
    $
    3,588

    $
    3,516

    Net Sales by Geography
     
     
     
     
     
     
    Three Months 2020
     
    Three Months 2019
     
    United States
    International
     
    United States
    International
    Orthopaedics:
     
     
     
     
     
    Knees
    $
    322

    $
    110

     
    $
    320

    $
    119

    Hips
    201

    115

     
    213

    123

    Trauma and Extremities
    260

    132

     
    254

    142

    Other
    69

    13

     
    63

    16

     
    $
    852

    $
    370

     
    $
    850

    $
    400

    MedSurg:
     
     
     
     
     
    Instruments
    $
    410

    $
    103

     
    $
    365

    $
    96

    Endoscopy
    364

    91

     
    376

    94

    Medical
    454

    133

     
    416

    115

    Sustainability
    66

    1

     
    64

    1

     
    $
    1,294

    $
    328

     
    $
    1,221

    $
    306

    Neurotechnology and Spine:
     
     
     
     
     
    Neurotechnology
    $
    301

    $
    182

     
    $
    300

    $
    169

    Spine
    196

    65

     
    208

    62

     
    $
    497

    $
    247

     
    $
    508

    $
    231

    Total
    $
    2,643

    $
    945

     
    $
    2,579

    $
    937

    Contract Assets and Liabilities
    On March 31, 2020 there were no contract assets recorded on our Consolidated Balance Sheets.
    Our contract liabilities arise as a result of consideration received from customers at inception of contracts for certain businesses or where the timing of billing for services precedes satisfaction of our performance obligations. We generally satisfy performance obligations within one year from the contract inception date. Our contract liabilities were $361 and $313 on March 31, 2020 and December 31, 2019.
    XML 42 R41.htm IDEA: XBRL DOCUMENT v3.20.1
    Debt and Credit Facilities (Details)
    		 3 Months Ended
    Apr. 30, 2020
    USD ($)
    Mar. 31, 2020
    USD ($)
    Rate
    Jan. 31, 2020
    USD ($)
    Rate
    Dec. 31, 2019
    USD ($)
    Amounts outstanding under commercial paper program   $ 0    
    Other Long-term Debt   26,000,000   $ 26,000,000
    Total debt   10,507,000,000   11,090,000,000
    Less current maturities of debt   1,103,000,000   859,000,000
    Total long-term debt   9,404,000,000   10,231,000,000
    Unamortized debt issuance costs   56,000,000   58,000,000
    Available secured borrowing capacity   1,403,000,000   1,403,000,000
    Fair value of senior unsecured notes   $ 10,904,000,000   11,910,000,000
    Commercial Paper        
    Debt instrument, maturity   397 days    
    Commercial Paper | Maximum        
    Commercial paper   $ 1,500,000,000    
    Senior Unsecured Notes 4.375% due 2020        
    Stated interest rate | Rate   4.375% 4.375%  
    Maturity Date   Jan. 15, 2020    
    Unsecured Debt   $ 0   500,000,000
    Debt instrument, repurchased face amount     $ 500,000,000  
    Senior Unsecured Notes Variable due 2020        
    Maturity Date   Nov. 30, 2020    
    Unsecured Debt   $ 328,000,000   333,000,000
    Senior Unsecured Notes 2.625% due 2021        
    Stated interest rate | Rate   2.625%    
    Maturity Date   Mar. 15, 2021    
    Unsecured Debt   $ 749,000,000   749,000,000
    Senior Unsecured Notes 1.125% due 2021        
    Stated interest rate | Rate   1.125%    
    Maturity Date   Nov. 30, 2023    
    Unsecured Debt   $ 599,000,000   609,000,000
    Senior Unsecured Notes 3.375% due 2024        
    Stated interest rate | Rate   3.375%    
    Maturity Date   May 15, 2024    
    Unsecured Debt   $ 588,000,000   587,000,000
    Senior Unsecured Notes 0.250% due 2024        
    Stated interest rate   0.25%    
    Maturity Date   Dec. 03, 2024    
    Unsecured Debt   $ 923,000,000   938,000,000
    Senior Unsecured Notes 3.375% due 2025        
    Stated interest rate | Rate   3.375%    
    Maturity Date   Nov. 01, 2025    
    Unsecured Debt   $ 746,000,000   746,000,000
    Senior Unsecured Notes 3.50% due 2026        
    Stated interest rate | Rate   3.50%    
    Maturity Date   Mar. 15, 2026    
    Unsecured Debt   $ 991,000,000   991,000,000
    Senior Unsecured Notes 2.125% due 2027        
    Stated interest rate | Rate   2.125%    
    Maturity Date   Nov. 30, 2027    
    Unsecured Debt   $ 815,000,000   829,000,000
    Senior Unsecured Notes 3.650% due 2028        
    Stated interest rate | Rate   3.65%    
    Maturity Date   Mar. 07, 2028    
    Unsecured Debt   $ 596,000,000   596,000,000
    Senior Unsecured Notes 0.750% due 2029        
    Stated interest rate   0.75%    
    Maturity Date   Mar. 01, 2029    
    Unsecured Debt   $ 869,000,000   884,000,000
    Senior Unsecured Notes 2.625% due 2030        
    Stated interest rate | Rate   2.625%    
    Maturity Date   Nov. 30, 2030    
    Unsecured Debt   $ 700,000,000   712,000,000
    Senior Unsecured Notes 1.000% due 2031        
    Stated interest rate   1.00%    
    Maturity Date   Dec. 03, 2031    
    Unsecured Debt   $ 809,000,000   823,000,000
    Senior Unsecured Notes 4.100% due 2043        
    Stated interest rate | Rate   4.10%    
    Maturity Date   Apr. 01, 2043    
    Unsecured Debt   $ 392,000,000   391,000,000
    Senior Unsecured Notes 4.375% due 2044        
    Stated interest rate | Rate   4.375%    
    Maturity Date   May 15, 2044    
    Unsecured Debt   $ 395,000,000   395,000,000
    Senior Unsecured Notes 4.625% due 2046        
    Stated interest rate | Rate   4.625%    
    Maturity Date   Mar. 15, 2046    
    Unsecured Debt   $ 981,000,000   $ 981,000,000
    Revolving Credit Facility        
    Leverage ratio   3.5    
    Revolving Credit Facility | Subsequent Event        
    Leverage ratio 4.5      
    Revolving Credit Facility | Subsequent Event | Credit Agreement        
    Debt instrument, maturity 364 days      
    Line of credit facility, maximum borrowing capacity $ 1,500,000,000      
    XML 43 R28.htm IDEA: XBRL DOCUMENT v3.20.1
    Revenue Recognition - Disaggregated Sales Analysis (Details) - USD ($)
    $ in Millions
    		 3 Months Ended
    Mar. 31, 2020
    Mar. 31, 2019
    Disaggregation of Revenue [Line Items]    
    Net sales $ 3,588 $ 3,516
    United States    
    Disaggregation of Revenue [Line Items]    
    Net sales 2,643 2,579
    International    
    Disaggregation of Revenue [Line Items]    
    Net sales 945 937
    Orthopaedics    
    Disaggregation of Revenue [Line Items]    
    Net sales 1,222 1,250
    Orthopaedics | United States    
    Disaggregation of Revenue [Line Items]    
    Net sales 852 850
    Orthopaedics | International    
    Disaggregation of Revenue [Line Items]    
    Net sales 370 400
    Orthopaedics | Knees    
    Disaggregation of Revenue [Line Items]    
    Net sales 432 439
    Orthopaedics | Knees | United States    
    Disaggregation of Revenue [Line Items]    
    Net sales 322 320
    Orthopaedics | Knees | International    
    Disaggregation of Revenue [Line Items]    
    Net sales 110 119
    Orthopaedics | Hips    
    Disaggregation of Revenue [Line Items]    
    Net sales 316 336
    Orthopaedics | Hips | United States    
    Disaggregation of Revenue [Line Items]    
    Net sales 201 213
    Orthopaedics | Hips | International    
    Disaggregation of Revenue [Line Items]    
    Net sales 115 123
    Orthopaedics | Trauma and Extremities    
    Disaggregation of Revenue [Line Items]    
    Net sales 392 396
    Orthopaedics | Trauma and Extremities | United States    
    Disaggregation of Revenue [Line Items]    
    Net sales 260 254
    Orthopaedics | Trauma and Extremities | International    
    Disaggregation of Revenue [Line Items]    
    Net sales 132 142
    Orthopaedics | Other    
    Disaggregation of Revenue [Line Items]    
    Net sales 82 79
    Orthopaedics | Other | United States    
    Disaggregation of Revenue [Line Items]    
    Net sales 69 63
    Orthopaedics | Other | International    
    Disaggregation of Revenue [Line Items]    
    Net sales 13 16
    MedSurg    
    Disaggregation of Revenue [Line Items]    
    Net sales 1,622 1,527
    MedSurg | United States    
    Disaggregation of Revenue [Line Items]    
    Net sales 1,294 1,221
    MedSurg | International    
    Disaggregation of Revenue [Line Items]    
    Net sales 328 306
    MedSurg | Instruments    
    Disaggregation of Revenue [Line Items]    
    Net sales 513 461
    MedSurg | Instruments | United States    
    Disaggregation of Revenue [Line Items]    
    Net sales 410 365
    MedSurg | Instruments | International    
    Disaggregation of Revenue [Line Items]    
    Net sales 103 96
    MedSurg | Endoscopy    
    Disaggregation of Revenue [Line Items]    
    Net sales 455 470
    MedSurg | Endoscopy | United States    
    Disaggregation of Revenue [Line Items]    
    Net sales 364 376
    MedSurg | Endoscopy | International    
    Disaggregation of Revenue [Line Items]    
    Net sales 91 94
    MedSurg | Medical    
    Disaggregation of Revenue [Line Items]    
    Net sales 587 531
    MedSurg | Medical | United States    
    Disaggregation of Revenue [Line Items]    
    Net sales 454 416
    MedSurg | Medical | International    
    Disaggregation of Revenue [Line Items]    
    Net sales 133 115
    MedSurg | Sustainability    
    Disaggregation of Revenue [Line Items]    
    Net sales 67 65
    MedSurg | Sustainability | United States    
    Disaggregation of Revenue [Line Items]    
    Net sales 66 64
    MedSurg | Sustainability | International    
    Disaggregation of Revenue [Line Items]    
    Net sales 1 1
    Neurotechnology and Spine    
    Disaggregation of Revenue [Line Items]    
    Net sales 744 739
    Neurotechnology and Spine | United States    
    Disaggregation of Revenue [Line Items]    
    Net sales 497 508
    Neurotechnology and Spine | International    
    Disaggregation of Revenue [Line Items]    
    Net sales 247 231
    Neurotechnology and Spine | Neurotechnology    
    Disaggregation of Revenue [Line Items]    
    Net sales 483 469
    Neurotechnology and Spine | Neurotechnology | United States    
    Disaggregation of Revenue [Line Items]    
    Net sales 301 300
    Neurotechnology and Spine | Neurotechnology | International    
    Disaggregation of Revenue [Line Items]    
    Net sales 182 169
    Neurotechnology and Spine | Spine    
    Disaggregation of Revenue [Line Items]    
    Net sales 261 270
    Neurotechnology and Spine | Spine | United States    
    Disaggregation of Revenue [Line Items]    
    Net sales 196 208
    Neurotechnology and Spine | Spine | International    
    Disaggregation of Revenue [Line Items]    
    Net sales $ 65 $ 62
    XML 44 R24.htm IDEA: XBRL DOCUMENT v3.20.1
    Acquisitions (Tables)
    		 3 Months Ended
    Mar. 31, 2020
    Business Combinations [Abstract]  
    Schedule of Business Acquisitions, by Acquisition
    Purchase Price Allocation of Acquired Net Assets
     
    2019
     
    Mobius
     
    OrthoSpace
    Tangible assets:
     
     
     
    Accounts receivable
    $
    3

     
    $
    1

    Inventory
    6

     
    1

    Other assets
    2

     
    1

    Contingent consideration
    (4
    )
     
    —

    Other liabilities
    (10
    )
     
    (29
    )
    Intangible assets:
     
     
     
    Customer relationship
    7

     
    —

    Developed technology and patents
    59

     
    120

    In-process research and development
    98

     
    —

    Non-compete agreements
    9

     
    —

    Goodwill
    303

     
    114

    Purchase price, net of cash acquired
    $
    473

     
    $
    208

    Weighted-average life of intangible assets
    12

     
    18
    Schedule of Finite-Lived Intangible Assets, Future Amortization Expense
    Estimated Amortization Expense
    Remainder of 2020
    2021
    2022
    2023
    2024
    $
    341

    $
    440

    $
    438

    $
    417

    $
    386
    XML 45 R20.htm IDEA: XBRL DOCUMENT v3.20.1
    Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)
    		 3 Months Ended
    Mar. 31, 2020
    Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
    Schedule of Accumulated Other Comprehensive Income (Loss)
    Three Months 2020
    Marketable Securities
    Pension Plans
    Hedges
    Financial Statement Translation
    Total
    Beginning
    $
    (3
    )
    $
    (179
    )
    $
    47

    $
    (471
    )
    $
    (606
    )
    OCI
    1

    (6
    )
    (39
    )
    55

    11

    Income taxes
    —

    —

    11

    (37
    )
    (26
    )
    Reclassifications to:
     
     
     
     
     
    Cost of sales
    —

    —

    3

    —

    3

    Other (income) expense
    (1
    )
    3

    (1
    )
    (7
    )
    (6
    )
    Income taxes
    —

    (1
    )
    —

    2

    1

    Net OCI
    $
    —

    $
    (4
    )
    $
    (26
    )
    $
    13

    $
    (17
    )
    Ending
    $
    (3
    )
    $
    (183
    )
    $
    21

    $
    (458
    )
    $
    (623
    )

    Three Months 2019
    Marketable Securities
    Pension Plans
    Hedges
    Financial Statement Translation
    Total
    Beginning
    $
    (4
    )
    $
    (137
    )
    $
    50

    $
    (540
    )
    $
    (631
    )
    OCI
    1

    (6
    )
    (19
    )
    94

    70

    Income taxes
    —

    1

    6

    (9
    )
    (2
    )
    Reclassifications to:
     
     
     
     
     
    Cost of sales
    —

    —

    (2
    )
    —

    (2
    )
    Other (income) expense
    —

    1

    —

    —

    1

    Income taxes
    —

    —

    (1
    )
    —

    (1
    )
    Net OCI
    $
    1

    $
    (4
    )
    $
    (16
    )
    $
    85

    $
    66

    Ending
    $
    (3
    )
    $
    (141
    )
    $
    34

    $
    (455
    )
    $
    (565
    )
    Reclassification out of Accumulated Other Comprehensive Income
    Three Months 2020
    Marketable Securities
    Pension Plans
    Hedges
    Financial Statement Translation
    Total
    Beginning
    $
    (3
    )
    $
    (179
    )
    $
    47

    $
    (471
    )
    $
    (606
    )
    OCI
    1

    (6
    )
    (39
    )
    55

    11

    Income taxes
    —

    —

    11

    (37
    )
    (26
    )
    Reclassifications to:
     
     
     
     
     
    Cost of sales
    —

    —

    3

    —

    3

    Other (income) expense
    (1
    )
    3

    (1
    )
    (7
    )
    (6
    )
    Income taxes
    —

    (1
    )
    —

    2

    1

    Net OCI
    $
    —

    $
    (4
    )
    $
    (26
    )
    $
    13

    $
    (17
    )
    Ending
    $
    (3
    )
    $
    (183
    )
    $
    21

    $
    (458
    )
    $
    (623
    )

    Three Months 2019
    Marketable Securities
    Pension Plans
    Hedges
    Financial Statement Translation
    Total
    Beginning
    $
    (4
    )
    $
    (137
    )
    $
    50

    $
    (540
    )
    $
    (631
    )
    OCI
    1

    (6
    )
    (19
    )
    94

    70

    Income taxes
    —

    1

    6

    (9
    )
    (2
    )
    Reclassifications to:
     
     
     
     
     
    Cost of sales
    —

    —

    (2
    )
    —

    (2
    )
    Other (income) expense
    —

    1

    —

    —

    1

    Income taxes
    —

    —

    (1
    )
    —

    (1
    )
    Net OCI
    $
    1

    $
    (4
    )
    $
    (16
    )
    $
    85

    $
    66

    Ending
    $
    (3
    )
    $
    (141
    )
    $
    34

    $
    (455
    )
    $
    (565
    )
    XML 46 R16.htm IDEA: XBRL DOCUMENT v3.20.1
    Income Taxes
    		 3 Months Ended
    Mar. 31, 2020
    Income Tax [Abstract]  
    Income Taxes INCOME TAXES
    Our effective tax rates were 16.4% and 14.2% in the three months 2020 and 2019. The increase in the effective tax rate for the three months was primarily due to a lower tax benefit related to share-based compensation.
    In March 2020 the Coronavirus Aid, Relief and Economic Security Act (the "CARES Act") was signed into law in the United States. We do not expect the provisions of the CARES Act to have a material impact on our annual effective tax rate or Consolidated Financial Statements in 2020.
    XML 47 R12.htm IDEA: XBRL DOCUMENT v3.20.1
    Fair Value Measurements
    		 3 Months Ended
    Mar. 31, 2020
    Fair Value Disclosures [Abstract]  
    Fair Value Measurements FAIR VALUE MEASUREMENTS
    Our policies for managing risk related to foreign currency, interest rates, credit and markets and our process for determining fair value have not changed from those described in our Annual Report on Form 10-K for 2019.
    There were no significant transfers into or out of any level in 2020.
    Assets Measured at Fair Value
    March
    December
    2020
    2019
    Cash and cash equivalents
    $
    3,964

    $
    4,337

    Trading marketable securities
    127

    149

    Level 1 - Assets
    $
    4,091

    $
    4,486

    Available-for-sale marketable securities:
     
     
    Corporate and asset-backed debt securities
    $
    32

    $
    32

    United States agency debt securities
    3

    2

    United States Treasury debt securities
    45

    49

    Certificates of deposit
    4

    5

    Total available-for-sale marketable securities
    $
    84

    $
    88

    Foreign currency exchange forward contracts
    240

    226

    Interest rate swap asset
    —

    17

    Level 2 - Assets
    $
    324

    $
    331

    Total assets measured at fair value
    $
    4,415

    $
    4,817


    Liabilities Measured at Fair Value
    March
    December
    2020
    2019
    Deferred compensation arrangements
    $
    127

    $
    149

    Level 1 - Liabilities
    $
    127

    $
    149

    Foreign currency exchange forward contracts
    $
    29

    $
    23

    Interest rate swap liability
    62

    —

    Level 2 - Liabilities
    $
    91

    $
    23

    Contingent consideration:
     
     
    Beginning
    $
    306

    $
    117

    Additions
    —

    298

    Change in estimate
    —

    (10
    )
    Settlements
    —

    (99
    )
    Ending
    $
    306

    $
    306

    Level 3 - Liabilities
    $
    306

    $
    306

    Total liabilities measured at fair value
    $
    524

    $
    478


    Fair Value of Available for Sale Securities by Maturity
     
    March 2020
    December 2019
    Due in one year or less
    $
    46

    $
    50

    Due after one year through three years
    $
    38

    $
    38


    On March 31, 2020 and December 31, 2019 the aggregate difference between the cost and fair value of available-for-sale marketable securities was nominal. Interest and marketable securities income recorded in other income (expense), net, was $40 and $39 in the three months 2020 and 2019.
    Our investments in available-for-sale marketable securities had a minimum credit quality rating of A2 (Moody's), A (Standard & Poor's) and A (Fitch). We do not plan to sell the investments, and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost basis, which may be maturity.
    XML 48 R31.htm IDEA: XBRL DOCUMENT v3.20.1
    Derivative Instruments (Narrative) (Details)
    € in Millions, $ in Millions
    		 3 Months Ended 12 Months Ended
    Mar. 31, 2020
    USD ($)
    Dec. 31, 2019
    USD ($)
    Dec. 31, 2019
    EUR (€)
    Dec. 31, 2019
    USD ($)
    Nov. 30, 2019
    EUR (€)
    Jul. 31, 2019
    USD ($)
    Nov. 30, 2018
    EUR (€)
    Foreign Exchange Contract              
    Notional amount $ 7,206     $ 8,088      
    Designated as Hedging Instrument | Foreign Exchange Contract              
    Notional amount 837   € 2,400 $ 1,113   $ 1,000 € 2,250
    Derivative, fair value 83            
    Cash flow hedge gain (loss) to be reclassified within twelve months 26            
    Other Income 27            
    Designated as Hedging Instrument | Interest Rate Swap              
    Notional amount 750            
    Cash flow hedge gain (loss) to be reclassified within twelve months   $ 6          
    Notional amount terminated | €         € 600    
    Net Investment Hedging [Member] | Designated as Hedging Instrument              
    Notional amount 1,094            
    Accrued Expenses | Designated as Hedging Instrument | Interest Rate Swap              
    Pretax losses recorded in AOCI $ 62            
    XML 49 R35.htm IDEA: XBRL DOCUMENT v3.20.1
    Fair Value Measurements (Narrative) (Details) - USD ($)
    $ in Millions
    		 3 Months Ended
    Mar. 31, 2020
    Mar. 31, 2019
    Fair Value Disclosures [Abstract]    
    Gain on sale of marketable securities $ 40 $ 39
    XML 50 R39.htm IDEA: XBRL DOCUMENT v3.20.1
    Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets (Details) - USD ($)
    $ in Millions
    		 12 Months Ended
    Dec. 31, 2019
    Mar. 31, 2020
    Goodwill $ 9,069 $ 9,025
    Mobius    
    Accounts receivable 3  
    Inventory 6  
    Other assets 2  
    Contingent consideration (4)  
    Other liabilities (10)  
    Goodwill 303  
    Assets and liabilities acquired, net $ 473  
    Weighted-average life of intangible assets 12 years  
    Mobius | Customer relationship    
    Intangible assets acquired $ 7  
    Mobius | Developed technology and patents    
    Intangible assets acquired 59  
    Mobius | In-process research and development    
    Intangible assets acquired 98  
    Mobius | Non-compete agreements    
    Intangible assets acquired 9  
    OrthoSpace, Ltd.    
    Accounts receivable 1  
    Inventory 1  
    Other assets 1  
    Contingent consideration 0  
    Other liabilities (29)  
    Goodwill 114  
    Assets and liabilities acquired, net $ 208  
    Weighted-average life of intangible assets 18 years  
    OrthoSpace, Ltd. | Customer relationship    
    Intangible assets acquired $ 0  
    OrthoSpace, Ltd. | Developed technology and patents    
    Intangible assets acquired 120  
    OrthoSpace, Ltd. | In-process research and development    
    Intangible assets acquired 0  
    OrthoSpace, Ltd. | Non-compete agreements    
    Intangible assets acquired $ 0  
    XML 51 R3.htm IDEA: XBRL DOCUMENT v3.20.1
    Consolidated Statements of Comprehensive Income (Unaudited) - USD ($)
    $ in Millions
    		 3 Months Ended
    Mar. 31, 2020
    Mar. 31, 2019
    Statement of Comprehensive Income [Abstract]    
    Net earnings $ 493 $ 412
    Other comprehensive income (loss), net of tax:    
    Marketable securities 0 1
    Pension plans (4) (4)
    Unrealized gains (losses) on designated hedges (26) (16)
    Financial statement translation 13 85
    Total other comprehensive income (loss), net of tax (17) 66
    Comprehensive income $ 476 $ 478
    JSON 52 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "syk10q3312020.htm": { "axisCustom": 0, "axisStandard": 21, "contextCount": 320, "dts": { "calculationLink": { "local": [ "syk-20200331_cal.xml" ] }, "definitionLink": { "local": [ "syk-20200331_def.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-eedm-def-2018-01-31.xml", "http://xbrl.fasb.org/srt/2018/elts/srt-eedm1-def-2018-01-31.xml" ] }, "inline": { "local": [ "syk10q3312020.htm" ] }, "labelLink": { "local": [ "syk-20200331_lab.xml" ], "remote": [ "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-doc-2018-01-31.xml", "https://xbrl.sec.gov/dei/2019/dei-doc-2019-01-31.xml" ] }, "presentationLink": { "local": [ "syk-20200331_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2019/dei-ref-2019-01-31.xml", "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-ref-2018-01-31.xml" ] }, "schema": { "local": [ "syk-20200331.xsd" ], "remote": [ "http://xbrl.fasb.org/srt/2018/elts/srt-2018-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2018/elts/srt-types-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-gaap-2018-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-roles-2018-01-31.xsd", "http://xbrl.fasb.org/srt/2018/elts/srt-roles-2018-01-31.xsd", "http://xbrl.sec.gov/country/2017/country-2017-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-types-2018-01-31.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.sec.gov/currency/2017/currency-2017-01-31.xsd", "https://xbrl.sec.gov/dei/2019/dei-2019-01-31.xsd", "https://xbrl.sec.gov/exch/2018/exch-2018-01-31.xsd", "http://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd", "http://xbrl.sec.gov/sic/2011/sic-2011-01-31.xsd", "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2018/elts/us-parts-codification-2018-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 398, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2018-01-31": 4, "http://xbrl.sec.gov/dei/2019-01-31": 5, "total": 9 }, "keyCustom": 15, "keyStandard": 271, "memberCustom": 34, "memberStandard": 45, "nsprefix": "syk", "nsuri": "http://www.stryker.com/20200331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001000 - Document - Document and Entity Information", "role": "http://www.stryker.com/role/DocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2106100 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI)", "role": "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAoci", "shortName": "Accumulated Other Comprehensive (Loss) Income (AOCI)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ComprehensiveIncomeNoteTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2107100 - Disclosure - Derivative Instruments", "role": "http://www.stryker.com/role/DerivativeInstruments", "shortName": "Derivative Instruments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2108100 - Disclosure - Fair Value Measurements", "role": "http://www.stryker.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2111100 - Disclosure - Contingencies and Commitments", "role": "http://www.stryker.com/role/ContingenciesAndCommitments", "shortName": "Contingencies and Commitments", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2112100 - Disclosure - Acquisitions", "role": "http://www.stryker.com/role/Acquisitions", "shortName": "Acquisitions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2114100 - Disclosure - Debt and Credit Facilities", "role": "http://www.stryker.com/role/DebtAndCreditFacilities", "shortName": "Debt and Credit Facilities", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2117100 - Disclosure - Income Taxes", "role": "http://www.stryker.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2118100 - Disclosure - Segment Information", "role": "http://www.stryker.com/role/SegmentInformation", "shortName": "Segment Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2201201 - Disclosure - Basis Of Presentation (Policies)", "role": "http://www.stryker.com/role/BasisOfPresentationPolicies", "shortName": "Basis Of Presentation (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2304301 - Disclosure - Revenue Recognition (Tables)", "role": "http://www.stryker.com/role/RevenueRecognitionTables", "shortName": "Revenue Recognition (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1001000 - Statement - Consolidated Statements Of Earnings (Unaudited)", "role": "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited", "shortName": "Consolidated Statements Of Earnings (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "lang": null, "name": "us-gaap:GrossProfit", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2306301 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)", "role": "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociTables", "shortName": "Accumulated Other Comprehensive (Loss) Income (AOCI) (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2307301 - Disclosure - Derivative Instruments (Tables)", "role": "http://www.stryker.com/role/DerivativeInstrumentsTables", "shortName": "Derivative Instruments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2308301 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.stryker.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2311301 - Disclosure - Contingencies and Commitments (Tables)", "role": "http://www.stryker.com/role/ContingenciesAndCommitmentsTables", "shortName": "Contingencies and Commitments (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2312301 - Disclosure - Acquisitions (Tables)", "role": "http://www.stryker.com/role/AcquisitionsTables", "shortName": "Acquisitions (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2314301 - Disclosure - Debt and Credit Facilities (Tables)", "role": "http://www.stryker.com/role/DebtAndCreditFacilitiesTables", "shortName": "Debt and Credit Facilities (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2318301 - Disclosure - Segment Information (Tables)", "role": "http://www.stryker.com/role/SegmentInformationTables", "shortName": "Segment Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404402 - Disclosure - Revenue Recognition - Narrative (Details)", "role": "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails", "shortName": "Revenue Recognition - Narrative (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "ix:continuation", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2404403 - Disclosure - Revenue Recognition - Disaggregated Sales Analysis (Details)", "role": "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails", "shortName": "Revenue Recognition - Disaggregated Sales Analysis (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1QTD_srt_StatementGeographicalAxis_country_US", "decimals": "-6", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2406402 - Disclosure - Accumulated Other Comprehensive (Loss) Income (AOCI) (Details)", "role": "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails", "shortName": "Accumulated Other Comprehensive (Loss) Income (AOCI) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "ix:continuation", "us-gaap:ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "us-gaap:ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2018Q4", "decimals": "-6", "lang": null, "name": "us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002000 - Statement - Consolidated Statements of Comprehensive Income (Unaudited)", "role": "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited", "shortName": "Consolidated Statements of Comprehensive Income (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "lang": null, "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember", "decimals": "-6", "first": true, "lang": null, "name": "syk:DerivativeNotionalAmount1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407402 - Disclosure - Derivative Instruments (Forward Currency Exchange Contracts) (Details)", "role": "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails", "shortName": "Derivative Instruments (Forward Currency Exchange Contracts) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember", "decimals": null, "lang": "en-US", "name": "us-gaap:MaximumRemainingMaturityOfForeignCurrencyDerivatives1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember", "decimals": "-6", "first": true, "lang": null, "name": "syk:DerivativeNotionalAmount1", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407403 - Disclosure - Derivative Instruments (Narrative) (Details)", "role": "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails", "shortName": "Derivative Instruments (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember_us-gaap_HedgingDesignationAxis_us-gaap_DesignatedAsHedgingInstrumentMember", "decimals": "-6", "lang": null, "name": "us-gaap:NetInvestmentHedgeDerivativeAssetsAtFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2407404 - Disclosure - Derivative Instruments (Income Statement Location) (Details)", "role": "http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails", "shortName": "Derivative Instruments (Income Statement Location) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1QTD_us-gaap_DerivativeInstrumentRiskAxis_us-gaap_ForeignExchangeContractMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:ForeignCurrencyTransactionGainLossBeforeTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408402 - Disclosure - Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)", "role": "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails", "shortName": "Fair Value Measurements (Valuation Of Financial Instruments By Pricing Categories) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408403 - Disclosure - Fair Value Measurements (Assets and Liabilities Measured At Fair Value On A Recurring Basis Using Unobservable Inputs (Level 3)) (Details)", "role": "http://www.stryker.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details", "shortName": "Fair Value Measurements (Assets and Liabilities Measured At Fair Value On A Recurring Basis Using Unobservable Inputs (Level 3)) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:MarketableSecuritiesGainLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2408404 - Disclosure - Fair Value Measurements (Narrative) (Details)", "role": "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails", "shortName": "Fair Value Measurements (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:MarketableSecuritiesGainLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1_srt_RangeAxis_srt_MinimumMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LossContingencyEstimateOfPossibleLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411402 - Disclosure - Contingencies and Commitments (Narrative) (Details)", "role": "http://www.stryker.com/role/ContingenciesAndCommitmentsNarrativeDetails", "shortName": "Contingencies and Commitments (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1_srt_RangeAxis_srt_MinimumMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:LossContingencyEstimateOfPossibleLoss", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2411403 - Disclosure - Contingencies and Commitments - Leases (Details)", "role": "http://www.stryker.com/role/ContingenciesAndCommitmentsLeasesDetails", "shortName": "Contingencies and Commitments - Leases (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:LeaseCostTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412402 - Disclosure - Acquisitions (Narrative) (Details)", "role": "http://www.stryker.com/role/AcquisitionsNarrativeDetails", "shortName": "Acquisitions (Narrative) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferred1", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2019Q4", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Goodwill", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412403 - Disclosure - Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets (Details)", "role": "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails", "shortName": "Acquisitions (Allocation Of The Preliminary Purchase Price To The Acquired Net Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2019Q4_us-gaap_BusinessAcquisitionAxis_syk_MobiusMember", "decimals": "-6", "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003000 - Statement - Consolidated Balance Sheets", "role": "http://www.stryker.com/role/ConsolidatedBalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "lang": null, "name": "us-gaap:AccountsReceivableNetCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2412404 - Disclosure - Acquisitions (Future Amortization Expense) (Details)", "role": "http://www.stryker.com/role/AcquisitionsFutureAmortizationExpenseDetails", "shortName": "Acquisitions (Future Amortization Expense) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommercialPaper", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2414402 - Disclosure - Debt and Credit Facilities (Details)", "role": "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails", "shortName": "Debt and Credit Facilities (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2020Q1", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommercialPaper", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "rate", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2417401 - Disclosure - Income Taxes (Details)", "role": "http://www.stryker.com/role/IncomeTaxesDetails", "shortName": "Income Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": "3", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "rate", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2418402 - Disclosure - Segment Information (Sales And Other Financial Information By Business Segment) (Details)", "role": "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails", "shortName": "Segment Information (Sales And Other Financial Information By Business Segment) (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1QTD_srt_ConsolidationItemsAxis_us-gaap_OperatingSegmentsMember", "decimals": "-6", "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": null, "groupType": "statement", "isDefault": "false", "longName": "1003501 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://www.stryker.com/role/ConsolidatedBalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R6": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004000 - Statement - Consolidated Statements Of Shareholders' Equity (Unaudited)", "role": "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited", "shortName": "Consolidated Statements Of Shareholders' Equity (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FI2018Q4_us-gaap_StatementEquityComponentsAxis_us-gaap_CommonStockMember", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005000 - Statement - Consolidated Statements Of Cash Flows (Unaudited)", "role": "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited", "shortName": "Consolidated Statements Of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "span", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": "-6", "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2101100 - Disclosure - Basis Of Presentation", "role": "http://www.stryker.com/role/BasisOfPresentation", "shortName": "Basis Of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "2104100 - Disclosure - Revenue Recognition", "role": "http://www.stryker.com/role/RevenueRecognition", "shortName": "Revenue Recognition", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "div", "div", "div", "body", "html" ], "baseRef": "syk10q3312020.htm", "contextRef": "FD2020Q1YTD", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 84, "tag": { "country_US": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "UNITED STATES", "terseLabel": "United States" } } }, "localname": "US", "nsuri": "http://xbrl.sec.gov/country/2017-01-31", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "domainItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r315" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r316" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r317" ], "lang": { "en-US": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r317" ], "lang": { "en-US": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r317" ], "lang": { "en-US": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r318" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r317" ], "lang": { "en-US": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r317" ], "lang": { "en-US": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r317" ], "lang": { "en-US": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r317" ], "lang": { "en-US": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r313" ], "lang": { "en-US": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of each class" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r314" ], "lang": { "en-US": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2019-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r115", "r122" ], "lang": { "en-US": { "role": { "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items [Axis]" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items [Domain]" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "domainItemType" }, "srt_MaximumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsNarrativeDetails", "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r124", "r184", "r186", "r305" ], "lang": { "en-US": { "role": { "label": "Product and Service [Axis]", "terseLabel": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Product and Service [Domain]", "terseLabel": "Product and Service [Domain]" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Range [Axis]", "terseLabel": "Range [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsNarrativeDetails", "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Range [Domain]", "terseLabel": "Range [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsNarrativeDetails", "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Geographical [Domain]", "terseLabel": "Geographical [Domain]" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r125", "r184", "r187", "r310", "r311" ], "lang": { "en-US": { "role": { "label": "Geographical [Axis]", "terseLabel": "Geographical [Axis]" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2018-01-31", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "stringItemType" }, "syk_AccountingPronouncementsRecentlyAdoptedPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Accounting Pronouncements Recently Adopted [Policy Text Block]", "label": "Accounting Pronouncements Recently Adopted [Policy Text Block]", "terseLabel": "Accounting Pronouncements Recently Adopted" } } }, "localname": "AccountingPronouncementsRecentlyAdoptedPolicyTextBlock", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "syk_AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "This item represents the fair value of debt securities which are expected to mature after one through three years of the balance sheet date and which are categorized neither as held-to-maturity nor trading securities.", "label": "Available for sale Securities, Debt Maturities, After One Through Three Years, Fair Value", "verboseLabel": "Due after one year through three years" } } }, "localname": "AvailableforsaleSecuritiesDebtMaturitiesAfterOneThroughThreeYearsFairValue", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "syk_BusinessCombinationConsiderationTransferredPricePerShare": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Business Combination, Consideration Transferred, Price Per Share", "label": "Business Combination, Consideration Transferred, Price Per Share", "terseLabel": "Consideration transferred (in dollars per share)" } } }, "localname": "BusinessCombinationConsiderationTransferredPricePerShare", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "syk_BusinessCombinationContingentConsiderationFutureMilestonePayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Business Combination, Contingent Consideration, Future Milestone Payments", "label": "Business Combination, Contingent Consideration, Future Milestone Payments", "terseLabel": "Future milestone payments" } } }, "localname": "BusinessCombinationContingentConsiderationFutureMilestonePayments", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "syk_BusinessCombinationParValueofOrdinarySharesofAcquiree": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Business Combination, Par Value of Ordinary Shares of Acquiree", "label": "Business Combination, Par Value of Ordinary Shares of Acquiree", "terseLabel": "Par value of ordinary shares of acquiree (in dollars per share)" } } }, "localname": "BusinessCombinationParValueofOrdinarySharesofAcquiree", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "perShareItemType" }, "syk_Changeinaccrualforrecallexpenses": { "auth_ref": [], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Change in accrual for recall expenses", "label": "Change in accrual for recall expenses", "terseLabel": "Recall-related payments" } } }, "localname": "Changeinaccrualforrecallexpenses", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "syk_CreditAgreementMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Credit Agreement [Member]", "label": "Credit Agreement [Member]", "terseLabel": "Credit Agreement" } } }, "localname": "CreditAgreementMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "syk_DebtInstrumentCovenantLeverageRatio": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Debt Instrument, Covenant, Leverage Ratio", "label": "Debt Instrument, Covenant, Leverage Ratio", "terseLabel": "Leverage ratio" } } }, "localname": "DebtInstrumentCovenantLeverageRatio", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "pureItemType" }, "syk_DerivativeNotionalAmount1": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Derivative, Notional Amount", "label": "Derivative, Notional Amount1", "terseLabel": "Notional amount", "verboseLabel": "Notional Amount" } } }, "localname": "DerivativeNotionalAmount1", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "syk_DerivativeNotionalAmountTerminated": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Derivative Notional Amount Terminated", "label": "Derivative Notional Amount Terminated", "terseLabel": "Notional amount terminated" } } }, "localname": "DerivativeNotionalAmountTerminated", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "syk_DocumentAndEntityInformationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Document and Entity Information [Abstract]", "label": "Document and Entity Information [Abstract]" } } }, "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.stryker.com/20200331", "xbrltype": "stringItemType" }, "syk_EndoscopyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Endoscopy [Member]", "label": "Endoscopy [Member]", "terseLabel": "Endoscopy" } } }, "localname": "EndoscopyMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "domainItemType" }, "syk_EuropeanMedicalDevicesRegulation": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "European Medical Devices Regulation", "label": "European Medical Devices Regulation", "negatedLabel": "Medical device regulations" } } }, "localname": "EuropeanMedicalDevicesRegulation", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "monetaryItemType" }, "syk_FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair Value, Liabilities Measured on Recurring Basis, Deferred Compensation Plan Liabilities", "label": "Fair Value Liabilities Measured On Recurring Basis Deferred Compensation Plan Liabilities", "terseLabel": "Deferred compensation arrangements" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisDeferredCompensationPlanLiabilities", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "monetaryItemType" }, "syk_HipsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Hips [Member]", "label": "Hips [Member]", "terseLabel": "Hips" } } }, "localname": "HipsMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "domainItemType" }, "syk_IncomeTaxAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Income Tax [Abstract]", "label": "Income Tax [Abstract]" } } }, "localname": "IncomeTaxAbstract", "nsuri": "http://www.stryker.com/20200331", "xbrltype": "stringItemType" }, "syk_InstrumentsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Instruments [Member]", "label": "Instruments [Member]", "terseLabel": "Instruments" } } }, "localname": "InstrumentsMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "domainItemType" }, "syk_InternallyDevelopedSoftwareMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Internally Developed Software [Member]", "label": "Internally Developed Software [Member]", "terseLabel": "In-process research and development" } } }, "localname": "InternallyDevelopedSoftwareMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails" ], "xbrltype": "domainItemType" }, "syk_KneesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Knees [Member]", "label": "Knees [Member]", "terseLabel": "Knees" } } }, "localname": "KneesMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "domainItemType" }, "syk_LandBuildingsAndImprovementsGross": { "auth_ref": [], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Land, Buildings and Improvements, Gross", "label": "Land, Buildings and Improvements, Gross", "terseLabel": "Land, buildings and improvements" } } }, "localname": "LandBuildingsAndImprovementsGross", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "syk_MedicalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Medical [Member]", "label": "Medical [Member]", "terseLabel": "Medical" } } }, "localname": "MedicalMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "domainItemType" }, "syk_MedsurgMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "MedSurg Equipment [Member]", "label": "MedSurg [Member]", "terseLabel": "MedSurg" } } }, "localname": "MedsurgMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails", "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "domainItemType" }, "syk_MobiusMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Mobius [Member]", "label": "Mobius [Member]", "terseLabel": "Mobius" } } }, "localname": "MobiusMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails", "http://www.stryker.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "syk_NetInvestmentHedgeGainLosstobeReclassifiedwithinTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Net Investment Hedge Gain (Loss) to be Reclassified within Twelve Months", "label": "Net Investment Hedge Gain (Loss) to be Reclassified within Twelve Months", "terseLabel": "Other Income" } } }, "localname": "NetInvestmentHedgeGainLosstobeReclassifiedwithinTwelveMonths", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "syk_NeurotechnologyAndSpineMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Neurotechnology And Spine [Member]", "label": "Neurotechnology And Spine [Member]", "terseLabel": "Neurotechnology and Spine" } } }, "localname": "NeurotechnologyAndSpineMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails", "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "domainItemType" }, "syk_NeurotechnologyMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Neurotechnology [Member]", "label": "Neurotechnology [Member]", "terseLabel": "Neurotechnology" } } }, "localname": "NeurotechnologyMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "domainItemType" }, "syk_OrthoSpaceLtd.Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "OrthoSpace, Ltd. [Member]", "label": "OrthoSpace, Ltd. [Member]", "terseLabel": "OrthoSpace, Ltd." } } }, "localname": "OrthoSpaceLtd.Member", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails", "http://www.stryker.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "syk_OrthopaedicsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Orthopaedics [Member]", "label": "Orthopaedics [Member]", "terseLabel": "Orthopaedics" } } }, "localname": "OrthopaedicsMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails", "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "domainItemType" }, "syk_OtherOrthopaedicsDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Other Orthopaedics [Domain]", "label": "Other Orthopaedics [Domain]", "terseLabel": "Other" } } }, "localname": "OtherOrthopaedicsDomain", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "domainItemType" }, "syk_RegulatoryandLegal": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Regulatory and Legal Matters", "label": "Regulatory and Legal", "negatedTerseLabel": "Regulatory and legal matters" } } }, "localname": "RegulatoryandLegal", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "monetaryItemType" }, "syk_SaleOfInventorySteppedUpToFairValueAtAcquisition": { "auth_ref": [], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sale of Inventory, Stepped-Up to Fair Value at Acquisition", "label": "Sale of Inventory, Stepped-Up to Fair Value at Acquisition", "terseLabel": "Sale of inventory stepped-up to fair value at acquisition" } } }, "localname": "SaleOfInventorySteppedUpToFairValueAtAcquisition", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "syk_SeniorUnsecuredNotes0.250due2024Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes 0.250% due 2024 [Member]", "label": "Senior Unsecured Notes 0.250% due 2024 [Member]", "terseLabel": "Senior Unsecured Notes 0.250% due 2024" } } }, "localname": "SeniorUnsecuredNotes0.250due2024Member", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotes0.750due2029Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes 0.750% due 2029 [Member]", "label": "Senior Unsecured Notes 0.750% due 2029 [Member]", "terseLabel": "Senior Unsecured Notes 0.750% due 2029" } } }, "localname": "SeniorUnsecuredNotes0.750due2029Member", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotes1.000due2031Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes 1.000% due 2031 [Member]", "label": "Senior Unsecured Notes 1.000% due 2031 [Member]", "terseLabel": "Senior Unsecured Notes 1.000% due 2031" } } }, "localname": "SeniorUnsecuredNotes1.000due2031Member", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotes1.125Due2021Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes, 1.125% Due 2021 [Member]", "label": "Senior Unsecured Notes, 1.125% Due 2021 [Member]", "terseLabel": "Senior Unsecured Notes 1.125% due 2021" } } }, "localname": "SeniorUnsecuredNotes1.125Due2021Member", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails", "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotes2.125Due2027Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes, 2.125% Due 2027 [Member]", "label": "Senior Unsecured Notes, 2.125% Due 2027 [Member]", "terseLabel": "Senior Unsecured Notes 2.125% due 2027" } } }, "localname": "SeniorUnsecuredNotes2.125Due2027Member", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails", "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotes2.625Due2030Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes, 2.625% Due 2030", "label": "Senior Unsecured Notes, 2.625% Due 2030 [Member]", "terseLabel": "Senior Unsecured Notes 2.625% due 2030" } } }, "localname": "SeniorUnsecuredNotes2.625Due2030Member", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails", "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotes2.625due2021MemberDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes 2.625% due 2021 [Member] [Domain]", "label": "Senior Unsecured Notes 2.625% due 2021 [Member] [Domain]", "terseLabel": "Senior Unsecured Notes 2.625% due 2021" } } }, "localname": "SeniorUnsecuredNotes2.625due2021MemberDomain", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotes3.375due2024Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes 3.375% due 2024 [Member]", "label": "Senior Unsecured Notes 3.375% due 2024 [Member]", "verboseLabel": "Senior Unsecured Notes 3.375% due 2024" } } }, "localname": "SeniorUnsecuredNotes3.375due2024Member", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotes3.375due2025MemberMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes 3.375% due 2025 [Member]", "label": "Senior Unsecured Notes 3.375% due 2025 [Member] [Member]", "terseLabel": "Senior Unsecured Notes 3.375% due 2025" } } }, "localname": "SeniorUnsecuredNotes3.375due2025MemberMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotes3.50due2026MemberDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes 3.50% due 2026 [Member] [Domain]", "label": "Senior Unsecured Notes 3.50% due 2026 [Member] [Domain]", "terseLabel": "Senior Unsecured Notes 3.50% due 2026" } } }, "localname": "SeniorUnsecuredNotes3.50due2026MemberDomain", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotes3.650due2028Domain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes 3.650% due 2028 [Domain]", "label": "Senior Unsecured Notes 3.650% due 2028 [Domain]", "terseLabel": "Senior Unsecured Notes 3.650% due 2028" } } }, "localname": "SeniorUnsecuredNotes3.650due2028Domain", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotes4.375due2044Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes 4.375% due 2044 [Member]", "label": "Senior Unsecured Notes 4.375% due 2044 [Member]", "terseLabel": "Senior Unsecured Notes 4.375% due 2044" } } }, "localname": "SeniorUnsecuredNotes4.375due2044Member", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotes4.625due2046MemberDomainDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes 4.625% due 2046 [Member] [Domain] [Domain]", "label": "Senior Unsecured Notes 4.625% due 2046 [Member] [Domain] [Domain]", "terseLabel": "Senior Unsecured Notes 4.625% due 2046" } } }, "localname": "SeniorUnsecuredNotes4.625due2046MemberDomainDomain", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotes410Due2043Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes 4.10% due 2043 [Member]", "label": "Senior Unsecured Notes 4.10% due 2043 [Member]", "terseLabel": "Senior Unsecured Notes 4.100% due 2043" } } }, "localname": "SeniorUnsecuredNotes410Due2043Member", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotes4375Due2020Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes Four Point Three Seven Five Percent Due Two Thousand Twenty [Member]", "label": "Senior Unsecured Notes 4.375% Due 2020 [Member]", "terseLabel": "Senior Unsecured Notes 4.375% due 2020" } } }, "localname": "SeniorUnsecuredNotes4375Due2020Member", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "syk_SeniorUnsecuredNotesVariableInterestRateDueNovember2020Member": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Senior Unsecured Notes, Variable Interest Rate, Due November 2020 [Member]", "label": "Senior Unsecured Notes, Variable Interest Rate, Due November 2020 [Member]", "terseLabel": "Senior Unsecured Notes Variable due 2020" } } }, "localname": "SeniorUnsecuredNotesVariableInterestRateDueNovember2020Member", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails", "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "syk_SpineMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Spine [Member]", "label": "Spine [Member]", "terseLabel": "Spine" } } }, "localname": "SpineMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "domainItemType" }, "syk_SustainabilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Sustainability [Member]", "label": "Sustainability [Member]", "terseLabel": "Sustainability" } } }, "localname": "SustainabilityMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "domainItemType" }, "syk_TraumaandExtremitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Trauma and Extremities [Member]", "label": "Trauma and Extremities [Member]", "terseLabel": "Trauma and Extremities" } } }, "localname": "TraumaandExtremitiesMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "domainItemType" }, "syk_WrightMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Wright [Member]", "label": "Wright [Member]", "terseLabel": "Wright" } } }, "localname": "WrightMember", "nsuri": "http://www.stryker.com/20200331", "presentation": [ "http://www.stryker.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AOCIAttributableToParentNetOfTaxRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "AOCI Attributable to Parent, Net of Tax [Roll Forward]", "terseLabel": "AOCI Attributable to Parent, Net of Tax [Roll Forward]" } } }, "localname": "AOCIAttributableToParentNetOfTaxRollForward", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r11", "r35" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Trade, Current", "verboseLabel": "Accounts payable" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r23", "r185" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.", "label": "Accounts Receivable, Net, Current", "terseLabel": "Accounts receivable, less allowance of $100 ($88 in 2019)" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesCurrent": { "auth_ref": [ "r17", "r286", "r297" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.", "label": "Accrued Income Taxes, Current", "verboseLabel": "Income taxes" } } }, "localname": "AccruedIncomeTaxesCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedIncomeTaxesNoncurrent": { "auth_ref": [ "r19", "r286", "r297" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.", "label": "Accrued Income Taxes, Noncurrent", "terseLabel": "Income taxes" } } }, "localname": "AccruedIncomeTaxesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesMember": { "auth_ref": [ "r39" ], "lang": { "en-US": { "role": { "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.", "label": "Accrued Liabilities [Member]", "terseLabel": "Accrued Expenses" } } }, "localname": "AccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDefinedBenefitPlansAdjustmentMember": { "auth_ref": [ "r59", "r65", "r66", "r191", "r224" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive (income) loss related to defined benefit plans attributable to the parent.", "label": "Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member]", "terseLabel": "Pension Plans" } } }, "localname": "AccumulatedDefinedBenefitPlansAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r33", "r156" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "terseLabel": "Less accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember": { "auth_ref": [ "r55", "r65", "r66", "r223" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges, attributable to the parent.", "label": "Accumulated Net Gain (Loss) from Cash Flow Hedges Attributable to Parent [Member]", "terseLabel": "Hedges" } } }, "localname": "AccumulatedNetGainLossFromDesignatedOrQualifyingCashFlowHedgesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedNetUnrealizedInvestmentGainLossMember": { "auth_ref": [ "r56", "r57", "r58", "r65", "r66" ], "lang": { "en-US": { "role": { "documentation": "Accumulated unrealized gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), attributable to parent.", "label": "Accumulated Net Investment Gain (Loss) Attributable to Parent [Member]", "terseLabel": "Marketable Securities" } } }, "localname": "AccumulatedNetUnrealizedInvestmentGainLossMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Accumulated Other Comprehensive Income (Loss) [Line Items]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Line Items]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r62", "r64", "r65" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "periodEndLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax at end of period", "periodStartLabel": "Accumulated Other Comprehensive Income (Loss), Net of Tax at beginning of period", "verboseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails", "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about components of accumulated other comprehensive income (loss).", "label": "Accumulated Other Comprehensive Income (Loss) [Table]", "terseLabel": "Accumulated Other Comprehensive Income (Loss) [Table]" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [ "r61", "r65", "r66", "r224" ], "lang": { "en-US": { "role": { "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.", "label": "AOCI Attributable to Parent [Member]", "terseLabel": "Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "AccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "auth_ref": [ "r54", "r65", "r66", "r224" ], "lang": { "en-US": { "role": { "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent.", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "verboseLabel": "Financial Statement Translation" } } }, "localname": "AccumulatedTranslationAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife": { "auth_ref": [ "r146" ], "lang": { "en-US": { "role": { "documentation": "Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Acquired Finite-lived Intangible Assets, Weighted Average Useful Life", "verboseLabel": "Weighted-average life of intangible assets" } } }, "localname": "AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r24" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid in Capital, Common Stock", "verboseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentForAmortization": { "auth_ref": [ "r92", "r151" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.", "label": "Amortization", "terseLabel": "Amortization of intangible assets" } } }, "localname": "AdjustmentForAmortization", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r193", "r194", "r197", "r198" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) from recognition of equity-based compensation.", "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition", "verboseLabel": "Share-based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net earnings to net cash provided by operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "auth_ref": [ "r46", "r127" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.", "label": "Allowance for Doubtful Accounts Receivable, Current", "terseLabel": "Allowance for doubtful accounts receivable" } } }, "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r92", "r144", "r151" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": 3.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of Intangible Assets", "negatedLabel": "Amortization of intangible assets", "terseLabel": "Amortization of intangible assets" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited", "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetBackedSecuritiesMember": { "auth_ref": [ "r133", "r189" ], "lang": { "en-US": { "role": { "documentation": "Securities that are primarily serviced by the cash flows of a discrete pool of receivables or other financial assets for example, but not limited to, credit card receivables, car loans, recreational vehicle loans, and mobile home loans.", "label": "Asset-backed Securities [Member]", "verboseLabel": "Corporate and asset-backed debt securities" } } }, "localname": "AssetBackedSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r117", "r283", "r296" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets", "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r5", "r7", "r48" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r254" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Fair Value Disclosure", "terseLabel": "Investments Fair Value Disclosure" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesCurrent": { "auth_ref": [], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in debt and equity securities categorized neither as trading securities nor held-to-maturity securities and intended be sold or mature one year or operating cycle, if longer.", "label": "Available-for-sale Securities, Current", "terseLabel": "Available-for-sale securities, current", "verboseLabel": "Marketable securities" } } }, "localname": "AvailableForSaleSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets", "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue": { "auth_ref": [ "r131", "r132", "r292" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), maturing in next fiscal year following latest fiscal year. Excludes interim and annual periods when interim period is reported on rolling approach, from latest statement of financial position date.", "label": "Debt Securities, Available-for-sale, Maturity, Allocated and Single Maturity Date, within One Year, Fair Value", "verboseLabel": "Due in one year or less" } } }, "localname": "AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details" ], "xbrltype": "monetaryItemType" }, "us-gaap_AvailableforsaleSecuritiesMember": { "auth_ref": [ "r135" ], "lang": { "en-US": { "role": { "documentation": "Investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Available-for-sale Securities [Member]", "terseLabel": "Available-for-sale marketable securities:" } } }, "localname": "AvailableforsaleSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BalanceSheetLocationAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by location on balance sheet (statement of financial position).", "label": "Balance Sheet Location [Axis]", "terseLabel": "Balance Sheet Location [Axis]" } } }, "localname": "BalanceSheetLocationAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BalanceSheetLocationDomain": { "auth_ref": [ "r235", "r240" ], "lang": { "en-US": { "role": { "documentation": "Location in the balance sheet (statement of financial position).", "label": "Balance Sheet Location [Domain]", "terseLabel": "Balance Sheet Location [Domain]" } } }, "localname": "BalanceSheetLocationDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]", "terseLabel": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails", "http://www.stryker.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r207", "r208" ], "lang": { "en-US": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]", "terseLabel": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails", "http://www.stryker.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]", "terseLabel": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r215", "r216", "r218" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "terseLabel": "Aggregate purchase price of acquisitions" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration [Abstract]", "terseLabel": "Contingent consideration:" } } }, "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r214", "r217", "r219" ], "calculation": { "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability", "negatedTerseLabel": "Contingent consideration" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r220" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "verboseLabel": "Acquisitions" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/Acquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationIntegrationRelatedCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Costs incurred to effect a business combination which have been expensed during the period. Such costs could include business integration costs, systems integration and conversion costs, and severance and other employee-related costs.", "label": "Business Combination, Integration Related Costs", "negatedLabel": "Acquisition and integration-related charges" } } }, "localname": "BusinessCombinationIntegrationRelatedCosts", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r210" ], "calculation": { "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "terseLabel": "Accounts receivable" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles": { "auth_ref": [ "r209", "r210" ], "calculation": { "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails": { "order": 7.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of identifiable intangible assets recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles", "terseLabel": "Intangible assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibles", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "auth_ref": [ "r209", "r210" ], "calculation": { "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of inventory recognized as of the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory", "terseLabel": "Inventory" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "auth_ref": [ "r210" ], "calculation": { "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Liabilities", "negatedTerseLabel": "Other liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets": { "auth_ref": [ "r210" ], "calculation": { "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of other assets expected to be realized or consumed after one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets", "terseLabel": "Other assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherNoncurrentAssets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r210" ], "calculation": { "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Assets and liabilities acquired, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r31", "r94" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets", "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r89", "r94", "r96" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "periodEndLabel": "Cash and cash equivalents at end of period", "periodStartLabel": "Cash and cash equivalents at beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r89", "r267" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Change in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths": { "auth_ref": [ "r251" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The estimated net amount of existing gains or losses on cash flow hedges at the reporting date expected to be reclassified to earnings within the next 12 months.", "label": "Cash Flow Hedge Gain (Loss) to be Reclassified within Twelve Months", "terseLabel": "Cash flow hedge gain (loss) to be reclassified within twelve months" } } }, "localname": "CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowHedgingMember": { "auth_ref": [ "r231" ], "lang": { "en-US": { "role": { "documentation": "Hedge of the exposure to variability in the cash flows of a recognized asset or liability, or of a forecasted transaction, that is attributable to a particular risk.", "label": "Cash Flow Hedging [Member]", "terseLabel": "Cash Flow Hedging [Member]" } } }, "localname": "CashFlowHedgingMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CertificatesOfDepositMember": { "auth_ref": [ "r294" ], "lang": { "en-US": { "role": { "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured.", "label": "Certificates of Deposit [Member]", "terseLabel": "Certificates of deposit" } } }, "localname": "CertificatesOfDepositMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]", "terseLabel": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommercialPaper": { "auth_ref": [ "r14", "r284", "r299" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of short-term borrowings using unsecured obligations issued by banks, corporations and other borrowers to investors. The maturities of these money market securities generally do not exceed 270 days.", "label": "Commercial Paper", "terseLabel": "Amounts outstanding under commercial paper program" } } }, "localname": "CommercialPaper", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommercialPaperMember": { "auth_ref": [ "r178" ], "lang": { "en-US": { "role": { "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds.", "label": "Commercial Paper [Member]", "terseLabel": "Commercial Paper" } } }, "localname": "CommercialPaperMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r165", "r175" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Contingencies and Commitments" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitments" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockDividendsPerShareDeclared": { "auth_ref": [ "r181" ], "lang": { "en-US": { "role": { "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding.", "label": "Common Stock, Dividends, Per Share, Declared", "terseLabel": "Cash dividends declared per share of common stock (in dollars per share)" } } }, "localname": "CommonStockDividendsPerShareDeclared", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited", "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r22" ], "lang": { "en-US": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r22", "r180" ], "lang": { "en-US": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "periodEndLabel": "Ending balance (in shares)", "periodStartLabel": "Beginning balance (in shares)" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValueOutstanding": { "auth_ref": [ "r22" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.", "label": "Common Stock, Value, Outstanding", "terseLabel": "Common stock, $0.10 par value" } } }, "localname": "CommonStockValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r69", "r71", "r72" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "totalLabel": "Comprehensive income" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNoteTextBlock": { "auth_ref": [ "r81" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for comprehensive income, which includes, but is not limited to, 1) the amount of income tax expense or benefit allocated to each component of other comprehensive income, including reclassification adjustments, 2) the reclassification adjustments for each classification of other comprehensive income and 3) the ending accumulated balances for each component of comprehensive income.", "label": "Comprehensive Income (Loss) Note [Text Block]", "terseLabel": "Accumulated Other Comprehensive (Loss) Income (AOCI)" } } }, "localname": "ComprehensiveIncomeNoteTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAoci" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r182", "r183", "r185" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability", "terseLabel": "Contract liabilities" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r123" ], "lang": { "en-US": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate, Non-Segment [Member]", "terseLabel": "Corporate and other" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r78" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": 2.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of sales", "verboseLabel": "Cost of sales" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails", "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfSalesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing cost of sales.", "label": "Cost of Sales [Member]", "verboseLabel": "Cost of sales" } } }, "localname": "CostOfSalesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]", "terseLabel": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Domain]", "terseLabel": "Credit Facility [Domain]" } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r212" ], "lang": { "en-US": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer relationship" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtCurrent": { "auth_ref": [ "r37" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of short-term debt and current maturity of long-term debt and capital lease obligations due within one year or the normal operating cycle, if longer.", "label": "Debt, Current", "terseLabel": "Current maturities of debt", "verboseLabel": "Less current maturities of debt" } } }, "localname": "DebtCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets", "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r179" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "Debt Disclosure [Text Block]", "verboseLabel": "Debt And Credit Facilities" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r16", "r17", "r18", "r285", "r287", "r295" ], "lang": { "en-US": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r263" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Debt Instrument, Fair Value Disclosure", "terseLabel": "Fair value of senior unsecured notes" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r41" ], "lang": { "en-US": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Stated interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r42", "r257" ], "lang": { "en-US": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in CCYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "Maturity Date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r43" ], "lang": { "en-US": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument, Name [Domain]", "terseLabel": "Debt Instrument, Name [Domain]" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentRepurchasedFaceAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Face (par) amount of the original debt instrument that was repurchased.", "label": "Debt Instrument, Repurchased Face Amount", "terseLabel": "Debt instrument, repurchased face amount" } } }, "localname": "DebtInstrumentRepurchasedFaceAmount", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt Instrument, Term", "terseLabel": "Debt instrument, maturity" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_DebtLongtermAndShorttermCombinedAmount": { "auth_ref": [], "calculation": { "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.stryker.com/role/DebtAndCreditFacilitiesDetailsCalc2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt.", "label": "Debt, Long-term and Short-term, Combined Amount", "totalLabel": "Total debt" } } }, "localname": "DebtLongtermAndShorttermCombinedAmount", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxAssetsNet": { "auth_ref": [ "r203" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.", "label": "Deferred Income Tax Assets, Net", "terseLabel": "Noncurrent deferred income tax assets" } } }, "localname": "DeferredIncomeTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r92", "r154" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation", "terseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssets": { "auth_ref": [ "r50", "r51", "r263" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, after the effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets not subject to a master netting arrangement and not elected to be offset.", "label": "Derivative Asset", "terseLabel": "Derivative asset" } } }, "localname": "DerivativeAssets", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetsLiabilitiesAtFairValueNet": { "auth_ref": [ "r227" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair values as of the balance sheet date of the net amount of all assets and liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments.", "label": "Derivative Assets (Liabilities), at Fair Value, Net", "terseLabel": "Pretax losses recorded in AOCI" } } }, "localname": "DerivativeAssetsLiabilitiesAtFairValueNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeContractTypeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset.", "label": "Derivative Contract [Domain]", "terseLabel": "Derivative Contract [Domain]" } } }, "localname": "DerivativeContractTypeDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails", "http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails", "http://www.stryker.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details", "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DerivativeFairValueOfDerivativeAsset": { "auth_ref": [ "r49", "r52", "r238", "r281" ], "calculation": { "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails": { "order": 1.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial asset or other contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes assets elected not to be offset. Excludes assets not subject to a master netting arrangement.", "label": "Derivative Asset, Fair Value, Gross Asset", "terseLabel": "Derivative assets" } } }, "localname": "DerivativeFairValueOfDerivativeAsset", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeLiability": { "auth_ref": [ "r49", "r52", "r238", "r281" ], "calculation": { "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails": { "order": 2.0, "parentTag": "us-gaap_DerivativeFairValueOfDerivativeNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value, before effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities elected not to be offset. Excludes liabilities not subject to a master netting arrangement.", "label": "Derivative Liability, Fair Value, Gross Liability", "negatedTerseLabel": "Derivative liabilities" } } }, "localname": "DerivativeFairValueOfDerivativeLiability", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFairValueOfDerivativeNet": { "auth_ref": [ "r263" ], "calculation": { "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of the assets less the liabilities of a derivative or group of derivatives.", "label": "Derivative, Fair Value, Net", "totalLabel": "Derivative, Fair Value, Net" } } }, "localname": "DerivativeFairValueOfDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeInstrumentRiskAxis": { "auth_ref": [ "r236", "r239", "r242", "r245" ], "lang": { "en-US": { "role": { "documentation": "Information by type of derivative contract.", "label": "Derivative Instrument [Axis]", "terseLabel": "Derivative Instrument [Axis]" } } }, "localname": "DerivativeInstrumentRiskAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails", "http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails", "http://www.stryker.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details", "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Derivative Instruments and Hedging Activities Disclosure [Abstract]" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "auth_ref": [ "r252" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts.", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "terseLabel": "Derivative Instruments" } } }, "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipAxis": { "auth_ref": [ "r233", "r236", "r242" ], "lang": { "en-US": { "role": { "documentation": "Information by type of hedging relationship.", "label": "Hedging Relationship [Axis]", "terseLabel": "Hedging Relationship [Axis]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails", "http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable": { "auth_ref": [ "r233", "r236", "r242", "r245", "r246", "r249", "r250" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about the location and amount of derivative instruments and nonderivative instruments designated as hedging instruments reported before netting adjustments, and the amount of gain (loss) on derivative instruments and nonderivative instruments designated and qualified as hedging instruments.", "label": "Derivative Instruments, Gain (Loss) [Table]", "verboseLabel": "Derivative Instruments, Gain (Loss) by Hedging Relationship, by Income Statement Location, by Derivative Instrument Risk [Table]" } } }, "localname": "DerivativeInstrumentsGainLossByHedgingRelationshipByIncomeStatementLocationByDerivativeInstrumentRiskTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeInstrumentsGainLossLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative Instruments, Gain (Loss) [Line Items]", "terseLabel": "Derivative Instruments, Gain (Loss) [Line Items]" } } }, "localname": "DerivativeInstrumentsGainLossLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Derivative [Line Items]", "terseLabel": "Derivative [Line Items]" } } }, "localname": "DerivativeLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DerivativeTable": { "auth_ref": [ "r101", "r228", "r229", "r230", "r233", "r234", "r241", "r242", "r247", "r248", "r250" ], "lang": { "en-US": { "role": { "documentation": "Schedule that describes and identifies a derivative or group of derivatives on a disaggregated basis, such as for individual instruments, or small groups of similar instruments. May include a combination of the type of instrument, risks being hedged, notional amount, hedge designation, related hedged item, inception date, maturity date, or other relevant item.", "label": "Derivative [Table]", "terseLabel": "Derivative [Table]" } } }, "localname": "DerivativeTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DesignatedAsHedgingInstrumentMember": { "auth_ref": [ "r233" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Designated as Hedging Instrument [Member]", "terseLabel": "Net Investment", "verboseLabel": "Designated as Hedging Instrument" } } }, "localname": "DesignatedAsHedgingInstrumentMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DevelopedTechnologyRightsMember": { "auth_ref": [ "r213" ], "lang": { "en-US": { "role": { "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.", "label": "Developed Technology Rights [Member]", "terseLabel": "Developed technology and patents" } } }, "localname": "DevelopedTechnologyRightsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DisaggregationOfRevenueLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Disaggregation of Revenue [Line Items]", "terseLabel": "Disaggregation of Revenue [Line Items]" } } }, "localname": "DisaggregationOfRevenueLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table]", "terseLabel": "Disaggregation of Revenue [Table]" } } }, "localname": "DisaggregationOfRevenueTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r184" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation of Revenue [Table Text Block]", "terseLabel": "Schedule of Disaggregated Revenue" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DividendsCash": { "auth_ref": [ "r181", "r293" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of paid and unpaid cash dividends declared for classes of stock, for example, but not limited to, common and preferred.", "label": "Dividends, Cash", "negatedLabel": "Cash dividends declared" } } }, "localname": "DividendsCash", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_DividendsPayableCurrent": { "auth_ref": [ "r11", "r39" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Carrying value as of the balance sheet date of dividends declared but unpaid on equity securities issued by the entity and outstanding. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Dividends Payable, Current", "terseLabel": "Dividends payable" } } }, "localname": "DividendsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Earnings Per Share [Abstract]", "verboseLabel": "Net earnings per share of common stock:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r75", "r104", "r107", "r108", "r109", "r110", "r112", "r291", "r304" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "verboseLabel": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r75", "r104", "r107", "r108", "r109", "r110", "r112", "r291", "r304" ], "lang": { "en-US": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "verboseLabel": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "perShareItemType" }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r267" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents", "terseLabel": "Effect of exchange rate changes on cash and cash equivalents" } } }, "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r100", "r201", "r202" ], "lang": { "en-US": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "terseLabel": "Effective income tax rate reconciliation, percent" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/IncomeTaxesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee-related Liabilities, Current", "terseLabel": "Accrued compensation" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r180" ], "lang": { "en-US": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails", "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivities": { "auth_ref": [ "r199" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.", "label": "Excess Tax Benefit from Share-based Compensation, Financing Activities", "terseLabel": "Cash paid for taxes from withheld shares" } } }, "localname": "ExcessTaxBenefitFromShareBasedCompensationFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details", "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r253", "r254", "r255", "r256", "r260", "r261" ], "lang": { "en-US": { "role": { "documentation": "Disclosure of information about financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table]", "terseLabel": "Fair Value Measurements, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details", "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r189", "r190", "r192", "r255", "r277" ], "lang": { "en-US": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]", "terseLabel": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details", "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r262" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r189", "r190", "r192", "r255", "r278" ], "lang": { "en-US": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Fair Value, Inputs, Level 1" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r189", "r190", "r192", "r255", "r279" ], "lang": { "en-US": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Fair Value, Inputs, Level 2" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details", "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r189", "r190", "r192", "r255", "r280" ], "lang": { "en-US": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Fair Value, Inputs, Level 3" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "auth_ref": [ "r259" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "terseLabel": "Additions" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease": { "auth_ref": [ "r258" ], "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease)", "negatedLabel": "Change in estimate" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "auth_ref": [ "r259" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "negatedLabel": "Settlements" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "auth_ref": [ "r258" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "periodEndLabel": "Ending", "periodStartLabel": "Beginning" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]", "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "verboseLabel": "Fair Value, Measurements, Fair Value Hierarchy [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details", "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "auth_ref": [], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized in the remainder of the fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Remainder of Fiscal Year", "terseLabel": "Remainder of 2020" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": { "auth_ref": [ "r152" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fifth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Five", "terseLabel": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "auth_ref": [ "r152" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the fourth fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Four", "terseLabel": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r152" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Three", "terseLabel": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r152" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of amortization expense for assets, excluding financial assets and goodwill, lacking physical substance with a finite life expected to be recognized during the second fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.", "label": "Finite-Lived Intangible Assets, Amortization Expense, Year Two", "terseLabel": "2021" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r145", "r147", "r150", "r153", "r282" ], "lang": { "en-US": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r145", "r149" ], "lang": { "en-US": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ForeignCurrencyContractsLiabilityFairValueDisclosure": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value portion of liability contracts related to the exchange of different currencies, including, but not limited to, foreign currency options, forward (delivery or nondelivery) contracts, and swaps entered into.", "label": "Foreign Currency Contracts, Liability, Fair Value Disclosure", "terseLabel": "Foreign currency exchange forward contracts" } } }, "localname": "ForeignCurrencyContractsLiabilityFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details", "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": { "auth_ref": [ "r264", "r265", "r266" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.", "label": "Foreign Currency Transaction Gain (Loss), before Tax", "terseLabel": "Net currency exchange rate gains (losses)" } } }, "localname": "ForeignCurrencyTransactionGainLossBeforeTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ForeignExchangeContractMember": { "auth_ref": [ "r189", "r244" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument whose primary underlying risk is tied to foreign exchange rates.", "label": "Foreign Exchange Contract [Member]", "terseLabel": "Foreign Exchange Contract", "verboseLabel": "Foreign currency exchange forward contracts" } } }, "localname": "ForeignExchangeContractMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails", "http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails", "http://www.stryker.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details", "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r140", "r141" ], "calculation": { "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "weight": 1.0 }, "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails", "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r77" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_HedgingDesignationAxis": { "auth_ref": [ "r233", "r246" ], "lang": { "en-US": { "role": { "documentation": "Information by designation of purpose of derivative instrument.", "label": "Hedging Designation [Axis]", "terseLabel": "Hedging Designation [Axis]" } } }, "localname": "HedgingDesignationAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_HedgingDesignationDomain": { "auth_ref": [ "r233" ], "lang": { "en-US": { "role": { "documentation": "Designation of purpose of derivative instrument.", "label": "Hedging Designation [Domain]", "terseLabel": "Hedging Designation [Domain]" } } }, "localname": "HedgingDesignationDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_HedgingRelationshipDomain": { "auth_ref": [ "r233" ], "lang": { "en-US": { "role": { "documentation": "Nature or intent of a hedge.", "label": "Hedging Relationship [Domain]", "terseLabel": "Hedging Relationship [Domain]" } } }, "localname": "HedgingRelationshipDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails", "http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments": { "auth_ref": [ "r99" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of income (loss) from continuing operations before deduction of income tax expense (benefit) and income (loss) attributable to noncontrolling interest, and addition of income (loss) from equity method investments.", "label": "Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest", "totalLabel": "Earnings before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationAxis": { "auth_ref": [ "r158" ], "lang": { "en-US": { "role": { "documentation": "Information by location in the income statement.", "label": "Income Statement Location [Axis]", "terseLabel": "Income Statement Location [Axis]" } } }, "localname": "IncomeStatementLocationAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementLocationDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Location in the income statement.", "label": "Income Statement Location [Domain]", "terseLabel": "Income Statement Location [Domain]" } } }, "localname": "IncomeStatementLocationDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r206" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r97", "r116", "r205" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense (Benefit)", "negatedTerseLabel": "Income taxes", "terseLabel": "Income taxes" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails", "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableTrade": { "auth_ref": [ "r91" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Change in recurring obligations of a business that arise from the acquisition of merchandise, materials, supplies and services used in the production and sale of goods and services.", "label": "Increase (Decrease) in Accounts Payable, Trade", "verboseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayableTrade", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r91" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayable": { "auth_ref": [ "r91" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.", "label": "Increase (Decrease) in Income Taxes Payable", "verboseLabel": "Income taxes" } } }, "localname": "IncreaseDecreaseInAccruedIncomeTaxesPayable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccruedLiabilities": { "auth_ref": [ "r91" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.", "label": "Increase (Decrease) in Accrued Liabilities", "verboseLabel": "Accrued expenses and other liabilities" } } }, "localname": "IncreaseDecreaseInAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInventories": { "auth_ref": [ "r91" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.", "label": "Increase (Decrease) in Inventories", "negatedLabel": "Inventories" } } }, "localname": "IncreaseDecreaseInInventories", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "auth_ref": [ "r91" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other.", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "negatedLabel": "Other, net" } } }, "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]" } } }, "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_InformationByCategoryOfDebtSecurityAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by category of debt security, either available-for-sale or held-to-maturity.", "label": "Debt Security Category [Axis]", "verboseLabel": "Schedule of Gain (Loss) on Investments, Including Marketable Securities and Investments Held at Cost, Reported Amounts, by Category [Axis]" } } }, "localname": "InformationByCategoryOfDebtSecurityAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r143", "r148" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Other intangibles, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestRateSwapMember": { "auth_ref": [ "r243" ], "lang": { "en-US": { "role": { "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period.", "label": "Interest Rate Swap [Member]", "terseLabel": "Interest Rate Swap" } } }, "localname": "InterestRateSwapMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails", "http://www.stryker.com/role/FairValueMeasurementsAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisUsingUnobservableInputsLevel3Details", "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "auth_ref": [ "r27", "r138" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.", "label": "Inventory, Finished Goods, Net of Reserves", "terseLabel": "Finished goods" } } }, "localname": "InventoryFinishedGoodsNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r3", "r47", "r137" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "totalLabel": "Total inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNetAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Inventory, Net [Abstract]", "terseLabel": "Inventories:" } } }, "localname": "InventoryNetAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_InventoryRawMaterialsAndSuppliesNetOfReserves": { "auth_ref": [ "r29", "r30", "r138" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Aggregated amount of unprocessed materials to be used in manufacturing or production process and supplies that will be consumed. This amount is net of valuation reserves and adjustments.", "label": "Inventory, Raw Materials and Supplies, Net of Reserves", "terseLabel": "Materials and supplies" } } }, "localname": "InventoryRawMaterialsAndSuppliesNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "auth_ref": [ "r28", "r138" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_InventoryNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.", "label": "Inventory, Work in Process, Net of Reserves", "terseLabel": "Work in process" } } }, "localname": "InventoryWorkInProcessNetOfReserves", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r306", "r307", "r308", "r309" ], "lang": { "en-US": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]", "terseLabel": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r306", "r307", "r308", "r309" ], "lang": { "en-US": { "role": { "documentation": "Asset obtained to generate income or appreciate in value.", "label": "Investments [Domain]", "terseLabel": "Investments [Domain]" } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentsClassifiedByContractualMaturityDateTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of maturities of an entity's investments as well as any other information pertinent to the investments.", "label": "Investments Classified by Contractual Maturity Date [Table Text Block]", "terseLabel": "Investments Classified by Contractual Maturity Date" } } }, "localname": "InvestmentsClassifiedByContractualMaturityDateTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeaseCostAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Lease, Cost [Abstract]", "terseLabel": "Other information" } } }, "localname": "LeaseCostAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsLeasesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r274" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease, Cost [Table Text Block]", "terseLabel": "Lease, Cost" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r38" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r26", "r288", "r301" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and shareholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and shareholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r40" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r254" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Financial and Nonfinancial Liabilities, Fair Value Disclosure", "terseLabel": "Total liabilities measured at fair value" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r36" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Line of Credit Facility, Maximum Borrowing Capacity", "terseLabel": "Line of credit facility, maximum borrowing capacity" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r36" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Line of Credit Facility, Remaining Borrowing Capacity", "terseLabel": "Available secured borrowing capacity" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityTable": { "auth_ref": [ "r36", "r98" ], "lang": { "en-US": { "role": { "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.", "label": "Line of Credit Facility [Table]", "terseLabel": "Line of Credit Facility [Table]" } } }, "localname": "LineOfCreditFacilityTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Long-term Debt, Unclassified [Abstract]" } } }, "localname": "LongTermDebtAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r43" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 }, "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long-term Debt, Excluding Current Maturities", "terseLabel": "Long-term debt, excluding current maturities", "verboseLabel": "Total long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets", "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LossContingenciesLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Loss Contingencies [Line Items]", "terseLabel": "Loss Contingencies [Line Items]" } } }, "localname": "LossContingenciesLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingenciesTable": { "auth_ref": [ "r166", "r167", "r168", "r170", "r171", "r172", "r174", "r176", "r177" ], "lang": { "en-US": { "role": { "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.", "label": "Loss Contingencies [Table]", "terseLabel": "Loss Contingencies [Table]" } } }, "localname": "LossContingenciesTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_LossContingencyEstimateOfPossibleLoss": { "auth_ref": [ "r169", "r173", "r176" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Reflects the estimated amount of loss from the specified contingency as of the balance sheet date.", "label": "Loss Contingency, Estimate of Possible Loss", "terseLabel": "Estimate of possible loss" } } }, "localname": "LossContingencyEstimateOfPossibleLoss", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MachineryAndEquipmentGross": { "auth_ref": [ "r8", "r155" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation of tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment, Gross", "terseLabel": "Machinery and equipment" } } }, "localname": "MachineryAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).", "label": "Marketable Securities, Gain (Loss)", "terseLabel": "Gain on sale of marketable securities" } } }, "localname": "MarketableSecuritiesGainLoss", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MaterialReconcilingItemsMember": { "auth_ref": [ "r119", "r120" ], "lang": { "en-US": { "role": { "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity.", "label": "Segment Reconciling Items [Member]", "terseLabel": "Segment Reconciling Items" } } }, "localname": "MaterialReconcilingItemsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MaximumRemainingMaturityOfForeignCurrencyDerivatives1": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Maximum amount of time remaining before foreign currency exchange rate derivatives mature or expire, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Maximum Remaining Maturity of Foreign Currency Derivatives", "terseLabel": "Maximum term in days" } } }, "localname": "MaximumRemainingMaturityOfForeignCurrencyDerivatives1", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" ], "xbrltype": "durationItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r89" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by (used in) financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r89" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r89", "r90", "r93" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash provided by operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r67", "r70", "r74", "r93", "r111", "r290", "r303" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 }, "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "netLabel": "Net earnings (loss)", "totalLabel": "Net earnings", "verboseLabel": "Net earnings" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited", "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited", "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgeDerivativeAssetsAtFairValue": { "auth_ref": [ "r239" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Fair value of all derivative assets designated as hedges of net investment in foreign operations.", "label": "Derivative Instruments in Hedges, Net Investment in Foreign Operations, Assets, Fair Value", "terseLabel": "Derivative, fair value" } } }, "localname": "NetInvestmentHedgeDerivativeAssetsAtFairValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetInvestmentHedgingMember": { "auth_ref": [ "r232" ], "lang": { "en-US": { "role": { "documentation": "Hedges of a net investment in a foreign operation.", "label": "Net Investment Hedging [Member]", "terseLabel": "Net Investment Hedging [Member]" } } }, "localname": "NetInvestmentHedgingMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails", "http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "New Accounting Pronouncements Not Yet Adopted" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/BasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NonUsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Countries excluding the United States of America (US).", "label": "Non-US [Member]", "terseLabel": "International" } } }, "localname": "NonUsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncompeteAgreementsMember": { "auth_ref": [ "r211" ], "lang": { "en-US": { "role": { "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.", "label": "Noncompete Agreements [Member]", "terseLabel": "Non-compete agreements" } } }, "localname": "NoncompeteAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r221" ], "lang": { "en-US": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Non-controlling interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_NondesignatedMember": { "auth_ref": [ "r233" ], "lang": { "en-US": { "role": { "documentation": "Derivative instrument not designated as hedging instrument under Generally Accepted Accounting Principles (GAAP).", "label": "Not Designated as Hedging Instrument [Member]", "terseLabel": "Non-Designated" } } }, "localname": "NondesignatedMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r80" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "terseLabel": "Other income (expense), net", "verboseLabel": "Other (income) expense" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails", "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "terseLabel": "Segment operating income", "totalLabel": "Operating income" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited", "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r271", "r275" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease, Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r270" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Lease liabilities, current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r270" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease, Liability, Noncurrent", "terseLabel": "Lease liabilities, non-current" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r269" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Right-of-use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsLeasesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r273", "r275" ], "lang": { "en-US": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease, Weighted Average Discount Rate, Percent", "terseLabel": "Weighted-average discount rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsLeasesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r272", "r275" ], "lang": { "en-US": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease, Weighted Average Remaining Lease Term", "terseLabel": "Weighted-average remaining lease term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ContingenciesAndCommitmentsLeasesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r115", "r122" ], "lang": { "en-US": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r1", "r226" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/BasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r34" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "verboseLabel": "Other noncurrent assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax": { "auth_ref": [ "r65", "r73" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), before Reclassifications, Net of Tax", "verboseLabel": "OCI" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossBeforeReclassificationsTax": { "auth_ref": [ "r63", "r204" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of tax expense (benefit) allocated to other comprehensive income (loss) before reclassification adjustment from accumulated other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss) before Reclassifications, Tax", "terseLabel": "Income taxes" } } }, "localname": "OtherComprehensiveIncomeLossBeforeReclassificationsTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax": { "auth_ref": [ "r55" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments, of increase (decrease) in accumulated gain (loss) from derivative instruments designated and qualifying as the effective portion of cash flow hedges and an entity's share of an equity investee's increase (decrease) in deferred hedging gain (loss).", "label": "Other Comprehensive Income (Loss), Derivatives Qualifying as Hedges, Net of Tax", "terseLabel": "Unrealized gains (losses) on designated hedges" } } }, "localname": "OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax": { "auth_ref": [ "r53", "r268" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 3.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature.", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax", "terseLabel": "Financial statement translation" } } }, "localname": "OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r68", "r71", "r73", "r180" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 2.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax and reclassification adjustments of other comprehensive income (loss).", "label": "Other Comprehensive Income (Loss), Net of Tax", "terseLabel": "Other comprehensive income (loss)", "totalLabel": "Total other comprehensive income (loss), net of tax", "verboseLabel": "Net OCI" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails", "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited", "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]", "terseLabel": "Other comprehensive income (loss), net of tax:" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax": { "auth_ref": [ "r60", "r62" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 1.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount, after tax and reclassification adjustment, of (increase) decrease in accumulated other comprehensive income for defined benefit plan.", "label": "Other Comprehensive (Income) Loss, Defined Benefit Plan, after Reclassification Adjustment, after Tax", "negatedTerseLabel": "Pension plans" } } }, "localname": "OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "auth_ref": [ "r56", "r62" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited": { "order": 4.0, "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount after tax, before reclassification adjustments, of unrealized holding gain (loss) on available-for-sale securities.", "label": "Other Comprehensive Income (Loss), Securities, Available-for-Sale, Unrealized Holding Gain (Loss) Arising During Period, after Tax", "terseLabel": "Marketable securities" } } }, "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfComprehensiveIncomeUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentAssetsMember": { "auth_ref": [ "r235", "r249" ], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other current assets.", "label": "Other Current Assets [Member]", "terseLabel": "Other current assets" } } }, "localname": "OtherCurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherCurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other current liabilities.", "label": "Other Current Liabilities [Member]", "terseLabel": "Other current liabilities" } } }, "localname": "OtherCurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r9", "r10", "r39" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Current", "verboseLabel": "Accrued expenses and other liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r44" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities, Noncurrent", "terseLabel": "Other noncurrent liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLongTermDebt": { "auth_ref": [ "r18", "r287", "r299" ], "calculation": { "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.stryker.com/role/DebtAndCreditFacilitiesDetailsCalc2": { "order": 2.0, "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of long-term debt classified as other.", "label": "Other Long-term Debt", "totalLabel": "Other Long-term Debt" } } }, "localname": "OtherLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNoncurrentAssetsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent assets.", "label": "Other Noncurrent Assets [Member]", "terseLabel": "Other noncurrent assets" } } }, "localname": "OtherNoncurrentAssetsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNoncurrentLiabilitiesMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.", "label": "Other Noncurrent Liabilities [Member]", "terseLabel": "Other noncurrent liabilities" } } }, "localname": "OtherNoncurrentLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsForwardCurrencyExchangeContractsDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Primary financial statement caption encompassing other nonoperating income (expense).", "label": "Other Nonoperating Income (Expense) [Member]", "terseLabel": "Other income (expense), net" } } }, "localname": "OtherNonoperatingIncomeExpenseMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsIncomeStatementLocationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain": { "auth_ref": [ "r134" ], "lang": { "en-US": { "role": { "documentation": "Provides the categories of debt securities, available-for-sale or held-to-maturity, on which an entity may recognize other than temporary impairments (OTTI) for which a portion related to credit losses has been recognized in earnings and a portion related to all other factors has been recognized in other comprehensive income.", "label": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]", "terseLabel": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]" } } }, "localname": "OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ParentMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Portion of equity, or net assets, in the consolidated entity attributable, directly or indirectly, to the parent. Excludes noncontrolling interests.", "label": "Parent [Member]", "terseLabel": "Total Stryker shareholders' equity" } } }, "localname": "ParentMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "auth_ref": [ "r86" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow to reacquire common stock during the period.", "label": "Payments for Repurchase of Common Stock", "negatedLabel": "Repurchases of common stock" } } }, "localname": "PaymentsForRepurchaseOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividends": { "auth_ref": [ "r86" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Cash outflow in the form of capital distributions and dividends to common shareholders, preferred shareholders and noncontrolling interests.", "label": "Payments of Dividends", "negatedLabel": "Dividends paid" } } }, "localname": "PaymentsOfDividends", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "auth_ref": [ "r82" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.", "label": "Payments to Acquire Businesses, Net of Cash Acquired", "negatedLabel": "Acquisitions, net of cash acquired", "terseLabel": "Acquisitions, net of cash acquired" } } }, "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsNarrativeDetails", "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r130" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Purchases of marketable securities" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r83" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Purchases of property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r4", "r6", "r139" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "auth_ref": [ "r85", "r88", "r102" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities classified as other.", "label": "Proceeds from (Payments for) Other Financing Activities", "terseLabel": "Other financing, net" } } }, "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess": { "auth_ref": [ "r84", "r87", "r95" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow from a borrowing net of the cash outflow from repayment of a borrowing having initial term of repayment within three months.", "label": "Proceeds from (Repayments of) Short-term Debt, Maturing in Three Months or Less", "terseLabel": "Proceeds (payments) on short-term borrowings, net" } } }, "localname": "ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from Sale and Maturity of Marketable Securities", "terseLabel": "Proceeds from sales of marketable securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductLiabilityAccrualPeriodExpense": { "auth_ref": [ "r166" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": 4.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The amount of loss reported during the period pertaining to product liability.", "label": "Product Liability Accrual, Period Expense", "negatedTerseLabel": "Recall-related matters", "terseLabel": "Recall charges" } } }, "localname": "ProductLiabilityAccrualPeriodExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited", "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited", "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Property, Plant and Equipment [Abstract]", "terseLabel": "Property, plant and equipment:" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r32", "r155" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "totalLabel": "Total property, plant and equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r12", "r13", "r157", "r302" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "totalLabel": "Property, plant and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Information by item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Axis]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Axis]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Domain]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income [Domain]" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies item reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Member]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of information about items reclassified out of accumulated other comprehensive income (loss).", "label": "Reclassification out of Accumulated Other Comprehensive Income [Table Text Block]", "terseLabel": "Reclassification out of Accumulated Other Comprehensive Income" } } }, "localname": "ReclassificationOutOfAccumulatedOtherComprehensiveIncomeTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r87" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments of Long-term Debt", "negatedTerseLabel": "Payments on long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r200", "r312" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research, development and engineering expenses" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestructuringCharges": { "auth_ref": [ "r92", "r160", "r162", "r163" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Excludes expenses related to a discontinued operation or an asset retirement obligation.", "label": "Restructuring Charges", "negatedTerseLabel": "Restructuring-related charges" } } }, "localname": "RestructuringCharges", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r25", "r181", "r300" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "verboseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r103", "r188" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue from Contract with Customer [Text Block]", "terseLabel": "Revenue Recognition" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/RevenueRecognition" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevenueRecognitionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Revenue Recognition [Abstract]" } } }, "localname": "RevenueRecognitionAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r76", "r114", "r115", "r121" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": 1.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Net sales" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited", "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails", "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]", "terseLabel": "Revolving Credit Facility" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "auth_ref": [ "r65" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss).", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "terseLabel": "Schedule of Accumulated Other Comprehensive Income (Loss)" } } }, "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r207", "r208" ], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails", "http://www.stryker.com/role/AcquisitionsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r207", "r208" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "terseLabel": "Schedule of Business Acquisitions, by Acquisition" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDebtTableTextBlock": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.", "label": "Schedule of Debt [Table Text Block]", "terseLabel": "Schedule of Long-term Debt Instruments" } } }, "localname": "ScheduleOfDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock": { "auth_ref": [ "r241" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the location and fair value amounts of derivative instruments (and nonderivative instruments that are designated and qualify as hedging instruments) reported in the statement of financial position.", "label": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value [Table Text Block]", "terseLabel": "Schedule of Derivative Instruments in Statement of Financial Position, Fair Value" } } }, "localname": "ScheduleOfDerivativeInstrumentsInStatementOfFinancialPositionFairValueTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock": { "auth_ref": [ "r237" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of derivative instruments (including nonderivative instruments that are designated and qualify as hedging instruments) of (a) the location and amount of gains and losses reported in the statement of financial performance and (b) the location and fair value amounts of the instruments reported in the statement of financial position.", "label": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]", "terseLabel": "Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location" } } }, "localname": "ScheduleOfDerivativesInstrumentsStatementsOfFinancialPerformanceAndFinancialPositionLocationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DerivativeInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": { "auth_ref": [ "r253" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]", "terseLabel": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis" } } }, "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r113", "r117", "r118", "r119", "r142" ], "lang": { "en-US": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table]", "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r113", "r117", "r118", "r119", "r142" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]", "terseLabel": "Sales and Other Financial Information by Business Segment" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/SegmentInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r149" ], "lang": { "en-US": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segments [Domain]", "terseLabel": "Segments [Domain]" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails", "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r126" ], "lang": { "en-US": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Segment Information" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/SegmentInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "auth_ref": [ "r79", "r136" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": 2.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.", "label": "Selling, General and Administrative Expense", "verboseLabel": "Selling, general and administrative expenses" } } }, "localname": "SellingGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r91" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.", "label": "Share-based Compensation", "terseLabel": "Share-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfCashFlowsUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermBorrowings": { "auth_ref": [ "r15", "r285", "r298" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Reflects the total carrying amount as of the balance sheet date of debt having initial terms less than one year or the normal operating cycle, if longer.", "label": "Short-term Debt", "verboseLabel": "Commercial paper" } } }, "localname": "ShortTermBorrowings", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r0", "r117", "r142", "r159", "r161", "r164", "r305" ], "lang": { "en-US": { "role": { "documentation": "Information by business segments.", "label": "Segments [Axis]", "terseLabel": "Segments [Axis]", "verboseLabel": "Business Segments [Axis]" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/RevenueRecognitionDisaggregatedSalesAnalysisDetails", "http://www.stryker.com/role/SegmentInformationSalesAndOtherFinancialInformationByBusinessSegmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r20", "r21", "r22", "r180" ], "lang": { "en-US": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]", "terseLabel": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r45", "r180" ], "lang": { "en-US": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]", "terseLabel": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AccumulatedOtherComprehensiveLossIncomeAociDetails", "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/AcquisitionsAllocationOfPreliminaryPurchasePriceToAcquiredNetAssetsDetails", "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited", "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails", "http://www.stryker.com/role/DerivativeInstrumentsNarrativeDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r21", "r22", "r180", "r181" ], "lang": { "en-US": { "role": { "documentation": "Number of shares (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of any shares forfeited. Shares issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.", "label": "Stock Issued During Period, Shares, Share-based Compensation, Net of Forfeitures", "verboseLabel": "Issuance of common stock under stock option and benefit plans (in shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r21", "r22", "r181", "r195", "r196" ], "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Value of stock (or other type of equity) issued during the period as a result of any equity-based compensation plan other than an employee stock ownership plan (ESOP), net of stock value of such awards forfeited. Stock issued could result from the issuance of restricted stock, the exercise of stock options, stock issued under employee stock purchase plans, and/or other employee benefit plans.", "label": "Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures", "verboseLabel": "Issuance of common stock under stock compensation and benefit plans" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "auth_ref": [ "r21", "r22", "r180", "r181" ], "lang": { "en-US": { "role": { "documentation": "Number of shares that have been repurchased and retired during the period.", "label": "Stock Repurchased and Retired During Period, Shares", "negatedTerseLabel": "Repurchase of common stock (in shares)" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "auth_ref": [ "r21", "r22", "r180", "r181" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital).", "label": "Stock Repurchased and Retired During Period, Value", "negatedLabel": "Repurchase of common stock" } } }, "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders' equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r221", "r222", "r225" ], "calculation": { "http://www.stryker.com/role/ConsolidatedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total shareholders' equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedBalanceSheets", "http://www.stryker.com/role/ConsolidatedStatementsOfShareholdersEquityUnaudited" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [], "lang": { "en-US": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r276" ], "lang": { "en-US": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r276" ], "lang": { "en-US": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TradingSecuritiesDebt": { "auth_ref": [ "r128", "r129" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in net income (trading).", "label": "Debt Securities, Trading", "terseLabel": "Trading marketable securities" } } }, "localname": "TradingSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_USGovernmentAgenciesDebtSecuritiesMember": { "auth_ref": [ "r189", "r289" ], "lang": { "en-US": { "role": { "documentation": "Debentures, notes, and other debt securities issued by US government agencies, for example, but not limited to, Government National Mortgage Association (GNMA or Ginnie Mae). Excludes US treasury securities and debt issued by government-sponsored Enterprises (GSEs), for example, but is not limited to, Federal Home Loan Mortgage Corporation (FHLMC or Freddie Mac), Federal National Mortgage Association (FNMA or Fannie Mae), and the Federal Home Loan Bank (FHLB).", "label": "US Government Agencies Debt Securities [Member]", "terseLabel": "United States agency debt securities" } } }, "localname": "USGovernmentAgenciesDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_USTreasurySecuritiesMember": { "auth_ref": [ "r189", "r192", "r289" ], "lang": { "en-US": { "role": { "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).", "label": "US Treasury Securities [Member]", "terseLabel": "United States Treasury debt securities" } } }, "localname": "USTreasurySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/FairValueMeasurementsValuationOfFinancialInstrumentsByPricingCategoriesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_UnamortizedDebtIssuanceExpense": { "auth_ref": [ "r34" ], "crdr": "debit", "lang": { "en-US": { "role": { "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.", "label": "Unamortized Debt Issuance Expense", "terseLabel": "Unamortized debt issuance costs" } } }, "localname": "UnamortizedDebtIssuanceExpense", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebt": { "auth_ref": [ "r18", "r287", "r299" ], "calculation": { "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLongTermDebt", "weight": 1.0 }, "http://www.stryker.com/role/DebtAndCreditFacilitiesDetailsCalc2": { "order": 1.0, "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-US": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Unsecured Debt", "terseLabel": "Unsecured Debt" } } }, "localname": "UnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/DebtAndCreditFacilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustment": { "auth_ref": [ "r110" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": 2.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "The sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.", "label": "Weighted Average Number Diluted Shares Outstanding Adjustment", "terseLabel": "Effect of dilutive employee stock compensation" } } }, "localname": "WeightedAverageNumberDilutedSharesOutstandingAdjustment", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r106", "r110" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-US": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "totalLabel": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-US": { "role": { "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]", "terseLabel": "Weighted-average shares outstanding (in millions):" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r105", "r110" ], "calculation": { "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited": { "order": 1.0, "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0 } }, "lang": { "en-US": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2018-01-31", "presentation": [ "http://www.stryker.com/role/ConsolidatedStatementsOfEarningsUnaudited" ], "xbrltype": "sharesItemType" } }, "unitCount": 7 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r1": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "http://asc.fasb.org/topic&trid=2122149" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6911-107765" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(n)(2))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690" }, "r103": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1448-109256" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1505-109256" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1252-109256" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=SL5780133-109256" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109260490&loc=d3e1337-109256" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6935-107765" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=109256448&loc=d3e4984-109258" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8721-108599" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8736-108599" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8813-108599" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8906-108599" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8924-108599" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8933-108599" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e8475-108599" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9031-108599" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=115929826&loc=d3e9038-108599" }, "r126": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "http://asc.fasb.org/topic&trid=2134510" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=84173941&loc=d3e5074-111524" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=109979856&loc=d3e26610-111562" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=109979856&loc=d3e26610-111562" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=109979856&loc=d3e26853-111562" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27161-111563" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27198-111563" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27232-111563" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=d3e27340-111563" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "8B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "http://asc.fasb.org/extlink&oid=82897076&loc=SL6284393-111563" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68048583&loc=d3e3636-108311" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=68049868&loc=d3e3927-108312" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.BB)", "Topic": "330", "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=77989000&loc=SL49117168-202975" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=108376223&loc=d3e13816-109267" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19)(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.3)", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(b))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14326-108349" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14615-108349" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14394-108349" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14435-108349" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14453-108349" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14472-108349" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14557-108349" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=82911808&loc=d3e14557-108349" }, "r175": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=115931803&loc=d3e12021-110248" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "460", "URI": "http://asc.fasb.org/extlink&oid=115931803&loc=d3e12053-110248" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "12A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=99376301&loc=SL5988623-112600" }, "r179": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "http://asc.fasb.org/topic&trid=2208564" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=82913815&loc=SL49130531-203044" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=82913815&loc=SL49130532-203044" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130545-203045" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=109196051&loc=SL49130549-203045" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=108792157&loc=SL49130690-203046-203046" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "http://asc.fasb.org/extlink&oid=108792157&loc=SL49130690-203046-203046" }, "r188": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "http://asc.fasb.org/topic&trid=49130388" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(24))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=108410482&loc=d3e1928-114920" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=112275985&loc=d3e4179-114921" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=79507207&loc=d3e4534-113899" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5047-113901" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109197908&loc=d3e5070-113901" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109196918&loc=d3e11149-113907" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109196918&loc=d3e11178-113907" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=109196918&loc=d3e11374-113907" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32698-109319" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e39076-109324" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=109238882&loc=d3e38679-109324" }, "r206": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "http://asc.fasb.org/topic&trid=2144680" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "37", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=108330185&loc=d3e2207-128464" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=84161108&loc=d3e4845-128472" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5263-128473" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5333-128473" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "38", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=77890550&loc=d3e5504-128473" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=109124213&loc=d3e6578-128477" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=109124213&loc=d3e6613-128477" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "http://asc.fasb.org/topic&trid=2303972" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568447-111683" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4568740-111683" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c),(3)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=84234705&loc=SL4590271-111686" }, "r226": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=6945355&loc=d3e41228-113958" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579240-113959" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5579245-113959" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5580258-113959" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(ii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)(iii)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41620-113959" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41638-113959" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5618551-113959" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a),(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624163-113959" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "4C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624171-113959" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624177-113959" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "4E", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=SL5624181-113959" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41641-113959" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109980867&loc=d3e41678-113959" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "182", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109975725&loc=SL5629052-113961" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "25", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=109977999&loc=d3e76258-113986" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=112277219&loc=d3e80748-113994" }, "r252": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "815", "URI": "http://asc.fasb.org/topic&trid=2229140" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19190-110258" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19207-110258" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=SL7498348-110258" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=99377789&loc=d3e19279-110258" }, "r262": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "820", "URI": "http://asc.fasb.org/topic&trid=2155941" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=109250915&loc=d3e13433-108611" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30700-110894" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b,c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=109240241&loc=d3e32211-110900" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888419&loc=SL77918627-209977" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888426&loc=SL77918686-209980" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "http://asc.fasb.org/extlink&oid=77888399&loc=SL77918982-209971" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=d3e107207-111719" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=d3e107207-111719" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=d3e107207-111719" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=d3e107207-111719" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "4D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=109247956&loc=SL51823488-111719" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13)(2))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(6)(a)(1))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=114873765&loc=SL114874048-224260" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(a)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=75019621&loc=d3e62586-112803" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "405", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=50488274&loc=d3e64164-112818" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(15)(b)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16)(a)(1))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6)(a)(5))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=114873790&loc=SL114874131-224263" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=99384497&loc=SL65671331-158438" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12(2)(i))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611133-123010" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12C(1)(a))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611225-123010" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13(1))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611282-123010" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=50485924&loc=d3e611379-123010" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6589523&loc=d3e617274-123014" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "http://asc.fasb.org/extlink&oid=6590653&loc=d3e638233-123024" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r313": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r314": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r315": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-13" }, "r316": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1-" }, "r317": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r318": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.13)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.14)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.17)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.4)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.6(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6676-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226000-175313" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a),(b),(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i),(j),(k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6787-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(i-k)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "10A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669646-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e637-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e640-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e681-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669686-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "17B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL34724394-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669619-108580" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6801-107765" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=SL7669625-108580" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=114867106&loc=d3e557-108580" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=109228884&loc=d3e1436-108581" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(21))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6812-107765" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=115205541&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "220", "URI": "http://asc.fasb.org/topic&trid=2134417" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3213-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3255-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3291-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3521-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=82887183&loc=d3e6904-107765" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3536-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3602-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3044-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=109223946&loc=d3e3098-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=98513485&loc=SL98516268-108586" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e),(f))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(h)(1)(i))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690" } }, "version": "2.1" } XML 53 R7.htm IDEA: XBRL DOCUMENT v3.20.1
    Consolidated Statements Of Cash Flows (Unaudited) - USD ($)
    $ in Millions
    		 3 Months Ended
    Mar. 31, 2020
    Mar. 31, 2019
    Operating activities    
    Net earnings $ 493 $ 412
    Adjustments to reconcile net earnings to net cash provided by operating activities:    
    Depreciation 80 76
    Amortization of intangible assets 118 114
    Share-based compensation 56 35
    Recall charges (6) 13
    Sale of inventory stepped-up to fair value at acquisition 6 24
    Changes in operating assets and liabilities:    
    Accounts receivable 204 50
    Inventories (122) (139)
    Accounts payable 63 (12)
    Accrued expenses and other liabilities (550) (166)
    Recall-related payments (4) (20)
    Income taxes 84 9
    Other, net 169 (83)
    Net cash provided by operating activities 591 313
    Investing activities    
    Acquisitions, net of cash acquired (23) (180)
    Purchases of marketable securities (8) (20)
    Proceeds from sales of marketable securities 12 19
    Purchases of property, plant and equipment (144) (122)
    Net cash used in investing activities (163) (303)
    Financing activities    
    Proceeds (payments) on short-term borrowings, net 4 (12)
    Payments on long-term debt (500) (1,341)
    Dividends paid (215) (195)
    Repurchases of common stock 0 (307)
    Cash paid for taxes from withheld shares (56) (97)
    Other financing, net (1) 5
    Net cash provided by (used in) financing activities (768) (1,947)
    Effect of exchange rate changes on cash and cash equivalents (33) (5)
    Change in cash and cash equivalents (373) (1,942)
    Cash and cash equivalents at beginning of period 4,337 3,616
    Cash and cash equivalents at end of period $ 3,964 $ 1,674
    XML 55 R17.htm IDEA: XBRL DOCUMENT v3.20.1
    Segment Information
    		 3 Months Ended
    Mar. 31, 2020
    Segment Reporting [Abstract]  
    Segment Information SEGMENT INFORMATION
     
    Three Months
     
    2020
    2019
    Orthopaedics
    $
    1,222

    $
    1,250

    MedSurg
    1,622

    1,527

    Neurotechnology and Spine
    744

    739

    Net sales
    $
    3,588

    $
    3,516

    Orthopaedics
    $
    392

    $
    437

    MedSurg
    401

    377

    Neurotechnology and Spine
    206

    199

    Segment operating income
    $
    999

    $
    1,013

    Items not allocated to segments:
     
     
    Corporate and other
    (137
    )
    (132
    )
    Acquisition and integration-related charges
    (37
    )
    (138
    )
    Amortization of intangible assets
    (118
    )
    (114
    )
    Restructuring-related charges
    (54
    )
    (56
    )
    Medical device regulations
    (24
    )
    (7
    )
    Recall-related matters
    6

    (13
    )
    Regulatory and legal matters
    —

    (25
    )
    Consolidated operating income
    $
    635

    $
    528


    There were no significant changes to total assets by segment from information provided in our Annual Report on Form 10-K for 2019.
    XML 56 R13.htm IDEA: XBRL DOCUMENT v3.20.1
    Contingencies and Commitments
    		 3 Months Ended
    Mar. 31, 2020
    Commitments and Contingencies Disclosure [Abstract]  
    Contingencies and Commitments CONTINGENCIES AND COMMITMENTS
    We are involved in various ongoing proceedings, legal actions and claims arising in the normal course of business, including proceedings related to product, labor, intellectual property and other matters that are more fully described below. The outcomes of these matters will generally not be known for prolonged periods of time. In certain of the legal proceedings, the claimants seek damages as well as other compensatory and equitable relief that could result in the payment of significant claims and settlements and/or the imposition of injunctions or other equitable relief. For legal matters for which management had sufficient information to reasonably estimate our future obligations, a liability representing management's best estimate of the probable loss, or the minimum of the range of probable losses when a best estimate within the range is not known, is recorded. The estimates are based on consultation with legal counsel, previous settlement experience and settlement strategies. If actual outcomes are less favorable than those estimated by management, additional expense may be incurred, which could unfavorably affect future operating results. We are self-insured for product liability claims and expenses. The ultimate cost to us with respect to product liability claims could be materially different than the amount of the current estimates and accruals and could have a material adverse effect on our financial position, results of operations and cash flows.
    Recall Matters
    In June 2012 we voluntarily recalled our Rejuvenate and ABG II Modular-Neck hip stems and terminated global distribution of these hip products. Product liability lawsuits relating to this voluntary recall have been filed against us. In November 2014 we entered into a settlement agreement to compensate eligible United States patients who had revision surgery prior to November 3, 2014 and in December 2016 the settlement program was extended to patients who had revision surgery prior to December 19, 2016. We continue to offer support for recall-related care and reimburse patients who are not eligible to enroll in the settlement program for testing and treatment services, including any necessary revision surgeries. In addition, there are remaining lawsuits that we will continue to defend against.
    In August 2016 and May 2018 we voluntarily recalled certain lot-specific sizes and offsets of LFIT Anatomic CoCr V40 Femoral Heads. Product liability lawsuits and claims relating to this voluntary recall have been filed against us. In November 2018 we entered into a settlement agreement to resolve a significant number of claims and lawsuits related to the recalls. The specific terms of the settlement agreement, including the financial terms, are confidential.
    We have incurred, and expect to incur in the future, costs associated with the defense and settlement of these matters. Based on the
    information that has been received, we have estimated the remaining range of probable loss related to these matters globally to be approximately $290 to $535. We have recorded charges to earnings representing the minimum of the range of probable loss. The final outcomes of these matters are dependent on many factors that are difficult to predict. Accordingly, the ultimate cost related to these matters globally may be materially different than the amount of our current estimate and accruals and could have a material adverse effect on our results of operations and cash flows.
    Leases
    March
     
    December
    2020
     
    2019
    Right-of-use assets
    $
    393

     
    $
    384

    Lease liabilities, current
    $
    89

     
    $
    86

    Lease liabilities, non-current
    $
    306

     
    $
    301

     
     
     
     
    Other information
     
     
     
    Weighted-average remaining lease term
    5.9 years

     
    6.2 years

    Weighted-average discount rate
    3.09
    %
     
    3.34
    %
     
    Three Months
     
    2020
     
    2019
    Operating lease cost
    $
    36

     
    34
    XML 57 R38.htm IDEA: XBRL DOCUMENT v3.20.1
    Acquisitions (Narrative) (Details)
    $ / shares in Units, $ in Millions
    		 1 Months Ended 3 Months Ended
    Dec. 13, 2019
    € / shares
    Dec. 13, 2019
    $ / shares
    Nov. 30, 2019
    USD ($)
    $ / shares
    Oct. 31, 2019
    USD ($)
    Mar. 31, 2019
    USD ($)
    Mar. 31, 2020
    USD ($)
    Mar. 31, 2019
    USD ($)
    Business Acquisition [Line Items]              
    Aggregate purchase price of acquisitions           $ 23 $ 308
    Acquisitions, net of cash acquired           $ 23 $ 180
    Mobius              
    Business Acquisition [Line Items]              
    Aggregate purchase price of acquisitions       $ 360      
    Future milestone payments       $ 130      
    OrthoSpace, Ltd.              
    Business Acquisition [Line Items]              
    Aggregate purchase price of acquisitions         $ 110    
    Future milestone payments         $ 110    
    Wright              
    Business Acquisition [Line Items]              
    Consideration transferred (in dollars per share) | $ / shares   $ 30.75 $ 30.75        
    Acquisitions, net of cash acquired     $ 5,400        
    Par value of ordinary shares of acquiree (in dollars per share) | € / shares € 0.03            
    XML 58 R30.htm IDEA: XBRL DOCUMENT v3.20.1
    Derivative Instruments (Forward Currency Exchange Contracts) (Details)
    € in Millions, $ in Millions
    		 3 Months Ended 12 Months Ended
    Mar. 31, 2020
    USD ($)
    Dec. 31, 2019
    EUR (€)
    Dec. 31, 2019
    USD ($)
    Jul. 31, 2019
    USD ($)
    Nov. 30, 2018
    EUR (€)
    Foreign Exchange Contract          
    Derivative [Line Items]          
    Notional Amount $ 7,206   $ 8,088    
    Maximum term in days 1555 days 1646 days      
    Derivative, Fair Value, Net $ 211   203    
    Foreign Exchange Contract | Other current assets          
    Derivative [Line Items]          
    Derivative assets 130   185    
    Foreign Exchange Contract | Other noncurrent assets          
    Derivative [Line Items]          
    Derivative assets 110   41    
    Foreign Exchange Contract | Other current liabilities          
    Derivative [Line Items]          
    Derivative liabilities (29)   (21)    
    Foreign Exchange Contract | Other noncurrent liabilities          
    Derivative [Line Items]          
    Derivative liabilities 0   (2)    
    Foreign Exchange Contract | Net Investment          
    Derivative [Line Items]          
    Notional Amount 837 € 2,400 1,113 $ 1,000 € 2,250
    Derivative, Fair Value, Net 33   40    
    Foreign Exchange Contract | Net Investment | Other current assets          
    Derivative [Line Items]          
    Derivative assets 30   0    
    Foreign Exchange Contract | Net Investment | Other noncurrent assets          
    Derivative [Line Items]          
    Derivative assets 5   40    
    Foreign Exchange Contract | Net Investment | Other current liabilities          
    Derivative [Line Items]          
    Derivative liabilities (2)   0    
    Foreign Exchange Contract | Net Investment | Other noncurrent liabilities          
    Derivative [Line Items]          
    Derivative liabilities 0   0    
    Foreign Exchange Contract | Non-Designated          
    Derivative [Line Items]          
    Notional Amount 5,275   6,174    
    Derivative, Fair Value, Net 73   169    
    Foreign Exchange Contract | Non-Designated | Other current assets          
    Derivative [Line Items]          
    Derivative assets 100   180    
    Foreign Exchange Contract | Non-Designated | Other noncurrent assets          
    Derivative [Line Items]          
    Derivative assets 0   0    
    Foreign Exchange Contract | Non-Designated | Other current liabilities          
    Derivative [Line Items]          
    Derivative liabilities 27   11    
    Foreign Exchange Contract | Non-Designated | Other noncurrent liabilities          
    Derivative [Line Items]          
    Derivative liabilities 0   0    
    Cash Flow Hedging [Member] | Foreign Exchange Contract | Net Investment          
    Derivative [Line Items]          
    Notional Amount     801    
    Derivative, Fair Value, Net     (6)    
    Cash Flow Hedging [Member] | Foreign Exchange Contract | Net Investment | Other current assets          
    Derivative [Line Items]          
    Derivative assets     5    
    Cash Flow Hedging [Member] | Foreign Exchange Contract | Net Investment | Other noncurrent assets          
    Derivative [Line Items]          
    Derivative assets     1    
    Cash Flow Hedging [Member] | Foreign Exchange Contract | Net Investment | Other current liabilities          
    Derivative [Line Items]          
    Derivative liabilities     (10)    
    Cash Flow Hedging [Member] | Foreign Exchange Contract | Net Investment | Other noncurrent liabilities          
    Derivative [Line Items]          
    Derivative liabilities     $ 2    
    Net Investment Hedging [Member] | Net Investment          
    Derivative [Line Items]          
    Notional Amount 1,094        
    Derivative, Fair Value, Net 105        
    Net Investment Hedging [Member] | Net Investment | Other current assets          
    Derivative [Line Items]          
    Derivative assets 0        
    Net Investment Hedging [Member] | Net Investment | Other noncurrent assets          
    Derivative [Line Items]          
    Derivative assets 105        
    Net Investment Hedging [Member] | Net Investment | Other current liabilities          
    Derivative [Line Items]          
    Derivative liabilities 0        
    Net Investment Hedging [Member] | Net Investment | Other noncurrent liabilities          
    Derivative [Line Items]          
    Derivative liabilities $ 0        
    XML 59 R34.htm IDEA: XBRL DOCUMENT v3.20.1
    Fair Value Measurements (Assets and Liabilities Measured At Fair Value On A Recurring Basis Using Unobservable Inputs (Level 3)) (Details) - USD ($)
    $ in Millions
    Mar. 31, 2020
    Dec. 31, 2019
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Due in one year or less $ 46 $ 50
    Due after one year through three years 38 38
    Fair Value, Inputs, Level 2 | Interest Rate Swap    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Foreign currency exchange forward contracts 62 0
    Fair Value, Inputs, Level 2 | Foreign Exchange Contract    
    Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
    Foreign currency exchange forward contracts $ 29 $ 23
    EXCEL 60 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 61 R2.htm IDEA: XBRL DOCUMENT v3.20.1
    Consolidated Statements Of Earnings (Unaudited) - USD ($)
    shares in Millions, $ in Millions
    		 3 Months Ended
    Mar. 31, 2020
    Mar. 31, 2019
    Income Statement [Abstract]    
    Net sales $ 3,588 $ 3,516
    Cost of sales 1,257 1,233
    Gross profit 2,331 2,283
    Research, development and engineering expenses 254 225
    Selling, general and administrative expenses 1,330 1,403
    Recall charges (6) 13
    Amortization of intangible assets 118 114
    Total operating expenses 1,696 1,755
    Operating income 635 528
    Other income (expense), net (45) (48)
    Earnings before income taxes 590 480
    Income taxes 97 68
    Net earnings $ 493 $ 412
    Net earnings per share of common stock:    
    Basic $ 1.32 $ 1.10
    Diluted $ 1.30 $ 1.09
    Weighted-average shares outstanding (in millions):    
    Basic 374.8 373.3
    Effect of dilutive employee stock compensation 4.9 6.0
    Diluted 379.7 379.3
    Cash dividends declared per share of common stock (in dollars per share) $ 0.575 $ 0.52

    XML 62 R6.htm IDEA: XBRL DOCUMENT v3.20.1
    Consolidated Statements Of Shareholders' Equity (Unaudited) - USD ($)
    shares in Millions, $ in Millions
    Total
    Total Stryker shareholders' equity
    Common Stock
    Additional Paid-In Capital
    Retained Earnings
    Accumulated Other Comprehensive Income (Loss)
    Non-controlling interest
    Beginning balance at Dec. 31, 2018     $ 37 $ 1,559 $ 10,765 $ (631)  
    Beginning balance (in shares) at Dec. 31, 2018     374.4        
    Increase (Decrease) in Stockholders' Equity [Roll Forward]              
    Issuance of common stock under stock compensation and benefit plans       (48)      
    Issuance of common stock under stock option and benefit plans (in shares)     1.3        
    Repurchase of common stock       (8) (299)    
    Repurchase of common stock (in shares)     (1.9)        
    Share-based compensation       35      
    Net earnings (loss) $ 412       412    
    Cash dividends declared         (195)    
    Other comprehensive income (loss) 66         66  
    Ending balance at Mar. 31, 2019 11,693 $ 11,693 $ 37 1,538 10,683 (565) $ 0
    Ending balance (in shares) at Mar. 31, 2019     373.8        
    Beginning balance at Dec. 31, 2019 12,807   $ 37 1,628 11,748 (606)  
    Beginning balance (in shares) at Dec. 31, 2019     374.5        
    Increase (Decrease) in Stockholders' Equity [Roll Forward]              
    Issuance of common stock under stock compensation and benefit plans     $ 1 (8)      
    Issuance of common stock under stock option and benefit plans (in shares)     0.9        
    Repurchase of common stock (in shares)     0.0        
    Share-based compensation       56      
    Net earnings (loss) 493       493    
    Cash dividends declared         (217)    
    Other comprehensive income (loss) (17)         (17)  
    Ending balance at Mar. 31, 2020 $ 13,115 $ 13,115 $ 38 $ 1,676 $ 12,024 $ (623) $ 0
    Ending balance (in shares) at Mar. 31, 2020     375.4        
    XML 63 R40.htm IDEA: XBRL DOCUMENT v3.20.1
    Acquisitions (Future Amortization Expense) (Details)
    $ in Millions
    Mar. 31, 2020
    USD ($)
    Business Combinations [Abstract]  
    Remainder of 2020 $ 341
    2021 440
    2022 438
    2023 417
    2024 $ 386
    XML 64 R25.htm IDEA: XBRL DOCUMENT v3.20.1
    Debt and Credit Facilities (Tables)
    		 3 Months Ended
    Mar. 31, 2020
    Long-term Debt, Unclassified [Abstract]  
    Schedule of Long-term Debt Instruments
    Summary of Total Debt
    March 2020
     
    December 2019
    Senior unsecured notes:
     
     
     
     
    Rate
     
    Due
     
     
     
     
    4.375%
     
    January 15, 2020
    $
    —

     
    $
    500

     
    Variable
     
    November 30, 2020
    328

     
    333

     
    2.625%
     
    March 15, 2021
    749

     
    749

     
    1.125%
     
    November 30, 2023
    599

     
    609

     
    3.375%
     
    May 15, 2024
    588

     
    587

     
    0.250%
     
    December 3, 2024
    923

     
    938

     
    3.375%
     
    November 1, 2025
    746

     
    746

     
    3.500%
     
    March 15, 2026
    991

     
    991

     
    2.125%
     
    November 30, 2027
    815

     
    829

     
    3.650%
     
    March 7, 2028
    596

     
    596

     
    0.750%
     
    March 1, 2029
    869

     
    884

     
    2.625%
     
    November 30, 2030
    700

     
    712

     
    1.000%
     
    December 3, 2031
    809

     
    823

     
    4.100%
     
    April 1, 2043
    392

     
    391

     
    4.375%
     
    May 15, 2044
    395

     
    395

     
    4.625%
     
    March 15, 2046
    981

     
    981

    Other
    26

     
    26

    Total debt
    $
    10,507

     
    $
    11,090

    Less current maturities of debt
    1,103

     
    859

    Total long-term debt
    $
    9,404

     
    $
    10,231

     
     
     
     

     
    March 2020
     
    December 2019
    Unamortized debt issuance costs
    $
    56

     
    $
    58

    Available secured borrowing capacity
    $
    1,403

     
    $
    1,403

    Fair value of senior unsecured notes
    $
    10,904

     
    $
    11,910
    XML 65 R21.htm IDEA: XBRL DOCUMENT v3.20.1
    Derivative Instruments (Tables)
    		 3 Months Ended
    Mar. 31, 2020
    Derivative Instruments and Hedging Activities Disclosure [Abstract]  
    Schedule of Derivative Instruments in Statement of Financial Position, Fair Value
    March 2020
    Cash Flow
    Net Investment
    Non-Designated
    Total
    Gross notional amount
    $
    837

    $
    1,094

    $
    5,275

    $
    7,206

    Maximum term in days
     
     
     
    1555

    Fair value:
     
     
     
     
    Other current assets
    $
    30

    $
    —

    $
    100

    $
    130

    Other noncurrent assets
    5

    105

    —

    110

    Other current liabilities
    (2
    )
    —

    (27
    )
    (29
    )
    Other noncurrent liabilities
    —

    —

    —

    —

    Total fair value
    $
    33

    $
    105

    $
    73

    $
    211


    December 2019
    Cash Flow
    Net Investment
    Non-Designated
    Total
    Gross notional amount
    $
    801

    $
    1,113

    $
    6,174

    $
    8,088

    Maximum term in days
     
     
     
    1646

    Fair value:
     
     
     
     
    Other current assets
    $
    5

    $
    —

    $
    180

    $
    185

    Other noncurrent assets
    1

    40

    —

    41

    Other current liabilities
    (10
    )
    —

    (11
    )
    (21
    )
    Other noncurrent liabilities
    (2
    )
    —

    —

    (2
    )
    Total fair value
    $
    (6
    )
    $
    40

    $
    169

    $
    203
    Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location
     
     
    Three Months
    Derivative instrument
    Recorded in:
    2020
    2019
    Cash Flow
    Cost of sales
    $
    (3
    )
    $
    2

    Net Investment
    Other income (expense), net
    7

    —

    Non-Designated
    Other income (expense), net
    (7
    )
    (2
    )
     
    Total
    $
    (3
    )
    $
    —
    XML 66 R29.htm IDEA: XBRL DOCUMENT v3.20.1
    Accumulated Other Comprehensive (Loss) Income (AOCI) (Details) - USD ($)
    $ in Millions
    		 3 Months Ended
    Mar. 31, 2020
    Mar. 31, 2019
    AOCI Attributable to Parent, Net of Tax [Roll Forward]    
    Accumulated Other Comprehensive Income (Loss), Net of Tax at beginning of period $ (606) $ (631)
    OCI 11 70
    Income taxes (26) (2)
    Cost of sales 1,257 1,233
    Other (income) expense (45) (48)
    Income taxes (97) (68)
    Net OCI (17) 66
    Accumulated Other Comprehensive Income (Loss), Net of Tax at end of period (623) (565)
    Reclassification out of Accumulated Other Comprehensive Income    
    AOCI Attributable to Parent, Net of Tax [Roll Forward]    
    Cost of sales 3 (2)
    Other (income) expense (6) 1
    Income taxes 1 (1)
    Net OCI (17) 66
    Marketable Securities    
    AOCI Attributable to Parent, Net of Tax [Roll Forward]    
    Accumulated Other Comprehensive Income (Loss), Net of Tax at beginning of period (3) (4)
    OCI 1 1
    Income taxes 0 0
    Accumulated Other Comprehensive Income (Loss), Net of Tax at end of period (3) (3)
    Marketable Securities | Reclassification out of Accumulated Other Comprehensive Income    
    AOCI Attributable to Parent, Net of Tax [Roll Forward]    
    Cost of sales 0 0
    Other (income) expense (1) 0
    Income taxes 0 0
    Net OCI 0 1
    Pension Plans    
    AOCI Attributable to Parent, Net of Tax [Roll Forward]    
    Accumulated Other Comprehensive Income (Loss), Net of Tax at beginning of period (179) (137)
    OCI (6) (6)
    Income taxes 0 1
    Accumulated Other Comprehensive Income (Loss), Net of Tax at end of period (183) (141)
    Pension Plans | Reclassification out of Accumulated Other Comprehensive Income    
    AOCI Attributable to Parent, Net of Tax [Roll Forward]    
    Cost of sales 0 0
    Other (income) expense 3 1
    Income taxes (1) 0
    Net OCI (4) (4)
    Hedges    
    AOCI Attributable to Parent, Net of Tax [Roll Forward]    
    Accumulated Other Comprehensive Income (Loss), Net of Tax at beginning of period 47 50
    OCI (39) (19)
    Income taxes 11 6
    Accumulated Other Comprehensive Income (Loss), Net of Tax at end of period 21 34
    Hedges | Reclassification out of Accumulated Other Comprehensive Income    
    AOCI Attributable to Parent, Net of Tax [Roll Forward]    
    Cost of sales 3 (2)
    Other (income) expense (1) 0
    Income taxes 0 (1)
    Net OCI (26) (16)
    Financial Statement Translation    
    AOCI Attributable to Parent, Net of Tax [Roll Forward]    
    Accumulated Other Comprehensive Income (Loss), Net of Tax at beginning of period (471) (540)
    OCI 55 94
    Income taxes (37) (9)
    Accumulated Other Comprehensive Income (Loss), Net of Tax at end of period (458) (455)
    Financial Statement Translation | Reclassification out of Accumulated Other Comprehensive Income    
    AOCI Attributable to Parent, Net of Tax [Roll Forward]    
    Cost of sales 0 0
    Other (income) expense (7) 0
    Income taxes 2 0
    Net OCI $ 13 $ 85

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